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The papers included in this thesis examine the host–parasite relationship in small and 
large animals following experimental challenges with Neospora caninum. This 
apicomplexan parasite is a major cause of abortion and reproductive losses in cattle 
worldwide. Economic and welfare issues make the development of a vaccine against the 
transplacental transmission of Neospora highly desirable.  
This thesis evaluates the host-parasite interactions in a non-pregnant mouse model 
examining whether the actively multiplying stage of the parasite (tachyzoite) could be 
attenuated through prolonged in vitro cultivation (passage) and used as a live vaccine. 
We show that continued maintenance of tachyzoites in tissue culture produced 
significantly reduced levels of morbidity and mortality in the mice following challenge, 
compared to mice receiving virulent parasites. Inoculation with a sub-lethal dose of 
tachyzoites was shown to protect against a subsequent lethal challenge of virulent 
parasites. Mice showing higher levels of cell mediated immunity (CMI) (antigen-
specific splenocyte proliferation and interferon-γ (IFN-γ) production) had lower parasite 
burdens compared to mice with less pronounced CMI responses. Combined, these works 
show that it is possible to protect against a lethal challenge using attenuated tachyzoites 
and that a strong T-helper Type-1 CMI response is involved in protection and in 
reducing clinical disease severity.  
As the most commonly known route of infection with N. caninum is transplacental, from 
dam to foetus, we also wanted to examine the host-parasite relationship in pregnant 
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cattle. This was done through the serial examination of the maternal and foetal immune 
responses of experimentally challenged cattle under controlled conditions at different 
stages throughout pregnancy. These works show the importance of the timing, location 
and magnitude of multiple components of the host immune response in determining 
foetal survival and also whether vertical transmission occurs. We show that both the 
maternal and foetal immune responses are critical in determining the clinical outcome of 
infection. A strong maternal CMI response was shown to aid foetal survival by reducing 
the numbers of parasites reaching and thus damaging the placenta. Due to the 
syndesmychorial nature of the ruminant placenta, any foetal responses observed are as a 
result of foetal infection. These experiments show that as pregnancy progresses the 
foetus goes from being immunologically immature and incapable of mounting a 
protective immune response (70 days of gestation (dg)) to becoming capable of 
mounting parasite-specific humoral, innate and CMI responses from around 140dg 
onwards. 
The experiments in pregnant cattle confirm the importance of parasite-specific 
proliferation and IFN-γ production, in reducing the magnitude of the parasite challenge 
reaching the maternal–foetal interface and aiding foetal survival. We also examined the 
immunodominant parasite peptides expressed in HPLC fractionated tachyzoite antigen, 
which are recognised by the cellular immune response of experimentally challenged 
cattle. Through LC-ESI-MS/MS, 6 Neospora proteins (including SAG1, SRS2 and 
GRA2) and a number of Toxoplasma gondii orthologues were identified and found to be 
recognised by CD4+ T-cells.   
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These works collectively demonstrate the complexity of the host-parasite interaction in 






Neospora caninum is a parasite that causes abortions in cows, sheep and goats all 
around the world. The work in this thesis starts by looking at what happens when mice 
get infected with the parasite. Some parasites can actually help protect animals against 
the more harmful parasites. These protected mice have more white blood cells helping to 
fight off the parasites, meaning that they get less sick and get better quicker. 
I have also looked at what happens when pregnant cows get infected with the parasite. 
As the parasite can cross the placenta from mum to baby, we wanted to look at what 
happens to the baby if the parasite gets across the placenta. We looked at the white 
blood cells that helped fight off the parasite at different points, at early, middle and late 
pregnancy. In early pregnancy when baby is still very small it cannot fight off the 
parasite and sadly can die. However as the baby gets bigger at middle and late 
pregnancy, it is able to fight off the parasite and is more likely to survive.  
When looking at the types of white blood cells that help fight off the parasite, we 
wanted to find out which parasite proteins (antigens) the white blood cells recognised 
and which ones may help produce an immune response and could possibly be used to 
make a vaccine against the parasite. 
The results from this thesis have helped us to understand how the immune systems of 
mice and cows respond if they are infected with Neospora. This information will help in 
developing a possible vaccine against the parasite.  
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1 General introduction 
Neospora caninum is considered to be one of the most commonly diagnosed causes of 
infectious bovine abortion and foetal death worldwide. Neosporosis is estimated to 
cause US$ 1.3 billion in losses annually worldwide, across the beef and dairy industries 
(Reichel et al., 2012). There are currently no commercially available vaccines, or 
licensed chemotherapeutics that can clear Neospora infections in cattle. As a result, 
farmers are reliant solely upon accurate diagnosis coupled with good animal husbandry 
and biological control strategies, to limit the spread of the parasite. Improved biological 
control strategies and the development of an effective vaccine are highly desirable aims, 
which will ultimately limit the economic impact of Neospora and improve farming 
efficiency. However to progress vaccine development and other control strategies, we 
require a better understanding of the aetiology of Neosporosis and the host-parasite 
interactions. When embarking on the body of work that comprises this thesis, the 
understanding in a number of critical areas was lacking and this thesis has sought to 
address several of these gaps.  
The processes involved in the initiation and maintenance of protective immune 
responses were not well understood. Mouse and cattle models were employed to 
examine in detail the host responses following a primary infection with Neospora 
caninum. Areas of interest included the involvement of toll like receptors and pro-
inflammatory cell-mediated (Th1 type) immune responses in protection against the 
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parasite. Identifying the protective responses against Neospora are important to ensure 
that any future vaccine stimulates an appropriate and proportionate response.  
Previous work has demonstrated that the bovine foetus was capable of mounting a 
protective immune response at mid-gestation (Day 140 of gestation) (Bartley et al., 
2004). In this thesis, I sought to further clarify at what stage of development the bovine 
foetus becomes capable of mounting a protective in utero immune response against 
Neospora. Furthermore it is also important to establish whether the timing of a primary 
Neospora infection is critical to foetal survival and parasite transmission, as this will 
have implications for control strategies. 
It is likely that vaccination will be the most effective strategy for controlling Neospora 
transmission in cattle. Live attenuated vaccines have been shown to be successful in 
controlling other protozoan parasites,  (e.g. Toxovax for the control of Toxoplasma 
gondii abortion in sheep (Buxton, 1993) and Paracox a live attenuated Eimeria vaccine 
used in chickens (Williams, 2002); Using a mouse model, I evaluated tissue-culture 
attenuated Neospora tachyzoites for their ability to generate a protective immune 
response against a subsequent lethal challenge with virulent parasite. In addition, I have 
sought to identify the immune-reactive components of a soluble fraction of Neospora 
tachyzoites that may be involved in protection and possible vaccine candidates.  
Together this body of work has significantly improved our understanding of the host-
parasite interactions of Neospora caninum. Of particularly importance is the 
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identification of the protective components of the host immune response and the critical 
nature of the timing of a primary infection, with respect to foetal survival and parasite 
transmission. This knowledge combined with the proteomic identification of vaccine 
candidates and the in vivo testing of a live attenuated strain of Neospora have added to 
the evidence indicating that vaccination may be a viable option for Neospora control. 
 
1.1 Discovery and identification of Neospora caninum  
Neospora caninum is an obligate intracellular protozoan parasite from the phylum 
apicomplexa, family Sarcocystidae, which was first described by Bjerkas and colleagues 
in 1984, as an unidentified cyst-forming sporozoon causing encephalomyelitis and 
myositis in dogs (Bjerkas et al., 1984). Dubey and colleagues (1988) formally identified 
the parasite, through the examination of histological sections of dogs that had suffered a 
fatal Toxoplasma-like illness. These examinations revealed an organism that was 
structurally distinct from Toxoplasma gondii and all other coccidian parasites. As a 
result of these finding the parasite was allocated a new genus and species, becoming 
Neospora caninum  (Dubey et al., 1988a). 
Since its first identification and isolation in dogs, N. caninum has been shown to be a 
major cause of abortions and reproductive losses in cattle worldwide (Dubey, 2003). 
Cases of bovine neosporosis have been reported in Europe (Stenlund et al., 1997), North 
and South America (Macedo et al., 2013, Pare et al., 1995), Africa (Jardine and Last, 
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1993) and Australasia (Miller et al., 2002). Natural N. caninum infections have also 
been reported in many other intermediate host species including sheep (Dubey and 
Lindsay, 1990), goats (Barr et al., 1992), deer (Dubey et al., 1996) and horses (Dubey, 
2003), though cases in these species are not as numerous or economically important as 
infections in cattle.  
What remains poorly understood are the factors that dictate whether or not abortion or 
the vertical transmission of the parasite occurs in cattle following an infection with N. 
caninum? Generally, pathogen induced abortions occur when a foetus and / or placenta 
becomes so damaged that foetal viability can no longer be maintained. It is clear that 
some cattle abort or vertically transmit the parasite, when under similar conditions 
others do not? Possible explanations for the differences in infection outcome, including 
maternal and foetal immune responses, foetal gestational age, parasite dose and strain 
virulence are examined further throughout this thesis. 
1.1.1 Initial isolation of Neospora caninum (NC1) parasites into tissue culture 
The first Neospora parasites (isolate NC1), which are used in all of the experiments 
included in this thesis, were isolated from naturally infected Labrador Retriever pups by 
Dubey and colleagues (1988b). Tissue homogenates from the pups were inoculated in 
vitro onto bovine cardiopulmonary arterial endothelial (CPAE) cell monolayers, which 
lead to the formation of tachyzoites (rapidly multiplying, actively invasive forms of the 
parasite, which are discussed in more detail in section 1.3.1) being seen within 5 days 
post inoculation. In vivo inoculation of Swiss white mice (n = 25) and beagle pups (n = 
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2) with the same Labrador pup tissue (NC1) homogenates resulted in the formation of 
tissue cysts containing bradyzoites (see section 1.3.2) in the brains of a number of the 
mice. But no demonstrable tachyzoites were found in the beagle pups (Dubey et al., 
1988b). A further beagle pup was inoculated with the in vitro culture derived NC1 
tachyzoites. This NC1 tachyzoite challenge resulted in an acute infection in the pup; 
leading to the formation of gross haemorrhagic lesions in the pups lungs and focal 
necrosis of the liver (these necrotic lesions were found to contain tachyzoites). Parasites 
were also found in limb and ocular muscles of the pup (Dubey et al., 1988b). The lack of 
an acute infection caused by the inoculation of the homogenised pup tissues into the 
beagles (n=2), could have been due to insufficient numbers of viable parasites being 
present. 
These initial experiments allowed Dubey and colleagues (1988b) to fulfil all of Koch’s 
postulates, which were formulated by Robert Koch and Friedrich Loeffler and first 
published in 1890. The postulates are four criteria, which were designed to establish a 
causal relationship between a microbe and a clinical disease and are still used in 
microbiology today.  
Koch's postulates are: 
1. The microorganism must be found in abundance in all organisms suffering from 
the disease, but should not be found in healthy organisms. 
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2. The microorganism must be isolated from a diseased organism and grown in 
pure culture. 
3. The cultured microorganism should cause disease when introduced into a healthy 
recipient host. 
4. The microorganism must be re-isolated from the inoculated, diseased 



















1.2 Known life cycle of Neospora caninum  
For effective control strategies to be developed against Neospora, we need to understand 
the clinical implications of Neospora infections in important host species, e.g. cattle and 
dogs and the roles that these species play in the transmission of the disease.  
A diagrammatic representation of the known life cycle of Neospora is illustrated in 
Figure 1. Following the ingestion of material containing parasite tissue cysts, dogs or 
other definitive hosts of Neospora, (see section 1.2.1) shed unsporulated oocysts. These 
oocysts sporulate and become infectious once in the environment, this can happen 
potentially in as little as 24 hours after excretion (Dubey et al., 2007). If these sporulated 
oocysts are ingested by intermediate hosts such as cattle (Gondim et al., 2004b) and 
sheep (O'Handley et al., 2002) (and many other animal species) through contaminated 
food or water, it can lead to the horizontal transmission of the parasite (see Figure 1). 
Once an intermediate host is infected, tissue cysts (containing bradyzoites) can form in 
the brain and other neural tissues, resulting in a chronic lifelong infection. However, 
should a primary infection occur whilst a host is pregnant, then the parasites can be 
transplacentally (vertically) transmitted to the foetus (see Figure 1), leading either to 
abortion, or the birth of a persistently (chronically) infected offspring (Dubey et al., 
1989). Should the parasite induce an abortion and the placenta or aborted materials 
containing viable parasites be consumed by a naïve canid (Dijkstra et al., 2001), then 
oocysts can be shed and the life cycle can begin again. The oocysts could potentially 
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result in the epidemic spread of the parasite on a farm, resulting in an abortion storm 
(described in more detail in section 1.5.3) 
1.2.1 Definitive hosts of Neospora caninum  
Lindsay and Dubey (1990) demonstrated that Neospora tissue cysts were resistant to 
HCl-pepsin solution, suggesting that carnivorism may play a part in the life cycle of the 
parasite (Lindsay and Dubey, 1990). A definitive host of Neospora was confirmed in 
1998, when a domestic dog (Canis lupus familiaris) was shown to shed oocysts 
following an experimental infection with N. caninum tissue cysts (McAllister et al., 
1998). Since the discovery of the dog as a definitive host, other canid species including 
the Coyote (Canis latrans) (Gondim et al., 2004c), Australian dingo (Canis lupus dingo) 
(King et al., 2010) and Gray wolf (Canis lupus) (Dubey et al., 2011) have now also been 
demonstrated as natural definitive hosts for Neospora caninum.  
Interestingly to date, the sexual stages of the Neospora have not been seen in any of the 
definitive host species currently identified. However it is known that in the closely 
related parasite species e.g. Toxoplasma gondii, schizogony (asexual reproduction) and 
gametogensis (sexual reproduction) both occur in the gut of a definitive host (a felid) 
(Hutchison et al., 1970). It is likely that the same processes of sexual reproduction (e.g. 
the formation of micro and macro gametes) occurs for Neospora in the gut epithelium 
cells of a canid, leading to the formation of unsporulated oocysts, which are then 
excreted in the faeces. 
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Neospora DNA has been found in a number of other carnivorous wildlife species 
including ferrets (Mustela furo), red foxes (Vulpes vulpes), European polecats (Mustela 
putorius), American mink (Neovison vison) and Eurasian badgers (Meles meles) 
(Bartley et al., 2013b). None of these other carnivorous species have been demonstrated 
as definitive hosts for Neospora. Though foxes (Schares et al., 2002b) and a number of 
mustelid species (ermine (Mustela erminae), weasels (Mustela frenata) and ferrets) 
(McAllister et al., 1999) have been examined experimentally to determine whether they 
shed Neospora oocysts following a primary infection, all of which were negative.  
 
1.3 Known life stages of Neospora caninum  
A better understanding of the life stages of the parasite and their roles in the 
transmission of the disease may affect the development of control strategies. For 
example a subunit vaccine containing unique antigens for all of the life cycle stages of 
Neospora would likely be more efficient than a vaccine that solely targets one life stage 
(i.e. the tachyzoite).  
To date, the life cycle stages of N. caninum that have been identified are the tachyzoite, 
bradyzoite and the oocyst (containing sporocysts and sporozoites). All of these life cycle 
stages are known to be involved in the transmission of the parasite (Dubey et al., 2007), 
either between a definitive host and intermediate host (horizontal), or from a dam to a 




The tachyzoites stage of N. caninum is motile, rapidly multiplying and actively invasive. 
Tachyzoites are ovoid, lunate or globular in shape and measure 3-7μm x 1.5μm 
depending on the stage of division (Dubey and Lindsay, 1993). Tachyzoites replicate by 
endodyogeny (asexual replication) into two daughter zoites, which are usually found 
within a parasitophorous vacuole located in the cytoplasm of the host cell. Tachyzoites 
contain all the organelles you would expect to find in a eukaryotic cell, including a 
nucleus, mitochondria, golgi complex, smooth and rough endoplasmic reticulum. 
However, tachyzoites also contain a number of additional organelles and structures 
(micronemes, rhoptries and dense granules) distinct to apicomlexan parasites, which are 
involved in host cell adhesion and invasion (Dubey and Lindsay, 1993) (Figure 2a). 
Tachyzoites have been identified in many cell types from naturally and experimentally 
infected animals, including neural cells, macrophages, fibroblasts, vascular endothelial 
cells, myocytes, renal tubular epithelial cells and hepatocytes (Dubey and Lindsay, 
1993). This relatively broad tissue tropism allows the parasite to disseminate rapidly 
around a host, infecting many different organs and tissues (Dubey, 2003).  
Tachyzoites are usually associated with active (acute) infections, during this early phase 
of an infection parasite DNA may be demonstrable by polymerase chain reaction (PCR) 
in the blood of infected animals (Dubey, 2003). The presence of parasites and parasite 
antigens in the circulatory system will lead to the generation both cell mediated and 
antibody responses against the parasite, which will be discussed in more detail in section 
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1.6. Tachyzoites have the ability to cross the blood–brain barrier, as well as invade other 
immune privileged sites such as the spinal cord (Dubey et al., 1988a) and optic nerves 
(Lindsay et al., 1996). Once in these tissues (sites of predilection), the parasite can 
differentiate (stage convert) into bradyzoites and form tissue cysts (section 1.3.2), 
causing a chronic (persistent) lifelong infection. In immune competent individuals the 
parasite remains sequestered in the brain (and other neurological tissues) causing little or 
no pathology (Anderson et al., 2000). However should the host become 
immunocompromised (i.e. during pregnancy), the bradyzoites can reactivate 
(recrudesce) and stage convert back into rapidly multiplying tachyzoites. An acute 
infection can ensue, the parasite may vertically transmit across the placenta, resulting in 
the abortion or the chronic in utero infection of the foetus (Dubey et al., 1990). In 
pregnant hosts the outcome of a Neospora infection depends on the stage of gestation 
and maturity of the foetal immune response (discussed in detail in 1.6.4). 
1.3.2 Bradyzoites in tissue cysts 
Tissue cysts containing bradyzoites are often round or oval and shape and can measure 
over 100µm in size (Figure 2b) (Dubey et al., 1988a, Lindsay et al., 1996). The 
bradyzoites contained within the tissues cysts are a similar size and shape as tachyzoites 
and contain the same apicomplexan specific organelles found within tachyzoites. 
However, bradyzoites are much slower replicating and are antigenically distinct to 
tachyzoites. Bradyzoites express a number of proteins and genes not seen to date in 
tachyzoites (i.e. SAG4, BSR4) (Fernandez-Garcia et al., 2006, Risco-Castillo et al., 
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2007). Following the formation of tissue cysts, the parasite can persist in the host for life 
(Trees et al., 1999), as there are currently no treatments (chemotherapeutics) available 
that will kill the bradyzoites (Hemphill et al., 2015). Tissue cysts are predominantly 
found in either the brain or neural tissues (sites of predilection), though they can also 
form in many different tissues including liver (Dubey, 2003) and skeletal muscle (Peters 
et al., 2001). This ability of the parasite to infect multiple organs and tissues, means that 
effective biological control strategies are vital in limiting the spread of the disease (see 
section 1.5.6).  
1.3.3 Oocysts 
The oocyst is the most recently identified life cycle stage of Neospora and was 
described when the dog was confirmed as a definitive host (McAllister et al., 1998). 
Unsporulated oocysts are passed in the faeces of infected canids approximately 5 days 
after infection and can be passed for several months (Dubey et al., 2009). Once excreted 
into an aerobic environment, oocysts begin to sporulate in 1-3 days (Gondim et al., 
2002). It is following sporulation that the oocysts become infectious and are then 
capable of causing parasite horizontal transmission (see Figure 1). Lindsay and 
colleagues (1999), clearly described the size (11.7 x 11.3µm), shape (spherical, 
subshperical) and internal structural arrangement of the sporulated oocysts. The 
sporocysts contained within the oocysts were ellipsoidal 8.4 x 6.1µm containing 
elongated sporozoites measuring 7.0 – 8.0µm x 2.0 – 3.0µm (Lindsay et al., 1999b).  
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It is likely that once consumed, the sporulated oocysts will excyst in the small intestines, 
with each oocyst releasing up to eight sporozoites (four from each of the two 
sporocysts). The sporozoites will then infect (parasitise) the intestinal epithelium cells 
and transform (stage convert) into tachyzoites. Following replication the Neospora 
tachyzoites will then spread via the circulatory system, resulting in an acute infection in 
the host. 
The life cycle of Neospora, is clearly complex, with both horizontal and vertical 
transmission occurring during natural infections. Parasite stage conversions also occur 
in all the known life stages, in both definitive and intermediate hosts. All of these factors 
are important considerations that must be taken into account when trying to develop 
effective control strategies. 
 
1.4 In vitro analysis of Neospora caninum tachyzoites 
Since its first isolation into tissue culture (Dubey et al., 1988b), the in vitro growth of N. 
caninum parasites (tachyzoites) has proved an invaluable tool, not only for the 
propagation of the actively multiplying tachyzoite stage of the parasite, but also as a 
means of examining and comparing the rates of multiplication of parasite isolates. 
The first in vitro studies to show differences in the in vitro growth (multiplication) rates 
of tachyzoites of different isolates was carried out by Innes and colleagues (1995). They 
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demonstrated that NC1 isolate tachyzoites replicated quicker than the Nc-Liv isolate 
tachyzoites, as measured by the incorporation of 
3
H uracil (Innes et al., 1995). Another 
study has also shown differences in the multiplication rates of the NC1 and NC-Liv 
isolates, though interestingly during this second study NC-Liv was found to multiply 
faster than NC1 (Schock et al., 2001). It has been suggested that the longer tachyzoites 
are maintained (passaged) in vitro, the more they become “tissue culture adapted“. 
However the findings of Schock and colleagues (2001) did not support this assertion. 
Schock and colleagues (2001) found that the parasite maintained for the longest period 
in vitro grew second fastest (NC1), while the second longest maintained parasite (Nc 
SweB1), was actually 5
th
 slowest growing of 6 isolates tested, suggesting that the 
differences in the in vitro multiplication rates are genetic (Schock et al., 2001). 
It has also been previously noted that prolonged in vitro cultivation of tachyzoites leads 
to a reduction in their in vivo pathogenicity (Long et al., 1998). Similar observations 
have been made for other parasites like Babesia bovis (Yunker et al., 1987), Theileria 
annulata (Preston et al., 2001) and Leishmania spp (Daneshvar et al., 2003), all of 
which have shown attenuation of in vivo virulence following prolonged in vitro culture. 
However 14 months of continuous culture of NC-Liv did not reduce its in vivo 
pathogenicity (Atkinson et al., 1999). While a study by Regidor-Cerrillo and colleagues 
(2011) has actually linked the increased invasion efficiencies of the NC-Spain 4 H and 
NC-Liv parasite isolates with increased virulence (Regidor-Cerrillo et al., 2011). It is 
clear that there are genetic differences between Neospora isolates (Campero et al., 2015, 
Regidor-Cerrillo et al., 2008). These differences will likely affect the rates of parasite 
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multiplication and in vivo virulence. However we still do not know what these 
differences are and if they can be exploited to help control the spread of the parasite. 
 
1.5 Genetic diversity of Neospora caninum 
1.5.1 Neospora Genome 
DNA sequencing first appeared in the late 1970s and is now commonly referred to as 
Sanger sequencing, after one of the pioneering scientists working in the field, Frederick 
Sanger (Sanger et al., 1977). However it is since the advent of the second wave of 
sequencing technologies (also known as next generation sequencing (NGS), that high 
throughput, low cost sequencing has become available, which is capable of producing 
millions to billions of sequence reads per run (Blake, 2015), These NGS platforms 
include technologies such as 454 pyrosequencing, sequencing by synthesis (Solexa, 
illumina), sequencing by oligo ligation detection (SOLiD) and ion semiconductor 
sequencing (ion torrent) (Bennett et al., 2005, Margulies et al., 2005, Valouev et al., 
2008).  
Seminal work in the field of Neospora genomics was carried out by Reid and colleagues 
(2012), who were the first group to sequence the entire Neospora genome (using 
tachyzoites of the NC Liverpool (NCLiv) strain), Reid and colleagues (2012) 
demonstrated that the Neospora (NCLiv) genome is 61.0Mb in size and is divided into 
14 chromosomes containing ~7500 predicted protein coding genes. The Neospora 
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genome is slightly smaller than that of T. gondii which is 63.0Mb, but is considerably 
larger than the genomes of Plasmodium falciparum which is only 23.3Mb long (Reid et 
al., 2012) and Eimeria tenella which is 51.8Mb, though interestingly E. tennela’s 
genome contains 8603 protein coding genes (Blake, 2015), which is ~1100 more genes 
than are found in Neospora.  
As well as comparing the entire Neospora genome to other Apicomplexan parasites, 
work has also been carried out using random amplification of polymorphic DNA 
(RAPD) (Schock et al., 2001), as well as using mini and microsatellite technologies to 
examine the repetitive DNA sequences found in the Neospora genome (Goodswen et al., 
2013). These repeated sequences are generally divided into three classes: highly 
repetitive, moderately repetitive and single (low) copy number sequences and provide an 
excellent source of DNA markers for investigating genetic diversity amongst parasites.  
Some of the initial work on genetic diversity in Neospora was carried out by and 
colleagues (2004), who demonstrated variations in the internal transcribed spacer 
1(ITS1) gene region between Brazilian, North American and European Neospora strains 
(Gondim et al., 2004a). More recently, multilocus genotyping has demonstrated 
extensive genetic diversity (polymorphisms) amongst laboratory maintained strains of 
Neospora (Al-Qassab et al., 2009, Regidor-Cerrillo et al., 2006). 
Microsatelite technologies have not solely been used to examine the differences in 
laboratory strains, but have also demonstrated significant genetic differentiation between 
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field isolates of Neospora, where DNA was isolated from aborted bovine foetuses in 
Scotland, Germany and Spain (Regidor-Cerrillo et al., 2013). Basso and colleagues 
(2010) have also used microsatellites to examine epidemic abortion outbreaks in cattle 
on 5 farms in Germany, where for each of the epidemic outbreak a common 
microsatellite pattern prevailed. Each of the farms demonstrated a unique microsatellite 
profile, suggesting that on each farm the infection was through a common point source 
(Basso et al., 2010). Microsatellite markers were also used in one of the experiments 
described in this thesis (chapter 6), to demonstrate that a control dam used in the 
experimental infection during late gestation was infected prior to the study and not as a 
consequence of an inoculation error.  
1.5.2 Transcriptomic analysis of Neospora caninum 
Most of the transcriptomic analysis of N. caninum has been carried in comparison to T. 
gondii, where mRNA sequencing (or RNAseq as it is commonly known) has been used 
to compare the expression levels of protein coding genes of tachyzoites from the two 
closely related parasites. Some of the most dramatic findings of the RNAseq work 
include the observation that Neospora appears to have no functional gene for the rhoptry 
kinase ROP18 (a rhoptry neck protein). High levels of expression of ROP18 have been 
linked with parasite virulence in T. gondii (Reid et al., 2012). A suggested function for 
ROP18 in T. gondii virulence, is that ROP18 proteins inactivate host immunity related 
GTPases (IRGs) which would otherwise disrupt the PV, killing the parasites. Neospora 
is also entirely missing the locus encoding a number of other rhoptry neck proteins 
including ROP2A, ROP2B and ROP8. It has been hypothesised that this lack of ROP18 
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and a reduced in vivo virulence compared to T. gondii could in fact be an adaptation of 
Neospora allowing the efficient spread of the parasite without killing the recipient host 
(Reid et al., 2012).  
Though Neospora appears deficient in a number of rhopty protein coding genes, it 
contains a much larger number of surface antigen (SAG) related sequences (SRS) genes 
with 227 compared to only 55 in T. gondii. Thought Neospora contains more SRS genes 
than Toxoplasma, in the tachyzoite stage, Neospora usually only expressed one gene at 
multigene locus, where Toxoplasma often expresses many (Reid et al., 2012). It has 
been suggested that this increased repertoire of SRS genes may actually have lead to the 
reduction in host range of Neospora compared to T. gondii (Reid et al., 2012) and that 
many of the SRS genes may be important in other developmental life cycle stages, such 
as bradyzoites.  
Though genomic differences have been described between strains of Neospora, at a 
phenotypic (Goodswen et al., 2013) and antigenic (Schock et al., 2001) level Neospora 
strains are extremely similar. The use of –omics data (genomics, transcriptomics and 
proteomics) should pinpoint the reasons for these differences, however to date there 
have not been any in depth –omics comparisons of strains of Neospora and is an area 




Figure 2. Neospora caninum tachyzoites (Panel A) and a tissue cyst containing 








A, Note several rhoptries (R) with electron-dense contents anterior to the nucleus and 
one rhoptry posterior to the nucleus. Also, note the conoid (C), micronemes (MI), dense 
granules (DG), nucleus (N) and mitochondria (MT) in the tachyzoites. Scale bars = 0.5 
μm.    Copied from: J.P. Dubey and D.S. Lindsay Parasitol Today 9 (1993), 452-458 
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1.6 Bovine neosporosis  
1.6.1 Economic impact and importance of bovine neosporosis 
The true economic impact of bovine neosporosis is difficult to calculate, as often the 
only directly attributable effect of N. caninum infection in cattle is the abortion of the 
foetus. The direct economic impact of an aborted foetus is the immediate loss of the 
value of the aborted animal, whether that is a dairy replacement animal or a beef animal 
destined for the food chain. However, there are also the added costs associated with 
having to service the dam again, leading to an increased calving interval. Two studies in 
Canada have demonstrated that animals that are seropositive for N. caninum have poorer 
reproductive performance than seronegative animals (Waldner et al., 2001a) and 
consequently have longer calving intervals (Waldner, 2005). A number of studies in 
England have all sited that a major reason for culling in dairy herds is poor levels of 
fertility amongst animals (Esslemont and Kossaibati, 1997, Whitaker et al., 2000, 
Whitaker et al., 2004). While other studies have demonstrated that Neospora positive 
animals were 1.6-1.73 times more likely to be culled than seronegative animals (Bartels 
et al., 2006, Thurmond and Hietala, 1996). 
Experimental evidence has shown that a primary Neospora infection during early 
pregnancy in cattle can result in foetal resorption (Maley et al., 2006). The economic 
impact of Neospora induced early foetal death and resorption in cattle is very difficult to 
estimate, as no prevalence data is available. How often foetal resorption occurs in 
natural infections with N. caninum is unknown, but it is likely to equate to a 
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considerable if unquantifiable economic loss to the cattle industry. Many of the animals 
suffering early foetal death and resorption may appear as having an increased time to 
conception, hence an increased calving interval, or present as being permanently 
infertile. 
Amongst dairy herds the profitability of an animal increases with age (Esslemont and 
Kossaibati, 1997). Culling an animal before its fourth lactation, may in fact lead to a net 
loss for a farmer, as the net milk sales against feed costs in the first three lactations are 
not considered large enough to be profitable (Esslemont and Kossaibati, 1997). 
Neospora seropositivity in dairy animals alone has not been linked to a significant 
decrease in milk production compared to seronegative animals (Bartels et al., 2006). 
However, a study in Canada showed that seropositive cows in herds with abortions 
attributable to N. caninum infection produced significantly less milk than seronegative 
cows (Hobson et al., 2002). The apparent lack of consistency in milk data might be 
caused by a number of factors including, differences in the virulence of the parasite 
strains infecting the cattle, farm husbandry practices and the geographical regions where 
the data was collected. The individual experimental design, selection criteria of animals 
and farms, as well as the methods of data collection and analysis may also affect the 
experimental results. 
All of the economic effects of bovine neosporosis described above, will have a profound 
negative impact on the saleable value of infected animals (Trees et al., 1999). Leading to 
an overall reduction in the value of breeding stock, especially given the fact that animals 
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remain infected for life and can transmit the parasite to their progeny (potentially over 
several successive generations).  
A recent article attempted to quantify the economic looses to both the dairy and beef 
industries worldwide. To do this, data was collected from papers published in Australia, 
New Zealand, Canada, Mexico, United States of America, Argentina, Brazil, the 
Netherlands, Spain and the United Kingdom, describing natural outbreaks of bovine 
neosporosis (Reichel et al., 2012). These data sets have estimated the total median 
economic impact of N. caninum in both beef and dairy industries is approximately US 
$1.298 billion per annum. The diary industry incurred the biggest annual losses at 
approximately US$842 million, while the beef industries annual sustained losses are 
approximately US $455 million. The last comprehensive survey in England and Wales 
attributed approximately 12.5% of abortions to neosporosis (Davison et al., 1999b), 
Reichel and colleagues estimated that these losses in the UK dairy industry were in the 
region of US$27 million per annum (Reichel et al., 2012).  
1.6.2 Routes of parasite transmission of Neospora caninum  
Any strategies to control Neospora transmission must take into account the complex 
nature of the life cycle of the parasite (Figure 1). Natural Neospora infections are known 
to occur in both definitive (Dubey et al., 1988a) and intermediate hosts (Dubey et al., 
1989) and can involve any of the known life cycle stages of the parasite (Anderson et 
al., 2000). So targeting one life cycle stage or one host species may not limit the spread 
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of the disease, a broader approach involving all economically important species is 
required. 
1.6.3 Natural routes of Neospora infection in cattle 
There are two major natural routes of infection with N. caninum, these are: the vertical 
(transplacental transmission) route, where an infected dam passes the infection directly 
to her foetus (Dubey et al., 2006), or the horizontal (post natal) route, where naïve 
animals (juveniles and adults) become infected through the ingestion of food or water 
contaminated with Neospora oocysts (Figure 1) (Dubey, 1999b). Horizontal 
transmission can also occur through the ingestion of tissues / organs infected with 
bradyzoites, or aborted placental / foetal tissues containing tachyzoites, though infection 
in this manner is most likely to occur in carnivorous or omnivorous animals, such as 
dogs and other canids (Dubey, 2003).  
Transplacental (vertical) transmission can occur as a consequence of infection in two 
different ways. Endogenous transplacental transmission (En TT) occurs as a result of the 
recrudescence (reactivation) of a persistent (chronic) infection in a dam, leading to an 
active acute infection and the vertical transmission of the parasite to the foetus. 
Exogenous transplacental transmission (Ex TT) occurs if a dam becomes infected for the 
first time during pregnancy, through the ingestion of sporulated oocysts (Figure 1) 
(Trees and Williams, 2005, Williams et al., 2009) and may lead to abortion (Gondim et 
al., 2004c), or the chronic in utero infection of the foetus.  
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Other natural routes of infection that have also been suggested, these include the 
venereal spread of the parasite through tachyzoite contamination in semen (Ortega-Mora 
et al., 2003). Placentophagia (the consumption of a infected placenta by another 
intermediate host) has also been suggested as another natural route of infection (Modry 
et al., 2001). However these routes of transmission have never been demonstrated in 
naturally occurring cases of bovine neosporosis and are unlikely to result in an infection. 
The parasite stage most likely to be involved would be the tachyzoite, which would be 
unlikely to survive long enough in such hostile environments as the gastric tract and 
uterus to cause an active acute infection in a healthy host.  
1.6.4 Experimental routes of Neospora infection in cattle 
Two routes of experimental infection have been extensively used in cattle, these are the 
intravenous (iv) or subcutaneous (sc) routes of inoculation (Macaldowie et al., 2004, 
Williams et al., 2000, Williams et al., 2009). The results from experimental studies 
comparing iv and sc challenges suggest that the iv route of inoculation leads to more 
severe clinical disease than a sc challenge (Macaldowie et al., 2004). This increased 
disease severity may in part be due to the haemotogenous nature of the iv challenge. 
Parasites rapidly enter the circulatory system causing placental and foetal damage before 
an appropriate immune response can be mounted (Macaldowie et al., 2004, Williams et 
al., 2000). Compared to the much slower sc route of infection, where the parasite must 
first migrate through tissues before reaching the circulatory system; during which time 
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the host will be starting to mount innate, cell mediated and humoral immune responses 
against the parasite. 
Other experimental routes of Neospora infection in cattle have also been examined; 
these include conjunctival (de Yaniz et al., 2007), intrauterine (Serrano-Martinez et al., 
2007) and intramuscular (Andrianarivo et al., 2001) challenges with tachyzoites. Studies 
have also used oral infections of Neospora oocysts in cattle (De Marez et al., 1999, 
McCann et al., 2007). However, none of these latter methods of administering the 
parasite are routinely used in large scale experimental infections in cattle. 
1.6.5 Epidemiology of Neospora caninum infections in cattle 
The main clinical symptom associated with bovine neosporosis is abortion, with 
Neospora being the most commonly diagnosed cause of infectious bovine abortion in 
the UK (Davison et al., 1999a). It has been estimated that approximately 13% of 
abortions in cattle in the UK and 20% of abortions in the USA are attributable to 
Neospora (Davison et al., 1999a, Dubey, 2003). Neospora infections are wide spread, in 
the Netherlands seropositive animals were found in 78% of dairy herds tested (Wouda et 
al., 1999a) and in 73% of dairy herds tested in Quebec, Canada (Pare et al., 1998). In 
healthy non-pregnant animals clinical symptoms rarely present following a Neospora 
infection (Wouda, 2000). Though natural clinical cases of neosporosis are uncommon, 
they have been reported in cattle (Dubey and Rommel, 1992) as well as in sheep and 
goats (Eleni et al., 2004, Moreno et al., 2012). The symptoms usually present in neonatal 
animals and can include paralysis, muscle atrophy and hind limb hyperextension (Barber 
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and Trees, 1996, Dubey and Lindsay, 1996). These clinical symptoms are associated 
with severe neurological damage, leading to early neonatal mortality (Dubey and 
Lindsay, 1993). Usually in experimentally challenged cattle, the only overt clinical 
symptoms seen during an acute Neospora infection are a short term febrile response 
(increased rectal temperature) and mild swelling (oedema) may be observed around sites 
of parasite inoculation (Maley et al., 2006, Maley et al., 2003b).  
Naturally occurring Neospora-associated bovine abortions have been described as 
having either an epidemic (abortion storms due to point source exposures) or an 
endemic pattern (recrudescence of chronic infections) (Thurmond and Hietala, 1997).  
1.6.6 Epidemic Neospora abortions in cattle 
Neospora induced epidemic abortion storms, are associated with primary Neospora 
infections of herds (both naïve calves and adult animals) en mass. Usually through 
exposure (ingestion) to sporulated oocysts, shed by a definitive host (i.e. a dog) (Figure 
1), leading to the exogenous transplacental transmission (Ex TT) of the parasite. A 
number of studies have examined natural point source outbreaks of Neospora (mass Ex 
TT events), that have induced abortions. These studies have defined an epidemic 
(abortion storm) as being when 10 - 15% of all susceptible animals at risk in a herd, 




1.6.7 Endemic Neospora abortions in cattle 
Endogenous transplacental transmission (En TT) is likely to be the major route of 
infection within herds of cattle considered to have endemic abortion problems. Though 
EnTT is unlikely to cause the mass abortion storms that can be seen following Ex TT 
events, it is likely to result in long term persistent problems on farms. This is in part due 
to the efficiency with which Neospora can be vertically transmitted, it has been 
suggested that between 80 – 95% of seropositive cattle will congenitally infect their 
offspring (Davison et al., 1999a, Pare et al., 1996). There is extensive evidence from 
both naturally and experimentally infected cattle, to support the association between 
infection status and risk of abortion. A study looking at congenitally infected heifers 
demonstrated that during their first pregnancy, Neospora infected cattle were 7.4 times 
more likely to abort than age matched non-infected controls (Thurmond and Hietala, 
1997). Data from the Netherlands demonstrated a 2–3 times increased likelihood of 
foetopathy in N. caninum infected animals, compared to uninfected animals (Moen et 
al., 1998). While, a study looking at over 1000 randomly selected cows in England and 
Wales demonstrated that Neospora infected animals were 3.5 times more likely to abort 
than seronegative animals (Davison et al., 1999b). Though the results from these studies 
were collected from a wide geographical area, they show a broadly similar outcome, 
with N. caninum infected cattle being approximately 3-4 times more likely to abort than 
negative animals. The data from these studies also suggests that the likelihood of 
abortion or foetopathy is higher in primiparous animals, compared to multigravida dams 
that have successfully carried more than one pregnancy to term.  
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1.6.8 Parasite strain virulence of Neospora caninum  
The effect of the “strain” on the outcome of an infection is known to be important factor 
across the study of almost all infectious agents. But what exactly is a strain. McKenzie 
et al., (2008) in a review of Plasmodium species described “strains” as autonomous, 
stable biological entities that are distinguishable from each other by clinical virulence, 
epidemiological or other features such as antigenic properties, drug resistance and 
ability to infect (McKenzie et al., 2008). This is compared to an “isolate” which 
McKenzie and colleagues describe as a sample of parasites which are not necessarily 
genetically homogeneous and have been collected from a naturally infected host on one 
single occasion.  
Though not all of the criteria used by McKenzie and colleagues to categorise 
Plasmodium parasites are true for Neospora, a number of them are. The NC1 parasites 
that are used throughout the experiments described in this thesis (Chapters 2-7) would 
fulfil the criteria of both a strain and an isolate. The NC1 parasites have been shown 
using both RFLP and Microsatelite technologies (Al-Qassab et al., 2009, Gondim et al., 
2004a) to be clearly distinguishable from other strains of Neospora. While the NC1 
tachyzoites themselves were isolated from a single naturally infected host ( a Labrador 
Retriever pup) (Dubey et al., 1988a) fulfilling the criteria of McKenzie and colleagues 
to also be considered as an isolate! 
Some isolates of N. caninum have been shown to be more pathogenic in cattle than 
others. Experimental challenges of cattle with the NC1 and Nc-Liv isolates have been 
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shown repeatedly to be highly pathogenic, causing abortion and foetopathy (Maley et 
al., 2003b, Williams et al., 2000). While other isolates such as NcSweB1 (Quinn et al., 
2002) and Nc-Spain 1H (Rojo-Montejo et al., 2009b) appear to be less virulent in cattle. 
These naturally occurring differences in virulence make the choice of parasite challenge 
strain crucial for experimental infections. The less pathogenic strains may not be 
suitable for use as challenge parasites, in vaccination/challenge models. If the challenge 
parasites naturally cause little or no pathology, a vaccine may appear more effective, 
than if a more virulent isolate of Neospora had been used as the challenge. 
1.6.9 Use of experimental models to examine the effect of the infectious dose of 
Neospora caninum parasites on the clinical outcome of disease 
The challenge dose of parasites is critical to the clinical outcome of a N. caninum 
infection. Work on cattle, carried out by Maley and colleagues (2003) demonstrated that 
a subcutaneous (sc) challenge with 1x10
7
 live tachyzoites (NC1 isolate) caused milder 
disease symptoms than a sc challenge with 5x10
8
 tachyzoites (Maley et al., 2003b).  
Similar findings have been observed using mouse models, where an increased inocula 
size resulted in greater lesion severity and an increased cerebral parasite loads 
(Collantes-Fernandez et al., 2006, Long et al., 1998). However, a recent study by 
Arranz-Solis and colleagues (2015) demonstrated similar levels of neonatal mortality in 
mouse pups in groups of dams receiving 1x10
5
 tachyzoites compared to those receiving 
100 tachyzoites (NC-Spain 7 strain). These results suggest, that in many experiments an 
excessive and highly unrealistic number of parasites are being administered (Arranz-
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Solis et al., 2015). This excessive dose results in high levels of parasitaemia, which may 
make identifying immune-reactive antigens and antigen combinations difficult, as the 
host immune response may be overwhelmed before a protective response can be 
generated. However we must use caution when comparing these data sets, as the 
experiments employed different model species, used different parasite strains, doses and 
routes of inoculation.  
Over recent years there have been calls to try and standardise experimental Neospora 
infections conditions in cattle, to allow easier comparisons of data from different 
research groups and experiments. If a standard dose was used then comparisons 
regarding the pathogenicity of isolates could be more easily made (Benavides et al., 
2014). However, a standard route of administration would also have to be employed, as 
discussed in section 1.6.2.2, the route of inoculation also clearly plays a critical role in 
the clinical outcome of the infection. 
1.6.10 Methods used in the routine diagnosis of bovine neosporosis 
Detection of Neospora infections in cattle has routinely been conducted using one of 
two methods. One is the microscopic examination of aborted foetal tissues, following 
post mortem examination. Using microscopy allows a differential diagnosis to be 
reached, if parasites are observed in lesions in the foetal tissues (Thilsted and Dubey, 
1989). Alternatively serological analysis can be used to detect anti-Neospora antibodies 
(Dubey et al., 1988b), as there are no currently no reliable ante mortem polymerase 
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chain reaction (PCR) tests to detect a parasitaemia in the brain or blood naturally 
infected cattle.  
Commonly used serological tests for bovine neosporosis are based on either whole 
tachyzoites for immunofluorescent antibody tests (IFAT) (Dubey et al., 1988b), or 
antigen generated from tissue culture derived tachyzoites, for enzyme linked 
immunosorbent assays (ELISA) (Bjorkman et al., 1994). While an IgG avidity ELISA 
will allow the serological discrimination between acutely and chronically infected 
animals, as the avidity of IgG antibodies increase over time. So the higher the antibodies 
avidity the longer an animal has been infected (Bjorkman et al., 1999). Other methods 
such as the Neospora (direct) agglutination test (NAT) (Romand et al., 1998) and the 
latex agglutination test (LAT) (Moraveji et al., 2012) have also been developed for 
Neospora diagnosis. However the method of choice for large scale serological screening 
is the Neospora tachyzoite antigen ELISA.  
This reliance on whole tachyzoites / tachyzoite antigens for use in diagnostics may have 
led to an under estimation of the levels of infection within herds of cattle, as chronically 
(persistently) infected animals may appear seronegative when tested against Neospora 
tachyzoites antigens (Conrad et al., 1993). In a recent study by Mazuz and colleagues 
(2014), approximately 10% of dams that tested serologically negative for Neospora gave 
birth to persistently infected offspring (Mazuz et al., 2014). Chronically infected animals 
are only likely to have a detectable parasitaemia (circulating tachyzoites) if they are 
undergoing parasite recrudescence. This usually only occurs when bradyzoites stage 
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convert back to tachyzoites, usually following host immunomodulation (i.e. pregnancy, 
immune suppression). In immunologically normal hosts (i.e. non-pregnant, 
immunocompetent) bradyzoites elicit minimal inflammatory reaction (Anderson et al., 
2000). Humoral responses against Neospora bradyzoites are highly variable (Aguado-
Martinez et al., 2008) and the levels of anti-Neospora bradyzoite antibodies will depend 
on the intensity and duration of antigen specific exposure during parasite reactivation 
(Guido et al., 2016). Recombinant versions of a number of bradyzoite specific proteins 
including SAG4 (Fernandez-Garcia et al., 2006) and BSR4 have been created (Risco-
Castillo et al., 2007). These recombinant bradyzoites antigens could be used to try and 
serologically detect chronic cases of neosporosis, in animals that were previously 
thought to be uninfected using a conventional tachyzoite antigen ELISA. However it is 
unclear if the sensitivity of assays using these antigens would be sufficient to accurately 
detect low anti-bradyzoite antibody responses in naturally infected animals. One method 
that may improve the rates of serological detection would be to use a combination of 
tachyzoite and bradyzoite antigens (Aguado-Martinez et al., 2008).  
1.6.11 Current strategies for the control of bovine neosporosis 
The most effective strategy to control bovine neosporosis would be a vaccine capable of 
inhibiting the vertical transmission of the parasite, this topic is discussed in detail in 
section 1.8. There are also currently no licensed chemotherapeutics for use in cattle that 
will kill the chronic tissue cyst stages of the parasite (Dubey et al., 2007). In the absence 
of a vaccine or chemotherapeutics, many of the strategies for controlling bovine 
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neosporosis are aimed at reducing the risks of primary infection (abortion storms) 
through good animal husbandry practices.  
Current husbandry strategies used to control bovine neosporosis include; reducing 
canine faecal contamination in and around cattle feed bins, water sources and pastures. 
Limiting the access of dogs (in particular young naïve dogs) to carcasses and aborted 
bovine material (foetal and placental) is also advised (Cavalcante et al., 2011). While 
feeding dogs raw meat should also be avoided where possible, Especially following the 
discovery of Neospora tissue cysts in bovine skeletal tissues from naturally infected 
animals (Peters et al., 2001). Work by Kramer and colleagues (2004) demonstrated that 
feeding dogs raw bovine material was a significant risk factor associated with 
seropositivity in canine neosporosis (Kramer et al., 2004). Rodent control and restricting 
the natural hunting behaviour of dogs may also prevent them from ingesting naturally 
infected wildlife reservoir host species (e.g. mice and rats) (Ferroglio et al., 2007) and 
thus prevent canine infection (Gondim, 2006). Work in the Netherlands demonstrated 
that there is a strong correlation between seropositivity of N. caninum antibodies in farm 
dogs and a high prevalence of anti-Neospora antibodies in the cattle (Wouda et al., 
1999b).  
Farmers may also choose not to use seropositive animals for breeding replacement 
stock, to try and reduce the incidence of En TT. Embryonic transfer has also been used 
to produce seronegative calves. Taking embryos from Neospora positive animals and 
implanting them into Neospora negative recipient animals resulted in the total 
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abrogation of parasite vertical transmission (Baillargeon et al., 2001, Landmann et al., 
2002). However, this method is likely to be very expensive and the economic benefit 
would probably only be seen in high value pedigree herds. 
The most drastic control measure that may be implemented on a farm would be the 
removal of all known infected cows and their offspring, also referred to as the test and 
cull method. However, this is only practical in low prevalence herds, as culling may 
have huge economic implications for the farmer (Wouda, 2000). Also, if there is under 
reporting of cases of bovine neosporosis, due to false negative serological tests, then 
infected animals may remain within herds, defeating the purpose of culling or removing 
known infected animals.  
 
1.7 Host - parasite relationship during bovine neosporosis 
A clear understanding of the involvement of all aspects of a protective immune response 
(innate, humoral and cell mediated) is required for any control strategy to be successful 
in inhibiting the transmission of Neospora. Knowledge relating to the importance of the 
type (Th1 or Th2), magnitude and location of these responses will also be critical in 
developing an effective vaccine. 
To be able to accurately study the immunological responses being produced by a host 
following an infection, species specific (or highly cross reactive) reagents are required. 
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Sadly until recently this is an area where immunological studies in cattle have struggled. 
There is less of a market for bovine and ovine immunological reagents than for the more 
widely funded human and rodent immunology. One of the first commercially produced 
bovine reagents was the BOVIGAM ELISA kit, which was produced by CSL in 1988 
and is used to detect the production of interferon gamma (IFN-γ) by cattle following an 
infection. The BOVIGAM kit is still commonly used in many countries today to test for 
bovine Tuberculosis (Mycobacterium bovis) infections (Wood and Jones, 2001). Since 
the development of the IFN-γ ELISA a number of other tests have been developed for 
other key cytokines including interleukin (IL)-4 (Hope et al., 2005), IL-10 (Kwong et 
al., 2002) and IL-12 (Hope et al., 2002), and tumour necrosis factor alpha (TNF-α) 
(Kwong et al., 2010), most of these assays are used to measure immune responses in 
pregnant dams and their foetuses in this thesis (Chapters 6-7). As well as ELISA for the 
detection of cytokines, antibodies are also available to detect a wide range of surface 
markers on immune cells, and key immunological components like toll like receptors 
(Kwong et al., 2011). Advances in molecular biology along with NGS and the first 
whole genome sequencing (WGS) of Bos taurus in 2004 (Zimin et al., 2012) have 
enabled the development of many other reagents such as qPCR primers and probes, that 
allow researchers to determine changes in the level of gene expression of key 
immunological components like TLR’s (Chang et al., 2009).Immune responses of non 
pregnant cattle to a primary infection with Neospora caninum  
Early work examining the immune responses against Neospora were conducted by Innes 
and colleagues (1995), who demonstrated that interferon-γ (IFN-γ) could significantly (p 
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= 0.02) reduce in vitro rates of parasite multiplication (Innes et al., 1995). While Marks 
and colleagues (1998) demonstrated the importance of CD4
+
 T-cells and the production 
of IFN-γ in response to a primary Neospora infection in cattle (Marks et al., 1998). Flow 
cytometric assays have shown that though CD4
+
 T-cells are the predominant producers 
of IFN-γ in response to Neospora, both CD8
+
 T-cells and Natural killer (NK) cells also 
contribute to IFN-γ production at early stages following a Neospora infection (Klevar et 
al., 2007). Work by Staska and colleagues (2003) showed that CD4
+
 T-cells not only 
work in a T-helper role, but also have a cytotoxic effect on Neospora infected 
autologous target cells (Staska et al., 2003). These results combined demonstrate the 
importance of CD4
+
 T-cells and IFN-γ in generating a protective Th1 type immune 
response against Neospora.  
Natural killer cells harvested from Neospora infected cattle have been used to examine 
the involvement of the innate immune responses during early Neospora infections. Live 
and heat inactivated Neospora tachyzoites triggered interleukin 2 (IL-2) activated 
bovine NK cells into producing IFN-γ independently of the cytokine interleukin 12 (IL-
12). Though the presence of IL-12 increased the magnitude of IFN-γ response seen in 
activated NK cells, which also showed increased cytotoxic activity when co-cultured 
with Neospora infected autologous fibroblasts (Boysen et al., 2006). Natural killer cells 
are important effector cells in the initiation and priming of an adaptive immune response 
against Neospora. Boysen and colleagues (2006) findings suggest that though an 
immune response can be initiated against Neospora in an IL-12 independent manner, IL-
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12 is clearly a potent activation factor for the innate immune response against the 
parasite.  
Interestingly both of the studies by Boysen and colleagues (2006) and Klevar and 
colleagues (2007) demonstrated that bovine NK cells failed to respond when stimulated 
with soluble Neospora tachyzoite antigens. This suggests that either intact tachyzoites or 
non-soluble NK cell stimulating tachyzoite antigens are required for NK cell triggering 
(Boysen et al., 2006, Klevar et al., 2007). This lack of NK cell activation by an 
incomplete repertoire of tachyzoite proteins may partially explain why Neospora subunit 
vaccines have failed to initiate a fully protective immune response against the parasite in 
cattle (discussed in more detail in section 1.8.2). It is likely that the activation process of 
a cellular response is highly complex, involving interactions between many facets of the 
immune response.  
1.7.1 Maternal immune responses to Neospora caninum in cattle during different 
stages of gestation 
The maternal immune responses against Neospora in pregnant cattle have been 
extensively studied, using both experimental and natural infection systems. These 
studies have demonstrated the importance of lymphoproliferative cell mediated 
responses and the production of IFN-γ in the protective immunity against Neospora 
(Andrianarivo et al., 2001, Rosbottom et al., 2011, Williams et al., 2000).  
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During early pregnancy the location of a maternal immune response is critical to 
determining disease outcome following either a primary infection, or during the 





cells, gamma-delta (γδ) T-cells and NK cells at the maternal placenta were linked to 
foetal death (Canton et al., 2014b, Maley et al., 2006). These infiltrating cells were also 
associated with increases in the expression of the Th1 type cytokines IL-12, IFN-γ and 
tumour necrosis factor α (TNF-α) at the placental interface (Canton et al., 2014a, 
Rosbottom et al., 2008), causing severe immune mediated pathology and foetal death 
(Macaldowie et al., 2004). These results were supported by Gibney and colleagues 
(2008), who showed that a challenge with Neospora tachyzoites during early pregnancy 
in cattle caused extensive focal epithelial necrosis and the infiltration of maternal 
mononuclear cells at the placenta, which was associated with foetal deaths (Gibney et 
al., 2008). While work by Flynn and Marshall (2011) demonstrated that macrophages 
from Neospora infected cattle were producing IL-17A as well as IFN-γ, and suggested 
that a combination of these two pro-inflammatory cytokines could be contributing to the 
immunopathology seen at the maternal foetal interface during Neospora infections in 
cattle (Flynn and Marshall, 2011).  
At mid gestation, maternal lymphoproliferative and IFN-γ responses against Neospora 
antigens have been detected in both the peripheral blood mononuclear cells (PBMC) and 
peripheral lymph nodes of experimentally challenged pregnant cattle. However these 
immune responses were not sufficient to stop parasite vertical transmission, but may 
have limited the severity of foetal infection (Bartley et al., 2004). Responses to the 
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mitogen concanavalin A, as well as antigen specific proliferative responses and IFN-γ 
production have been shown to be down regulated at mid gestation, irrespective of 
infection status of the dams (Innes et al., 2001). Similar observations were made by 
Almeria and colleagues (2003) who showed a suppression of maternal responses in 
PBMC at around day 126 (week 18) of gestation (Almeria et al., 2003). The immune 
responsiveness of dams has been shown to return by late gestation (Innes et al., 2001). 
This modulation of the maternal immune response is likely to be caused by the 
endocrine system. Levels of the hormone progesterone increase steadily in pregnant 
cattle from early to mid-gestation (Pope et al., 1969). While prostaglandin E2 which is 
also produced during pregnancy, is known to suppress T-cell proliferation and inhibit 
interleukin -2 (IL-2) production (Chouaib et al., 1985), thus biasing a cell mediated 
immune (CMI) response towards a Th2 type response (Kalinski et al., 1997). 
Trophoblast and decidual cells have also been shown to suppress immune responses 
(Raghupathy, 1997), through the release of decidua-associated suppressor signals (Clark 
et al., 1984). While some lymphocytes can produce progesterone-induced blocking 
factor (PIFB). The presence of PIFB along with IL-4 and IL-10, will also bias an 
immune response away from Th1, towards a Th2 type response (Raghupathy, 1997). 
This immunomodulation (towards a Th2 type response) could explain why rates of 
vertical transmission increase as gestation progresses, as it may allow parasite 
recrudescence to occur, leading to foetal infections (see Figure 3). This may also explain 
why many Neospora associated bovine abortions occur at around day 150 of gestation 
(Dubey, 1999a). If during a chronic infection large numbers of parasites recrudesce and 
cross the placenta, they may overwhelm the developing foetal immune responses and 
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result in an abortion. However a lower parasite challenge could be controlled by the 
foetus, resulting in chronic infection but no foetal death, reiterating the importance of 
the infectious parasite dose.  
The experimental evidence examining Neospora infections during late pregnancy in 
cattle is limited. The available data suggests that primary infections at this stage of 
pregnancy are often associated with high rates of vertical transmission, but low rates of 
foetal mortality. Andrianarivo and colleagues (2001) demonstrated vertical transmission 
and foetal infection in 5/5 dams challenged with Neospora during late pregnancy (days  
219-231 of gestation) (Andrianarivo et al., 2001). While Benavides and colleagues 
(2012), observed vertical transmissionin in all infected animals from 28 days post 
challenge (day 238 of gestation) (Benavides et al., 2012). Previous observations have 
also shown that following a challenge with Neospora at late gestation foetal viability 
was associated minimal placental necrosis, mild inflammatory infiltration and reduced 
levels of IFN-γ expression (Gibney et al., 2008, Rosbottom et al., 2008). These findings 
were supported by the work of Canton and colleagues (2014a and 2014b). Where is was 
shown that the lack of foetal death was likely due in part to the mild inflammatory 
cellular infiltration at the maternal placenta (Canton et al., 2014b), with scarce 
production of pro inflammatory cytokines (i.e. IFN-γ) (Canton et al., 2014a). This lack 
of immunopathology is likely due to the Th2 biased environment at the placenta, leading 
to a reduction (suppression) of the harmful pro-inflammatory responses (Raghupathy, 
1997). However, the main factor that will reduce the rates of foetal death is the 
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increasing maturity of the foetuses immune response against Neospora as gestation 
progresses. 
1.7.2 Ontogeny of the foetal bovine immune system 
Due to the syndesmochorial (synepitheliochorial) nature of the ruminant placenta, under 
normal circumstances no maternal immune factors including immune cells, antibodies 
and cytokines can cross the maternal-foetal interface. This means that any immune 
responses seen in utero are as a direct result of foetal infection. Implantation of the 
bovine foetus begins to occur around day 19 of gestation (MacIntyre et al., 2002). In a 
normal healthy bovine foetus, lymphoid development is seen from day 42 of gestation, 
while the spleen is structurally present by day 60 of gestation (Schultz et al., 1973). 
Monocytes and T-cells have been shown in large numbers at 3 months of gestation in 
bovine foetal thymus and spleen samples. At the same gestational period (approx. 90 
days) low numbers of B-cells were also identified. The lower concentration of B-cells is 
as expected, as B-cells predominantly proliferate and differentiate in an antigen 
dependent manner (Senogles et al., 1979). Experimental data from cattle clearly shows 
that as gestational age increases, the risk of foetal death associated with a primary 
Neospora infection decreases (Andrianarivo et al., 2001). However as gestation 
progresses the chance of the parasite being vertically transmitted to the foetus increases 
(Figure 3) (Benavides et al., 2012).  
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1.7.3 Development of the bovine foetal immune responses against Neospora 
caninum  
As described in section 1.6.3, in cattle the structure of a foetal immune system is in 
place from as early as 42 – 60 days of gestation (Schultz et al., 1973). Considerable 
research has focused on whether the foetus is capable of mounting an effective immune 
response against a Neospora infection and if so, at what stage of gestation does the 
foetal immune response become protective? Though immune cells and lymphoid tissues 
are present during the first trimester of pregnancy, the cells do not appear capable of 
mounting protective antigen specific immune responses. Should vertical transmission 
occur during the early stages of pregnancy the result will likely be foetal death 
(Andrianarivo et al., 2001, Rosbottom et al., 2008).  
By mid gestation the bovine foetal immune response is more fully developed and has 
been shown to be capable of mounting antigen specific immune responses from about 
131 – 154 days of gestation (Almeria et al., 2003). These responses are predominated by 
CD4
+
 T-cells and IFN-γ production (Almeria et al., 2003, Bartley et al., 2004, Rojo-
Montejo et al., 2009a). By mid gestation the bovine foetuses are also capable of 
mounting humoral immune responses against Neospora, which is predominated by IgG1 
isotype antibodies (Andrianarivo et al., 2001).  
There is currently a lack of experimental data examining the bovine foetal immune 
responses against Neospora during late gestation, most experiments have focused on 
either the maternal immune responses (Rosbottom et al., 2007) or the immunopathology 
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at the placenta (Gibney et al., 2008). The available data shows that by the third trimester 
of pregnancy bovine foetuses are able produce strong humoral responses, with anti-
Neospora antibody titres of ≥1:20,000 (tested by IFAT) and CMI responses against 
Neospora, including lymphocyte proliferation and IFN-γ production in PBMC, 
mesenteric lymph node (LN), prescapular LN and spleen (Andrianarivo et al., 2001). 
 
1.7.4 The effect of host genetic diversity in cattle on immunological responses 
against Neospora caninum 
An area of research that has not been extensively explored in the field of bovine 
neosporosis is the role host genetic diversity plays in resistance to infection; in particular 
the role of the major histocompatability complex (MHC) class II. The genes encoding 
the MHC II are known to be highly polymorphic, producing large numbers of distinct 
alleles, for example the DRB3*2703 and 2707 alleles are associated with resistance to a 
number of disease including bovine Leukemia virus (BLV) (Schwab et al., 2009) In 
Neospora infected cattle the DRB3*1001 allele was associated with pregnancy loss, 
while DRB3*2703 was found only in dams that gave birth to live healthy calves 
(Schwab et al., 2009). 
Neospora infected Cattle with disparate MHC haplotypes have been shown to develop 
parasite specific CD4
+
 T-cells which killed autologous infected cells, but not 





parasite killing (Staska et al., 2003). Further work by Staska and colleagues (2005) has 
demonstrated that MHC class II heterozygous Holstien cattle infected with Neospora all 
demonstrated IFN-γ secretion by CD4
+
 cytotoxic T-lymphocytes (CTL) directed against 
Neospora NcSRS2 peptides. Suggesting that the cattle can respond against Neospora 
irrespective of MHC haplotype (Staska et al., 2005). These findings were further 
supported by the work of Baszler and colleagues (2008), who also demonstrated that 
Neospora infected cattle with disparate MHC haplotypes all responded to NcSRS2 
peptides with lymphoproliferative and IFN-γ responses (Baszler et al., 2008). 
Though there is still quite limited data regarding the impact of MHC haplotypes on 
protection against Neospora infections, it is clear that the MHC class II plays an 
important role in the protective immunity and needs to be considered when developing 





Figure 3. Graphical representation of the relationship between the gestational age 
of the bovine foetus, the magnitude of the maternal immune response and the 







1.8 Investigating the host – parasite relationship of Neospora caninum 
using experimental mouse models 
Mice are known to be intermediate hosts for Neospora, with naturally infected animals 
having been found in numerous countries around the world (Dubey, 2003). However, 
mice are probably most important as experimental model systems for examining the 
disease dynamics, immunology and pathology relating to Neospora infections. 
Experimental mouse models offer an excellent opportunity to study the host–parasite 
interaction in a cost effective manner, prior to committing to large expensive 
experimental cattle studies. We must however be careful when extrapolating the 
immunological findings from mice and applying them to larger animals (i.e. ruminants), 
although it is an obvious statement “a mouse is not a cow”; murine immunology as well 
as placental biology (haemochorial) differs greatly from that of ruminants 
(syndesmochorial). Thus the host/parasite interactions, particularly around the placenta 
may also be different. Though there are clear differences in immunology and biology 
between mice and cattle. The ease with which mice can be handled, the short duration of 
murine pregnancies (19 - 20 days) (Lopez-Perez et al., 2008) and the number reagents 
available to study murine immunology, make mouse models an excellent starting point 
for many in vivo experiments. 
As with all in vivo experimentation, consideration must also be given to host strain and 
parasite isolate choices, as these can have an impact on the outcome of infection. Some 
of the differences in clinical manifestations that are observed in the host, may be a result 
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of natural genetic resistance to Neospora infection. For example, work using microarray 
analysis to compare BALB/c and Qs mice, demonstrated clear transcriptional 
differences in levels of gene expression between the two breeds of mice. These 
differences were observed 6 hours after a subcutaneous challenge with either NC 
Liverpool or NC-Nowra tachyzoites (Ellis et al., 2010). Compared to the susceptible 
BALB/c mice, the resistant Qs mice showed upregulation of the genes regulating the 
Jak-STAT signalling pathway (Stat2 and Stat3), which is involved in B-cell 
development and the regulation of IL-10 and IL-12 expression. This upregulation of 
early immune response genes in the Qs mice will likely lead to improved priming of the 
immune response, which may help reduce the parasite dissemination and the associated 
pathology. 
1.8.1 Host-parasite interactions of Neospora caninum in non pregnant 
experimental mouse models 
Non pregnant mice offer an opportunity to examine the immunological responses during 
acute and chronic (cerebral) neosporosis, in animals which develop a clear 
symptomatology, that is easily characterised within a matter of days following infection 
(Collantes-Fernandez et al., 2006, Rojo-Montejo et al., 2012).  
Mice also offer excellent opportunities for investigating Neospora dissemination, 
allowing easy comparisons of the tissue trophisms of different parasite isolates to be 
made. Work by Collantes-Fernandez and colleagues (2006) showed that during acute 
Neospora infections, parasites can be detected in the blood and numerous other organs, 
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while during chronic infections that parasites are usually limited to the brain (Collantes-
Fernandez et al., 2006). Similar findings were reported by Pereira Garcia-Melo and 
colleagues (2010), where a mouse model was used to examine the pathogenicity of a 
number of Neospora isolates (from asymptomatic calves). Parasite DNA was found in 
the blood and lungs of mice during acute infections, then only in the brains of 
chronically infected mice (Pereira Garcia-Melo et al., 2010). These data indicate that we 
must sample appropriate organs and tissues, depending on whether acute or chronic 
infections are being investigated. For example should a parasite isolate be being 
examined for its ability to persist long term following an infection, then the brain and 
central nervous system (CNS) should be the preferred sampling choices. However 
during acute phase dissemination studies, the blood, and visceral organs would be better 
options to find parasites / parasite DNA (Collantes-Fernandez et al., 2006). 
Many aspects of the murine immune response against Neospora have been examined 
and these finding have often been used to steer and inform immunological and vaccine 
research in ruminants. Some of the earliest work using a mouse model clearly 
demonstrated the importance of IFN-γ and IL-12 (Baszler et al., 1999, Khan et al., 1997, 
Long et al., 1998) in a protective immune response against an acute infection with 
Neospora tachyzoites. While Ritter and colleagues (2002) demonstrated that the 
adoptive transfer of IFN-γ producing immune cells to a IFN-γ / genetic knockout mouse 
could significantly lengthen survival, following a challenge with Neospora tachyzoites 
(Ritter et al., 2002). Nishikawa and colleagues (2003) demonstrated that resistance to an 
acute Neospora infection in wild type BALB/c mice was associated with increased 
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production of both IFN-γ and IL-4, compared to susceptible mice (Nishikawa et al., 
2003) Though the Th1 associated cytokines are critical in a protective immune response, 
a balance must also be found with the Th2 types cytokines, in particular IL-4 and IL-10. 
However an immune response that is overly-biased toward a Th2 type response can also 
be detrimental. This was the case in BALB/c mice immunised with soluble tachyzoites 
antigen, then challenged with Neospora tachyzoites, where an increase in IL-4 
production was correlated with exacerbated encephalitis and neurological disease in the 
vaccinated mice, compared to the unvaccinated / challenged controls (Baszler et al., 
2000). It appears that immunisation with tachyzoite antigens led to the generation of an 
inappropriate overly-biased Th2-type response, which was detrimental to the survival of 
the mice following challenge. These data are important considerations for vaccine 
development, as a vaccine needs to produce a balanced, appropriate and proportionate 
immune response against the parasite, which will not result in either pathology or 
chronic infections. 
The importance of the humoral immune response during a Neospora infection was 
confirmed using a mouse model. B-cell deficient C57BL/6 µMT mice were shown to be 
more highly susceptible to infection with Neospora tachyzoites than wild type C57BL/6 
mice. This susceptibility resulted in greater parasite dissemination, leading to a lethal 
outcome of infection. The µMT mice’s susceptibility was not just associated with the 
deficiency in B-cells and the absence of anti-Neospora antibodies, but was also 
manifested through decreased antigen specific proliferation of the splenocytes and 
reduced IFN-γ production (Eperon et al., 1999). This lack of immunological 
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responsiveness of the splenocytes is likely due to poor immune priming caused by the 
deficient B-cells. The importance of immune priming during Neospora infections was 
demonstrated using flow cytometic analysis of CD69
+
 activated B-cells, from Neospora 
infected BALB/c mice. The activated B-cells demonstrated increased surface expression 
of the molecules CD80 and CD86, which are known to interact with CD28 on the 
surface of T-cells, leading to T-cell activation, and the production of various interleukins 
(Teixeira et al., 2005).  
Antibodies directed against the Neospora tachyzoite surface protein NcSRS2 have been 
generated in mice. These antibodies inhibited the in vitro attachment and invasion of 
parasites to ovine foetal trophoblast cells. It is hypothesized that the inhibition may have 
been achieved by the antibodies binding to and inducing conformational changes in the 
NcSRS2 protein on the tachyzoites surface, which in turn meant that the protein was 
unable to recognise host cell surface molecules. Alternatively the antibodies may have 
just physically blocked the interactions between the parasites and the corresponding host 
cell surface proteins (Haldorson et al., 2006). 
Mouse models have also been used to demonstrate the importance of the innate immune 
response during primary Neospora infections. Work by Mineo and colleagues (2009 and 
2010) showed that myeloid differentiation factor 88 (MyD88) and toll like receptor-2 
(TLR-2) are involved in the initial immune recognition of Neospora parasites in mice, 
leading to the generation of a protective effector immune response (Mineo et al., 2009, 
Mineo et al., 2010). Upregulation of MyD88 is associated with IL-12 production and 
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 T-cells and NK cells (Mineo et al., 2009), 
while TLR-2 is involved in antigen presenting cell (APC) activation and T-cell 
proliferation (Mineo et al., 2010). All of the processes controlled by the innate immune 





 C57BL/6 Knockout mice that lack of these innate processes are 
known to show increased susceptibility to Neospora infection, compared to wild type 
C57BL/6 mice (Mineo et al., 2009, Mineo et al., 2010). 
When examining the host - parasite relationship in non pregnant animals it is important 
to remember that immune factors that are potentially important in controlling infection 
in non pregnant animals may be affected by the immunomodulation that occurs during 
pregnancy and may no longer have the same protective effect. This could however be 
overcome if a protective immune response could be established before a host becomes 
pregnant. 
1.8.2 Host–parasite interactions of Neospora caninum using experimental 
pregnant mouse models 
Experimental infections of Neospora using pregnant mouse models have been 
comprehensively examined, looking at both acutely (Long and Baszler, 1996, Lopez-
Perez et al., 2008) and chronically infected animals (Jimenez-Ruiz et al., 2013, Omata et 
al., 2004, Rettigner et al., 2004). 
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Mouse models have been used to examine differences in the virulence of parasite 
isolates and the transmission dynamics of Neospora, in pregnant mice (Pereira Garcia-
Melo et al., 2010, Rojo-Montejo et al., 2009b). However Regidor-Cerrillo and 
colleagues (2010) carried out the most comprehensive study, where the rates of vertical 
transmission in mice, were examined using 10 Neospora isolates. Following an acute 
infection, differences in the rates of neonatal mortality (from 32 – 95%) and vertical 
transmission (from 50 – 100%) were identified between the isolates (Regidor-Cerrillo et 
al., 2010). These results indicate clear variations in the pathogenicity (virulence) and 
transmission efficiency of isolates of Neospora. 
Like in cattle, a number of studies in mice have shown that the timing of acute infection 
during pregnancy affects the clinical outcome. Acute infections of mice on day 7 of 
gestation not only lead to increased levels of neonatal mortality, but also lead to the 
retardation of normal development in surviving pups (Lopez-Perez et al., 2010).  
Infection during mid pregnancy (days 7-12 of gestation) resulted in higher levels of 
neonatal mortality compared to infection during mid-late pregnancy (days 12-14 of 
gestation) (Liddell et al., 1999, Lopez-Perez et al., 2008). There is likely to be greater 
disease severity at early-mid gestation compare to mid-late gestation, because during the 
early stages of pregnancy (day 7 of gestation) the placenta is still developing and the 
embryo has only just implanted (on approx 4-5 days of gestation), therefore any 
parasites reaching the placenta are likely to cause more severe damage leading to 
transplacental infection, while in later gestation the placenta is fully formed and the 
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embryo is more developed, creating a more effective barrier to parasite invasion (Lopez-
Perez et al., 2010).  
Collantes-Fernandez and colleagues (2012) made an interesting discovery that could 
explain how Neospora parasites bypass the haematochorial placenta of mice, when they 
showed that Neospora tachyzoites exploit natural cellular traficking pathways, by 
infecting dendritic cells (DCs) to help cross cell barriers (i.e. transplacental transmit) 
(Collantes-Fernandez et al., 2012). The importance of this cellular traffic in ruminants is 
however unknown, as under normal conditions a syndesmochorial placentation will not 
allow the transfer of maternal immune cells. However, this form of cellular trafficking 
would aid parasites in rapidly disseminating around a host and reaching the placenta. 
Allowing the parasite more time to establish and replicate, increasing the parasites 
chances of vertically transmitting, before an immune response can be initiated.   
In mice chronically infected with Neospora, efficient vertical transmission of the 
parasite from dam to offspring has been shown in the first generation of breeding 




 generations of breeding from 
chronically Neospora infected mice, almost no vertical transmission was observed 
(Jimenez-Ruiz et al., 2013, Rettigner et al., 2004). This would suggest that a natural 
immunity is developing in the mice against the parasite across successive generations. 
This data would suggest that only primigravida animals should be used in experiments 
when trying to compare rates of vertical transmission.  
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The results from experimental mouse models support the findings seen in cattle, 
indicating that strong Th1 type immune responses, along with the innate and humoral 
responses are all required to successfully control Neospora infections and inhibit the 
vertical transmission of the parasite.  
 
1.9 Prospects for developing a vaccination strategy to control the 
spread of Neospora caninum  
As with many other protozoan parasites, the development of a vaccine is an important 
goal in the area of Neospora research. Experimental evidence from cattle shows that 
animals can be protected against vertical transmission (Innes et al., 2001) and that prior 
exposure to Neospora decreased the chances of abortion compared to a primary 
infection with the parasite (McAllister et al., 2000). So a vaccine that mimics the 
immune responses generated by live Neospora should create a solid immunity against 
the parasite. 
1.9.1 Live parasite vaccines tested against acute Neospora caninum infections 
using experimental mouse models 
There is a considerable body of data examining the effects of live vaccine formulations 
used to protect mice against experimental infections with Neospora. Lindsay and 
colleagues (1998) produced temperature sensitive isolates of Neospora that protected 
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against a subsequent lethal challenge. However, the attenuation was not stable and the 
temperature sensitive isolates reverted to a virulent wild type state when re-cultured at 
37
o
C (Lindsay et al., 1999a). While inoculation with γ-irradiated tachyzoites also 
protected against a lethal primary challenge with Neospora (Ramamoorthy et al., 2006). 
However the efficacy of the temperature sensitive tachyzoites and γ-irradiated parasites 
were never tested in a pregnant mouse model. A live transgenic NC1 strain of Neospora 
tachyzoites (Nc-1 SAG4(c)2.1) which constitutively expressed the bradyzoite specific 
gene SAG4, has also been tested in pregnant mice. Vaccination with Nc-1 SAG4(c)2.1 
produced significant reductions in levels of vertical transmission in challenged animals 
compared to unvaccinated controls. However the transgenic strain of Neospora still 
induced chronic infections in mice and has not been tested in ruminants (Marugan-
Hernandez et al., 2011b). Rojo-Montejo and colleagues (2012), tested an experimental 
vaccine consisting of the naturally low virulence Nc-Spain 1H parasites in mice, the 
vaccination was shown to completely abrogate cerebral infection in all vaccinated 
animals challenged with Neospora Nc-Liv tachyzoites (Rojo-Montejo et al., 2012). The 
evidence clearly shows that live Neospora vaccines are effective at producing a 
protective immune response, when tested in mice. 
1.9.2 Live vaccines tested in cattle against natural and experimental infections 
with Neospora caninum  
A number of research groups have also examined the efficacy of live parasite vaccines 
using pregnant cattle. Innes and colleagues (2001) demonstrated that prior exposure to 
Neospora induced protection against the vertical transmission of the parasite using an 
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experimental cattle model. Cattle were vaccinated with Neospora tachyzoites prior to 
pregnancy, challenged at mid gestation and then monitored through to birth. Calves born 
to vaccinated dams were negative for anti-Neospora antibodies and PCR negative for 
parasite DNA. These results suggest that the immune responses generated in the dams 
prior to pregnancy protected against the vertical transmission of the parasite following a 
challenge during mid pregnancy (Innes et al., 2001). In a study by Rojo-Montejo and 
colleagues (2013) Nc-Spain 1H parasites failed to completely protect against the vertical 
transmission of Neospora when tested in cattle. However vaccination with Nc-Spain 1H 
parasites did lead to a reduction in the rates of vertical transmission and increased 
neonatal survival, following a mid-gestation challenge with Nc-Liv tachyzoites compare 
to the unvaccinated animals (Rojo-Montejo et al., 2013). Webber and colleagues (2013) 
have also shown a reduction of vertical transmission by between 70-90% (depending on 
the route of vaccination). Heifers were vaccinated either iv or sc with Nc-Nowra 
parasites before pregnancy, then challenged with virulent NeosporaNc-S197 tachyzoites 
on day 139 of gestation. One dam that was vaccinated (iv) with Nc-Nowra but not 
challenged aborted a Neospora PCR positive foetus. Indicating that the attenuation of 
Nc-Nowra is incomplete and there is still the capacity for a reversion to virulence 
(Weber et al., 2013). A field trial of vaccinations with the NeosporaNcIs491 isolate, led 
to a 10% reduction in abortions in vaccinated compared to non-vaccinated cattle, but 
appeared to have no effect on inhibiting vertical transmission in naturally infected 
animals (Mazuz et al., 2015). Hecker and colleagues (2015) showed that animals 
vaccinated with live NC-6 Neospora parasites prior to pregnancy then challenged on day 




, γδ T-cells and 
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macrophages, and very low levels of expression of the cytokines IFN-γ, IL-4, IL-10, IL-
12 and TNF-α (Hecker et al., 2015), though no data on rates of vertical transmission 
were presented in this experiment. The results of Hecker and colleagues (2015) agree 
with the finding of Innes and colleagues (2001) and suggest that the immune responses 
generated by the dams prior to pregnancy have successfully limited the spread of the 
parasites; meaning that very few parasites are reaching the placenta, resulting in a very 
mild inflammatory response.  
The need for more research into developing a live vaccine to control bovine neosporosis 
was raised by Reichel and colleagues (2015) in a recent letter to the journal “Vaccine”. 
The letter urged pharmaceutical companies, veterinarians, farmers and researchers alike 
to invest in the development of a live vaccine to treat bovine neosporosis, as a live 
vaccine will likely be more efficacious than either killed or subunit vaccines (Reichel et 
al., 2015). 
1.9.3 Killed vaccines tested against experimental infections with Neospora 
caninum in mice 
Killed vaccines have had mixed success in producing protective immune responses 
against Neospora infections in mice. Inoculation with crude Nc-Nowra tachyzoite 
antigen, reduced the incidence of vertical transmission, however this inhibition was 
much less successful compared to a vaccination with live Nc-Nowra parasites (Miller et 
al., 2005). Heat killed tachyzoites have also been shown to induce lower levels of IFN-γ 
production in splenocytes and bone marrow derived dendritic cells than a comparable 
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dose of live parasites, suggesting poorer immune priming by the heat killed tachyzoites, 
compared to the live parasites (Feng et al., 2010). Vaccination with heat killed 
tachyzoites has also actually led to an increase in host susceptibility to Neospora in mice 
(Baszler et al., 2000). 
1.9.4 Killed vaccines tested against natural and experimental infections with 
Neospora caninum in ruminants 
In a field trial, the killed Neospora tachyzoite vaccine (Neoguard®) was administered to 
cattle naturally infected with Neospora, vaccination led to a reduction in rates of 
abortion by 9% compared to control animals. However no data was given comparing 
rates of vertical transmission from these animals (Romero et al., 2004). A more recent 
study looking at Neoguard® actually showed an increased risk of abortions in 
vaccinated cattle, compared to the unvaccinated controls (Weston et al., 2012). The 
findings of Weston and colleagues (2012) agree with the previous findings from mouse 
studies, in that using killed vaccines can lead to increased host susceptibility to 
Neospora infections. This lack of protection induced by killed vaccines could in part be 
explained by the observations made by Boysen (2006) and Klevar (2007), who 
suggested that killed vaccines lack key immune stimulatory molecules that are needed to 
generate a protective immune response.  
Crude tachyzoite antigens have also been used to try and vaccinate sheep against 
Neospora infections. These experiments showed a slight decrease in rates of abortion in 
vaccinated animals compare to the controls, but vertical transmission was still seen in 
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both vaccinated and challenged / control animals (Jenkins et al., 2004b, O'Handley et 
al., 2003). 
Though live vaccines have many efficacious advantages over killed vaccines (i.e. they 
actually work), they are more problematic to produce. Pharmaceutical companies are 
less likely to want to produce live vaccines compared to killed / subunit vaccines as they 
are comparatively expensive to manufacture, usually require a cold chain for storage, 
have a short shelf life and have the capacity to revert to virulence.  
1.9.5 Testing of subunit vaccines against Neospora caninum in experimental 
mouse models 
Recombinant subunit vaccines, both monovalent and polyvalent (multivalent) antigen 
cocktails have been tested for their ability to create a protective immune response 
against primary infections and the vertical transmission of Neospora. The target antigens 
for these subunit vaccines are often either parasite surface antigens, like Neospora 
surface antigen NcSRS2 (Pinitkiatisakul et al., 2007), surface antigen 1 (SAG1) (Cannas 
et al., 2003a) or antigens relating to the molecules involved in cellular invasion, like 
rhoptory protein 1 (ROP1) (Debache et al., 2009), microneme (MIC) proteins, MIC1 
(Ramamoorthy et al., 2007a), MIC3 (Cannas et al., 2003b) and the dense granule (GRA) 
proteins GRA2, GRA6 (Ramamoorthy et al., 2007b) and GRA7 (Jimenez-Ruiz et al., 
2012) or the bradyzoite specific surface antigens like BSR4 (Marugan-Hernandez et al., 
2011a) and SAG4 (Jimenez-Ruiz et al., 2012). 
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Many monovalent antigens fail to elicit protective responses when administered alone, 
most need to be give as polyvalent antigen cocktails before any meaningful responses 
are seen. For example the antigens SAG4, BSR4 and SRS9 when used independently 
did not offer protection (Jimenez-Ruiz et al., 2012), likewise no protection against 
vertical transmission was observed using Nc MIC3-R (Monney et al., 2012) and 
NcMIC1, NcMIC3 and NcROP2 (Monney et al., 2013) independently. However a 
number of antigen cocktail formulations have shown promise in limiting or completely 
inhibiting vertical transmission of Neospora in pregnant mouse experiments (Haldorson 
et al., 2005, Jenkins et al., 2004a, Liddell et al., 2003, Nishikawa et al., 2001).  
To date, the only subunit vaccine cocktail tested in ruminants, failed to produce positive 
results. A vaccination combining rNcSAG1, rNcHSP20, rNcGRA7 using immune 
stimulating complexes (ISCOMS) adjuvant failed to prevent foetal infection in cattle 
challenged on day 70 of gestation (Hecker et al., 2014). Cattle vaccinated with this 
cocktail of recombinant antigens (rNcSAG1, rNcHSP20, rNcGRA7) and challenged on 




, γδ T-cells and 
macrophages, and increased expression of the cytokines IFN-γ, IL-4, IL-10, IL-12 and 
TNF-α. Compared to animals vaccinated with live parasites that showed minimal 
infiltration of immune cells and low levels of cytokine expression at the placenta. These 
results suggest that the recombinant antigens are were unable to stop the parasites 
reaching the maternal-foetal interface, resulting in immune mediated pathology (Hecker 
et al., 2015).  
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1.9.6 Appropriate adjuvant selection for use with subunit and killed vaccines 
against Neospora caninum  
Appropriate adjuvant selection is likely to be critical to the success of a subunit / killed 
vaccine. Many adjuvants have been tested with limited success, these include 
Immunmax (Vertex®) used with crude tachyzoite antigen preparations in pregnant 
sheep (Jenkins et al., 2004b, O'Handley et al., 2003). Havlogen (Intervet®) which was 
used in conjunction with the Neoguard® vaccine (Weston et al., 2012). Immune 
stimulating complexes (ISCOMS) was used with a multivalent subunit vaccine but 
failed to stop foetal infection, following a challenge on day 70 of gestation in pregnant 
cattle (Hecker et al., 2014). However vaccines using Polygen
TM
 (MVP Laboratories) and 
Freunds have stimulated immune responses comparable to infection with live parasites 
(Andrianarivo et al., 1999, Baszler et al., 2008, Staska et al., 2005). These two adjuvants 
(Polygen
 
and Freunds) may have been more successful as they induce a Th1 type 
response. However these formulations have not been tested for their efficacy in 
preventing vertical transmission and abortion in pregnant cattle. 
To date the only method that appears to clearly protect against the vertical transmission 
of Neospora in cattle is the exposure of animals to live parasites prior to pregnancy. 
Prior exposure to the Neospora tachyzoites leads to the generation of a long lasting 
protective immune response, capable of stopping vertical transmission (Innes et al., 
2001). However the possibility of a reversion to virulence of Neospora tachyzoites is 
probably the biggest safety concern that is limiting the development of a live vaccine 




The aims of the experiments included in this thesis were: 
 To determine whether long term in vitro cultivation (tissue culture) of Neospora 
caninum tachyzoites produced an attenuation of virulence when tested in an 
experimental mouse model. 
 To determine whether tissue culture attenuated Neospora caninum tachyzoites 
could protect naïve animals against a known lethal challenge with the parasite. 
 To determine if there were differences in the immunological responses of hosts 
following an inoculation with either tissue culture attenuated or wild type 
virulent Neospora caninum tachyzoites. 
 Examine the maternal and foetal immune responses in cattle challenged with 
Neospora caninum tachyzoites at different stages of gestation to help identify 
key components of a protective immune response  
 Examine the immunological responses of Neospora caninum infected cattle to 
liquid chromatographically fractionated water soluble tachyzoite antigen, with 
the purpose of identifying cell populations responding to immunoreactive 









2 Long term passage of tachyzoites in tissue culture can 
attenuate virulence of Neospora caninum in vivo 
 








2.1 Manuscripts main hypotheses  
 
The main hypotheses hat were tested in this manuscript are: 
1. Does an extended period of in vitro cultivation attenuate the in vivo virulence of 
Neospora caninum tachyzoites when using a non pregnant mouse model? 
2. Are both attenuated and virulent parasites capable of causing clinical disease in 
an experimental mouse model? 
3. Is the severity of clinical disease caused by the Neospora tachyzoites dose 
dependent? 
4. Are there differences in the in vitro growth characteristics of the attenuated and 
virulent tachyzoites? 
The results from this series of experiments clearly demonstrated that the tachyzoites 
maintained for a longer period in tissue culture (referred to as the attenuated parasites) 
showed decreased in vivo virulence, compared to the wild type (virulent) tachyzoites. 
This attenuation was manifest through reduced levels of morbidity and mortality in 
inoculated animals. However both wild type (virulent) and attenuated parasites were still 
capable of causing clinical disease in mice, which increased in severity when the 
parasite dose was increased. Both the virulent and attenuated parasites were capable of 
causing not only acute but also chronic infections in the host, as was evident through the 
presence of tissue cysts containing baradyzoites, which were found in the brains of mice 
receiving either virulent or attenuated parasites. However the incidence of tissue cysts 
was reduced in the mice receiving the attenuated parasites compared to those receiving 
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the virulent parasites. Using the incorporation of 
3
H Uracil as a measure of in vitro 
intracellular multiplication, the attenuated tachyzoites were shown to multiply faster 
than the virulent parasites between 6, 12, 24, 48, 72 and 96 hours, suggesting the 
attenuated parasites have become more tissue culture adapted than the virulent 
tachyzoites.  
Though clear evidence of attenuation was demonstrated during this study, the 
attenuation is incomplete as the attenuated parasites are still able to cause chronic 
infections (form tissue cysts) and the mechanisms by which the parasites have become 
attenuated is still unclear. Further comparisons of the virulent and attenuated parasites 
are required to determine processes involved in attenuation. One method that could yield 
useful and interesting results would be RNAseq (transciptomic) comparison of the 
parasites, this would highlight any differences in the expression of protein coding genes 
and may also identify proteins which could be exploited in helping to control Neospora. 
The numbers of parasites used for each infectious dose are also too high. A reduced 
number of parasites would have improved the survival rates / times of the animals, This 
would have allowed for more rigorous screening and comparisons of the 
histopathological changes in the brains of animals receiving either the attenuated or the 
virulent parasites at later time points, which were unavailable during this current 
experiment due to the early culling of many animals.  
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2.2 Author contributions 
PMB, SW, DB and EAI were involved in all aspects of the experimental design and 
planning of the experiments. This included the morbidity scoring system which was 
created in accordance with the guidelines agreed by the UK Home Office. All 
experiments were approved by Moredun Research Institutes experimental ethics 
committee. 
PMB and SW inoculated all the mice and were responsible for making clinical 
observations, daily morbidity scoring, weighing of individual mice and the culling of 
animals when needed. At post mortem examination PMB and SW collected all tissue 
samples for PCR and histological analysis and blood samples for serological screening.  
PMB maintained the Vero cells and Neospora tachyzoites in tissue culture, enumerated 
the cells and tachyzoites using a Neubauer haemocytometer and prepared all of the 
inocula (Vero cells and tachyzoites) used during the experiments and was responsible 
for performing all in vitro growth rate experiments comparing the virulent and 
attenuated parasites. PMB extracted the DNA from all of the tissue samples examined 
and performed all ITS1 PCR analysis. PMB collated all of the data including the in vitro 
growth rates, morbidity, mouse weight, and mortality data and prepared all of the graphs 
and tables presented in the manuscript. 
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SW separated serum from clotted blood samples and performed all serological testing 
(IgM and IgG) by IFAT, while FC and DB performed all histological and 
immunohistological analysis and provided the images presented in the manuscript.  
JS performed all statistical analysis on the mean morbidity score, mouse weight, group 
morbidity and IFAT data. 
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SUMMARY
To determine whether prolonged in vitro passage would result in attenuation of virulence in vivo, Neospora caninum
tachyzoites were passaged for different lengths of time in vitro and compared for their ability to cause disease in mice.
Groups of Balb/c mice were inoculated intraperitoneally with 5r106 or 1r107 of low-passage or high-passageN. caninum
tachyzoites. The mice were monitored for changes in their demeanour and body weight, and were culled when severe
clinical symptoms of murine neosporosis were observed. Mice inoculated with the high-passage parasites survived longer
(P<0.05), and showed fewer clinical symptoms of murine neosporosis, compared to the mice receiving the low-passage
parasites. The parasite was detected in the brains of inoculated mice using immunohistochemistry and ITS1 PCR. Tissue
cysts containing parasites were seen in mice inoculated with both low-passage and high-passage parasites. When the
in vitro growth rates of the parasites were compared, the high-passage parasites initially multipliedmore rapidly (P<0.001)
than the low-passage parasites, suggesting that the high-passage parasites had become more adapted to tissue culture.
These results would suggest that it is possible to attenuate the virulence of N. caninum tachyzoites in mice through
prolonged in vitro passage.
Key words: Neospora caninum, in vitro culture, attenuation in vivo.
INTRODUCTION
Neospora caninum is an apicomplexan parasite,
first described by Bjerkås et al. in 1984 and isolated
and named by Dubey et al. (1988).Neospora caninum
has a worldwide distribution and is a major cause
of reproductive failure in cattle (Innes et al. 2001).
Considerable economic losses are attributed to
N. caninum in the farming industry, including the
costs of still birth and neonatal mortality, increased
calving interval resulting from early foetal death,
increased culling, reduced milk production and
reduced value of breeding stock (Trees et al. 1999;
Dubey, 2003). There are currently no suitable
chemotherapeutic agents to prevent transplacental
transmission or to eliminate the parasite in cattle,
making the development of an effective vaccine
highly desirable. Epidemiological evidence indi-
cates that persistently infected animals are less likely
to abort following a point-source exposure than
previously naı̈ve animals, suggesting that cattle
may develop some protective immunity against the
disease (McAllister et al. 2000). Due to the intra-
cellular nature of the parasite, it is expected that
cell-mediated immunity (CMI), involving lympho-
proliferative responses and the production of the
cytokine interferon gamma (IFN-c) will have a
major protective role (Innes et al. 1995; Khan
et al. 1997; Baszler et al. 1999). Eperon et al. (1999)
demonstrated the importance of B-cells (and pre-
sumably antibodies) in controlling Neospora infec-
tions in mice. Although the role of antibodies in
a protective immune response has still to be deter-
mined, a likely function would be in controlling the
spread of extracellular stages of the parasite (Innes
et al. 2002). Recent experimental studies in cattle
have demonstrated that inoculation with N. caninum
prior to pregnancy can protect against a second
challenge administered at mid-gestation; trans-
placental transmission only occurred in the naı̈ve
control animals (Innes et al. 2001). In addition
Williams et al. (2003) showed that seropositive cattle
naturally infected with N. caninum were protected
against abortion when experimentally challenged
in early gestation. These two studies indicate vacci-
nation may be a feasible option for the control of
bovine neosporosis.
Neospora caninum infections can be established in
mice, providing a convenient experimental model
with which to test potential vaccination strategies.
Live vaccines are more likely to induce appropriate
CMI responses in host animals (Innes et al. 2002).
Protective immunity against acute infection has
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been induced in mice using live attenuated,
temperature-sensitive mutant strains of N. caninum
(Lindsay et al. 1999) and sublethal doses of live
N. caninum tachyzoites (Lundén et al. 2002). Virus-
vectored vaccines including canine herpes virus
(CHV) and vaccinia virus expressing the NcSRS2
N. caninum protein have also induced protective
immune responses in mice (Nishikawa et al. 2000,
2001).
Attenuation of parasite virulence has been suc-
cessfully applied in the development of live vaccines
against other protozoan parasites. Leishmania major
and Leishmania mexicana have been attenuated
by repeated in vitro passage in the presence of gen-
tamicin, and both attenuated strains of Leishmania
induced significant protection in mice challenged
with wild-type parasites (Daneshvar et al. 2003).
Attenuation of virulence of Theileria annulata has
been demonstrated following prolonged in vitro
passage of schizont-infected cells (Hall et al. 1999).
Babesia bovis and Babesia bigemina have both
shown reduced virulence after repeated passage
through splenectomized cattle (Pipano et al. 2002).
Vaccination against Toxoplasma gondii-induced
abortion in sheep has been achieved using a live
incomplete (S48) strain of the parasite (O’Connell
et al. 1988; Wilkins et al. 1988). The S48 strain of
T. gondii was passaged over 3000 times in mice
and has lost the ability to form both tissue cysts and
oocysts (Buxton, 1993). A commercial vaccine based
on this product is currently available in several
countries worldwide and is licensed for veterinary
use only.
The purpose of our study was to determine
whether prolonged in vitro culture of N. caninum
tachyzoites by repeatedly passaging parasites into
fresh cell monolayers, would lead to attenuation of
virulence in vivo. This study compared tachyzoites
that were passaged successively between 33 and
39 times (low passage) and tachyzoites passaged
between 70 and 84 times (high passage).
MATERIALS AND METHODS
Parasites and experimental inocula
Neospora caninum tachyzoites (NC1 isolate) (Dubey
et al. 1988) were successively propagated as
previously described (Innes et al. 1995). Briefly,
N. caninum parasites were cultured in Vero cell
monolayers in 25 cm2 canted neck tissue-culture
flasks (Corning, NY, USA). The monolayers were
then disrupted using a sterile cell scraper (Corning,
NY, USA), parasites were counted in a Neubauer
haemocytometer and resuspended in phosphate-
buffered saline (PBS) to produce inocula containing
either 5r107 or 1r108 tachyzoites per ml. The
control inoculum contained the same number of
Vero cells as was present in the parasite inoculum
and was prepared in the same manner. Both the
parasites and Vero cells were inoculated into mice
intraperitoneally (i.p.) within 1 h of their prep-
aration in the laboratory, in a volume of 100 ml per
mouse. During the routine passage of the parasites,
aliquots were cryopreserved at regular intervals
and stored in liquid nitrogen as described below.
The parasites described in this paper were iso-
lated from a single source. The passage numbers
refer to the continuous in vitro passage of the same
stock of parasites for different lengths of time.
Cryopreservation and resuscitation of
N. caninum tachyzoites
Infected monolayers were disrupted to release
N. caninum tachyzoites as previously described
(Innes et al. 2001). The tachyzoites were then
counted and concentrated by centrifugation at
630 g for 5 min. The supernatant was discarded and
the parasites resuspended at a concentration of
1r107/ml in freezing medium (45% Iscoves
modified Dulbecco’s medium (IMDM) (Gibco
BRL, Paisley, UK) 100 U/ml penicillin and
100 mg/ml streptomycin, (Northumbria Biologicals,
Cramlington, UK), 45% foetal bovine serum (FBS)
(Labtech, Austria) and 10% dimethyl sulphoxide
(DMSO) (Sigma, Irvine, UK)). The parasites were
aliquotted into 1 ml cryotube vials (Nunc, Roskilde,
Denmark) and placed in 1 xC cryofreezing containers
(Nalgene, USA) stored at x70 xC for 24 h, then
transferred to vapour-phase liquid nitrogen storage.
The parasites were resuscitated from liquid nitrogen
storage by being rapidly warmed to 37 xC, then
washed in 10 ml of IMDM supplemented with 5%
FBS. Following centrifugation as above, parasites
were resuspended in 2 ml of IMDM supplemented
with 5%FBS, then inoculated into two 25 cm2 canted
neck tissue culture flasks (Corning, NY, USA), each
seeded 24 h previously with 1r105 Vero cells.
Experimental design
Female Balb/c mice, approximately 12 weeks old,
were randomly assigned into groups of 10, identified
by ear-marking, and fed rodent proprietary mix
and fresh water ad libitum. The mice were inoculated
intraperitoneally (i.p.) and observed daily. The
morbidity of the animals was assessed according
to a system agreed with the UK Home Office
Inspectorate, (Table 1). A cumulative score of 5
on any day or a score of 4 for 2 consecutive days
resulted in the mouse being culled. All surviving
mice were euthanized on day 28 post-inoculation
(p.i.) by CO2 inhalation. At post-mortem, samples
of brain were removed and stored at x20 xC for
analysis by N. caninum polymerase chain reaction
(PCR). Brain, lung, liver and kidney samples were
also removed and stored in 10% formal saline for
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histopathological examination, and blood was drawn
from the heart to obtain serum.
Groups of mice were inoculated i.p. with different
doses of low-passage (LP) and high-passage (HP)
parasites or a control inoculum of Vero cells as
indicated in Table 2.
ITS1 PCR
DNA was extracted from 25 mg samples of brain
using the DNeasy Kit (Qiagen) as per manu-
facturer’s instructions. Following extraction the
DNA was stored at x20 xC prior to analysis by
PCR. A nested PCR was used to detect N. caninum-
specific internal transcribed spacer 1 (ITS1) DNA
(Holmdahl and Mattsson, 1996) using the method
previously described by Buxton et al. (1998). This
produced a band of 297 bp when the products
(5 ml each) were analysed by agarose gel electro-
phoresis (1.8%), stained with ethidium bromide
and visualized under UV light.
Samples for histology and immunohistochemistry
Post-fixation, the brains were sliced coronally and,
along with blocks of the other tissues, were processed
to paraffin wax. Sections 5 mm thick were cut and
stained with haematoxylin and eosin (H&E). To
detect N. caninum, specific immunohistochemistry
was used as previously described (Buxton et al.
1997). Briefly, tissue sections were incubated at
4 xC overnight with a primary polyclonal rabbit
antiserum toN. caninum (diluted 1 : 1000). The slides
were washed in 0.5 M sodium chloride in 0.01 M
phosphate buffer, a biotinylated goat-anti-rabbit
IgG was used as a secondary antibody. Bound anti-
body was detected using the commercially available
Vector-elite ABC system (Vector Laboratories,
Peterborough, UK), with diaminobenzidine (DAB)
being used as the chromogen. Sections were then
counterstained with Mayer’s haematoxylin and
mounted under coverslips.
Serology
Blood taken at post-mortem was collected into
sterile 1.5 ml tubes, allowed to clot overnight at
4 xC and then centrifuged at 5000 g for 2 min. The
serum was decanted and stored at x20 xC prior to
analysis. An indirect fluorescent antibody test
(IFAT) for the detection of IgG was carried out
as previously described (Buxton et al. 1997). Test
sera were titrated in 2-fold dilutions from 1 : 16 to a
final concentration of 1 : 4096. The endpoint was
determined as the final concentration demonstrating
distinct whole tachyzoite fluorescence (Conrad et al.
1993). The same procedure was used for the detec-
tion of IgM with the exception that fluorescein iso-
thiocyanate (FITC)-conjugated goat anti-mouse
IgM was used as the secondary antibody.
In vitro growth characteristics
The in vitro growth characteristics of the parasites
were determined by quantifying their differential
incorporation of tritiated [3H]uracil. Three replicate
experiments were undertaken for low passage para-
sites (p.37, p.38 and p.39) and for high passage
parasites using (p.74, p.75 and p.76). The procedure
was carried out as previously described (Innes
et al. 1995). In brief, Vero cells were cultured at
a concentration of 5r104 cells per well, in 96-well
flat bottomed micro-titre plates (Nunc, Roskilde,
Denmark) for 24 h prior to inoculation with the
parasites. Parasites were added to quadruplicate
wells containing Vero cells at a parasite to cell ratio
of 4 tachyzoites: 1 cell. The cultures were labelled
with 37 kBq of [3H]uracil per well (Amersham,
Bucks, UK) and incubated at 37 xC in a humidified
Table 1. Morbidity score categories in accordance













10% weight loss 1
20% weight loss 2





A reluctance to move 1
Total Score=A+B+C.
Table 2. Experimental design
Experiment Group n Inoculum*
1 1 10 5r106 low-passage (LP)
(p.33) tachyzoites
2 10 5r106 high-passage (HP)
(p.70) tachyzoites
3 10 1r106 Vero cells
2 4 10 5r106 LP (p.39) tachyzoites
5 10 5r106 HP (p.84) tachyzoites
6 10 1r107 LP (p.39) tachyzoites
7 10 1r107 HP (p.84) tachyzoites
8 10 4.9r105 Vero cells
* (p.33)=Passage number 33; (p.70)=passage number
70; (p.39)=passage number 39 and (p.84)=passage
number 84.
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5% CO2 atmosphere. Immediately prior to harvest-
ing, parasite multiplication was stopped by the
addition of 10 ml of 1 M sodium hydroxide. Cul-
tures were harvested at 6, 12, 24, 48, 72 and 96 h
post-inoculation onto glass-fibre filters and the
parasite-associated radioactivity was quantified
using a MATRIX 96TM gas proportional counter
(Canberra Packard, Meriden CT, USA).
Statistical analysis
The mortality data from both Experiments 1 and
2 were analysed using the Kaplan-Meier procedure.
In Exp. 2, mice were generally weighed on alternate
days. A repeated measures model was fitted to data
for days 2, 4 and 6 p.i. only as no mice in Group 6
(1r107 LP) survived beyond day 7 p.i. The lack of
independence between observations on the same
mouse was modelled using an autoregressive
type 1 correlation structure. To allow for the differ-
ent mean starting weights for the groups, the day 0
reading was included in the model as a covariate.
For ease of interpretation the results have been
presented graphically as percentage changes from
baseline. Analysis of variance (ANOVA) was used
to analyse the in vitro growth experiment and IgG,
IgM IFAT results. For the in vitro experiment a
mixed model was used: counts per minute were
analysed on a log scale, with low/high passage fitted
as a fixed effect and the replicates within each type
of passage fitted as random effects. A one-way
ANOVA was used for the IgG and IgM data with
the age of the animal at sampling being included
in the model as a covariate. Differences in morbidity
scores between two groups over successive times
were assessed using Mann-Whitney tests. To ac-
count for multiple comparisons, the false discovery
control method of Benjamini and Hochberg (1995)
was used, as justified in this context by Benjamini
and Yekutieli (2001). All statistical analyses were
undertaken using Genstat 8th Edition apart from
the false discovery rate procedure that was im-
plemented within Microsoft Excel.
RESULTS
Exp. 1. Comparison of morbidity and mortality
in mice inoculated with 5r106 low- or high-passage
N. caninum tachyzoites
Clinical observations. Low-passage parasites.
Group 1 mice (5r106 LP) developed ruffled coats
from day 1 p.i., and from day 4 p.i. additional
clinical symptoms were observed including
hunching, reluctance to move, tottering gait and a
stiff stary coat. A drop in group mean body weight
of 6.6% (1.3 g) was observed by day 6 p.i. (data not
shown). Animals were scored and culled in ac-
cordance with the scheme in Table 1 and results are
illustrated in Fig. 1. By day 9 p.i. only 1 of the
original 10 mice remained (Fig. 2). This animal
became asymptomatic on day 17 p.i., and remained
so until the end of the experimental period.
High-passage parasites. Group 2 mice (5r106 HP)
had less severe clinical symptoms of infection,
when compared to the group 1 animals. Ruffled
coats were seen on days 1–4 p.i., with the animals
becoming asymptomatic on day 5 p.i. From day



























Fig. 1. Mean group morbidity score in Experiment 1. # – Group 1 (5r106 LP). & – Group 2 (5r106 HP). – Group
3 (1r106 Vero cells). Error bars (S.E.M.).
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a reluctance to move, and a tottering gait were
observed in a few mice and were responsible for a
group mean score of between 1 and 2 being main-
tained to the end of the experiment (Fig. 1). Only 1 of
the 10 mice in group 2 died, and this occurred on day
23 p.i. (Fig. 2). Group 2 had a maximum group
mean weight loss of 2.8% (0.6 g) on day 21 p.i. and
by day 28 p.i. had returned to the group mean
starting weight (data not shown).
Control animals. The control animals (group 3)
showed no clinical symptoms andmaintained a stable
body weight throughout the experiment.
Exp. 2. Comparison of morbidity and mortality
in mice inoculated with different doses of low- or
high-passage N. caninum tachyzoites
This experiment examined whether the difference
in virulence demonstrated in Exp. 1 could be re-
peated following cryopreservation and resuscitation
of parasites and using different doses of inoculum.
Low-passage parasites. Group 4 mice (5r106 LP)
displayed symptoms from day 4 p.i., including
hunching, reluctance to move, tottering gait and a




























































Fig. 3. Mean group morbidity score in Experiment 2. # – Group 4 (5r106 LP). $ – Group 5 (5r106 HP). % – Group
6 (1r107 LP). & – Group 7 (1r107 HP). – Group 8 (4.9r105 Vero cells). Error bars (S.E.M.).
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body weight of 20.9% (4.5 g) (Fig. 4) was also
observed. All 10 animals in group 4 were culled
or died by day 17 p.i. (Fig. 5).
Group 6mice (1r107 LP) hadmore severe clinical
symptoms by day 5 p.i. (Fig. 3), including an 8.3%
(1.8 g) drop in group mean body weight between
days 4 and 6 p.i. (see Fig. 4). All 10 mice were culled
or died by day 8 p.i. (Fig. 5).
High-passage parasites. Group 5 mice (5r106 HP)
displayed milder symptoms of murine neosporosis
than group 4, symptoms included a ruffled coat,
weight loss and reluctance to move which were
observed throughout the experiment (Fig. 3). The
mean morbidity score for group 5 was significantly
lower (P<0.05) (using Benjamini and Hochberg’s
false discovery control method) between 6 and
11 days p.i., compared to that seen in the animals
in group 4 (5r106 LP). A drop in group mean
body weight was observed from day 12 p.i., reaching
a maximum mean decrease of 17.6% (3.9 g) on
day 25 p.i. (see Fig. 4). Only 2 mice in group 5 were
culled or died prior to day 28 p.i. (Fig. 5). When the











































Fig. 4. Mean group % weight change from baseline in Experiment 2. # – Group 4 (5r106 LP). $ – Group 5 (5r106































Fig. 5. Mortality rate in Experiment 2 # – Group 4 (5r106 LP). $ – Group 5 (5r106 HP). % – Group 6 (1r107 LP).
& – Group 7 (1r107 HP). – Group 8 (4.9r105 Vero cells).
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using the Kaplan-Meier procedure, group 5 was
shown to have survived significantly longer
(P<0.001) than group 4.
Group 7 animals (1r107 HP) showed fewer
symptoms than either group 4 or group 6 (Fig. 3).
The mean morbidity score for group 7 was signifi-
cantly lower (P<0.05) between 6 and 7 days p.i.,
compared to that seen in the animals in group 6
(1r107 LP) (using Benjamini and Hochberg’s
false discovery control method). This dose of the
high-passage parasites, however, resulted in a 29.9%
(6.9 g) drop in group mean body weight (Fig. 4),
and all 10 mice in this group died or were culled
by day 25 p.i. (Fig. 5). When the survival times
from groups 6 and 7 were compared using the
Kaplan-Meier procedure, group 7 was shown to
have survived significantly longer (P=0.006) than
group 6.
Control animals. The control animals (group 8)
displayed no clinical symptoms and maintained a
stable body weight throughout the experiment.
Histopathology and PCR
Histological examination was performed on all
samples collected and the extent of pathology, was
based on the number and size of lesions observed
in the brain. Lesions in the tissues were assessed
histologically and the presence of parasites was
demonstrated by immunohistochemistry. In all
groups the severity of lesions was related to the
time of survival. In general, mice culled before
day 12 p.i. had mild or no lesions, whereas mice
that survived for 15 days or longer had more severe
pathology.
Low-passage parasites. The mice from group 4
(5r106LP) that died before day 12 p.i. showed either
mild, (Fig. 6A), or no pathology. The brains from
the 2 mice that survived to days 15 and 18 p.i. had
severe lesions, characterized by mononuclear peri-
vascular cuffs and necrotic foci (Fig. 6C). Parasite
tissue cysts or tachyzoites seen in H & E sections
were confirmed by means of IHC (Fig. 6B and D).
Group 6 mice (1r107 LP) were all culled at day 7
p.i., 6 mice had mild lesions characterized by small
to moderate numbers of foci of gliosis and necrosis
(Fig 6E), whilst in 2 mice lesions and parasites were
not detected. Parasite tissue cysts or tachyzoites
were detected in 5 mice by histology (Fig. 6F) or
IHC (Fig. 6G).
Parasite DNA was detected in 10 out of 10 brain
samples from mice in group 4 (5r106 LP) and in
7 out of 8 brain samples in group 6 mice (1r107 LP).
High-passage parasites. Seven mice from group 5
(5r106 HP), culled at the end of the experiment (day
28 p.i.) were severely affected (Fig. 7A), character-
istically with large mononuclear perivascular cuffs,







Fig. 6. Group 4 (5r106 LP) and Group 6 (1r107 LP). (A). Brain from a mouse culled at day 7 p.i. showing small
glial focus (gf) and a mild perivascular cuff (pc), (H&E). (B). Tissue cyst and tachyzoites within a small focus of gliosis
in the brain of the same mouse (indicated within circle) (IHC). (C) Brain from a mouse that was culled at day 18 p.i.
showing severe foci of necrosis (nf) and perivascular cuffing by mononuclear cells (pc) (H&E). (D) Small clumps
of Neospora caninum parasites within lesions in the brain of the same mouse (indicated within circle) (IHC). (E). Brain
from a mouse culled at day 7 p.i. showing a focus of necrosis. (F). N. caninum tissue cyst (arrow) (H&E). (G). Small
aggregates of N. caninum parasites (arrow) within a focus of necrosis in the brain of the same mouse (IHC).
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necrotic and glial foci and mononuclear meningitis.
Many tissue cysts and tachyzoites were also observed
(Fig. 7B and C), while in 1 mouse in group 5 only
mild histological changes were detected.
In group 7 (1r107 HP), 7 mice had similar
lesions to those observed in group 5. These mice
were culled between days 18 and 25 p.i. and fre-
quent foci of severe necrosis with gliosis and
perivascular cuffing were recorded (Fig. 7D). Many
tissue cysts and tachyzoites were present, mainly
associated with lesions (Fig. 7E and F). In the 2
mice culled at day 7 p.i. only small foci of mild gliosis
were seen.
Parasite DNA was detected in 7 out of 8 brain
samples in group 5 mice (5r106 HP) and in 9 out
of 9 brain samples in group 7 animals (1r107 HP).
Control animals. The control animals in group 8
had no clinical pathology, lesions, detectable para-
sites or parasite DNA.
Serology
Low-passage parasites. Group 4 mice (5r106 LP)
had IgM titres ranging from <1 : 16 to 1 : 128 and
IgG titres ranging from<1 : 16 to 1 : 64.While group
6 (1r107 LP) had IgM titres ranging from 1 : 16 to
1 : 256 and IgG titres of between<1 : 16 and 1 : 16. In
general, low antibody titres were associated with
early death or culling. The mouse in group 4 that
survived to day 18 p.i. gave the highest IgG
titre (1 : 64) whilst also giving to lowest IgM titre
(<1 : 16).
High-passage parasites. Group 5 mice (5r106 HP)
mice showed no detectable IgM (titre of<1 : 16) but
had IgG titres ranging from 1 : 256 to 1 : 1024. Group
7 (1r107 HP), had IgM titres ranging from <1 : 16
to 1 : 256 while the IgG titres in group 7 ranged
from 1 : 256 to 1 : 2048.
When the IgG results were compared it was
evident that group 5 produced greater levels of IgG
than that produced by the animals in group 4, and
group 7 produced greater levels of IgG than group 6.
However, as IgG generally increased with time these
differences are largely a reflection of the increased
survival times in the groups receiving HP parasites.
Control animals. The control animals (group 8)
had no detectable Neospora-specific IgM or IgG
antibody titres.
In vitro multiplication rates of parasites
Parasite multiplication was measured by the differ-
ential incorporation of [3H]uracil by the multiplying
parasites, and expressed as counts per min. Both








Fig. 7. Group 5 (5r106 HP) and Group 5 (1r107 HP). (A). Brain from a mouse culled at day 28 p.i. showing severe
lesions characterized by focal gliosis and vascular inflammation. (B) A small tissue cyst (arrow) associated with a focus
of inflammation in the brain of the same mouse (H&E). (C). A small tissue cyst (arrow) and numerous tachyzoites
within an area of necrosis and inflammation in the brain of the same mouse (IHC). (D). Brain from a mouse culled at
day 24 p.i. showing a severe focus of necrosis in the molecular layer of the cerebellum, with associated meningeal
inflammation. (E). One tissue cyst (arrow) and tachyzoites (arrowheads) in parasitophorous vacuoles, in the brain of a
mouse culled on day 24 p.i. (H&E). (F) Neospora caninum tissue cysts (arrows) and tachyzoites within parasitophorous
vacuoles in a focus of necrosis in the brain of a mouse culled at day 21 p.i. (IHC).
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(p.74–p.76) parasites multiplied steadily up to
48 h (Fig. 8), after which growth declined. There was
strong evidence (P<0.001) of a difference in the
pattern of growth rates over time between the high-
and low-passage parasites with the high-passage
parasites multiplying faster than the low-passage
parasites at every time-point. The decrease in
multiplication seen towards the end of the exper-
iments is likely to be due to the tachyzoites lysing
the Vero cell monolayers. The uninfected Vero cell
controls did not incorporate [3H]uracil at any of the
time-points tested.
DISCUSSION
Attenuation of virulence of N. caninum tachyzoites
was achieved by continuous, passage of parasites
in cell culture. In our study, differences were
clearly demonstrated in the in vivo pathogenicity
of N. caninum tachyzoites maintained for different
lengths of time in tissue culture. The animals in-
fected with the low-passage (virulent) parasites
demonstrated a very rapid progression to severe
clinical symptoms following inoculation with
5r106 parasites, resulting in 95.0% (19/20) of the
animals (groups 1 and 4) dying or being culled within
28 days p.i. By contrast, animals inoculated with the
high-passage (attenuated) parasites, showed milder
clinical symptoms and a 15.0% mortality rate with
only 3 of 20 animals in groups 2 and 5 dying or
being culled before day 28 p.i. The attenuation
effect appears to be dose dependent as the mice
that received 1r107 high-passage parasites had all
died by day 26 p.i. However, as a group they survived
significantly longer than the mice that received
1r107 low-passage parasites which all died or were
culled by day 8 p.i. The attenuation phenotype
observed in our study appears stable following
cryopreservation and resuscitation, as similar re-
sults were obtained in 2 separate experiments.
Other studies have shown that a subcutaneous (s.c.)
inoculation with 2r105 NC1 strain tachyzoites
in Balb/c mice resulted in a mortality rate of 58%
by day 70 p.i. (Lindsay et al. 1995). A subsequent
paper reported a mortality rate of 70% in Balb/c mice
within 41 days of an s.c. challenge with 5r105 NC1
strain tachyzoites (Lindsay et al. 1999). These papers
show that an s.c. inoculation of as few as 2r105 NC1
strain parasites may be lethal in Balb/c mice, al-
though no information is provided in these papers
concerning the length of time the parasites had
been maintained in culture prior to inoculation
into the mice.
Symptoms of clinical neosporosis in mice include
a rough coat, depressed appetite, dehydration,
weight loss, tottering gait and reluctance to move
(Lindsay and Dubey, 1989). Weight loss appears
to be a characteristic symptom during a primary
experimental infection with N. caninum tachyzoites
in mice, as a 23% reduction in weight was observed
by day 25 p.i. in Balb/c mice infected with NC
Liverpool strain N. caninum parasites (Quinn et al.
2002). The initial weight loss that occurs during
experimental N. caninum infections in mice is prob-
ably due to parasite multiplication causing tissue
damage to the peritoneum and internal organs,
leading to reduced appetite and dehydration. That
this weight loss is due to tissue damage rather
than the method of inoculation, is confirmed by the
control animals, which received an i.p. inoculation of
Vero cells but did not lose weight. Levels of weight

























Fig. 8. In vitro growth rates of Neospora caninum tachyzoites assessed by the differential uptake of [3H]uracil and
expressed as counts per minute (cpm). % – (low-passage tachyzoites p.37–p.39). & – (High-passage tachyzoites
p.74–p.76). – (Vero cells) Error bars (S.E.M. from 3 separate experiments using quadruplicate samples).
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disease, following a primary experimental challenge
with N. caninum parasites.
Detection of specific antibodies in mice inoculated
with N. caninum was related to survival time, with
higher antibody titres recorded in mice inoculated
with HP parasites. The humoral immune response
was characterized by an initial rise in levels of IgM
for the first few days following infection. The anti-
body response then switched to IgG at about 12 days
p.i. Those mice that succumbed to infection early
still demonstrated detectable IgM titres (ranging
from 1 : 16 to 1 : 256) and had either undetectable
or very low titres of IgG (ranging from <1 : 16 to
1 : 64). Higher specific antibody responses (both
IgM and IgG) were seen in the mice inoculated
with 1r107 HP N. caninum tachyzoites, compared
to those inoculated with 5r106 HP N. caninum
tachyzoites, suggesting that the antibody titre
produced was related to the challenge dose of
parasites. The importance of the humoral immune
response during murine Neospora infections was
demonstrated by Eperon et al. (1999), using B-cell
deficient mMT mice, which showed increased
susceptibility to infection with the parasite, com-
pared to wild-type mice. The anti-parasite function
of antibodies is yet to be determined, although
a likely role may involve controlling the spread of
extracellular parasites (Innes et al. 2005).
The severity of the pathology seen in our study
appears to be related to the survival time in the mice,
with those that survived longest demonstrating
the most severe lesions. Similar histological obser-
vations to those described in our study were seen by
Long et al. (1998), Lindsay et al. (1995, 1999) and
Lundén et al. (2002) when examining CNS tissue
from infected mice. In these studies mice that
received a primary challenge with NC1 N. caninum
tachyzoites developed severe neuropathological
lesions, including focal inflammation, focal necrosis
and perivascular cuffing. The findings from our
study are in agreement with those of Long et al.
(1998), who observed a positive correlation between
the dose of parasite challenge and levels of neuro-
pathology, with mice that received larger challenge
doses exhibiting more severe pathology than mice
that received lower challenge doses.
Positive N. caninum specific ITS1 PCR results
were seen as early as day 7 p.i. in samples of brain
from animals inoculated with either low-passage
or high-passage parasites, demonstrating that both
are capable of disseminating to the brains of in-
fected animals. Parasite DNA was detected in the
brains of 17/18 mice that received the low-passage
(virulent) parasites (groups 4 and 6), and 16/17 mice
that received the high-passage (attenuated) para-
sites. Tissue cysts containing N. caninum parasites
were seen in the brains of mice infected with either
the low-passage (virulent) parasites or the high-
passage (attenuated) parasites, demonstrating that
both are capable of stage differentiation. Loss of
life-cycle stage differentiation has been seen with
T. gondii, where in 1 case following as few as 35–40
passages of tachyzoites in mice, the parasite lost its
ability to form oocysts when the tissue cysts were
fed to cats (the definitive host of T. gondii) (Frenkel
et al. 1976). However, these parasites still retained
the ability to form tissue cysts in mice. The S48
strain of T. gondii (O’Connell et al. 1988; Wilkins
et al. 1988) was passaged over 3000 times in mice
(Bos, 1993) and was found to have lost the ability
to differentiate into either oocysts or bradyzoites.
As the S48 strain tachyzoites undergo limited
multiplication in vivo but do not persist, they proved
to be a very effective means of immunizing animals
against T. gondii (Buxton and Innes 1995). This
attenuated (S48) strain of T. gondii is marketed
as ToxovaxTM, a successful tissue culture-grown
vaccine capable of controlling T. gondii induced
abortion in sheep (O’Connell et al. 1988; Wilkins
et al. 1988; Bos, 1993; Buxton, 1993).
The comparison of in vitro growth rates demon-
strated that the high-passage (attenuated) parasites
multiplied faster than the low-passage (virulent)
parasites throughout. This may be because the
attenuated parasites had become more adapted to
tissue culture. A study by Schock et al. (2001) dem-
onstrated no link between length of time in tissue
culture and the in vitro growth rates of 6 different
N. caninum isolates; although this study did not
compare the growth rates of different passage
numbers of the same isolate. The findings described
in our paper suggest that the length of time in culture
may have an effect on the pathogenicity of Neospora
parasites in vivo. Long et al. (1998) noted that pro-
longed in vitro cultivation of N. caninum tachyzoites
led to a reduction in virulence in vivo. However,
Atkinson et al. (1999) demonstrated no attenuation
effect in vivo of NC Liverpool strain N. caninum
following 14 months of continuous in vitro culture,
when compared to a culture of NC Liverpool stored
in liquid nitrogen during this time. The same authors
showed that there were considerable differences
in the in vivo pathogenicity of NC Liverpool strain
N. caninum in mice compared to the NC-SweB1
strain (Atkinson et al. 1999).
The mechanisms involved in the attenuation
of other protozoan parasites are still not fully
understood. Daneshvar et al. (2003) demonstrated
attenuation of L. mexicana and L. major through
repeated in vitro culture of promastigotes in the
presence of gentamicin. Attenuation of T. annulata
parasites has also been achieved through prolonged
in vitro cell culture where the loss of virulence in vivo
is thought to be a complex and gradual process
caused by changes in the interaction between parasite
and host cells (Preston et al. 2001). The less severe
lesions observed following inoculation of the at-
tenuated strain of T. annulata into cattle has also
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been linked with a reduced expression of matrix
metalloproteases, which are required in cell adhesion
and migration (Hall et al. 1999).
Lindsay et al. (1999) characterized 3 N. caninum
temperature-sensitive mutants (NCts-4, NCts-8 and
NCts-12) produced following exposure of parasites
to N-methyl-N-nitro-N-nitrosoquanidine followed
by 3–8 months continuous cell culture at 32.5 xC.
These temperature-sensitive mutant parasites
caused less severe lesions in Balb/c mice when com-
pared to wild type NC1 strain parasites. However
NCts-4, and NCts-12 reverted to the virulent wild
type phenotype following culture at 37 xC, while
NCts-8 showed a significantly reduced incidence
of reversion to virulence following culture at 37 xC.
This study by Lindsay et al. (1999) also demon-
strated that vaccination of Balb/c mice with the
NCts-8 parasites induced significant protection
against a challenge with wild type NC1 strain
N. caninumparasites.Live attenuated strains of intra-
cellular protozoan parasites are attractive vaccine
candidates as they are more likely to induce protec-
tive cell-mediated immune responses compared to
immunization with killed vaccine preparations.
An interesting question arising from this study
is whether the attenuation phenotype is due to the
selection of a single genetic clone from a hetero-
geneous mix of parasites, or if the starting material
was already clonal, then attenuation must have
occurred through a more complex process such as
loss or mutation of genes.
The results from our study show that it is possible
to attenuate the virulence of N. caninum tachyzoites
for mice through prolonged in vitro cell culture. The
stability of the phenotype and the mechanisms in-
volved in the attenuation process are still unknown
and are the subject of continuing study.
The authors would like to acknowledge the Scottish
Executive Environment and Rural Affairs Department for
funding this study.
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3.1 Manuscripts main hypotheses  
 
The main hypotheses that were tested in this manuscript are 
1. Can inoculation of mice with a low dose (1x106) of live virulent or attenuated 
Neospora caninum tachyzoites protect against a subsequent known lethal 
challenge with the parasite? 
2. Does prior exposure to a low dose of virulent or attenuated Neospora caninum 
tachyzoites result in a reduction in the severity of histopathological lesions in the 
brains of animals following a lethal challenge with the parasite? 
3. Does prior exposure to a low dose of virulent or attenuated Neospora caninum 
tachyzoites result in a reduction in the incidence lesions in the brains of animals 
which contain parasites (tachyzoites) following a lethal challenge with the 
parasite? 
4. Does prior exposure to a low dose of virulent or attenuated Neospora caninum 
tachyzoites result in a reduction in the formation of tissue cysts in the brains of 
animals following a lethal challenge with the parasite? 
This study clearly shows that prior exposure to a low dose (1x10
6
) of either live virulent 
or attenuated tachyzoites conferred complete protection against death, as both 
vaccinated groups suffered 0% mortality following the lethal challenge. However 
animals from both groups still demonstrated severe histopathological lesions, and the 
presence of parasites / parasite antigens (as demonstrated using IHC). Though a 
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vaccination with attenuated parasites was unable to completely ameliorate the effects of 
the lethal challenge, animals receiving the attenuated vaccination generally 
demonstrated milder pathology and had a lower incidence of Neospora DNA positive 
brain samples compared to the animals vaccinated and challenged with the virulent 
parasites alone.  
One of the major flaws with the experimental design of this experiment was: As NC1 
strain parasites were used for both vaccination and challenge there was no way to 
determine if the parasites (parasite DNA) found in the brains of the animals were a 
result of the vaccination or the challenge. Had a different virulent Neospora strain been 
used for the challenge (i.e. Nc Liverpool), then RFLP or microsatellite technologies 
could have been used to differentiate the DNA from the two strains. This would have 
allowed a clearer measurement of the level of attenuation and whether the attenuated 
parasites still cause chronic infections.  
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SUMMARY
Neospora caninum tachyzoites attenuated through passage in tissue culture were tested for their ability to induce protective
immunity against a lethal challenge dose of parasites. Balb/c mice were each inoculated with either 1r106 live virulent
tachyzoites (Group 1) or 1r106 live attenuated tachyzoites (Group 2), while (Group 3) received a control inoculum. All
mice were each challenged 28 days later with 5r106 virulent parasites. Histopathological lesions in the brains including
necrosis andmicrogliosis were observed following post-mortem on day 28 post-challenge (p.c.) in 71% of Group 1 and 56%
of Group 2. Immunohistochemistry (IHC) of these lesions showed tachyzoites andNeospora antigens to be associated with
moderate brain lesions in 17% of Group 1, while in 11% of Group 2N. caninum tissue cysts were detected, but these were
not associated with lesions, Parasite DNAwas detected by PCR in the brains of 86% of mice in Group 1 and 56% of mice in
Group 2. Following challenge the mice in Group 3 showed high morbidity and 100%mortality within 17 days p.c. Positive
IHC forN. caninum was seen in 88% of the Group 3 mice and parasite DNA was detected in all brain samples. This study
shows that it is possible to protect against a lethal challenge ofN. caninum through inoculation with attenuated or virulent
tachyzoites. However, more severe pathology developed in mice initially inoculated with virulent parasites following a
secondary challenge, compared to mice initially inoculated with attenuated parasites.
Key words: Neospora caninum, attenuated tachyzoites, protective immunity.
INTRODUCTION
Neospora caninum is an obligate intracellular proto-
zoan parasite, closely related to Toxoplasma gondii.
First described in 1984 (Bjerkås et al.), it has a
worldwide distribution and is amajor cause of bovine
abortion (Dubey et al. 2006). Infection can be
transmitted either transplacentally from mother to
foetus, or through ingesting feed or water contami-
nated with oocysts, shed by infected dogs (a defini-
tive host of N. caninum) (McAllister et al. 1998).
Experiments with cattle have demonstrated that
protective immunity can be induced to prevent the
transplacental transmission of N. caninum following
a challenge with the parasite (Innes et al. 2001;
Williams et al. 2007). Williams et al. (2003) showed
that while naturally infected cows challenged with
N. caninum early in gestation (10 weeks) were pro-
tected against abortion, vertical transmission of the
parasites to the foetus still occurred, These studies
taken together show that cattle develop a degree of
protective immunity following prior exposure to
the parasite and lend weight to the hypothesis that
vaccination is a feasible option for controlling the
infection.
Experimental mouse models of neosporosis offer
an economic and convenient system for testing
potential vaccination candidates. Live attenuated
temperature-sensitive mutants (Lindsay et al. 1999),
sublethal doses of live N. caninum tachyzoites
(Lundén et al. 2002) and live c-irradiatedN. caninum
tachyzoites (Ramamoorthy et al. 2006) have all in-
duced protection in Balb/c mice against a lethal
challenge with the parasite. Killed and subunit vac-
cines have also shown some success in inducing
protective immune responses in mice. Studies using
E. coli expressed recombinant antigens NCMIC3
(Cannas et al. 2003) and NCSRS2 (Pinitkiatisakul
et al. 2005) and virus-vectored expression of re-
combinant NcGRA7 (Liddell et al. 2003; Jenkins
et al. 2004) have all induced protection in mice
against a challenge with N. caninum. However,
Baszler et al. (2000) demonstrated an exacerbation of
neurological disease in mice immunized with soluble
N. caninum tachyzoite antigens and subsequently
challenged with the parasite.
Attenuation of virulence through in vitro culture
has been examined in a number of protozoan parasite
species including Theileria (Preston et al. 2001) and
Leishmania (Daneshvar et al. 2003). The main
objectives of this study were to determine whether
N. caninum parasites attenuated through prolonged
in vitro culture (Bartley et al. 2006) will induce pro-
tection against a known virulent challenge and to
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compare any differences in the protective effects
between the virulent and attenuated parasites.
MATERIALS AND METHODS
Parasites and experimental inocula
Neospora caninum tachyzoites (NC1 isolate) (Dubey
et al. 1988) were maintained (Innes et al. 1995) and
used to prepare experimental inocula (Bartley et al.
2006) as previously described. Briefly, N. caninum
parasites cultured in Vero cell monolayers were dis-
rupted using a sterile cell scraper (Corning, NY,
USA), parasites were counted in a Neubauer hae-
mocytometer and resuspended in phosphate-buf-
fered saline (PBS) to produce inocula containing
either 1r107 or 5r107 tachyzoites per ml. The
virulent parasites were passaged 43 times in tissue
culture (passage (p.43)) while the attenuated para-
sites were passaged 88 times (passage (p.88)). Prior to
their use as experimental inocula, the virulent chal-
lenge parasites had been subcultured 39 times
(passage (p.39)). In a previous study (Bartley et al.
2006), prolonged culture ofNeospora in vitro resulted
in attenuation of their virulence in vivo. The control
inoculum contained the equivalent number of Vero
cells present in the parasite preparations and was
prepared in the same manner. Both the parasite
and the Vero cells were inoculated into mice in-
traperitoneally (i.p.) within 1 h of their preparation
in the laboratory, in a volume of 100 ml per mouse.
Experimental design
Female Balb/c mice, approximately 12 weeks old,
were randomly assigned into groups (n=10), indi-
vidually identified by ear-marking and fed rodent
proprietary mix and fresh water ad libitum. The mice
were inoculated i.p. with liveN. caninum tachyzoites
(see Table 1) and observed daily for 28 days post-
inoculation (p.i.) On day 28 all mice were challenged
i.p. with live N. caninum tachyzoites (see Table 1),
defined as day 0 post-challenge (p.c.) The morbidity
of the animals was assessed according to a system
agreed with the UK Home Office Inspectorate
(Bartley et al. 2006). All surviving mice were
euthanased on day 28 p.c. by CO2 inhalation. At post-
mortem examination, samples of brain were removed
and stored at x20 xC for analysis by N. caninum
internal transcribed spacer 1 (ITS1) and quantitative
polymerase chain reaction (PCR). Samples of brain,
lung, liver, kidney and spleen were also removed and
stored in 10% formal saline for histopathological
examination, and blood was drawn from the heart
and the serum was separated and stored at x20 xC
prior to testing.
Serology
Serum collected at the time of post-mortem exam-
ination as previously described (Bartley et al. 2006)
was examined with an indirect fluorescent antibody
test (IFAT) for the detection of Neospora-specific
IgG and IgM (Buxton et al. 1997). Briefly, 5 ml
volumes of a 1r107/ml suspension of 0.2% (v/v)
formalin-treated N. caninum tachyzoites were ap-
plied to each well of a 15-well multitest slide (ICN
Biomedicals, Aurora OH) and allowed to dry over-
night. Test sera were titrated in 2-fold dilutions from
1 : 16 to a final concentration of 1 : 4096 before ad-
dition to wells and incubated for 30 min at room
temperature. Slides were washed 3 times in PBS
before being incubated for 30 min with fluorescein
isothiocyanate (FITC)-conjugated goat anti-mouse
IgG (diluted 1 : 50 in PBS). They were then washed 3
times in PBS before cover-slips were mounted with
buffered glycerol and viewed under an Olympus
BX50 fluorescence microscope, with a U-MNB filter
cube, using a r40 objective. The endpoint was de-
termined as the final concentration of serum dem-
onstrating distinct whole tachyzoite fluorescence
(Conrad et al. 1993). The same procedure was used
for the detection of Neospora-specific IgM with the
exception that FITC-conjugated goat anti-mouse
IgM was used as the secondary antibody.
Histology and immunohistochemistry
All samples were fixed and sectioned for histological
and immunohistochemical analysis as described
(Bartley et al. 2006).
Table 1. Experimental design
(NC1 p.39 tachyzoites) – passage number 39, (NC1 p.43 tachyzoites) – passage




1 10 1r106 NC1 p.43 (Virulent) 5r106 NC1 p.39 (Virulent)
2 10 1r106 NC1 p.88 (Attenuated) 5r106 NC1 p.39 (Virulent)
3 10 2.45r104 Vero cells 5r106 NC1 p.39 (Virulent)
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ITS1 PCR
DNAwas extracted from brain samples and stored at
x20 xC prior to analysis by PCR (Bartley et al.
2006). A Neospora-specific nested-PCR was used to
detect the internal transcribed spacer 1 (ITS1) gene
(Holmdahl and Mattsson, 1996) using the method
previously described by Buxton et al. (1998). This
produced a band of 297 bp when the products were
analysed by 1.8% agarose gel electrophoresis, stained
with ethidium bromide and visualized under UV
light.
Quantitative SYBR green PCR
A quantitative PCR (qPCR) for the NC5 sequence of
N. caninum (Kaufmann et al. 1996) was performed
using the method and oligonucleotide primers de-
scribed by Collantes-Fernández et al. (2002). The
28S rRNA gene was chosen for the quantification of
host DNA (Collantes-Fernández et al. 2002), while
the primers to the 28S rRNA gene were also used as
‘housekeeping genes’, to act as a control to determine
the presence of potential PCR inhibiting compounds
in the extracted DNA samples.
To prepare standards, DNA was extracted from
tissue-culture derived Neospora tachyzoites using
the DNeasy Kit (Qiagen) as per manufacturers’ in-
structions. Total DNA was determined by spectro-
photometry (Beckman Coulter DU530), adjusted
with distilled water to a concentration of 2000 pg/ml
and used to make a serial logarithmic dilution (2000,
200, 20, 2, 0.2 and 0.02 pg/ml). Host genomic DNA
was extracted and quantified as previously described
from brain tissue of an uninfected mouse and used to
prepare standards at 20, 10, 5, 2, 1 and 0.5 ng/ml.
TheNeosporaNC5 and 28s rRNAprimers (MWG
Biotech AG, Germany) were performed as separate
assays, with each reaction containing 1r platinum
SYBR green qPCR supermix UDG (Invitrogen)
consisting of 0.75U platinum TaqDNA polymerase,
10 mM Tris-HCl, 25 mM KCl, 1.5 mM MgCl2,
100 mM of each deoxynucleoside triphosphate
(dATP, dCTP, dGTP) and 200 mM dUTP, 0.5U
uracil-DNA-glycosylase, 10 pmol of each forward
and reverse primer, 6 ml ultra-pure distilled water
and 5 ml DNA (25 ml total volume). All standards and
samples were undertaken in duplicate. Amplifi-
cations were performed with an ABI 7000 prism
sequence detector (Applied Biosystems), using the
manufacturer’s recommended protocol (2 min at
50 xC, 10 min at 95 xC, 40 cycles of 95 xC for 15 sec
and 60 xC for 1 min), the calculated cycle threshold
(Ct) was exported for analysis in Microsoft excel.
Quantities of parasite and genomic DNA in samples
were calculated by interpolation on the two standard
curves, where Ct values were plotted against the log
of known concentrations of Neospora and host
genomic DNA respectively. Following amplification
of both Neospora and host DNA, melting curves for
each were generated by a stepwise increase in tem-
perature from 55 xC to 95 xC, to ensure amplification
resulted in a single PCR product and no primer-
dimers.
Statistical analysis
One-way analysis of variance (ANOVA) was applied
to the morbidity, weight change and on qPCR data
using Minitab statistical software (v13.1).
RESULTS
Clinical observations
Group 1. The animals in group 1 showed no clinical
symptoms following the primary inoculation (1r106
NC1 p.43 tachyzoites).
Following challenge (5r106 NC1 p.39 tachy-
zoites), clinical symptoms, including a ruffled coat
and slight weight loss, were seen from day 1 post-
challenge (p.c.), resulting in a group mean maximum
morbidity score of 1.0 on day 1 (see Fig. 1), the
animals in this group returned to being clinically
normal on day 5 p.c. Changes in the mean group
weight were calculated by comparing the weight at
each time-point to the weight on day 0 p.c. Group 1
demonstrated a mean weight loss on day 2 p.c. of
0.3 g, which was regained by day 4 p.c., the mice
ended the experiment 2.3 g heavier than on day 0 p.c.
(see Fig. 2). Group 1 suffered 0%mortality following
challenge, with all the mice (n=7) surviving to the
end of the experiment (see Fig. 3).
Group 2. The animals in Group 2 showed no
clinical symptoms following the primary inoculation
(1r106 NC1 p.88 tachyzoites). Following challenge
(5r106 NC1 p.39 tachyzoites), clinical symptoms
including a ruffled coat and slight weight loss were
seen from day 1 p.c., resulting in a group mean
morbidity score of between 0.2 and 1.0, the mice
returned to being clinically normal by day 18 p.c. (see
Fig. 1), there was no significant difference in the
morbidity scores of Groups 1 and 2 at any time-point
tested following challenge. The weight loss seen in
Group 2 reached a maximum of 1.4 g on day 2 p.c.,
this weight was regained throughout the course of
the experiment and the mice ended the experiment
0.7 g heavier than on day 0 p.c. (see Fig. 2). There
were no statistical differences in the mean group
weights when groups 1 and 2 were compared. Group
2 suffered 0% mortality following challenge, with all
the mice (n=9) surviving to the end of the exper-
iment (see Fig. 3).
Group 3. The animals in Group 3 showed no
clinical symptoms following the primary inoculation
(2.45r104 Vero cells). Following challenge (5r106
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NC1 p.39 tachyzoites), clinical symptoms including
a stiff stary coat were seen from as early as day 1 p.c.
progressing through hunching, a tottering gait, a
reluctance to move and weight loss; resulting in a
group mean maximum morbidity score of 5.0 on day
16 p.c. (see Fig. 1). The weight loss started on day 2
p.c. with amean group loss of 4.5 g by day 16 p.c. (see
Fig. 2). The weight loss seen in Group 3 was sig-
nificant (P=0.001) from day 12 p.c. onwards, when
compared to Groups 1 and 2. Group 3 suffered 100%
mortality following the parasite challenge, the first
animals were culled on day 8 p.c. and the final mouse
was culled on day 17 p.c. (see Fig. 3).
Three animals in Group 1 and 1 animal in Group 2
died on day 0 p.c. due to complications resulting
from the administration of the challenge inoculum.
Results from these animals were not used in any
calculations.
Serology
IgM. Neospora-specific IgM titres of <1/16 were
detected in all the mice from Group 1 (n=7) and
Group 2 (n=9), while Group 3 had IgM titres of























Fig. 2. Changes in mean group weight following challenge with virulent Neospora caninum tachyzoites. & – Group 1,
1r106 NC1 p.43 tachyzoites. m – Group 2, 1r106 NC1 p.88 tachyzoites. $ – Group 3, 2.45r104 Vero cells. All























Fig. 1. Mean group morbidity scores following challenge with virulent Neospora caninum tachyzoites. & – Group 1,
1r106 NC1 p.43 tachyzoites. m – Group 2, 1r106 NC1 p.88 tachyzoites. $ – Group 3, 2.45r104 Vero cells. All
groups were challenged with 5r106 NC1 p.39 tachyzoites. (Error bars ¡ S.E.M.).
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IgG. Group 1 demonstratedNeospora-specific IgG
titres that ranged between 1/1024 (n=2), 1/2048
(n=3) and 1/4096 (n=2), while Group 2 gave IgG
titres of 1/1024 (n=1), 1/2048 (n=5) and 1/4096
(n=3). The IgG titres seen in the mice fromGroup 3
ranged from <1/16 (n=3) to 1/16 (n=2) and 1/32
(n=3). (We were unable to collect samples from 2
mice in Group 3.)
Pathology and PCR results
The extent of the histopathological changes post-
challenge, based on the number and size of lesions
observed in the brain, were assessed and the pres-
ence of the parasite was demonstrated by
immunohistochemistry (IHC) andNeospora-specific
PCR.
Group 1. Two animals in Group 1 had no demon-
strable pathology, while a third mouse showed mild
mononuclear perivascular cuffs. The remaining 4
mice in Group 1 showed large severe foci of mono-
nuclear inflammation including perivascular cuffing;
severe foci of necrosis and microgliosis. One of the
mice with severe lesions also had foci of mineraliza-
tion in the brain, while tachyzoites and parasite
antigens were demonstrated in moderate lesions
associated with mononuclear infiltrates in the brain
of another severely affected mouse (see Fig. 4A).
Positive Neospora-specific PCR results were ob-
tained from 6 mice in this group (see Table 2), in-
cluding 1 mouse in which lesions were not detected.
One mouse was negative by PCR and by histo-
pathology and IHC.
Group 2. Histopathological lesions were not de-
tected in 4 of the mice from Group 2. In 1 mouse
there was mild microgliosis along with mild
mononuclear perivascular cuffs, while in another





























Fig. 3. Mortality rates following challenge with virulent Neospora caninum tachyzoites. & – Group 1, 1r106 NC1 p.43
tachyzoites. m – Group 2, 1r106 NC1 p.88 tachyzoites. $ – Group 3, 2.45r104 Vero cells. All groups were challenged
with 5r106 NC1 p.39 tachyzoites.
BA
Fig. 4. (A) (Group 1). Neospora antigens (arrow) associated with mononuclear cells within a moderate brain lesion. (B)
(Group 3). Neospora antigen associated with mononuclear cells ; a tissue cyst (arrow) and tachyzoites (arrowhead) within
a severe lesion.
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microgliosis. In the 3 remaining animals in the group
there were large severe foci of microgliosis, necrosis
and mononuclear perivascular cuffs. Parasite anti-
gens were detected in the brains of these 3 mice by
IHC, but only in a very small number of cells and
these were not associated with any lesions. In 1 of the
mice with severe lesions a small tissue cyst was ob-
served and was associated with inflammation but no
necrosis or microgliosis. Positive PCR results were
obtained from 5 mice in this group (see Table 2) and
all 5 demonstrated pathological changes. Four mice
gave negative PCR results ; these animals also had no
pathological changes.
Group 3. One mouse in Group 3 (post-mortemed
on day 10 p.c.) showed no pathology in the brain, but
had moderate numbers ofN. caninum parasites in the
lungs. Two other mice also culled on day 10 p.c.
showed foci of mild mononuclear perivascular cuffs,
mild microgliosis, and mild necrosis. The remaining
5 mice in the group were all culled between days 13
and 17 p.c. and demonstrated moderate to severe
mononuclear perivascular cuffs, microgliosis, and
necrosis. A number of these mice also showed signs
of splenic haemorrhaging and hepatic vacuolation.
Parasite cysts were detected in 5 animals, 2 of these
animals were post-mortemed on day 10 p.c., and in 1
of these 2 mice tachyzoites were present in the brain.
In 6 mice, positive labelling for parasite antigens in
infiltrating mononuclear cells were observed as well
as tachyzoites and tissues cysts in brain samples
analysed by IHC (see Fig. 4B). These Neospora
antigen-positive cells were associated with moderate
to severe lesions in all 5 of the mice. All of the mice
sampled in Group 3 (n=8) gave positive Neospora-
specific PCR results (see Table 2). (We were unable
to collect samples from 2 mice in Group 3.)
Quantitative PCR
DNA extracted from brain samples of mice in Group
1 had a mean concentration of Neospora DNA of
0.011 pg/ng host genomic DNA (standard error of
the mean (S.E.M.) ¡0.004 pg). Group 2 had a mean
concentration of Neospora DNA of 0.042 pg/ng host
genomic DNA (¡0.014 pg). When the results from
Groups 1 and 2 were compared by one-way
ANOVA, it was shown that there was no statistical
difference (P=0.088) between the amount of
Neospora DNA per ng of host genomic DNA be-
tween the two groups. The results fromGroup 3 gave
a mean concentration ofNeospora DNA of 2.519 pg/
ng host genomic DNA (¡0.493 pg). When the re-
sults from Groups 1 and 2 were compared (one-way
ANOVA) against those of Group 3, both groups that
had previously been inoculated with either virulent
or attenuated parasites showed significantly less
(P=0.001) parasite DNA per ng of host genomic
DNA than the control animals.
DISCUSSION
Previous work showed that it is possible to attenuate
the virulence of N. caninum tachyzoites through
prolonged passage in tissue culture (Long et al. 1998;
Bartley et al. 2006). This present study shows that
prior exposure to these attenuated parasites is suf-
ficient to protect against a lethal challenge of virulent
parasites. Mice exposed to low doses of virulent
parasites were also protected against a lethal chal-
lenge, but demonstrated more severe pathology and
a greater incidence of Neospora-DNA in the brain
(86% positive) post-challenge, compared to the ani-
mals inoculated with attenuated parasites (56%
Neospora-DNA positive).
The mortality rate in the control (Group 3) ani-
mals reached 100% by day 17 p.c., while all the
vaccinated mice were protected against the lethal
challenge and survived to the end of the experiment
on day 28 p.c. Previous studies in Balb/c mice have
shown mortality rates of up to 70% following a sub-
cutaneous challenge with as few as 2.5r105 NC1
strain N. caninum tachyzoites (Lindsay et al. 1999)
and up to 95% in mice following an i.p. challenge
with 5r106 tachyzoites (Bartley et al. 2006). Lundén
et al. (2002) previously showed that sublethal doses
of liveN. caninum tachyzoites were protective against
a lethal challenge with the parasites; while, Lindsay
et al. (1999) demonstrated protection against a lethal
challenge with Neospora using live attenuated tem-
perature sensitive mutant strains of the parasite.
Ramamoorthy et al. (2006) have also demonstrated
protection in Balb/c mice, through vaccination with
c-irradiated tachyzoites. This vaccine offered com-
plete protection against parasite-induced mortality,
whereas all the unvaccinated control animals chal-
lenged with 2r107 tachyzoites died by day 7 p.c.
(Ramamoorthy et al. 2006)
The clinical symptoms seen in themice during this
study were similar to those described by Lindsay and
Dubey (1989) and Lindsay et al. (1995), including
rough coats, hunching, a reluctance to move, totter-
ing gait and weight loss caused by a depressed
appetite and dehydration. The naı̈ve control mice
that received the challenge of virulent parasites
demonstrated a rapid onset of many of these
Table 2. Neospora-specific ITS1 PCR
Group n
Neospora-specific ITS1 PCR results
Number positive % Positive
1 7 6 86
2 9 5 56
3 8 8 100
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symptoms, which resulted in 100% (10/10) of the
animals in the group being culled by day 17 p.c.
Animals previously exposed to the parasite showed
minimal clinical symptoms of infection, with limited
ruffling of the coat, demonstrating that prior ex-
posure to the parasite was sufficient to protect against
the severe morbidity associated with Neospora chal-
lenge infections in Balb/c mice. Pinitkiatisakul et al.
(2005) made similar observations, where mice im-
munized with recombinant NcSRS2 antigen then
challenged i.p. with 1r107 live tachyzoites showed
almost no morbidity; the non-immunized mice,
however, showed neurological symptoms of neo-
sporosis.
Previous studies have shown weight loss of 23% to
29.9% (Quinn et al. 2002; Bartley et al. 2006) fol-
lowing inoculation of Balb/c mice with Neospora
parasites. In this present study a mean weight loss of
4.5 g (23.7%) occurred in primary challenge animals,
while mice previously exposed to Neospora and then
challenged continued to gain weight. This demon-
strates weight loss to be a good indicator of severity of
N. caninum infection in Balb/c mice, as the animals
exhibiting the most severe morbidity also showed the
greatest percentage weight loss.
Pathological changes were seen in the brains of
many of the inoculated animals, indicating that prior
exposure to the parasite does not always confer
complete protection against infection with N. cani-
num. The pathology seen in the mice that initially
received the attenuated parasite was milder than that
seen in themice inoculated with the virulent parasite,
where a greater incidence of large foci of severe
perivascular cuffing and necrosis was observed. The
pathology observed in this study was comparable to
that observed in previous experimental infections of
mice (Lindsay et al. 1995; Long et al. 1998; Bartley
et al. 2006). An interesting observation from this
study was that there appeared to be no correlation
between the presence of lesions in the brains of mice
and the presence of overt clinical symptoms. Similar
findings were reported by Ramamoorthy et al.
(2006), where mice vaccinated with c-irradiated
tachyzoites showed no clinical signs of murine
neosporosis, but at post-mortem neuropathologywas
observed.
PositiveNeospora-specific ITS1 PCR results were
seen in all the brain samples from mice in Group 3
from as early as day 10 p.c. These results are con-
sistent with the findings of previous experiments,
where positive PCR results were seen from day 7 p.i.
following an i.p. inoculation with 5r106 NC1
tachyzoites (Bartley et al. 2006). Parasite DNA was
detected in 86% of brain samples from mice in group
1 (which received the virulent parasites), but in only
56% of mice in Group 2 (which received the atten-
uated parasites). Previous work (Bartley et al. 2006)
has shown that the attenuated parasites are still
capable of dissemination and stage differentiation.
The qPCR forNeosporaDNA allowed reproducible,
sensitive quantification of parasite burdens in in-
fected mice. The qPCR results from this present
study illustrated that there were significantly
(P<0.001) lower levels of Neospora DNA in the
brains of previously inoculated animals than was
found in the brains of the control animals challenged
with the virulent parasites. Prior exposure to the at-
tenuated parasites resulted in 44% of the mice in
Group 2 being PCR negative following challenge and
lead to a significant reduction in the quantity of
parasite DNA, compared to the control group.
Although inoculation with virulent parasites also
lead to a significant reduction in the quantity of
parasite DNA post-challenge, only 14% of mice were
PCR negative. These data would suggest that in-
oculation with the attenuated or virulent parasites is
capable of reducing both the severity of infection and
the parasite burden found in the brains of challenged
animals.
The importance of the humoral immune response
in mice during N. caninum infections was demon-
strated by Eperon et al. (1999) who showed increased
susceptibility to infection with the parasite in mMT
B-cell deficientmice, compared to wild-typemice. In
our study mice that were culled or died early in the
experiment were seen to be producing N. caninum-
specific IgM.Teixeira et al. (2005) also demonstrated
production ofN. caninum-specific IgM by day 7 p.c.
followed by the production of IgG from about day 14
p.c., which is similar to the finding from our exper-
iment, where all mice that survived to the end of the
experiment seroconverted, producing high titres of
Neospora-specific IgG. Though the role of the hu-
moral immune response against Neospora has not
been conclusively demonstrated; a likely role of
antibodies would be in controlling the spread of the
extracellular tachyzoite stage of the parasite (Innes
et al. 2005). This hypothesis was further strength-
ened when Haldorson et al. (2006) showed that
antibodies directed against the tachyzoite surface
protein NcSRS2 inhibited the attachment and
invasion of parasites in vitro. A further role of
the B-cells may be in the activation of T-cells, since
Teixeira et al. (2005) demonstrated that some
CD69+ B-cells from N. caninum-infected mice
were also expressing CD80 and CD86, suggesting a
role in T-cell activation.
The results from our study show that prior ex-
posure to live attenuated tachyzoites not only pro-
tects against a lethal challenge ofN. caninum, but also
leads to milder pathology and a lower number of
PCR-positive samples compared to inoculation and
challenge with virulent parasites. Prior inoculation
with either the attenuated or the virulent parasites
significantly reduced morbidity, mortality and
quantity of parasite DNA in brain tissue, compared
to the control animals following challenge of all the
groups with virulent parasites. Further work is
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required to examine the immunological responses
induced by these attenuated parasites and to deter-
mine whether vaccination with the attenuated tachy-
zoites can inhibit the transplacental transmission of
the parasite.
The authors would like to acknowledge the Scottish
Executive Environment and Rural Affairs Department for
funding this study.
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4 The development of immune responses in Balb/c mice 
following inoculation with attenuated or virulent Neospora 
caninum tachyzoites 
 








4.1 Manuscripts main hypotheses  
 
The main hypothesis that was tested in this manuscript is: 
1 Are there quantifiable differences in the humoral and cell mediated immune 
responses generated in mice following a challenge with virulent or attenuated 
Neospora tachyzoites. 
Where comparisons could be made (day 14 pi only) mice inoculated with either the 
virulent or the attenuated parasites had demonstrable anti-Neospora IgG titres. However, 
at the same time point (day 14 pi) higher levels of splenocyte proliferation and IFN-γ, 
IL-2, IL-4 and IL-10 production were seen in the mice receiving the attenuated parasites 
compared to those that received the virulent parasites. This experiment also 
demonstrated that prior exposure to the attenuated parasites not only protected against a 
challenge of 1x10
7
 virulent tachyzoites, which our previous work had shown to be 
highly lethal. But also lead to a reduction in the parasite burdens in the vaccinated / 
challenged animals, as demonstrated by both qPCR and IHC compared to the 
unvaccinated challenged mice. 
Though this experiment clearly demonstrated that there were quantifiable differences in 
both the humoral and cell mediated immune responses between animals receiving 
attenuated or virulent parasites at day 14 pc, inter-group comparisons could only be 
made at one time point, as the initial challenge dose for the virulent parasites was too 
high. The dose (5x10
6
) of parasites was chosen as it had previously been shown that that 
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number of parasites would produce a strong clinical response in Balb/c mice. Which 
when looking at a single time point, or at overall morbidity / mortality is fine. However 
for this experiment, as we were looking to compare responses over a time course 





 tachyzoites would have probably been more appropriate. A lower 
parasite dose would have resulted in reduced mortality, allowing more detailed analysis 
of the immunological responses against the virulent Neospora parasites to be made over 
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SUMMARY
Balb ⁄ c mice were inoculated intraperitoneally (i.p.) with
either 5 · 106 live virulent (group 1) or 5 · 106 live attenu-
ated (group 2) tachyzoites, or Vero cells (group 3). Animals
were killed at 0, 14, 28 and 42 days post-inoculation
(p.i.), with the remaining mice receiving a lethal challenge
on day 48 p.i. Serum, spleen and brain samples were col-
lected post-mortem to examine humoral and cell-mediated
immune responses as well as pathological lesions and to
quantify parasite loads. On day 14 p.i. group 2 (attenuated)
demonstrated statistically significant (P < 0Æ001) lower lev-
els of mean morbidity and weight loss, while also showing
significantly (P = 0Æ01) higher levels of splenocyte prolifera-
tion and IFN-c production (P = 0Æ003), compared to group
1 (virulent). Histology of brain samples showed milder
lesions and a lower incidence of positive immunohistochemis-
try, demonstrating tachyzoites and tissue cysts, and statisti-
cally significant (P = 0Æ03) lower mean burdens of parasite
DNA in group 2 (attenuated) compared to group 1 (viru-
lent). All mice in group 2 were protected following challenge
on day 48 p.i. whereas nave control mice succumbed to the
challenge. No mice from group 1 (virulent) survived beyond
day 24 p.i. so they were not included in the challenge.
Keywords Balbc, cell mediated immunity, Neospora cani-
num
INTRODUCTION
Neospora caninum is an apicomplexan parasite which was
first described in 1984, as an unidentified cyst forming
sporozoan (1). Neospora is closely related to Toxoplasma
gondii, has a world wide distribution and is considered to
be a major cause of reproductive failure in cattle (2,3),
and thus neosporosis has a major economic impact on the
cattle (beef and dairy) industries (4).
A major route of transmission of Neospora in cattle is
transplacentally from dam to foetus, though a primary
infection may also occur following the ingestion of oocysts
shed by dogs (a definitive host of the parasite) (5). Cattle
infected with Neospora are 3–7 times more likely to abort
than uninfected animals (6). However, McAllister et al. (7)
have shown that cows exposed to Neospora prior to preg-
nancy are less likely to abort during a point source out-
break than cows with a primary infection. A recent study
by Williams et al. (8) demonstrated protection against foe-
tal death with an inoculation of live N. caninum tachyzo-
ites, while Innes et al. (2) demonstrated that dams
previously exposed to N. caninum inhibited the vertical
transmission of the parasite following a challenge at mid
gestation. All these results indicate that a level of protec-
tive immunity can be generated and that vaccination
against neosporosis is a possibility.
Due to the intracellular nature of the parasite the
predicted protective immune response would be predomi-
nantly a type 1 (Th1) cell-mediated immune (CMI)
response with strong emphasis on lymphoproliferative
responses as well as IFN-c and IL-12 production. A
number of experimental mouse models have shown this
to be true (9–11). However, several recent studies have
also suggested that a balanced Th1–Th2 response is
required to limit a damaging host immune response,
with great importance being placed on the production
of IL-4 (12–15).
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We have previously demonstrated that it is possible to
attenuate the virulence of Neospora through prolonged
in vitro passage (16) and that exposure to these attenuated
parasites protects against a lethal challenge with the
organism (17). This present study set out to investigate the
development of humoral and CMI responses, parasite
development and resultant pathology elicited by inocula-
tion with either attenuated or virulent tachyzoites.
MATERIALS AND METHODS
Parasites and experimental inocula
Neospora caninum tachyzoites (NC1 strain) (18) were
propagated as previously described (19). Briefly, the para-
sites were maintained by repeated passage in Vero cell
monolayers in 25 cm2 canted neck tissue culture flasks
(Corning, NY, USA). Tachyzoites were harvested from the
cell monolayers by disruption with a sterile cell scraper
(Corning, NY, USA) and counted using a Neubauer
haemocytometer then resuspended at a concentration of
5 · 107 ⁄ mL or 1 · 108 ⁄ mL (see Table 1). The control
inoculum contained the equivalent number of Vero cells
present in the parasite inoculum and was prepared in the
same manner. All were inoculated intraperitoneally (i.p.)
into mice within 1 h of their preparation in the laboratory,
with each mouse receiving a 100 lL dose.
The N. caninum isolate used in this study is defined by
the number of times (p.) it has been passaged (sub-cul-
tured) in vitro. In previous studies (16,17) prolonged cul-
ture of N. caninum tachyzoites in vitro lead to the
attenuation of virulence in vivo. The virulent parasites have
been passaged continuously 34 times or 36 times, while the
attenuated parasites have been passaged 76 times.
Experimental design
Female Balb ⁄ c mice approximately 12 weeks of age were
randomly assigned into two groups each of 30 mice, group
1 (virulent) and group 2 (attenuated) and one group of 15
mice group 3 (Vero cells). The mice were individually iden-
tified by ear marking and given fresh water and rodent
propriety mix ad libitum. The mice were inoculated i.p.
with live N. caninum tachyzoites (Table 1) and observed
daily. The morbidity of the animals was assessed according
to a system agreed with the UK Home Office Inspectorate
(16). Mice were randomly ascribed numbers at the start of
the experiment and then killed in order, with six mice
from group 1 and group 2 and three mice from group 3 to
be killed on days 0, 14, 28 and 42 post-inoculation (p.i.).
The remaining mice from all groups were administered
with an i.p. challenge comprising live N. caninum tachyzo-
ites on day 48 p.i. (see Table 1) and observed for a further
15 days. Mice were killed by CO2 inhalation and at post-
mortem examination blood was drawn from the heart to
obtain serum, the spleen was excised and processed for
immunological assays. The brain was then removed, cut
longitudinally into two along the midline and one half
was placed in 10% formal saline for histopathology and
immunohistochemistry, while the other half was frozen
and stored at )20C prior to analysis by internal tran-
scribed spacer (ITS1) PCR and SYBR green q-PCR.
Processing cells for immunological assays
At post-mortem examination the spleen was removed and
placed in 5 mL wash buffer [Hanks balanced saline solution
supplemented with 2% heat inactivated foetal bovine serum
(DH-FBS) (Labtech, Mornington, Australia), 100 IU ⁄ mL
penicillin and 100 lg ⁄ mL streptomycin (Northumbria Bio-
logicals, Cramlington, UK)]. In the laboratory the spleen
was placed in a sterile Petri dish and slowly injected with
10 mL of wash buffer, using 2 · 5mL syringes and 21G
needles, causing the spleen to expand and rupture to
release splenocytes, which were then decanted into a sterile
universal and centrifuged at 280 g for 5 min. The spleno-
cytes were washed · 2 in 10 mL wash buffer by repeated
centrifugation, counted using a Neubauer haemocytometer
and resuspended at a concentration of 2 · 106 cells ⁄ mL in
cell culture media (CCM) (Iscoves modified Dulbecco’s
Table 1 Experimental design
Group Inoculationa (day 0 p.i.)
Days p.i. ⁄ no. of mice (no. at PM)
Challengea (day 48 p.i.)
Day p.i.
54–630 14 28 42
1 5 · 106 NC1 (p. 34) (virulent) 6 (6) 6 (4) 6 (0) 6 (0) 1 · 107 NC1 (p. 36) (virulent) 6 (0)
2 5 · 106 NC1 (p. 76) (attenuated) 6 (6) 6 (6) 6 (5) 6 (5) 1 · 107 NC1 (p. 36) (virulent) 6 (6)
3 4Æ35 · 105 Vero cells 3 (3) 3 (3) 3 (3) 3 (3) 1 · 107 NC1 (p. 36) (virulent) 3 (3)
a(p. 34), passage number 34; (p. 76), passage number 76; (p. 36), passage number 36.
p.i., post-inoculation; NC, Neospora caninum.
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medium) supplemented with 10% DH-FBS, 100 IU ⁄ mL
penicillin and 100 lg ⁄ mL streptomycin).
Cell proliferation assays
Equal volumes of splenocytes (2 · 106 ⁄ mL) (see above) and
antigens were added in triplicate to 96-well round-bottomed
tissue culture plates (Nunc, Roskilde, Denmark). The
N. caninum antigen (NCA) consisted of a water-soluble
lysate of tissue culture derived N. caninum tachyzoites, pre-
pared as previously described by Innes et al. (2). The NCA
was used in culture at a final concentration of 2Æ5 lg ⁄ mL.
Cells were also cultured with the T-cell mitogen Con A at a
final concentration of 2Æ5 lg ⁄ mL, which was used as a posi-
tive control, while Vero cell antigen at a final concentration
of 1 lg ⁄ mL was used to ensure the immune responses
observed were Neospora specific and not against the con-
taminating Vero cells. The CCM was used as a negative con-
trol to determine the background level of cell proliferation.
Plates were placed in a 37C incubator with a humidified 5%
CO2 atmosphere for 4 days. Cells were pulsed for the final
18 h with 18Æ5 KBq 3H thymidine (Amersham Biosciences,
Bucks, UK) per well, then harvested onto fibreglass filters
(Wallac, Turku, Finland), the cell associated radioactivity
was determined using a microbeta Trilux liquid scintillation
counter (Perkin Elmer, Wellesley, MA, USA).
A duplicate assay was set up for each sample; cell-free
supernatants were harvested after 4 days and stored at
)20C prior to analysis for levels of cytokine production.
Enzyme-linked immunosorbent assays for the detection
of murine cytokines
Cell-free supernatants (see above) were examined for the
presence of IL-2, IL-4, IL-10 and IFN-c using commer-
cially available ELISA kits (Diaclone, BesanÅon, France).
Assays were performed as per manufacturers instructions.
Standard curves were generated for each cytokine by plot-
ting absorbance reading (optical density (OD) value)
against known standard cytokine concentrations. The OD
value of each experimental sample was extrapolated
against these standard curves to determine experimental
cytokine concentrations.
Serology
Serum collected post-mortem was processed as described by
Bartley et al. (17) and tested for the presence of Neospora-
specific IgM and IgG by indirect fluorescent antibody test
using the procedure described by Bartley et al. (16). The
endpoint was determined as the final concentration of sera
that demonstrated whole tachyzoites fluorescence (20).
ITS1 and SYBR Green q-PCR
The nested PCR used to detect Neospora-specific ITS1
DNA (21) was performed using the method previously
described by Buxton et al. (22). This produced a band of
297 bp, when the amplification products were analysed
using 1Æ8% agarose gel electrophoresis, stained using ethi-
dium bromide and visualized under ultraviolet light. Sam-
ples that tested positive by the ITS1 PCR were tested
using the qPCR for the NC5 sequence of N. caninum,
which was performed using the primers previously
described by Collantes-Fernandez et al. (23) and the
method, standards and amplification conditions previously
described by Bartley et al. (17).
Histology and immunohistochemistry
After 2–4 weeks fixation each half brain was sliced coro-
nally to give blocks through the anterior cerebrum, mid-
cerebrum at the level of the thalamus, the posterior cere-
brum at the level of the hippocampus, the midbrain, the
cerebellum and the pons. These samples were processed
through graded alcohols to paraffin wax. Sections 4-lm
thick were cut and stained with haematoxylin and eosin as
described by Lunden et al. (12). Pathological findings in
the brain were scored as follows: 0 = no changes;
1 = pathological changes present (mild); 2 = pathological
changes moderate (often only involving one or two sec-
tions); 3 = pathological changes severe (usually also
involving all sections). Serial sections were cut and sub-
jected to an immunohistochemical method to demonstrate
both N. caninum bradyzoites in tissue cysts and tachyzo-
ites, as previously described by Lunden et al. (12).
Statistical analysis
The Kruskal–Wallis one-way analysis of variance was
applied to evaluate the average morbidity score data of
individual mice from day 0 to 14 p.i, with a nonparametric
two-sided Mann–Whitney test being used to compare the
data from group 1 (virulent) and group 2 (attenuated)
mice. A repeated measures model was fitted to the body
weight data, using a first order autoregressive correlation
structure with P-values estimated using modified F-statis-
tics (24). Multiple comparisons with Bonferonni approxi-
mation were used to compare the body weights of group 1
(virulent) and group 2 (attenuated) mice. The CMI
responses from the proliferation assays were evaluated
using a linear mixed model with P-values estimated using
modified F-statistics (24). For the cytokine (IFN-c, IL-2,
IL-4 and IL-10) and humoral (IgG and IgM) responses,
data were categorized into different categories and two-
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sided Fisher’s exact test for an m · n contingency table
was carried out. A Student’s unpaired two-sample t-test
(two-tailed) allowing for unequal sample variances was
used to compare the quantitative PCR data from group 1
(virulent) and group 2 (attenuated). All statistical analyses
were undertaken using the GenStat 10th edition statistical
package (VSNI, Hemel Hempstead, UK) except the
Fisher’s exact test, which was implemented in the statisti-
cal package R, version 2.6.0. Where applicable, results are
presented as mean values along with the standard error of
mean values.
RESULTS
Mice from group 1 (virulent) were killed at different time
points due to high morbidity scores and as a result no
mice from group 1 survived beyond day 24 p.i., and sam-
ples could not always be collected from all animals. Sam-
ples from animals that were killed ⁄ died before day 14 p.i.
were compared only by PCR and histology. From day 14
p.i. onwards animals that were killed ⁄ died were not
included in the analyses as no group comparison could be
made.
Clinical observations
Three mice from group 1 (virulent) were incorrectly inocu-
lated, as a result, these animals showed no clinical symp-
toms, generated no humoral or CMI responses, were
negative by ITS1 PCR and demonstrated no pathology.
As a consequence, the results from these animals were
removed from all data sets.
Group 1 mice (virulent) demonstrated ruffled coats from
day 1 p.i., other symptoms including a reluctance to move,
tottering gait, a stiff stary coat and weight loss were
observed from day 4 p.i., resulting in an increase in the
group mean morbidity score (see Figures 1 and 2). Group
2 mice (attenuated) demonstrated very mild transient
symptoms of murine neosporosis, with a ruffled coat being
observed from day 2 p.i., all mice in group 2 returned to
being clinically normal by day 6 p.i. (see Figure 1). No
weight loss was seen in group 2 following the inoculation
(see Figure 2). When the morbidity data from group 1 and
group 2 were compared, group 1 demonstrated a statisti-
cally significant (P < 0Æ001) higher mean morbidity score
than group 2 between days 5 and 14 p.i. When the weights
of the mice in group 1 and group 2 were compared; group
1 demonstrated statistically significant (P < 0Æ001) levels
of mean weight loss between day 6 p.i. and day 14 p.i. (see
Figure 2). Group 2 continued to show no clinical symp-
toms and demonstrated no weight loss between day 28 p.i.
and 42 p.i. All mice in group 2 showed a slightly ruffled
coat from day 1 post-challenge (p.c.) (day 49 p.i.), then
returned to being clinically normal on day 4 p.c. (day 52
p.i.) (data not shown). Group 3 mice (Vero cells) showed
no clinical symptoms (see Figure 1) nor demonstrated
any weight loss between day 0 p.i. and day 48 p.i. (see
Figure 2). Following the challenge on day 48 p.i. all the
mice in group 3 showed a ruffled coat from day 1 p.c.
(day 49 p.i.), symptoms progressed to include a stiff stary
coat, hunching, a reluctance to move, tottering gait and
weight loss, which resulted in all the mice in group 3 being
culled on day 6 p.c. (day 54 p.i.) (data not shown).
Cell-mediated immune response
The results from the proliferation assays are expressed as
stimulation indices (S.I.), these are calculated by dividing
the mean counts per minutes (cpm) from the NCA stimu-
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Figure 1 Mean group morbidity score following i.p. inoculation
with live N. caninum tachyzoites. Group 1, - - 5 · 106 NC1
(p. 34) (virulent). Group 2, -h- 5 · 106 NC1 (p. 76) (attenuated).
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Figure 2 Mean group weight change (g) following i.p. inoculation
with live N. caninum tachyzoites. Group 1, - - 5 · 106 NC1
(p. 34) (virulent). Group 2, -h- 5 · 106 NC1 (p. 76) (attenuated).
Group 3 -•- 4Æ35 · 105 Vero cells. Error bars € SEM.
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Cell proliferation
On day 14 p.i., group 1 mice (virulent) demonstrated anti-
gen-specific responses to NCA, with a mean S.I. of 12Æ00
(€5Æ19), while group 2 mice (attenuated) demonstrated a
mean NCA specific S.I. of 18Æ84 (€1Æ23). When the prolif-
eration data from group 1 and group 2 on day 14 p.i. were
compared; group 2 was seen to produce a statistically sig-
nificant (P = 0Æ01) greater level of NCA specific prolifera-
tion than group 1 (see Figure 3). Group 2 mice
maintained elevated levels of antigen specific proliferation
throughout the course of the experiment on days 28 and
42 p.i. and on day 15 p.c. (day 63 p.i.) group 2 demon-
strated a mean NCA-specific S.I. 6Æ29 (€2Æ01) (see Fig-
ure 3). Group 3 mice (Vero cells) demonstrated a low
background level of cell proliferation on days 14, 28 and
42 p.i. (S.I. 1Æ49 € 0Æ14, 1Æ51 € 0Æ31 and 0Æ62 € 0Æ03
respectively). Following the challenge with virulent N. can-
inum parasites on day 48 p.i, a mean NCA-specific cell
proliferation S.I. 9Æ54 (€7Æ84) was seen in group 3 mice on
day 54 p.i. (day 6 p.c.) (see Figure 3). Low background
levels of cell proliferation to NCA were observed in all
groups on day 0 p.i. (see Figure 3).
Cytokine responses
Supernatants from splenocytes stimulated for 4 days with
NCA were tested for the production of IFN-c, IL-2, IL-
4 and IL-10. On day 14 p.i. NCA supernatants from
group 1 (virulent) and group 2 (attenuated) showed produc-
tion of IFN-c, IL-2, IL-4 and IL-10 (see Figure 4a–d),
when the quantities of cytokine produced in groups 1
and 2 were compared, it was seen that group 2 pro-
duced statistically significant (P = 0Æ003) more IFN-c
than group 1. However, although the levels of IL-2,
IL-4 and IL-10 produced were higher in group 2, these
differences were not statistically significant (P = 0Æ085,
P = 0Æ186 and P = 0Æ172 respectively) (see Figure 4a–d).
In group 2 mean levels of IFN-c peaked on day 14 p.i.,
then decreased on days 28 and 42 p.i. (see Figure 4a);
mean levels of IL-2 peaked on day 42 p.i. (see
Figure 4b), while on days 28 and 42 p.i. mean levels of
IL-4 and IL-10 remained low but detectable; however,
following the virulent challenge administered on day 48
mean levels of IL-4 and IL-10 increased from baseline
(see Figure 4c and d). Group 3 (Vero cells) produced
very low or undetectable levels of IFN-c, IL-2, IL-4 and
IL-10 on days 14, 28 and 42 p.i. Following the chal-
lenge with virulent N. caninum parasites levels of all the
cytokines tested in group 3 increased from baseline (see
Figure 4a–d).
On day 0 p.i. IFN-c, IL-2, IL-4 and IL-10 was pro-
duced in low levels or in levels that were below the detec-
tion threshold of the ELISA (see Figure 4a–d) in all three
groups.
Serology
On day 14 p.i. group 1 mice (virulent) showed IgG titres
of 1 ⁄ 64–1 ⁄ 128. Group 2 mice (attenuated) showed IgG
titres of 1 ⁄ 64–1 ⁄ 256. When the levels of IgG from group 1
and group 2 on day 14 p.i., were compared it was seen
that the mice in group 1 generally had lower IgG titres
than group 2, though this difference was not statistically
significant (P = 0Æ065). Group 2 mice demonstrated IgG
titres of 1 ⁄ 256–1 ⁄ 512 on day 28 p.i., on day 42 p.i. all
group 2 mice tested had IgG titres of 1 ⁄ 1024, on day 15
p.c. (day 63 p.i.) the IgG titres were between 1 ⁄ 2048 and
1 ⁄ 4096. Group 3 mice (Vero cells) showed IgG titres of
<1 ⁄ 16 on days 14, 28 and 42 p.i. Following the challenge
with virulent parasites on day 48 p.i., no anti-Neospora
antibodies were detectable in samples collected from group
3 mice on day 6 p.c. (day 54 p.i.). On day 0 p.i. IgG titres
of <1 ⁄ 16–1 ⁄ 16 were detected for all three groups.
Titres of IgM between <1 ⁄ 16–1 ⁄ 64 were detected from
all three groups of mice at all of the time points tested,
giving no statistically significant differences between any
of the groups at any of the time points tested.
ITS1 and SYBR green PCR
In group 1 (virulent), positive results were seen in all
(8 ⁄ 8) of brain samples tested between day 8 and 14 p.i.
The results from the qPCR show that these mice had a
mean value of 1Æ19 (€0Æ44) pg of Neospora DNA per ng
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Figure 3 Mean proliferation results of splenocytes following stim-
ulation with NCA (expressed as S. I.). Group 1, - - 5 · 106 NC1
(p.34) (virulent). Group 2, -h- 5 · 106 NC1 (p.76) (attenuated).
Group 3 -•- 4Æ35 · 105 Vero cells, PC = post-challenge, error
bars € SEM.
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results were seen in (2 ⁄ 6) of brain samples on days 13
and 14 p.i. The qPCR showed that the samples that
tested positive by ITS1 PCR had a mean of 0Æ005
(€0Æ004) pg of Neospora DNA per ng of host genomic
DNA. When the qPCR results from group 1 and group
2 were compared, group 1 was seen to have a statisti-
cally significant (P = 0Æ03) higher parasite burden than
group 2 between days 8 and 14 p.i. In group 2 on day
28 p.i. positive ITS1 PCR samples were seen in 2 ⁄ 5
samples, (0Æ36 € 0Æ34 pg of Neospora DNA per ng of
host genomic DNA), whilst on day 42 p.i. 1 ⁄ 4 samples
were positive (0Æ006 € 0Æ02 pg of Neospora DNA per ng
of host genomic DNA). In group 2 following the chal-
lenge with virulent N. caninum parasites, 2 ⁄ 6 samples
tested positive on day 15 p.c. (day 63 p.i.). The qPCR
results from these mice demonstrated a mean parasite
burden of 0Æ087 € 0Æ027 pg per ng host DNA. All the
samples tested from mice in group 3 (Vero cells) on
days 14, 28 and 42 p.i. were negative by ITS1 PCR.
Following the virulent challenge all three remaining mice
in group 3 were PCR positive on day 6 p.c. (day 54
p.i.), where a mean of 0Æ47 (€0Æ22) pg of Neospora
DNA per ng host DNA was seen. All the samples
tested from all three groups were negative by ITS1 PCR
on day 0 p.i.
Pathology and immunohistochemistry
In group 1 (virulent) four mice culled on days 9 and 13
p.i. demonstrated mild pathological changes (see Table 2),
this composed of, in each case, one small clearly delin-
eated focus of necrosis infiltrated by a mixed population
of cells, comprised chiefly of microglia and mononuclear
inflammatory cells and also containing nuclear debris.
Immunohistochemistry allowed identification of Neospora
tachyzoites in the periphery of the lesion with some also
in the surrounding neuropil (Figure 5). A small tissue cyst
was present adjacent to one focus. In those mice sampled
on day 14 p.i. there were moderate changes made up typi-
cally of several foci of inflammation some small and
clearly delineated and some larger, more diffuse and less
intense. Cells were chiefly microglia and mononuclear infil-
trating cells. Associated capillaries were prominent due to
a combination of pericyte proliferation and the presence
of infiltrating inflammatory cells (Figure 6). Neospora
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Figure 4 Cytokine production following stimulation with NCA. Group 1, - - 5 · 106 NC1 (p. 34) (virulent). Group 2, -h- 5 · 106 NC1
(p. 76) (attenuated). Group 3 -•- 4Æ35 · 105 Vero cells, PC = post-challenge, error bars € SEM.
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eight mice, while bradyzoites in tissue cysts were present in
three of the eight mice tested between days 9 and 14 p.i.
In group 2 (attenuated). histopathological changes were
present to a variable extent on days 13 and 14 p.i., of the
six mice sampled, three had no lesions, two had mild
changes and one had moderate changes, of the five mice
sampled on day 28 p.i. two had no changes, one had mild,
one had moderate and one had severe changes. In all cases
there was lymphoid cuffing and associated microgliosis.
Neospora antigen was demonstrated only in this last case
and it consisted of traces of particulate antigen. On day
42 p.i. mild pathological changes were seen in one of the
five mice sampled while moderate changes were present in
the other four (see Table 2). In one of which there were
traces of particulate antigen and in another there were a
few scattered tachyzoites. Following the challenge with vir-
ulent parasites on day 48 p.i. all the mice in group 2 sur-
vived to the end of the experiment on day 15 p.c. (day 63
p.i.). Samples taken from the mice at post-mortem showed
that two had no pathological changes, three showed mild
pathological changes and one mouse showed moderate
pathological changes. The only IHC positive sample seen
at this time was in one mouse with mild lesions, in which
there were a few scattered tachyzoites associated with
inflammation. The only tissue cyst seen in group 2 was in
one mouse killed on day 14 p.i. Group 3 showed no patho-
logical changes in any of the brains from mice sampled on
days 14, 28 and 42 p.i. A small focus of nonsuppurative
inflammation was present in the cerebellum of one of the
three mice in group 3 sampled on day 6 p.c. (day 54 p.i.),
numerous tachyzoites were also visible within this lesion by
IHC. No pathological changes were seen in any of the
brain samples taken from all three groups on day 0 p.i.
DISCUSSION
The results from this study show clear differences in the
development of host immune responses and lesions in
mice inoculated with attenuated or virulent N. caninum
tachyzoites. Mice inoculated with the attenuated parasite
demonstrated statistically significant reduced clinical
symptoms (P < 0Æ001), higher levels of Neospora specific
Table 2 Individual pathology scores
Days p.i.
Individual pathology scores
0–6a 7–13a 14–20a 21–27a 28–34a 35–41a 42a Day 15 p.c.a
Group 1 0, 0, 0, 0, 0, 0 1, 1, 1, 1 2, 2, 2, 2, 2, 2 3, 3, 3, 3, 3, 3 – – – Challenge –
Group 2 0, 0, 0, 0, 0, 0 1 2, 0, 0, 1, 0 – 2, 0, 1, 3, 0 0 2, 2, 2, 1, 2 1, 2, 0, 0, 1, 1
Group 3 0, 0, 0 – 0, 0, 0 – 0, 0, 0 – 0, 0, 0 –b
aNo statistical differences observed between groups; bMice culled on day 6 p.c.
p.c., post-challenge.
Figure 5 A small focus of necrosis in the cerebrum of a mouse
in group 1 (virulent) killed on day 9 p.i. showing dividing
N. caninum tachyzoites (arrows). (Immunohistochemistry).
Figure 6 A focus of inflammation in the neuropil of the cerebrum
(arrows) with associated inflammation in the adjacent meninges
(I) of a mouse in group 1 (virulent) killed on day 14 p.i. (haemat-
oxylin and eosin).
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cell proliferation (P = 0Æ01) and IFN-c production
(P = 0Æ003). Group 2 also produced higher levels of IL-2,
IL-4 and IL-10 production and stronger antibody (IgG)
responses than the mice that were inoculated with the vir-
ulent parasites. The mice inoculated with the attenuated
parasites also demonstrated milder pathological changes,
reduced evidence of parasite in brain samples, leading to
lower parasite burdens as demonstrated by both IHC and
qPCR, when compared with the mice inoculated with the
virulent parasite. However, as we were only able make
comparisons between the mice inoculated with either the
virulent or attenuated parasites at a single time point (day
14 p.i.); we must also acknowledge the fact that the kinet-
ics of infection of the virulent and attenuated parasites
may differ, which may contribute to differences in morbid-
ity, mortality as well as the immune responses observed at
this time point.
The milder clinical symptoms seen in the mice inocu-
lated with the attenuated parasites, compared to those in
the mice inoculated with the virulent parasites were similar
to the results of previous studies (16,25). The attenuation
of parasites through prolonged in vitro passage, (16) has
also been shown for Babesia bigemina, where microaero-
philous stationary phase cultures repeatedly passaged
in vitro elicited no signs of clinical babesiosis following
inoculation into nave calves (26). Attenuation of
Leishmania spp. has also been achieved through the in vitro
passage of mid- to late-log phase promastigotes, cultured
in the presence of gentamicin (27). Inoculation into
susceptible hosts with these attenuated parasites resulted
in reduced morbidity and protection against a subsequent
lethal challenge with wild-type virulent parasites.
This present study shows a strong stimulation of CMI
responses, involving Neospora-specific lymphoproliferation
of splenocytes, following in vitro stimulation with NCA
and the production of the cytokines IFN-c and IL-2, as
well as the production of IL-4 and IL-10. Due to the
intracellular nature of N. caninum, the protective immune
response is likely to involve cell-mediated immunity and
studies have emphasized the importance of IL-12 and
IFN-c (9–11). Little is currently known about the induc-
tion of IFN-c responses to Neospora in mice during the
early (acute) phase of infection. However, work carried
out on the closely related parasite T. gondii has shown that
the parasites can directly induce macrophages to produce
TNF-a and IL-12, which in turn induces NK cells to pro-
duce IFN-c (28). This increase in IL-12 has been detected
in spleen and peritoneal cells as early as 2 days post-infec-
tion (29). During intracellular infections with T. gondii
and L. major, IL-12 and IFN-c have been shown to medi-
ate the development of antigen-specific Th1 cells which
secrete the effector cytokines IL-2 and TNF-b. These acti-
vated Th1 cells promote cytolytic responses and antibody
class switching towards antibody-dependent cell killing
(30). Both IL-12 and IFN-c have been shown to be critical
in protection against N. caninum in previous studies, where
IL-12 and IFN-c knockout (IL-12 KO and IFN-c KO)
mice and the in vivo depletion of either IL-12 or IFN-c
using monoclonal antibodies lead to increased susceptibil-
ity to the parasite (10,11). Recent studies in cattle have
also demonstrated that; NK cells play a key role in early
innate immune responses to Neospora through the IL-12
independent production of IFN-c (31). Klevar et al. (32)
have also demonstrated that NK cells and CD8+ T-cells
are important in producing IFN-c in the early stages fol-
lowing Neospora infection in calves.
Our findings showed that the mice generating the stron-
gest IFN-c response also demonstrated the strongest IL-10
response and these mice tended to show the mildest patho-
logical changes, with reduced parasite loads. This finding
is supported by a recent study by Nishikawa et al. (14)
who demonstrated that both Th1 ⁄ Th2 type responses are
crucial in controlling a Neospora infection and limiting the
immunopathology caused by an excessive pro-inflamma-
tory response. Long et al. (10) demonstrated increased sus-
ceptibility in mice producing high levels of the Th2 type
cytokine IL-4 following an i.p. inoculation with live Neo-
spora tachyzoites. In addition, Baszler et al. (9) demon-
strated that a bias towards a Th2 response lead to
increased disease and severity of brain lesions in mice
inoculated with Neospora antigen and Freund’s complete
adjuvant then challenged with live tachyzoites. Our find-
ings would suggest that while the Th1 cytokine IFN-c
may be important in controlling the spread of the parasite,
Th2 cytokines including IL-10 may play a role in limiting
the pathological changes caused by an excessive pro-
inflammatory response.
The importance of the humoral response during murine
neosporosis was demonstrated by Eperon et al. (33) who
showed increased susceptibility to N. caninum in lMT B-
cell deficient mice, compared to wild type C57BL ⁄ 6 mice.
The humoral response described here, showed an increase
in IgG over time. Similar findings were observed by Teixe-
ira et al. (34) who described that an ip inoculation of mice
with live tachyzoites induced a rapid increase in the num-
bers of peritoneal and splenic B-cells, preceding a rise in
serum levels of Neospora-specific immunoglobulins. A sug-
gested function of antibodies is in clearing the extracellu-
lar tachyzoites (35), this idea is supported by work from
Haldorson et al. (36) who demonstrated that antibodies
directed against the Neospora tachyzoite surface protein
NCSRS2 significantly blocked the invasion of the parasite
into host cells. B-cells however not only play a central role
in antibody production and regulation, but can also act as
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antigen presenting cells and are capable of secreting Th1-
and Th2-type cytokines (37).
The pathological changes observed in mice inoculated
with N. caninum in this study was comparable to that
of previous in vivo experiments (16,17). The mice that
were inoculated with the attenuated parasites showed a
much lesser incidence and severity of pathological
changes, compared to the mice inoculated with the viru-
lent parasites. Similar findings were seen in experiments
where mice immunized with live temperature sensitive
mutant NCts-8 parasites (38), live c-irradiated parasites
(39) and bacterially expressed recombinant NCMIC3
(40) or NcSRS2 (41) not only demonstrated protection
against a lethal challenge with N. caninum, but also
showed reduced morbidity and milder pathological
changes compared to nave mice challenged with virulent
N. caninum parasites.
Lesser parasite burdens were observed in the brains of
mice inoculated with the attenuated parasites, when com-
pared to the mice that were inoculated with the virulent
parasites confirming results from previous studies (16,17).
In addition within group 2, (attenuated) substantially
more mice were PCR negative compared to group 1 (viru-
lent), suggesting a very low parasite burden in the mice
inoculated with the attenuated parasites. Interestingly,
there was no correlation between neuropathology and
overt clinical symptoms of murine neosporosis, as one
mouse that received the attenuated parasites showed severe
pathological changes but had appeared clinically normal;
Ramamoorthy et al. (39) made similar observations in
mice inoculated with c-irradiated parasites which were
then challenged.
The results from this study show that inoculation with
live attenuated parasites generates a protective immune
response against Neospora and that this protection
involves both the humoral (IgG) and CMI responses.
While the lymphoproliferative and IFN-c responses are
critical in controlling dissemination of the parasite, IL-10
may help to limit the immunopathology caused by the
Th1 cytokines. This suggests that a balance is needed
between the immune responses that are important in con-
trolling infection and those involved in reducing immuno-
pathology. Mice inoculated with the attenuated parasites
also showed reduced incidence and burdens of parasite
DNA in the CNS, compared to mice inoculated with viru-
lent parasites.
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5.1 Manuscripts main hypotheses  
 
The main hypotheses that were tested in this manuscript are: 
1. Can size-exclusion HPLC be used to fractionate Neospora caninum tachyzoite 
water soluble antigens (NcWSA)?  
2. Can T-cells (CD4+) derived from experimentally infected cattle be used to screen 
for immunologically reactive proteins from the HPLC separated fractions of 
NcWSA? 
3.  Can LC-ESI-MS/MS (liquid chromatography electrospray ionisation tandem 
mass spectrometry) identify individual immunoreactive proteins? 
 
The results from this experiment shows that HPLC effectively fractionates NcWSA and 
that immune screening using CD4
+
 T-cells from experimentally infected cattle identified 
3 highly immunoreactive fractions (fractions 3, 4 and 5). Phenotypic analysis of the 
responding T-cells clarified that CD4
+
 are the predominant cells involved in the 
proliferative response, with a minor involvement of CD8
+
 and γδ T-cells. The LC-ESI-
MS/MS analysis of the individual fractions identified a number of Neospora surface 
proteins including SAG1, SRS2 as well as dense granule proteins GRA2 and GRA7 and 
microneme proteins MIC3 and MIC11. Along with the Neospora peptides, 17 
Toxoplasma gondii homologues were also identified. Many of the Neospora peptides 
recognised by this assay have known functions in either parasite attachment or host cell 
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invasion, meaning that these proteins are often exposed to the host immune response and 
are highly antigenic. 
Though this experiment identified a number of highly immunogenic parasite antigens, it 
failed to produce or identify any novel antigens. Though NcMIC11 had previously been 
identified, it had not been shown to be immunologically reactive. The HPLC method of 
fractionation is also too crude, as it only separates by peptide size, meaning that each 
fraction still contains large numbers of different peptides. It also must be remembered 
that this paper only demonstrates that peptides are immuno-reactive, not that they 
immuno-protective. Further studies would be required, either in cattle or mice to 
actually demonstrate a role for each of the peptides in a protective immune response.  
For a clearer indication of the roles of individual peptides then each HPLC fraction 
should be further separated i.e. by 2D electrophoresis, then individual spots could be 
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Abstract
Neospora caninum is recognised worldwide as a major cause of bovine infectious abortion. There is a real need to
develop effective strategies to control infection during pregnancy which may lead to either abortion or congenital
transmission. Due to the intracellular nature of the parasite, cell-mediated immune (CMI) responses involving CD4+ve,
CD8+ve, g/δ TCR+ve T cells and NK cells, as well as production of IFN-g, are thought to be important for protective
immunity. In this study we applied a combination of proteomic and immunological approaches to identify antigens
of N. caninum that are recognized by CD4+ve T cell lines derived from infected cattle. Initially, N. caninum tachyzoite
Water Soluble Antigens (NcWSA) were fractionated by size-exclusion HPLC and then screened for immune-potency
using CD4+ve T cell lines. LC-ESI-MS/MS (liquid chromatography electrospray ionisation tandem mass spectrometry)
was employed to catalogue and identify the proteins comprising three immunologically selected fractions and led to
the identification of six N. caninum target proteins as well as sixteen functional orthologues of Toxoplasma gondii.
This approach allows the screening of biologically reactive antigenic fractions by the immune cells responsible for
protection (such as bovine CD4+ve cells) and the subsequent identification of the stimulating components using
tandem mass spectrometry.
Introduction
Neospora caninum is a protozoan parasite, closely related
to Toxoplasma gondii, which has emerged as a major
cause of reproductive failure in cattle worldwide [1,2].
The parasite is now recognised as the most commonly
diagnosed cause of abortion in areas with an intensive
dairy industry [3]. Infection during pregnancy may result
in abortion, depending on the stage of gestation when
parasitaemia occurs, or may lead to the birth of a conge-
nitally infected calf [4]. Treatment options are limited,
with few chemotherapeutics available which may be pro-
blematic to use in meat or milk-producing livestock.
Applying management and biosecurity measures such as
those detailed in a management scheme recently
launched by Defra in the UK (Herdsure) [5], may help to
reduce infection levels in the herd; culling of seropositive
animals has also been suggested as a method of control
[6]. All these approaches can constitute a substantial cost
for the farming industry.
There is accumulating evidence that cattle previously
exposed to the parasite are less likely to abort than those
undergoing a primary infection [7] suggesting the devel-
opment of some form of protective immunity and the
feasibility of a vaccination approach. To date only one
commercial vaccine [8], based on an inactivated tachy-
zoite preparation adjuvated with Havlogen [9], has been
registered in some countries. This vaccine demonstrated
variable reduction in the number of abortions under field
challenge condition in Costa Rica [10] and New Zealand
[11]. However, it did not prevent foetal infection [12] and
did not allow discrimination between vaccinated and
naturally infected animals. Studies that have focussed on
the evaluation of N. caninum tachyzoite proteins as vac-
cine candidates in mouse models have given ambiguous
results, ranging from 70-90% protection using live atte-
nuated tachyzoites [13] to very little or no protection
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with the SRS2 antigen and ISCOMs [14]. It appears that
immunisation with live attenuated organisms is more
effective than killed organisms, presumably as a reflection
of more efficient antigen processing and presentation to
T cells.
Immunological screening requires knowledge of the
immune mechanisms responsible for protection, the so-
called correlates of protection [15]. Cattle infected with N.
caninum produce parasite-specific antibodies although
their contribution to protective immunity is not clear
[7,16]. There is mounting evidence that, as for other intra-
cellular protozoan parasites, the most important correlate
of protection for N. caninum is the establishment of a cell
mediated immune response [7,17]. In vitro studies have
shown that treatment of cultured cells with recombinant
interferon gamma (IFN-g), a cytokine produced by acti-
vated T-lymphocytes, significantly inhibits the intracellular
multiplication of N. caninum [18]. A number of studies
have also demonstrated that activated T-lymphocytes can
recognise and respond to parasite-infected cells by produ-
cing inhibitory cytokines [19,20]. Staska et al. have shown
a T-helper type 1 response in infected cattle involving
CD4+ve cytotoxic T cells and IFN-g production [21],
whereas Boysen et al. showed that cytotoxic NK cells also
play a role in the control of the disease through both cyto-
toxic and an IFN-g mediated mechanisms [22]. Therefore,
the development of vaccines directed against N. caninum
should focus on selecting antigens that are capable of eli-
citing mainly a cell mediated immune response involving
CD4+ve T cells and IFN-g, in addition to a serological
response.
The aim of this work was to identify N. caninum tachy-
zoite antigens that are recognised by the cell-mediated
immune (CMI) response of experimentally infected ani-
mals. Neospora caninum water soluble antigens were initi-
ally separated by size exclusion HPLC and tested for their
ability to induce proliferative responses in a NcWSA-spe-
cific bovine CD4+ve test system. A number of fractions
which consistently induced significant proliferative
responses were further investigated by tandem mass spec-
trometry allowing the identification of the proteins pre-
sent. This type of approach demonstrated that is possible
to use biologically relevant screening tools to select T-cell
reactive fractions, thus facilitating the downstream analysis




Neospora caninum water-soluble antigen (NcWSA) was
subdivided into smaller, less complex protein pools by
size exclusion HPLC. Three identical aliquots of the
same preparation of NcWSA were run in three consecu-
tive size exclusion separations and tested in vitro for
immune recognition by short-term NcWSA specific
CD4+ve cell lines derived from cattle experimentally
infected with N. caninum. Immuno-reactive fractions
were subjected to SDS-PAGE and LC-ESI-MS/MS prior
to downstream database mining and bioinformatic analy-
sis to identify their respective protein compositions.
Parasites, inocula and immunisation schedules
Neospora caninum tachyzoites (NC1 isolate) [23] were
maintained in Vero cells as previously described [18] and
used to prepare infectious inocula as detailed below.
Experimental live tachyzoite challenge confers protection
against abortion [24] and has been employed in the past
by us and other groups to characterise protective immune
responses [25,26]. Calves (see below) were infected subcu-
taneously over the left pre-femoral lymph node with the
live inoculum containing 1 × 108 tachyzoites per calf.
A control inoculum containing an equivalent number of
Vero cells as present in the parasite inocula was adminis-
tered to control calves. All experimental animals employed
in this study were reared, housed and handled in accor-
dance to the UK Animals (Scientific Procedures) Act
1986; the experimental design was approved by the
Moredun Ethical Review Committee. Five male calves,
dehorned and castrated, aged two months and serologi-
cally negative for N. caninum antibodies by IFAT [27] and
a commercial ELISA (NC Herdcheck, IDEXX Labora-
tories, Chalfont St Peter, UK) were randomly assigned to
two groups. Three animals received the infectious inocu-
lum whereas the two remaining animals received the con-
trol. Rectal temperatures were monitored from day 2
to day 14 post-infection (pi) and blood samples were
collected up to one month post-infection for serological
analysis. Seroconversion was confirmed by ELISA. Twelve
months after the first inoculation the animals were
boosted with a further similar dose of either live
N. caninum tachyzoites or control Vero cell inoculum.
Lymphocyte Transformation Tests (LTT)
Initiation of a CMI response was confirmed by LTT (Lym-
phocyte Transformation Test) on Peripheral Blood Mono-
nuclear Cells (PBMCs) isolated according to previously
published protocols [28]. Briefly, PBMCs were resuspended
in cell culture medium (CCM) (comprising IMDM [Gibco,
Invitrogen, Paisley, UK], 10% heat inactivated foetal bovine
serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin,
100 μg/mL streptomycin and 5 μg/mL Amphotericin B [all
from Sigma, Gillingham, UK]). PBMCs were cultured in
96-well plates (Nunc, Roskilde, Denmark) at concentration
of 2 × 105/well and stimulated with 200 ng/well of antigen
(NcWSA-see below) for 5 days in a humidified 5% CO2
atmosphere at 37°C. Controls included cell culture media,
Concanavalin A (ConA) (1 μg/well, Sigma, UK) and Vero
cell lysate (200 ng/well). Cultures were pulsed with 1 μCi
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of [3H]-thymidine (GE HealthCare, Bucks, UK) for the final
18 h of incubation. Cells were harvested onto glass fibre fil-
ters (Wallac, Turku, Finland) and [3H]-thymidine incor-
poration quantified using an automated scintillation
counter (Perkin Elmer, Cambridge, UK) and expressed as
counts per minute (CPM), with each test performed in
quadruplicate. Stimulation indices (SI) were calculated by
dividing the median value of the test by the median value
of the media control.
Preparation of N. caninum Water-Soluble Antigen (NcWSA)
NcWSA was produced as follow: 1-2 × 109 tachyzoites,
prepared accordingly to previously published methods
[29] were washed three times in PBS (650 × g for 5 min)
then stored at -20°C prior to antigen preparation. After
thawing, tachyzoites were suspended in distilled water
and disrupted by three cycles of freezing and thawing in
liquid nitrogen followed by homogenisation using a Pre-
cellys tissue homogenizer (Precellys, Bertin Technologies,
Tarnos, France). The homogenised suspension was cen-
trifuged at 10 000 × g for 30 min at +4°C to recover the
supernatant containing the N. caninum WSA. Protein
concentration was assessed using the BCA reagent
(Pierce Chemicals, Rockford IL, USA). NcWSA was then
aliquotted and stored at +4°C prior to chromatographic
fractionation, which was performed within 24 h of anti-
gen preparation.
Size exclusion HPLC of NcWSA
Size exclusion chromatography was performed using a
Beckman System Gold HPLC apparatus (Beckman Coulter,
High Wycombe, UK) in combination with a Superose 12
gel filtration column (GE Healthcare) pre-equilibrated with
PBS pH 6.8. Individual 200 mL injections of 0.45 mm-
filtered NcWSA (935 mg total protein) were applied to the
column and the proteins resolved isocratically in PBS pH
6.8 at a flow rate of 0.5 mL/min over a period of 60 min.
Proteins eluting from the column were monitored by UV
(280 nm) and chromatographic data was recorded and
analysed using 32 Karat Gold ™ chromatograpy analysis
software (Beckman Coulter). Fractions of 1.0 mL were col-
lected and stored at +4°C in sealed low-protein-binding
tubes (Eppendorf, Cambridge, UK) until required. Repro-
ducibility of the fractionation was confirmed by overlaying
the chromatograms of three consecutive separations as
shown in results.
Protein quantification of individual antigen fractions
was performed using the NanoOrange® protein quantifi-
cation kit (Molecular Probes, Invitrogen, Paisley, UK) in
accordance with the manufacturer’s instruction and an
automated fluorescence reader (CytoFluor, PerSeptive
Biosystems, Framingham, MA, USA). Protein concentra-
tions were then adjusted between fractions to ensure
equal concentration of each fraction used in the T-cell
lines proliferation assays, and fractions were stored at
-20°C until required for the T cell assay.
Generation and characterization of bovine CD4+ve T cell
lines and antigen screening assay
Short-term antigen specific T cell lines were prepared
from the infected animals as follows: for the first round of
stimulation each well of a 96-well round bottom tissue
culture plate (Nunc, Denmark) was seeded with 2 × 105
freshly isolated PBMCs resuspended in CCM and stimu-
lated with 200 ng NcWSA. Cells were cultured at 37°C in
a humidified 5% CO2 atmosphere for seven days then har-
vested, washed (300 × g for 10 min), resuspended in CCM
supplemented with 10 U/mL of recombinant human IL-2
(rhu IL-2, Proleukin, Novartis, East Hanover NJ, USA) and
seeded into fresh 96-well round bottom plates. Six days
later an aliquot of cells was removed for phenotypical ana-
lysis and the remaining cells were cultured for a further
24 h prior to use in the antigen screening assay. The phe-
notypic composition of the short-term T cell lines was
analysed using a panel of monoclonal antibodies (MoAbs)
recognizing specific bovine leukocyte populations accord-
ing to previously published methods [30]. Antibody bind-
ing was revealed with Alexa 488-conjugated anti-mouse
IgG (Invitrogen, UK) (0.5 μg/mL final) and data acquired
using a CyAn flow cytometer (CyAn, Dako-BeckmanCoul-
ter, USA) equipped with a 488 nm argon-ion laser and
analyzed using Summit software (Dako, Fort Collins, CO,
USA). A minimum of 10 000 cells were acquired for each
sample.
These short term lines prepared from the three infected
animals were used to test each fraction generated from
the three different HPLC runs (n = 9). Test wells for the
T cell lines screening assays were set up in triplicate in
96 well round bottom tissue culture plates. Each well
contained 5 × 104 T cells, 5 × 105 autologous antigen
presenting cells (APC) (3000 rad g-irradiated PBMCs; at
a 1:10 ratio) and the different HPLC-separated fractions
(1-25) at a final concentration of 10 ng/well. Negative
controls comprised T cells or APCs with medium only as
well as APCs plus T cells with only CCM or with Vero
lysate. Positive controls included T cells, APCs or APCs
plus T cells cultured with 500 ng/well ConA or unfractio-
nated NcWSA with a final concentration comprised
between 200 and of 10 ng/well. Cells were cultured at
37°C in a humidified 5% CO2 atmosphere and prolifera-
tion was quantified by 3H-thymidine incorporation as
described previously for the proliferation assay.
Shotgun proteomic analysis of selected reactive fractions
All protemics-based analysis were performed by the
Moredun Proteomic Facility, (Moredun Research Insti-
tute, Penicuik, UK). A pool of each homologous fraction
selected on the basis of the CD4+ve T cell reactivity was
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dialyzed overnight against HPLC-grade water (mem-
brane cut-off 3 kDa), snap-frozen in liquid nitrogen
then freeze-dried. Each pellet was resuspended in 25 μL
of reducing SDS-PAGE sample buffer, heated at 95°C
for 5 min, separated using a SDS-PAGE gel (4-12%
Tris-glycine gradient, NuPage, Invitrogen, UK) and
finally stained with Simply Blue Safe Stain ™ (Invitro-
gen, UK). The gel lanes were excised in their entirety
then divided equally into slices of 2.5 mm deep to yield
25 gel slices. Each slice was then de-stained before pro-
cessing using standard in-gel reduction, alkylation and
trypsinolysis procedures [31]. The resulting peptides
were analysed by Liquid Chromatography Electrospray
Ionisation Tandem Mass Spetrometry (LC-ES-MS/MS)
using a U3000 nano-flow UHPLC apparatus (Dionex,
Camberley, UK) and amaZon high capacity ion trap
mass spectrometer (Bruker, Coventry, UK). Parameters
for tandem MS analysis were set as previously described
[32]. Processed MS/MS data, in mascot generic format
(mgf), was mined against a) the NCBInr database [33]
using alveolata as taxonomical search and b) a cognate
Neospora caninum genomic database (N.c. Liverpool
strain) [34]. The presentation and interpretation of MS/
MS data was performed in accordance with published
guidelines [35]. A more detailed description of the Tan-
dem Mass Spectrometry procedure can be found in the
additional file 1.
Results
Clinical and immunological reactivity after challenge
Between 72 and 96 h after the initial N. caninum chal-
lenge, the infected animals showed pyrexia and swelling of
the ipsilateral draining lymph nodes, whereas the negative
control animals remained normal. In the infected animals
seroconversion was demonstrated 14 days post infection
(dpi) by ELISA (data not shown) and antigen specific CMI
responses were detected one month after infection by
LTT (SI values between 14 and 135). Control animals
showed no seroconversion or antigen-specific responses
(SI values between 2 and 3; data not shown). Twelve
months after the initial challenge the infected animals
were inoculated with a second live immunisation, using a
similar dose and route as described in material and meth-
ods. Following the second immunisation, LTT reactivity
was evident and serological reactivity was demonstrated
using Western blot analysis (an example of Western blot
reactivity is shown in an additional figure - additional file
2). The animals were employed to prepare CD4+ve T cell
lines starting from three weeks after the second challenge.
HPLC fractionation of N. caninum water-soluble antigen
Corresponding fractions (1-25) from each of three identi-
cal size exclusion separations of NcWSA were combined
to yield 25 pooled fractions. Chromatograms of each
separation were superimposed to demonstrate consis-
tency over the three replicate runs (Figure 1A). In addi-
tion, similarity between homologous fractions obtained
from the three consecutive runs was confirmed by SDS-
PAGE analysis on three representative fractions (Figure
1B). An example of SDS-PAGE analysis of the HPLC-
separated fractions is shown in an additional figure (see
additional file 3). These results demonstrate the robust-
ness of the HPLC fractionation and show that this is
independent from the size of the separated proteins.
Antigen fraction screening using CD4+ve T cell lines
Short term stimulation of immune PBMCs with NcWSA
and IL-2 produced 2-week old cell lines that consistently
comprised a majority of CD3+ve and CD4+ve T cells
(CD3+ve: average 97%, min 94.3% and max 98.5%; CD4+ve
average 87%, min 77.2% and max 93.2%) with very low
CD8+ve and g/δ TCR+ve T cells contamination (on average
less than 5% for CD8 and 8% for g/δ TCR+ve). These cells
were employed in the T cells assays for the antigen frac-
tion screening test where we identified three fractions
(fractions 3, 4 and 5) which consistently induced a cellular
reactivity above all the other fractions tested (Figure 2).
This reactivity corresponded, on the HPLC trace, to pro-
teins collected between 14 and 20 min. from the start of
the chromatographic separation. Fraction 3 showed the
highest reactivity, closely followed by fraction 4, whereas
fraction 5 was higher than all the remaining fractions but
to a large extent lower than 3 and 4. Despite the presence
of higher concentration of proteinaceous (as visualised by
SDS-PAGE, additional file 3) and non-proteinaceus mate-
rial (as deduced from the peaks in the HPLC trace) in
other fractions, the remaining fractions were only margin-
ally stimulatory to the T cell lines. In addition, fractions 17
to 25 consistently failed to induce reactivity above back-
ground level. On this basis, fractions 3, 4 and 5 were
selected for further analysis.
Proteomic analysis of selective reactive fractions
Proteins contained within fractions 3, 4 and 5, identified as
consistently reactive with the CD4+ve T cell lines, were
separated by SDS-PAGE and catalogued by shotgun pro-
teomic analysis using LC-ESI-MS/MS. For each individual
fraction sample, a non-redundant list of identified proteins
was prepared, and a master list was generated, which
was termed as N. caninum reactive protein list (NCRP)
which comprises a total of six unique N. caninum proteins
(Table 1) as well as sixteen T. gondii homologues (Tables 2
and 3). Surface antigens, proteasome subunits, microneme
and dense granule proteins as well as some putative
uncharacterised proteins were identified. Three of the
N. caninum proteins were present both in fractions 3 and 4
(SAG1, SRS2 and GRA2), two were found exclusively in
fraction 3 (microneme protein Nc-MIC3 and GRA7) and
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Figure 1 Size exclusion fractionation of N. caninum Water Soluble Antigen. (A). Three identical aliquots of NcWSA were divided into
fractions comprising molecules of progressively lower mass by size exclusion HPLC. The superimposed absorbance profiles of the fractions
generated in three successive runs are shown. Horizontal axis: time, vertical axis: 280 nm absorbance. Fraction collection started 10 min into the
run, flow rate was 0.5 mL/min and a new fraction was collected every 2 min. The horizontal dotted lines indicate which portion of the NcWSA
antigen corresponded to each collected fraction; bold numbers above the dotted lines represent the fraction number, vertical numbers
represent retention time in minutes. (B): Silver stained SDS PAGE gel (4-12% Bis-Tris gradient) of three representative fractions (3, 7 and 11)
obtained in three separate runs (.1, .2 and .3) of size-exclusion chromatography. MW: molecular weight markers; 3.1: fraction 3 run 1; 3.2: fraction
3 run 2; 3.3: fraction 3 run 3; the numeration is equivalent for the further two fractions.
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only one was identified exclusively in fraction 4 (micro-
neme protein NcMIC11). Homologues of T. gondii proteins
identified comprised surface, ribosomal, proteasome, his-
tone and rhoptry proteins, seven of which were identified
in fraction 3, nine in fraction 4 and three in fraction 5. In
some cases the same protein was indentified in contiguous
fractions (Table 2) however, the majority of T. gondii
homologues were present exclusively in a single fraction
(Table 3).
Discussion
The primary objective of this work was to identify
immunologically (cell mediated) relevant antigens of
N. caninum, using a combination of proteomics-based
and immunological approaches. As CD4+ve T cells are
important in disease protection [17] we expanded
immune precursors from this population to screen
tachyzoite antigens generated through size exclusion
fractionation. Selected fractions were then analysed by
LC-ESI-MS/MS to catalogue their respective protein
profiles. This initial immuno-potency screening of the
soluble fractionated antigens was deemed necessary
because, whilst proteomic characterisation of an organ-
ism provides information on its composition and com-
plexity, it does not always reflect the relative
immunological importance of the molecules identified.
We initially demonstrate that size-exclusion fractiona-
tion using an aqueous mobile phase is highly reproducible
and generates material that is free of detergents and salt
concentrations that are incompatible with the in vitro
CD4+ve test, and for the same reason we opted to use a
soluble preparation of the parasite as starting material.
A selection based on Western blot reactivity (see addi-
tional file 2) would have suggested deeper interrogation of
fractions 2 to 7, which correspond to the majority of the
proteins present in the original water soluble antigen.
However, a comparison of the serological reactivity pro-
files with the cellular reactivity suggested that only frac-
tions 3, 4 and 5 would benefit from a further analysis.
Shotgun proteomics analysis of the selected fractions led
to the identification of six N. caninum reactive proteins as
well as sixteen functional orthologues of T. gondii
proteins.
Among the six proteins identified from mining the N.
caninum database and common to both fractions three
and four were the surface antigens SAG1 and SRS2 and
the dense granule protein GRA2. SAG1 is a tachyzoite gly-
cosylphosphatidylinositol (GPI)-anchored surface molecule
[36] thought to be implicated in host cell attachment and
invasion [37] and is serologically immunodominant [38].
Recombinant SAG1 immunisation has been attempted
with inconsistent results in rodents using a vaccinia virus





Figure 2 Proliferation of CD4+ve T cell lines in response to the
fractionated N. caninum water-soluble antigen. Average
proliferative response of 9 different cell lines (three each from three
animals) to the first 16 HPLC fractionated antigen preparations.
Results are expressed as count per minute (cpm-vertical axis). F1-F16
represents the fraction number. Each box plot spans the interquartile
range of cpm values, with the inside line indicating the median
value. Whiskers extend as far as the minimum and maximum values.
The fractions selected for further proteomic analysis are shadowed.
Fractions 17 to 25 were not recognised or recognised at background
level by the cell lines and are not represented in the figure.








3, 4 AAD25091 SAG1 Surface antigen SAG1* 1048 9 K.EIPLESLLPGANDSWWSGVDIK.T; K.SVSSPEVYCTVQVEAER.
A
3, 4 AAX38598 SRS2 Surface protein SRS2** 760 9 K.LLSEDDGLIVCNESDGEDECEK.N; R.
LRPITVNPENNGVTLICGPDGK.A
3, 4 AAG28489 GRA2 GRA2 protein 287 4 R.GTVNGQPVGSGYSGYPR.G; R.ESMAAPEDLPGER.Q
3 AAF19184 MIC3 Microneme protein Nc-
MIC3
219 5 K.NPMCYPTCEEMGGK.D; K.DAECVEDLNAGGSVR.C
3 P90661 DG1 GRA7*** 116 2 K.LAVPVVGALTSYLVADR.V; R.VLPELTSAEEEGTESIPGK.K




* also known as Nc-p29 or Nc-p36; ** also known as Nc-p35 or Nc-p43; *** also known as NCDG1 [39].
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[40] or rSAG1 protein only [41]. SRS2 (or Nc-p43) [42] is
localised on the surface of N. caninum of both bradyzoites
and tachyzoites [43], is involved in the host cell invasion
process [44] and its neutralisation inhibits parasite attach-
ment and in vitro invasion of placental trophoblasts [45].
By homology with T. gondii we also identified a second
SRS domain-containing protein in fractions 3 and 4, in
addition to the N. caninum SRS2 protein. SRS-domain
containing proteins are considered extremely immuno-
genic in Toxoplasma [46] as well as being present in a
large number on the parasite surface, and are thought to
facilitate the invasion of multiple host and cell types [47].
Therefore the identification of more than one of these
proteins in our N. caninum reactive fractions is perhaps
not surprising. NcSRS2 has been selected as candidate
antigen for vaccination by a number of groups. Rodent
challenge with N. caninum following vaccination with
NcSRS2 demonstrated improved survival [41] reduced
transplacental transmission [48] and the development of
humoral and cellular immune responses to N. caninum
tachyzoites [49]. In cattle, NcSRS2 peptide-specific T lym-
phocytes have been detected ex vivo in peripheral blood of
infected animals [21]. Baszler et al. [50] also demonstrated
the induction of a cell-mediated immune response similar
to that induced by the live parasite in animals vaccinated
with NcSRS2 in combination with Freund’s adjuvant.






3, 4 XP_002369822 SRS domain containing
proteins
821 16 K.IDLDPEDLHGHVYLPLVEQVDPMR.L; K.
DLGQFGYVPPGDGRDPAGDEVQECK.Y
4, 5 XP_002365950 Glutamine synthetase,
putative
168 4 K.IDPPPPADCDAAEVDSPLVR.S; R.TLVDAADLMMVYK.Y + 2
Oxidation (M)
4, 5 EEE20214 20S Proteasome subunit
alpha
194 4 K.VEVEVGLIGNDSCGVFK.M; R.IAAVTETIGIAVAGLAADGR.Q






3 EEE22451 Putative uncharacterized
protein
837 7 K.LEVGETCTIEMLPQNSK.V; K.HKLEVGETCTIEMLPQNSK.V
3 EEE23072 Putative uncharacterized
protein
194 4 R.ATVHPGDTVTMQCPGAISSNPADVSK.Y; R.
LILDIEKSEEEVVR.T




3 EEE29336 Histone H4 110 2 R.ISGLIYEEIR.G;
R.DNIQGITKPAIR.R
3 XP_002370897 ROP 2 Rhoptery protein 2 91 3 R.DSGDVILEELFK.R;
K.GPSAIVFEATDR.E
3 EEE23774 Ribosomal protein S8 82 2 K.NSIVAIDATPFK.A;
K.LDPLLEEQFNTGR.L
4 AAD38419 HSP 60 283 4 K.QVASTTNDIAGDGTTTATLLAR.A; K.TLTHELELVEGLK.F
4 XP_002369317 Proteasome subunit alpha
(Type 2)
215 7 R.YNPDIELEDAIHTAILTLK.E; K.EGFEGAMNEHNIEIGVVGEDR.
K + Oxidation (M)
4 EEE23454 Proteasome subunit alpha
(Type 1)
182 3 K.ELSLDEIQALLDK.M; R.NFESFPGLSPEELELHAMK.A
4 XP_002366589 Proteasome subunit alpha
(Type 4)
162 4 K.EDLDVDAALLLAAK.V; K.QEWKEDLDVDAALLLAAK.V












Proteins were identified in each fraction by blasting the results of the peptide analysis versus the N. caninum and T. gondii genomic.
Proteins were identified in each fraction by blasting the results of the peptide analysis versus the N. caninum and T. gondii genomic databases. Table 1 lists
protein identified from the N. caninum database; Table 2 T. gondii homologues identified in more than one fraction and Table 3 T. gondii homologues present
only in one of the three fractions. MOWSE scores (for Molecular Weight Search) indicate the likelihood of having correctly identified a specific protein from the
molecular weight of the peptides created by its proteolytic digestion and measured with mass spectrometry. The dot (.) in the peptide sequence denotes trypsin
cleavage sites.
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In addition to surface expressed antigens, we also detected
dense granule antigens such as NcGRA2 (p29) and
NcGRA7. Neospora caninum GRA2 was originally identi-
fied by Ellis and collaborators [51] because of its signifi-
cant amino acid sequence homology (50%) with the GRA2
antigen of T. gondii; similarly NcGRA7 (or dense granule
protein 1) shows 42% identity with T. gondii GRA7 [42].
Dense granule antigens are specialised secretory organelles
belonging to the parasitophorous vacuole synthesized at
the time of infection and implicated in the cellular inva-
sion process [52] as well as in nutrient acquisition [53].
NcGRA2 is another immunodominant antigen and is
recognised by IgM from sera of N. caninum-infected cattle
[54]. E. coli expressed NcGRA2 demonstrated immuno-
genicity but only partial reduction in foetal infection and
pup mortality in a mouse model [55] and Ramamoorthy
reported that vaccination of mice with recombinant
NcGRA2 induced only partial protection against vertical
transmission [56]. Two microneme proteins (Nc-MIC3
and NcMIC11) were also identified in the reactive frac-
tions. Micronemes are secretory organelles which are
discharged by exocytosis during the attachment to the
host cell surface to facilitate cell invasion [57]. Despite
their low molecular weight, microneme proteins could
have been eluted in one of the early fractions as protein-
complexes, since most of them have putative adhesive
functions, are naturally secreted as multiprotein com-
plexes, and immunoprecipitation experiments in T. gondii
have confirmed that specific microneme proteins form a
stable complex within the microneme [58]. In analogy
with T. gondii, different microneme proteins such as
NcMIC11, an ortholog of TgMIC11 [59], NcMIC1 [58]
and NcMIC4 [60] have been identified in N. caninum but
so far only one, Nc-MIC3, has been associated with immu-
nological (serological) reactivity [36]. Use of microneme
proteins in vaccination and challenge studies has given
contradictory results in rodent models: vaccination with
NcMIC4 increased mortality following challenge [61]
whereas immunisation with NcMIC1 [62] or NcGRA7
[63] elicited only partial protection. Additional proteins
from cellular cytoplasm (rhoptries, ribosomes, HP60),
nucleus (hystones) as well as enzymes (proteasome com-
plex, glutamine synthetase, cytosol aminopeptidase) and
some additional molecules of unknown function were also
found in the reactive fractions by homology with T. gondii
proteome. The identification of TgROP2 homologue is
also promising since immunisation with recombinant
NcROP2 in a mouse model has been effective in reducing
mortality and cerebral infection [64], in addition to redu-
cing vertical transmission [65] when used in combination
with two microneme antigens (NcMIC1 and NcMIC3).
Involvement of proteasome genes in the generation of
a protective response to N. caninum in mice has been
recently suggested by Ellis [66] and HSP60 has been
identified as a serologically immunodominant protein
[54]. Neospora caninum rhoptry antigens have also been
identified as serologically immunodominant [67] while
in T. gondii, some of the rhoptries proteins have been
linked to increased virulence [68].
Cell-mediated antigen screening has in the past lead to
the identification of parasite fractions capable of being
recognised by memory T cells [69,70]. However, because
the antigenic components of the parasite were not identi-
fied, these previous studies did not allow the selection of
specific candidate antigens. Our approach, which com-
bines cellular screening and proteomic characterisation,
refines these previous investigations and show that it is
possible to streamline the screening of biologically reactive
fractions, narrowing the number of molecules of potential
interest to a manageable size. Each identified protein can
now be investigated to further select those capable of gen-
erating the correct in vivo immunological response.
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6.1 Manuscripts main hypotheses  
 
The main hypotheses that were tested in this manuscript are 
1 At what stage of early gestation are bovine foetuses capable of mounting an 
in utero immune response against Neospora caninum? 
2 What effect does the timing and location of the maternal immune response 
have on the outcome of pregnancy in dams experimentally challenged with 
Neospora caninum tachyzoites on day 70 of gestation? 
3 Does the route of parasite administration have an effect on the clinical 
outcome of disease in dams experimentally challenged with Neospora 
caninum tachyzoites on day 70 of gestation? 
The results from this experiment clearly demonstrate that the timing of a primary 
challenge with Neospora caninum during gestation is critical to foetal survival. A 
challenge during early pregnancy resulted in foetal deaths being recorded by day 14 post 
inoculation. The results also show that the route of inoculation plays a role in foetal 
survival, as 6/6 dams challenged intravenously (iv) all showed foetal death while a 
subcutaneous (sc) challenge only resulted in foetal deaths in 3/6 animals. This 
experiment also showed the importance of the maternal immune response in foetal 
survival. The dams carrying live foetuses demonstrated stronger cell mediated immune 
(CMI) responses than the dams carrying dead foetuses.  
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Though mitogenic responses were shown from foetal tissues from as early as day 84 of 
gestation indication the presence of lymphoid cells, no parasite specific CMI responses 
were recorded, demonstrating that the foetuses are still too immunologically immature 
during early gestation to mount a protective in utero immune response against the 
parasite. 
One of the major limiting factors during this experiment was group size, with only 2 
animals being studied for each group at each time point, more animals could have 
increased the power and significance of some of the observations made during this 
study. A more comprehensive examination of the role of the innate immunity (NK cell 
and TLR responses) particularly during the priming and initiation of the early maternal 
immune response would have been informative, especially when comparing the 
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following an experimental challenge with
Neospora caninum at day 70 of gestation
Paul M Bartley1*, Stephen E Wright1, Stephen W Maley1, Colin N Macaldowie1, Mintu Nath2, Clare M Hamilton1,3,
Frank Katzer1, David Buxton1 and Elisabeth A Innes1Abstract
The immune responses of pregnant cattle and their foetuses were examined following inoculation on day 70 of
gestation either intravenously (iv) (group 1) or subcutaneously (sc) (group 2) with live NC1 strain tachyzoites or
with Vero cells (control) (group 3). Peripheral blood mononuclear cell (PBMC) responses to Neospora antigen and
foetal viability were assessed throughout the experiment. Two animals from each group were sacrificed at 14, 28,
42 and 56 days post inoculation (pi). At post mortem, maternal lymph nodes, spleen and PBMC and when possible
foetal spleen, thymus and PBMC samples were collected for analysis. Inoculation with NC1 (iv and sc) lead to foetal
deaths in all group 1 dams (6/6) and in 3/6 group 2 dams from day 28pi; statistically significant (p≤ 0.05) increases
in cell-mediated immune (CMI) responses including antigen-specific cell proliferation and IFN-γ production as well
as increased levels of IL-4, IL-10 and IL-12 were observed in challenged dams compared to the group 3 animals.
Lymph node samples from the group 2 animals carrying live foetuses showed greater levels of cellular proliferation
as well as significantly (p≤ 0.05) higher levels of IFN-γ compared to the dams in group 2 carrying dead foetuses.
Foetal spleen, thymus and PBMC samples demonstrated cellular proliferation as well as IFN-γ, IL-4, IL-10 and IL-12
production following mitogenic stimulation with Con A from day 14pi (day 84 gestation) onwards. This study
shows that the generation of robust peripheral and local maternal CMI responses (lymphoproliferation, IFN-γ) may
inhibit the vertical transmission of the parasite.
Keywords: Neospora caninum, Cattle, Early gestation, Maternal – foetal cellular immuneIntroduction
The protozoan parasite Neospora caninum is a major
cause of abortion and reproductive failure in cattle
worldwide. The most common route of infection with N.
caninum appears to be the transplacental (vertical) trans-
mission of the parasite from mother to foetus; this may
result in abortion or the birth of clinically normal but
persistently infected offspring [1,2]. Horizontal transmis-
sion of the parasite may occur in intermediate hosts
through the ingestion of oocysts (shed by a definitive
host i.e. dog) in contaminated feed and water [3], poten-
tially leading to point source outbreaks (abortion storms)
of neosporosis. Previous studies in cattle have shown that* Correspondence: Paul.bartley@moredun.ac.uk
1Moredun Research Institute, Pentlands Science Park, Bush Loan, Midlothian,
EH26 0PZ, Scotland, United Kingdom
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145N. caninum infections can be maintained over several
generations through vertical transmission of the parasite
[1,4], Moen et al. (1998) demonstrated that as a result of
a primary infection, cattle were 3–7 times more likely to
abort than uninfected animals [5]. However, animals that
have aborted due to neosporosis are less likely to abort
due to the parasite during subsequent pregnancies, com-
pared to cows undergoing N. caninum infection during
their first pregnancy [6], suggesting that a certain level of
protective immunity builds following infection. Experi-
mental data by Innes et al., (2001) [7] demonstrated that
exposure of cattle to Neospora prior to pregnancy pro-
tected against the vertical transmission of the parasite
following an experimental challenge with N. caninum
during pregnancy. Other factors influencing the outcome
of N. caninum infections in pregnant cattle include; the
quantity and duration of the parasitaemia [8], theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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virulent than others, in cattle) [9], the immune status of
the dam and the gestational age of the foetus at the time
of infection [7,8]. Experimental infections of pregnant
cattle have shown that foetal death may occur when
dams were challenged with N. caninum tachyzoites at
day 70 of gestation [10,11], while a challenge adminis-
tered around mid gestation resulted in the vertical trans-
mission of the parasite, but no foetal death [12,13].
These observations would suggest that the timing of a
parasitaemia during pregnancy is critical in the clinical
outcome and will likely be influenced by both the mater-
nal and foetal immune responses to the parasite. Work
carried out by Williams et al. (2000); Collantes-Fernan-
dez et al., (2006) and Rosbottom et al., (2007) [10,14,15]
would support this conclusion.
The intracellular nature of N. caninum suggests that a
cell-mediated immune (CMI) response is likely to be im-
portant to protect the host [12]. Increasing experimental
data from pregnant cattle has confirmed this [7,15-18].
Work by Bartley et al., (2004) [13] demonstrated a
strong CMI response in dams and foetuses challenged
with N. caninum on day 140 of gestation. Although, no
foetal deaths were recorded, vertical transmission of the
parasite occurred and the maternal and foetal immune
responses appeared to contribute to the resolution of in-
fection. Numerous other studies have illustrated the im-
portance of a pro-inflammatory T-helper (Th)-1 type
response, interferon-γ (IFN-γ) in particular has been
shown to be crucial in controlling infection both in vivo
[15,16,19] and in vitro [20-22]. The timing and location
of these pro-inflammatory immune responses has also
been shown to be critical to the clinical outcome of a
Neospora infection in cattle. Work by Maley et al.,
(2006) [23] demonstrated in cattle experimentally chal-
lenged with Neospora on day 70 of gestation; that the in-
filtration of large numbers of immune cells and
increased levels of expression of IFN-γ mRNA in the pla-
centa lead to foetal death and abortion.
In this study, we compared the maternal and foetal im-
mune responses in cattle inoculated either intravenously
(iv) or subcutaneous (sc), with live N. caninum (NC1
strain) tachyzoites at day 70 of gestation. A serial exam-
ination of the maternal and foetal immune responses
was conducted looking at Neospora specific cell prolif-
eration and cytokine production in PBMC and lymph
node samples following experimental challenge.
Materials and methods
Animals, inoculum and experimental design
Twenty four pregnant Holstein-Friesian cattle aged 1.3
to 4 years and seronegative for N. caninum, Toxoplasma
gondii, bovine viral diarrhoea virus, infectious bovine rhi-
notracheitis and Leptospira hardjo were assigned into146three groups. Pregnancy and foetal viability was con-
firmed in all experimental animals by ultrasound scan-
ning 36 days after insemination. On day 70 of gestation,
group 1 dams (n = 8) received an intravenous (iv) inocu-
lation in the right jugular vein of 5×108 live N. caninum
(NC1 isolate) tachyzoites. Group 2 dams (n = 8) received
a subcutaneous (sc) inoculation of 5×108 live N. caninum
(NC1 isolate) tachyzoites over the left pre-femoral lymph
node. Group 3 (n = 8), the control animals each received
an iv inoculation of 5×106 Vero cells. This dose of Vero
cells was used, as it was the equivalent number of cells
present in the parasite inocula. Blood was collected by
weekly jugular venipuncture throughout the experiment
for immunological analysis. Two animals from each
group were sacrificed at days 14, 28, 42 and 56 post in-
oculation (pi). At post mortem samples of left pre-fem-
oral lymph node (LPF), right pre-femoral lymph node
(RPF), left uterine lymph node (LUL), right uterine
lymph node (RUL), mesenteric lymph node (MLN), ret-
ropharyngeal lymph node (RLN), spleen and peripheral
blood mononuclear cells (PBMC) were collected from
each dam; When possible spleen, thymus and PBMC
samples were collected from the foetuses.
Preparation of cells for immunological assays
Single cell suspensions of PBMC were prepared as previ-
ously described [7]. Samples from lymph nodes collected
at post mortem were prepared as previously described
[13]. In brief, excess fat was trimmed from the tissues,
which were then cut into small pieces and placed in
10 ml wash buffer (Hank’s balanced salt solution (HBSS)
supplemented with 2% foetal bovine serum (FBS) (Lab-
tech International, Ringmer, UK) 100 IU/ml penicillin
and 50μg/ml streptomycin) (Northumbria Biologicals,
Cramlington, UK), placed in a stomacher bag (Seward
Medical, Northampton, UK) and homogenised for 10
seconds. The resultant cell suspension was decanted into
a sterile universal through sterile lens tissue to remove
clumps of cells, washed twice by repeated centrifugation
at 260 × g, counted using a Neubauer haemocytometer
and resuspended at a final concentration of 2×106 cells/
ml in cell culture media (CCM) (Iscoves modified Dul-
becco’s media (IMDM) (Gibco, Paisley, UK) supplemen-
ted with 10% FBS, 100 IU/ml penicillin and 50μg/ml
streptomycin).
Cell proliferation assays
Single cell suspensions of both PBMC and lymph node
tissues were treated as previously described [13]. In brief,
equal volumes (100 μl) of cells (2×106/ml) and antigen
were added in quadruplicate to 96-well round bottom
plates (Nunc, Roskilde, Denmark). Water-soluble N.
caninum tachyzoite antigen (NCA) [7] was used at a
final protein concentration of 1μg/ml, the T-cell mitogen
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a final concentration of 5μg/ml, CCM alone was used as
a negative control to determine the background level of
proliferation. A Vero cell lysate antigen at 1 μg/ml was
used as a control antigen. The cultures were incubated
at 37°C in a humidified 5% CO2 atmosphere for 5 days.
The cultures were pulsed with 18.5 kBq 3H Thymidine/
well (Amersham Biosciences, Little Chalfont, UK) for the
final 18 hours, before being harvested onto glass-fibre fil-
ters (Canberra Packard, Meriden, CT, USA) and the cell-
associated radioactivity was quantified using a MATRIX
96TM gas proportional counter.
Cytokine responses
Duplicate cell proliferation assays were prepared to those
described above. Cell free supernatants were collected
after 4 days incubation, to measure the levels of secreted
cytokines (interferon-gamma (IFN-γ), interleukin-4 (IL-
4), IL-10 and IL-12). The supernatant samples were
stored at −20°C prior to analysis.
IFN-γ
Levels of IFN-γ production were quantified using a com-
mercially available enzyme linked immunosorbent assay
(ELISA) kit (CSL Veterinary, Parkville, Australia). A
standard curve was generated using doubling dilutions of
known quantities (ng/ml) of recombinant bovine IFN-γ
(rBoIFN-γ) (Pfizer Animal Health, Parkville, Australia).
Mean optical density (OD) values were plotted against
ng/ml rBoIFN-γ and a standard regression curve was fit-
ted to the data. Experimental samples were extrapolated
against the standard regression curve to determine the
levels of IFN-γ in the test samples.
IL-10
Levels of bovine IL-10 were quantified using an ELISA
method as previously described [24]. In brief, 96-well
ELISA plates (Greiner, Stonehouse, UK) were coated with
50μl (4μg/ml) per well with a primary anti-bovine IL-10
capture antibody and incubated at room temperature over-
night. The plates were washed x 5 using phosphate buf-
fered saline (PBS) supplemented with 0.05% Tween 20
(PBS-T) between each step, with the exception of the final
TMB – H2SO4 stage. The plates were blocked at room
temperature for 1 hour with PBS-T supplemented with 3%
bovine serum albumin (BSA). Samples and standards (50μl
each) were added and incubated at room temperature for
1 hour. Plates were then coated with (1μg/ml) secondary
biotinylated anti IL-10 antibody (Diluted in PBS-T 1%
BSA) (50μl per well) and incubated at room temperature
for 1 hour. Streptavidin-horseradish peroxidase (HRP)
(Dako Cytomation, Glostrup, Denmark) diluted 1:500 in
PBS-T 1%BSA (50μl/well) was added and incubated at
room temperature for 45 minutes. Colour was developed147by the addition of TMB (3,3′,5,5′-tetramethylbenzidine)
substrate (Insight Biotech. Ltd., Wembley, UK) (100μl/
well) and incubated in the dark for 10–15 minutes. Reac-
tions were stopped by adding 50μl/well 1 M H2SO4. The
plates were read at 450/650 nm using a MRX II plate
reader (Dynex, East Grinstead, UK). Doubling dilutions of
known quantities of recombinant bovine IL-10 (rBoIL-10)
were used to generate a standard regression curve against
which the test sample concentrations were extrapolated.
IL-12
Interleukin-12 (IL-12) was quantified using the same
method described above for the detection of IL-10, with
the following changes. A primary anti IL-12 capture anti-
body (4μg/ml) was used along with a secondary biotiny-
lated anti IL-12 antibody (8μg/ml). Known quantities of
recombinant ovine IL-12 (rOvIL-12) were used as stan-
dards and standard regression curve was fitted to the
data [25].
IL-4
Interleukin-4 (IL-4) was quantified using the same
method described above for the detection of IL-10 and
IL-12, with the following changes. A primary anti IL-4
capture antibody (6μg/ml) was used along with a second-
ary biotinylated anti IL-4 antibody (2μg/ml). Known
quantities of recombinant bovine IL-4 (rBoIL-4) were
used as standards and a standard regression curve was
fitted to the data [26].
All primary and secondary antibodies used for the cap-
ture and detection of IL-4, IL-10 and IL-12 were pur-
chased from AbD Serotec, (Oxford, UK). All rBoIL-4,
rBoIL-10 and rOvIL-12 cytokines (Moredun Research
Institute, Edinburgh, UK)
Foetal serology
At post mortem examination blood was drawn from the
foetuses (when available) into non-heparinised evacuated
tubes (Vacutainer, Becton Dickinson, Oxford,UK) and
allowed to clot before centrifugation at 2000 x g for 15
minutes, the serum was removed and stored at −20°C
prior to being tested for IgM and IgG to N. caninum by
an indirect fluorescent antibody test (IFAT), as previ-
ously described [27]; an IFAT titre of ≥1:64 was consid-
ered positive.
Statistical analysis
The maternal cell proliferation data (PBMC, lymph
nodes and spleen) and IFN-γ ELISA data were analysed
with a linear mixed model, using a first-order autoregres-
sive model to specify the temporal covariance structure.
Both the proliferation and IFN-γ ELISA data were nor-
malised by logarithmic transformation (base 10) prior to
the analysis. The linear mixed model included the animal
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interaction effect of treatment and day as fixed effects.
Parameters of the linear mixed models were estimated
using the REML method and p-values were estimated
using the modified F-statistic. If the F-statistic was statis-
tically significant (p≤ 0.05), two-sided probabilities for
each treatment comparison were obtained; these prob-
abilities were then adjusted using a False Discovery Rate
approach [28]. This value, denoted in this paper as pf,
therefore summarises the strength of evidence for there
being a real difference in a way analogous to a standard
p-value.
The foetal proliferation and IFN-γ data (PBMC and
spleen) were analysed using non-parametric Kruskal-
Wallis one way analysis of variance (ANOVA) using
treatment as a grouping factor. No data was available for
group 1 for the foetal thymus, (proliferation and IFN-γ
ELISA) hence a two sample non-parametric Mann–
Whitney test was conducted. All statistical analyses were
carried out using GenStat 13th Edition software (VSN
International, Hemel Hempstead, UK)
Results
Clinical observations, pathology and foetal mortality
Foetal viability following experimental challenge is
shown in Additional file 1. In group 1 (iv) viable foetuses
were only seen on day 14 pi, both foetuses were found
dead on day 28 pi and no foetuses were found on days
42 and 56 pi. In group 2 (sc) two viable foetuses were
found on day 14 pi and one live and one dead foetus on
days 28, 42 and 56 pi. In the group 3 (control) animals,
two live foetuses were found at each time point. The ma-
ternal serology and histopathology data from this experi-
ment is described in Macaldowie et al., (2004) Neospora
caninum parasites were only demonstrated in placental
and foetal tissues from challenged animals carrying dead
foetuses and they were associated with lesions [11].
Maternal PBMC
Cell proliferation
The results from the PBMC proliferation assays from
group 1 (iv) demonstrated statistically significantly
higher mean levels of antigen-specific proliferation on
days 14 (pf= 0.020), 21 (pf= 0.004), 42 (pf= 0.043) and 56
pi (pf< 0.001) compared to group 3 (control). The
mean cell proliferation results from group 2 (sc) were
found to be statistically significantly higher than group
3 on days 7 (pf = 0.004), 14 (pf = 0.011), 21 (pf< 0.001),
42 (pf< 0.001), 49 (pf = 0.020) and 56 pi (pf< 0.001). A
comparison of the data from group 1 and group 2
showed that the mean antigen-specific proliferation in
group 2 was higher than group 1 on day 7 pi (pf=0.003). At
subsequent time points, the mean level of antigen specific
PBMC proliferation of group 2 animals were higher in148comparison to group 1 animals, though these differences
were not statistically significant. (Additional file 2).
Cytokine responses
The levels of antigen-specific cytokine production was
determined using the cell-free supernatants from mater-
nal PBMC, lymph nodes and spleen samples following
stimulation with NCA for 4 days
IFN-γ
The log10 transformed antigen specific-IFN-γ data from
PBMC cultured with NCA (Additional file 3). Group 1
(iv) showed a rise in IFN-γ from days 7 to 21 pi and
reached a peak on day 28 pi, then declined to baseline
levels on day 56 pi. Though group 1 maintained an ele-
vated level of IFN-γ compared to the group 3 (control)
animals, there was no evidence of a difference between
the mean IFN- γ levels of the two groups (pf= 0.107). In
group 2 (sc), levels of IFN-γ were consistently higher
than other groups at all time points and reached a peak
on day 21 pi. The mean level of IFN-γ from group 2 was
statistically significantly different from that of group 3
(pf= 0.005), though there was no evidence of a difference
between the mean IFN-γ levels of group 1 and 2
(pf= 0.118).
IL-4
In group 1 (iv) demonstrable antigen-specific IL-4 was
observed in PBMC samples of one dam on day 14 pi
(1.543U/ml), IL-4 production was seen in PBMC from
both group 1 dams on day 28 pi (8.37U/ml and 2.54U/
ml); while on days 42 and 56 pi PBMC samples from
group 1 were below the detection level of the ELISA. De-
tectable levels of IL-4 were only seen in the PBMC from
one of the group 2 (sc) animals on day 28 pi (carrying a
dead foetus), these levels were much lower (0.518U/ml)
than those seen in group 1, though no statistical differ-
ences were observed between groups 1 and 2. The levels
of IL-4 in the group 3 (control) PBMC were either below
the detection threshold of the ELISA at 0.114U/ml or
only just detectable (data not shown).
IL-10
Demonstrable antigen-specific IL-10 was observed in
PBMC from one group 2 (sc) animal carrying a dead
foetus on 42 pi (0.286U/ml). All PBMC samples from
groups 1 (iv) and 3 (control) were below the detection
threshold (0.17U/ml) of the ELISA at all time points
(data not shown).
IL-12
Levels of antigen-specific IL-12 were demonstrable in most
PBMC samples collected from all three groups on days 14,
28 and 42 pi. Group 2 (sc) animals demonstrated higher
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the group 2 dam carrying the dead foetus demonstrated
39.1U/ml while, 94.3U/ml was recorded from the dam car-
rying the live foetus. By day 56 pi levels of IL-12 were ei-
ther below the detection threshold (0.3U/ml) or only just
detectable in all three groups (data not shown).
Maternal lymph nodes and spleen
Cell proliferation
The log10 transformed antigen specific proliferation in
maternal lymph nodes and spleen samples following
stimulation with NCA. On day 14 pi, samples of LPF
from group 2 (sc) had significantly (pf= 0.010) higher
mean proliferation than group 3 (control). While mean
proliferation from spleen samples from groups 1 (iv) and
group 2 were significantly higher (p= 0.05 and p= 0.047
respectively) than group 3 (Additional file 4).
On day 28 pi, samples of LPF from group 1 and 2 had
significantly higher mean proliferation than group 3 (pf=
0.006 and pf= 0.025 respectively), while samples of RLN
and RPF from group 1 showed higher values than groups
2 and 3 (pf= 0.023 and p= 0.05 respectively) and
(p= 0.033 and p= 0.015 respectively) (Additional file 4).
On day 42 pi, samples of LPF from group 2 and 3 had
significantly higher mean proliferation than the group 1
(pf= 0.005 and pf= 0.031 respectively) (Additional file 4).
On day 56 pi, group 2 demonstrated statistically sig-
nificantly higher mean proliferation than group 3 from
RPF (pf= 0.051), LPF (pf< 0.001), RLN (pf= 0.023) and
RUL (p= 0.021) and MLN (p= 0.007) samples. Group 2
also demonstrated significantly higher mean proliferation
than group 1 for LPF samples (pf <0.001), while group 1
had significantly higher mean proliferation than group 3




Following the stimulation of cells from spleen and lymph
nodes with NCA for 4 days; group 1 (iv) and group 2 (sc)
both showed detectable levels of antigen specific-IFN-γ
(ng/ml) in all samples tested from day 14 pi onwards, while
group 3 (control) produced almost undetectable levels of
IFN-γ at each of the time points tested (Additional file 5).
The mean levels of IFN-γ from group 1 was statistically
significantly higher than group 3 for RPF (pf=0.001), RUL
(pf< 0.001), LUL (pf=0.013), RLN (pf=0.003) and spleen
(pf=0.001). Similarly, the mean levels of IFN-γ from group
2 were statistically significantly higher than group 3 for
RPF (pf = 0.004), LPF (pf = 0.005), RUL (pf = 0.005), RLN
(pf = 0.009) and spleen (pf = 0.004). There was no evi-
dence in the present data that the mean IFN-γ values of
group 1 and 2 were different for any of the lymph node
or spleen.149IL-4
Group 1 (iv) showed demonstrable antigen-specific IL-4
from both dams for all spleen and lymph node samples
(except for LPF and RPF – only one dam responded) on
day 28 pi and in LUL of one dam on 42 pi. All samples
tested from group 2 (sc) and group 3 (control) were either
below the detection threshold of the ELISA at 0.114U/ml
or only just detectable and hence no statistical analysis
was undertaken (data not shown).IL-10
Group 1 (iv) was the only group with demonstrable
antigen-specific IL-10, this was seen in LUL (2.61U/ml)
and RLN (1.27U/ml) samples on day 42 pi, All samples
tested from group 2 (sc) and group 3 (control) were below
the detection threshold of the ELISA and hence no statis-
tical analysis was undertaken (data not shown).IL-12
Group 1 (iv) had demonstrable levels of antigen-specific
IL-12 in RPF, LUL, RUL, MLN, RLN and spleen on days
14, 28 and 42 pi, with the highest levels being observed
on day 42pi (126.75U/ml, 210.55U/ml, 98.00U/ml,
114.71U/ml, 307.9U/ml and 137.09U/ml respectively). By
day 56 pi the levels of IL-12 had dropped below the detec-
tion threshold of the ELISA (0.3U/ml). Group 2 (sc)
demonstrated levels of IL-12 below or barely above the
threshold in most samples on days 14 and 28 pi. Levels of
IL-12 peaked on day 42 pi, in the RLN and spleen,
(23.64U/ml and 33.23U/ml respectively); by day 56 pi levels
of IL-12 had dropped below threshold. Group 3 (control)
showed low but detectable levels of antigen specific IL-12
from samples at all time points. Due to paucity of data, no
statistical analysis was undertaken (data not shown).Foetal PBMC, thymus and spleen
Cell proliferation
Samples collected from the foetuses for immunological
analysis are shown in Table 1. No Neospora antigen-specific
cell proliferation was demonstrated from any of the
samples from any of the foetuses tested.
From day 14 pi (day 84 of gestation) PBMC samples
showed proliferation following stimulation with Con A
(Figure 1). On day 28 pi (day 98 of gestation) mitogenic
proliferation was demonstrated in the spleen and thymus
of foetuses from both group 2 (sc) and group 3 (control).
On day 42 pi (day 112 of gestation) proliferative
responses to Con A were continued to be seen in PBMC,
thymus and spleen samples from the foetuses from both
group 2 and group 3. On day 56 pi (day 126 of gestation)
PBMC, spleen and thymus all showed proliferation fol-
lowing Con A stimulation (Figure 1). When the
responses of the foetal tissues were compared, no
Table 1 Foetal samples collected at post mortem examination
Number of foetal samples collected/Total number of foetuses
Group 1 (iv) Group 2 (sc) Group 3 (Control)
Day pi PBMC Thymus Spleen PBMC Thymus Spleen PBMC Thymus Spleen
14 2/2 0/2 2/2 2/2 0/2 2/2 2/2 0/2 2/2
28 0/2{ 0/2{ 0/2{ 0/2 1/2{ 1/2{ 0/2 2/2 2/2
42 0/2† 0/2† 0/2† 1/2{ 1/2{ 1/2{ 2/2 2/2 2/2
56 0/2† 0/2† 0/2† 1/2{ 1/2{ 1/2{ 0/2 2/2 2/2
{− Foetus found dead in utero (No Samples able to be collected).
†−No foetus found (due to resorption or abortion).
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in the levels of mitogenic proliferation.
Cytokine responses
Following stimulation with NCA, levels of antigen-specific
IFN-γ IL-4, IL-10 and IL-12 were below detectable limits
in all the foetal samples tested.
IFN-γ
The levels of IFN-γ following Con A stimulation on Day
14 pi (day 84 of gestation) were below detectable limits for
all the samples tested. On days 28, 42 and 56 pi (days 98,
112 and 126 of gestation respectively) PBMC, spleen and
thymus samples produced demonstrable quantities of
IFN-γ, following stimulation with Con A. There were no
significant differences observed in the levels of IFN-γ pro-
duced in Con A stimulated cells from any of the groups, at
any of the time points tested (data not shown).
IL-4
Following Con A stimulation, on day 14 pi all samples
tested from all three groups were below the detection
threshold of the ELISA. On day 28 pi (day 98 of gesta-
tion), production of IL-4 was demonstrated in one group
3 (control) foetal thymus sample (0.117U/ml). On day 42
pi (day 112 of gestation) one group 3 foetal thymus
(0.178U/ml) and both group 3 spleen (0.221U/ml,
0.214U/ml) samples produced demonstrable IL-4. On
day 56 pi (day 126 of gestation), IL-4 was produced by
the thymus samples of all three foetuses (group 2 and 3)
and in the PBMC samples from both group 3 foetuses
(data not shown).
IL-10
Following Con A stimulation, on day 14 pi all samples
tested from all three groups were below the detection
threshold of the ELISA. On day 28 pi (day 98 of gesta-
tion), IL-10 was produced by one group 3 (control) foetal
spleen sample (0.587U/ml). On day 42 pi (day 112 of ges-
tation) IL-10 was produced by group 2 (sc) and group 3
thymus samples (0.201U/ml and 0.194U/ml respectively);
and in thymus, (0.359U/ml) spleen (0.947U/ml) and150PBMC (1.681U/ml) samples from both group 2 and group
3 on day 56 pi (day 126 of gestation) (data not shown).
IL-12
Following Con A stimulation, IL-12 was expressed in
foetal spleen and PBMC samples from all three groups
from as early as day 14 pi (day 84 of gestation). Produc-
tion of IL-12 continued to be demonstrated in all tissues
tested from both group 2 (sc) and group 3 (control);
peaking in the thymus (8.66U/ml) and spleen (12.17U/
ml) on day 28 pi (day 98 of gestation) and in PBMC
(12.92U/ml) on day 56 pi (day 126 of gestation) (data not
shown).
Foetal serology
The results from the foetal anti-Neospora IgG IFAT show
that on day 28 pi (day 98 of gestation) a serum sample
collected from one of the foetuses from group 1 (iv)
which was found dead in utero, gave a positive IFAT re-
sult with a titre of 1:128. On days 42 and 56 pi (days 112
and 126 of gestation respectively) no foetuses were
present for sample collection. In groups 2 (sc) and 3
(control), serum samples were collected from live foe-
tuses, these all tested negative for IgG IFAT (titre ≤1:64).
All the samples tested from all the groups were negative
(titre ≤1:64) for anti-Neospora IgM (data not shown).
Comparison of maternal immune responses in group 2
(sc) dams carrying live or dead foetuses
The immune responses of the dams in group 2 (sc) car-
rying live or dead foetuses were compared; The dam car-
rying a live foetus demonstrated considerably higher
levels of cellular proliferation in LUL and RUL on days
28, 42 and 56 pi compared to the dam carrying the dead
foetus; while on days 42 and 56 pi higher levels of prolif-
eration were also seen in the PBMC of the dams carrying
the live foetus compared to the dams carrying the dead
foetuses. Though there were no significant differences
seen in the levels of maternal proliferation, when the
log10 data were compared using a linear mixed model,
the dams carrying the live foetuses generally demon-



















Figure 1 Proliferative responses of foetal PBMC, spleen and
thymus samples following stimulation with Con A for 5 days.
Samples of PBMC, spleen and thymus were collected at post
mortem examination when available. Samples were stimulated with
Con A for 5 days (37°C in a humidified 5% CO2 atmosphere), with
18.5 kBq 3 H Thymidine/well being added for the final 18 hours,
before being harvested onto glass-fibre filters. The box plots illustrate
the combined counts per minute (cpm) ×103 values from the foetal
samples from all three group s at each time point. The boxes
represent the upper and lower values obtained for each sample, the
horizontal line = the median value.
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151lymph nodes stimulated with NCA, compared to the
dams carrying the dead foetuses (data not shown). Com-
parisons were also made in the levels of antigen specific-
cytokine responses (IFN-γ, IL-4, IL-10 and IL-12) in
PBMC and lymph nodes of dams carrying live foetuses
compared to the dams carrying dead foetuses in group 2.
On day 28 pi, greater levels of antigen specific-IFN-γ
were seen in samples from the LPF, LUL, RUL and RPF
from dams carrying live foetuses compared to the dams
carrying dead foetuses (data not shown). On days 42
(Figure 2A) and 56 pi, (Figure 2B) dams carrying live foe-
tuses demonstrated increased levels of IFN-γ in all sam-
ples except RLN (on day 56 pi) compared to the dams
carrying dead foetuses. When IFN-γ data from days 28,
42 and 56 pi were combined and analysed using a linear
mixed model, the IFN-γ responses in the RPF and spleen
of dams carrying live foetuses were statistically signifi-
cantly higher than in dams carrying dead foetuses
(p= 0.008 and p= 0.005 respectively). Dams carrying live
foetuses also showed higher levels of antigen specific-IL-
12 on day 28 pi (RPF, LUL, RUL, spleen and PBMC). On
day 42 pi, the dam with the live foetus had higher levels
of antigen specific-IL-12 in RLN (23.64U/ml), spleen
(33.27U/ml) and PBMC (94.30U/ml) compared to the
dam carrying a dead foetus (1.23U/ml, 13.9U/ml, and
39.11U/ml respectively). None of the dams carrying live
foetuses had demonstrable antigen specific-IL-4 at any
time point, while one dam carrying a dead foetus on day
42 pi showed antigen-specific IL-4 production in LUL,
RUL, MLN, spleen and PBMC. No differences were seen
in levels of antigen-specific IL-10 production between
the dams carrying live and dead foetuses at any of the
time points tested.
Discussion
This paper examines the maternal and foetal cell-
mediated immune (CMI) responses of pregnant cattle
experimentally inoculated with live N. caninum tachy-
zoites on day 70 of gestation (for a full description of the
clinical observations and pathological findings see
Macaldowie et al., (2004) and Maley et al., (2006) re-
spectively) [11,23]. The route of inoculation of N. cani-
num tachyzoites played an important role in the
outcome of infection, with 100% of group 1 (iv) animals
having dead, reabsorbed or aborted foetuses from day 28
pi, compared to only 50% of the group 2 (sc) animals.
The dams in group 2 (sc) proved to be very interesting,
allowing us to compare the CMI responses in dams car-
rying live compared to dead foetuses following an identi-
cal challenge. Although the number of animals in the
experiment was limited these results will aid our under-
standing of a protective maternal immune response,
which is critical for foetal survival, due to the immaturity
of the foetal immune response at this stage of gestation.
A Day 42 pi
B Day 56 pi
- Dead  - Live
- Dead  - Live
Figure 2 Comparison of IFN-γ production by group 2 (sc) dams carrying live or dead foetuses. Maternal lymph node, spleen and PBMC
samples were collected at post mortem examination. Following stimulation with NCA for 4 days (37°C in a humidified 5% CO2 atmosphere), ELISA
were performed to determine the concentration of IFN-γ produced. The data is expressed as ng/ml. –◊– Live, –♦– Dead.
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day 84 of gestation (day 14 pi) and anti-Neospora IgG
was demonstrable from day 98 of gestation (day 28 pi).
Maternal immune response
The CMI responses observed in the dams in this study
provides further evidence that cell-mediated immunity
and in particular IFN-γ is important in protection
against the rapidly multiplying intracellular tachyzoite
stage of the parasite. Our data would suggest that a
strong Th1 type cell-mediated immune response in both
the peripheral and uterine lymph nodes as well as in
PBMC, in particular in the group 2 (sc) dams carrying
live foetuses, appears to have been sufficient to prevent
the transplacental transmission of the parasite. When the
immune responses of the dams in group 2 (sc) carrying
live and dead foetuses were compared, it was seen that
dams carrying live foetuses tended to exhibit stronger
antigen-specific lymphocyte proliferation, significantly
higher levels of IFN-γ as well as increased IL-12 produc-
tion in samples of PBMC and lymph nodes, compared to
dams in the same group (sc) carrying dead foetuses.
Work carried out by Williams et al., (2000) [10] demon-
strated that infection of pregnant cattle at 10 weeks152gestation with N. caninum was accompanied by high
levels of IFN-γ and lymphoproliferative responses indi-
cating a profound Th1 helper T-cell like response in
PBMC. Rosbottom et al., (2007) [15] observed prolifera-
tion of CD4+ T-cells and the expression of IFN-γ and IL-
4 in PBMC stimulated with N. caninum antigen in preg-
nant cattle challenged on day 70 of gestation.
However, when a strong immunological response
occurs in the placenta during early gestation, this can be
detrimental to the pregnancy. Davies et al., (2004) [29]
demonstrated that the activation of the maternal muco-
sal immunity within the uterus during early placentome
development, may lead to immune mediated abortion.
During our study, the group 2 (sc) animals carrying dead
foetuses (examined by Maley et al. (2006) [23]) demon-
strated infiltration of large numbers of T lymphocytes,
γδ T-cells, NK cells and IFN-γ mRNA, leading to exten-
sive immune mediated damage (necrosis) of the placenta,
compared to the dams carrying the live foetuses who
showed mild or no infiltration of the immune cells, no
demonstrable IFN-γ mRNA and consequently little or
no immune mediated placental damage. Similar observa-
tions were made by Rosbottom et al., (2008) [30] who
found in pregnant cattle, following a challenge with N.
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with extensive placental necrosis, which corresponded to
CD4+ T-cell and macrophage infiltration and increased
expression of IFN-γ.
Route of infection
Our data shows that the route of inoculation plays a crit-
ical role in the outcome of infection, with iv inoculation
(5x108 live tachyzoites) leading to a greater incidence of
foetal mortality than a sc inoculation with the same dose
of parasites. This may be due in part to the haemotogen-
ous nature of the iv inoculation, allowing the rapid trans-
portation of the parasites to the placenta, before an
effective maternal CMI response can be initiated to limit
the spread of the tachyzoites. Comparing the immuno-
logical responses generated by the different routes of in-
oculation, group 2 animals (sc) demonstrated stronger
proliferative responses in PBMC (by day 7 pi) and many
of the lymph nodes (by day 14 pi) than the group 1 (iv)
animals. Superior priming of the immune responses in
the group 2 (sc) animals appears to have prevented the
transplacental transmission of the parasite in 50% of
cases. The animals in group 2 (sc) carrying live foetuses
may have initiated an innate immune response more rap-
idly than the group 1 (iv) animals. This initiation is likely
through the interaction of pathogen associated molecular
patterns (PAMP) with toll like receptors (TLR) on the
surface of antigen presenting cells (APC); this interaction
induces a signalling pathway that will in turn lead to the
activation of APC’s and the production of pro-inflamma-
tory cytokines, as well as leading to the maturation and
migration of dendritic cells (DC) to local draining lymph
nodes [31]. This APC migration may have been more
rapid in the group 2 (sc) animals, as they were inoculated
over a lymph node (left pre femoral lymph node). To
date there is little experimental evidence demonstrating
a role for the innate immune response in bovine neos-
porosis; work by Boysen et al., (2006) [20] and Klevar et
al., (2007) [32] demonstrated a role for Natural killer
(NK) cells during early infection in calves, in producing
IFN-γ, and observed NK cytotoxicity in N. caninum
infected fibroblast cells. Work in mice by Dion et al.,
(2011) [33] demonstrated that both DC and macro-
phages secrete IL-12 following exposure to viable N.
caninum parasites, and that interactions between T lym-
phocytes and DC were involved in inducing IFN-γ pro-
duction by T lymphocytes. Evidence from the closely
related parasite Toxoplasma gondii has demonstrated an
important role for innate mechanisms in a protective im-
mune response including TLR [34-36]. Our experiment
demonstrates through serial analysis; differences in the
PBMC as well as lymph node responses of animals ex-
perimentally challenged by two different routes of inocu-
lation (iv and sc). These differences appear to have been153sufficient to protect against the vertical transmission of
the parasite in some sc inoculated animals, compared to
the iv challenged animals where vertical transmission
and foetal death occurred in all animals from day 28 pi
onwards.
Foetal immunology
As ruminants have a syndesmochorial placentation,
which does not usually allow the transplacental passage
of maternal immune factors including immunoglobulins
and cytokines [37], any immune responses detected in
the foetus are likely to be due to a response to an active
infection in utero. Our study showed that foetuses at day
98 of gestation (day 28 pi) are capable of mounting a
humoral (IgG) immune response against Neospora. This
finding would agree with work by Senogles et al., (1979)
[38] who demonstrated that at 3 months (approx 90 days)
gestation bovine foetal PBMC contained B cells that la-
belled positively for the presence of IgG. By day 98 gesta-
tion, components of a cell-mediated immune response
are also starting to develop. Our study demonstrated the
presence of lymphoproliferative responses as well as the
production of IFN-γ, IL-4, IL-10, and IL-12 being
observed in foetal spleen, thymus and PBMC samples
following mitogenic (Con A) stimulation. Schultz et al.,
(1973) [39] demonstrated in cattle the development of
follicles of lymphoid thymus from as early as day 42 of
gestation, while the spleen appears to develop from day
55 of gestation; while, Senogles et al., (1979) [38] demon-
strated the presence of T-cells in the bovine foetal thy-
mus, spleen and PBMC from 3 months of gestation.
Work carried out by Hein et al., (1988) [40] showed that
by day 120 of gestation bovine foetal lymphocytes were
well developed and capable of mitogenic stimulation as
well as the production of IL-2. Our work would suggest
that this development occurs by around day 100 of ges-
tation. The lack of any Neospora-specific CMI or
humoral responses in the live foetuses from the group 2
(sc) dams was due to the fact that the foetuses were
naïve to Neospora, due to no vertical transmission having
occurred. The lack of histopathological lesions or dem-
onstrable Neospora antigen in the placentomes or foetal
tissues [11] indicates that vertical transmission had not
occurred in the group 2 (sc) dams carrying live foetuses.
Other studies looking at the development of foetal im-
munology in cattle experimentally infected with Neos-
pora have demonstrated that foetuses from infected
dams at day 131 of gestation are capable of producing
both Th1 and Th2 type cytokines [13,16]. Bartley et al.
(2004) [9] showed that the foetuses from dams inocu-
lated with N. caninum at mid gestation (day 140) are
capable of mounting a specific cell-mediated immune re-
sponse from 14 days post inoculation (day 154 gestation).
While Andrianarivo et al. (2001) [17] demonstrated
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foetuses (days 219–231 of gestation).
Timing of infection
We demonstrate that experimental inoculation of cattle
at day 70 of gestation can lead to foetal mortality be-
tween 14–28 days post inoculation (pi) (days 84–98 of
gestation). Studies by Barr et al., (1994), Williams et al.,
(2000), Collantes-Fernandez et al. (2006) and Rosbot-
tom et al., (2007, 2008) [14,30,41,42] have demonstrated
that experimental infections with N. caninum in the first
trimester of pregnancy leads to increased foetal mortal-
ity and higher parasite burdens and greater dissemin-
ation of parasites in foetal tissues than infections at mid
or late pregnancy in cattle. Though Rojo-Montejo et al.,
2009b observed no demonstrable foetopathy in cattle
challenged on day 70 of gestation with the Neospora iso-
late Nc Spain 1 H [43]. While, Williams et al., (2000),
Maley et al. (2003), Rosbottom et al., (2007) and
Almeria et al., (2011) [10,12,15,44] demonstrated that a
primary challenge in naïve pregnant heifers around mid
gestation led to the transplacental transmission of the
parasite but no foetal death. The results from these
studies demonstrate that the timing of a primary infec-
tion during pregnancy is critical to the survival of the
foetus. As gestation progresses the severity of a foetal in-
fection decreases but the chances of congenital infection
increases.
Conclusions
Our study demonstrates the development of maternal
and foetal immune responses in lymph nodes and
PBMC following challenge with live N. caninum
tachyzoites. The innate immune response in the
group 2 (sc) dams carrying live foetuses appears to
have lead to superior priming of a cell mediated im-
mune response, which inhibited the vertical transmis-
sion of the parasite, compared to the group 2 dams
carrying dead foetuses. The route of inoculation of
N. caninum tachyzoites has an impact on the clinical
outcome of pregnancy in cattle, with an iv route of
inoculation resulting in greater incidence of foetal
mortality and less efficient immune priming com-
pared to a sc inoculation of the same number of
parasites. Foetuses from day 84 of gestation are cap-
able of producing cellular responses to the mitogen
Con A; these include lymphocyte proliferation as well
as cytokine (IFN-γ, IL-4, IL-10, and IL-12) production.
Our data has also shown that by day 98 of gestation foe-
tuses are able to mount a humoral (IgG) response to
Neospora. However should vertical transmission of the
parasite occur, the foetuses are still too immunologically154immature to mount a protective immune response,
resulting in foetal mortality.
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Additional file 1: Foetal viability results following either iv (group 1) or sc (group 2) inoculation with live NC1 strain tachyzoites 
 
 
Days post inoculation 
Number of live viable foetuses / Total number of foetuses 
Group Inoculation 14 28 42 56 
1 (n=8) 5x108 NC1 (iv) 2 / 2 0 / 2‡ 0 / 2† 0 / 2† 
2 (n=8) 5x108 NC1 (sc) 2 / 2 1 / 2‡ 1 / 2‡ 1 / 2‡ 
3 (n=8) 5x106 Vero cells 2 / 2 2 / 2 2 / 2 2 / 2 
 




Additional File 2. Log10 transformed maternal PBMC proliferation data following stimulation with 
NCA for 5 days 
 
 
Blood was collected by weekly venapuncture throughout the experiment and processed to 
determine levels of Neospora-specific proliferation. The processed cells were stimulated with NCA 
for 5 days (37oC in a humidified 5% CO2 atmosphere), with 18.5kBq 3H Thymidine / well being 
added for the final 18 hours, before being harvested onto glass-fibre filters. The data was then 
log10 transformed before analysis using a linear mixed model 
-▲- Group 1 (iv), -♦- Group 2 (sc), -■- Group 3 (Control)  
Error Bars Error bars (± standard error of the mean (S.E.M.)) 
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Additional file 3. Mean Log10 antigen-specific IFN-γ concentrations from maternal lymph node and spleen samples following 











Mean Log10 antigen-specific IFN-γ concentrations from maternal lymph node and spleen 
samples following stimulation for 4 days with NCA  
Lymph node and spleen tissue samples were collected at post mortem examination and 
processed to determine levels of Neospora-specific proliferation. The processed cells were 
stimulated with NCA for 4 days (37oC in a humidified 5% CO2 atmosphere); ELISA were 
performed to determine the concentration of IFN-γ produced. 




Additional File 4. Log10 transformed proliferative responses from maternal lymph nodes and spleen samples following stimulation with 














Log10 transformed proliferative responses from maternal lymph nodes and spleen samples 
following stimulation with NCA for 5 days  
Lymph node and spleen tissue samples were collected at post mortem examination and 
processed to determine levels of Neospora-specific proliferation. The processed cells were 
stimulated with NCA for 5 days (37oC in a humidified 5% CO2 atmosphere), with 18.5kBq 3H 
Thymidine / well being added for the final 18 hours, before being harvested onto glass-fibre 
filters. The data was then log10 transformed before analysis using a linear mixed model.  
-▲- Group 1 (iv), -♦- Group 2 (sc), -■- Group 3 (Control) Error Bars (±S. E.)  
 
162
Additional file 5. Levels of antigen specific-IFN-γ (ng/ml) produced by maternal lymph node and spleen samples following stimulation 











Levels of antigen specific-IFN-γ (ng/ml) produced by maternal lymph node and spleen 
samples following stimulation for 4 days with NCA. 
Lymph node and spleen tissue samples were collected at post mortem examination and 
processed to determine levels of Neospora-specific proliferation. The processed cells were 
stimulated with NCA for 4 days (37oC in a humidified 5% CO2 atmosphere); ELISA were 
performed to determine the concentration of IFN-γ produced.  
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7.1 Manuscripts main hypotheses  
 
1 What is the clinical outcome of a subcutaneous (sc) challenge with Neospora 
caninum tachyzoites in pregnant cattle at late gestation? 
2 Is there an increase in the expression of toll like receptor (TLR) 2 and TLR-9 
in maternal and foetal lymphoid tissues following a challenge with N. 
caninum tachyzoites at late gestation? 
3 What function do the maternal and foetal immune responses play in 
protection against a challenge with N. caninum at late gestation? 
The results from this study demonstrate that though the clinical severity of an 
infection with N. caninum decreases as gestation progresses, the incidence of 
vertical transmission increases, with all of the challenged dams vertically 
transmitting the parasite to their foetuses. Though evidence of vertical transmission 
was seen in all challenged dams, there was no foetal mortality observed. During this 
study both dams and foetuses showed clear involvement of cell mediated, humoral 
and innate immune responses to Neospora.  
This experiment  showed just how rapidly vertical transmission can occur, even at 
day 14 post inoculation samples of foetal spleen showed evidence of significant 
antigen specific proliferation. This would suggest that the parasite must have crossed 
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the placenta within days of the initial challenge, to allow sufficient time for an 
antigen specific T-cell response to be produced. 
As with much of the experimental work using large animals, this experiment would 
have benefited from larger group sizes, however due to the cost implications of 
buying and maintaining large animals for a prolonged period of time this was not 
possible. Meaning each challenge group had only 3 animals and the control data (3 
animals) needed to be grouped. Though this study was the first to demonstrate a role 
of TLR-2 and TLR-9 in the immunity of cattle against Neospora, no function was 
ascribed to the TLR’s. Further study is required to examine the cell types and 
activation pathways involved in the innate immunity during a N. caninum infection. 
One disadvantage of a serial kill experiment is you only get to examine an animal at 
one time point, which only gives you a snapshot of the immune response. It would 
be interesting to sequentially examine the immune responses of the animals from 
immediately after inoculation until a defined endpoint (i.e. 56 Days pi), this could be 
done through PBMC or even through lymphatic cannulation. If the lymph node that 
drains the site of infection could be examined, it could yield important information 
on the initiation of the anti-Neospora immune response. This method could be used 
to examine differences the initiation and development of the immune responses at 
different stages of gestation, to try and improve our understanding of why at mid and 
late gestation the maternal immune response appears unable to limit the spread of 
the parasite and stop vertical transmission from occurring. 
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7.2 Author contributions 
 
PMB, FK, MSR, SWM, JB, FC, JT and EAI were involved in all aspects of the 
experimental design and planning of the experiments. All experiments were approved by 
Moredun Research Institutes experimental ethics committee. 
PMB, JBS and SWM inoculated all of the cattle, PMB and MSR collected routine blood 
samples for serological screening. PMB, FK, MSR, SWM, JB, FC, JT and EAI were all 
involved in the post mortem examinations of both dams and foetuses and for collecting 
all of the tissue samples used for immunological and histological analysis.  
PMB maintained the Vero cells and Neospora tachyzoites in tissue culture and 
enumerated the cells and tachyzoites using a Neubauer haemocytometer and prepared all 
of the inocula (Vero cells and tachyzoites) used during the experiment. PMB and EAI 
performed lymphocyte stimulation assays on PBMC and lymph node and spleen 
samples from both dams and foetses, through the incorporation of 
3
H thymidine and 
collected the cell stimulation assay supernatant samples. PMB analysed the supernatant 
samples from dams and foetuses by ELISA for the presence of the cytokines IL-4, IL-
10, IL-12 and IFN-γ. PMB performed all RNA extractions, cDNA synthesis and SYBR 
green qPCR analysis for the presence of TLR-2, TLR-9 and GAPDH in both maternal 
and foetal spleen and lymph node samples. PMB collated all of the data and prepared all 
of the graphs and tables presented in the manuscript. 
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YP separated serum from clotted maternal and foetal blood samples from and performed 
all serological testing (IgG) using the commercially available IDEXX anti-Neospora 
IgG ELISA, while SWM, JB, GC and FC performed all histological and 
immunohistological analysis.  
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http://www.veterinaryresearch.org/content/44/1/91RESEARCH Open AccessDevelopment of maternal and foetal immune
responses in cattle following experimental
challenge with Neospora caninum
at day 210 of gestation
Paul M Bartley1*, Frank Katzer1, Mara S Rocchi1, Stephen W Maley1, Julio Benavides1,2, Mintu Nath3,
Yvonne Pang1, Germán Cantón1,4, Jackie Thomson1, Francesca Chianini1 and Elisabeth A Innes1Abstract
This study examined the immunological responses of pregnant cattle and their foetuses following an experimental
challenge with live Neospora caninum tachyzoites at day 210 of gestation. Animals were bled prior to and weekly
throughout the experiment and sacrificed at 14, 28, 42 and 56 days post inoculation (dpi). At post mortem
examination, samples of lymph nodes and spleen were collected from both dam and foetus for immunological
analysis. Subcutaneous (sc) inoculation over the left prefemoral (LPF) lymph node of pregnant cattle at day 210 of
gestation, led to the vertical transmission of parasites by 14 dpi, however no foetal deaths were observed in the
infected animals. Foetuses from infected dams mounted Neospora-specific humoral and cell-mediated immune
(CMI) responses by 14 dpi. These responses involved anti-Neospora IgG, antigen-specific lymphocyte proliferation,
and the production of the cytokines IFN–γ, interleukin (IL)-4 and IL-10. There was also evidence of innate immunity
during the response against Neospora from infected dams, with statistically significant (p < 0.05) increases in mean
expression of toll like receptors (TLR)-2 on 56 dpi in maternal spleen, LPF, right prefemoral (RPF), left uterine (LUL)
and right uterine (RUL) lymph nodes and TLR-9 in retropharyngeal (RLN), LPF and RPF lymph nodes from 28 dpi.
Statistically significant (p < 0.05) increases in mean TLR-9 were detected in spleen samples from foetuses of infected
dams, compared to the foetuses from control animals. Our results show that vertical transmission of the parasite
occurred in all infected dams, with their foetuses showing effective Neospora-specific cell mediated, humoral and
innate immune responses.Introduction
Neospora caninum is recognised worldwide as a major
cause of abortion and foetal death in farmed ruminants,
mainly affecting cattle [1]; though sporadic cases have
been reported leading to foetal deaths in sheep [2] and
goats [3]. Infection with Neospora can occur either
through vertical (transplacental) transmission of the
parasite from dam to foetus [4], or through the ingestion
of oocysts, shed by infected dogs [5] in contaminated
feed, water and pasture (horizontal transmission).
Current control strategies for bovine neosporosis mainly* Correspondence: Paul.bartley@moredun.ac.uk
1Moredun Research Institute, Pentlands Science Park, Bush Loan, Midlothian,
EH26 0PZ, Scotland, United Kingdom
Full list of author information is available at the end of the article
© 2013 Bartley et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
170involve farm management and bio-security practices
(reviewed by Dubey et al.) [1].
It has become clear from natural and experimental
data that primary Neospora infections in cattle can lead
to abortions and reproductive losses, with cattle infected
with Neospora for the first time during pregnancy being
3–7 times more likely to abort than uninfected animals
[6,7]. Animals can develop a level of natural immunity
to the parasite, as cows previously naturally exposed to
Neospora are less likely to abort following a secondary
infection than pregnant animals with primary infections
of the parasite [8]. In addition, multigravidae animals
that have aborted due to neosporosis are less likely to
abort due to neosporosis during subsequent pregnancies,
compared to primigravidae cattle [9]. There is alsoLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Experimental design
Post mortem dpi/n =
Group Inoculum 14 28 42 56
Infected 5 × 108 NC1 Tachyzoites 3 3 3 2
Control 5 × 107 Vero cells 1 1 1 1
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of cattle to N. caninum prior to pregnancy can protect
against the vertical transmission of the parasite following
an experimental challenge during mid gestation. How-
ever in naturally infected cows that were experimentally
challenged on day 70 of gestation, the animals showed
protection against foetopathy, but vertical transmission
of the parasite still occurred [11]. These results suggest
that a protective immune response may be induced that
can protect against abortion, however, it may be more
difficult to prevent endogenous vertical transmission of
the parasite.
The gestational stage and immunological maturity of
the foetus at time of infection with N. caninum are crit-
ical in determining the clinical outcome of infections in
pregnant cattle [10,12,13]. Infection with N. caninum
during early gestation leads to high levels of foetal mor-
tality [14] and more severe pathology than infection of
cattle with N. caninum at mid and late gestation [15].
While an experimental challenge with the parasite at
mid gestation did not result in foetal mortality, it did
however result in moderate pathology in the foetal cen-
tral nervous system (CNS) and within the placenta [12].
The foetuses of cattle challenged at mid gestation were
shown to be capable of mounting parasite-specific CMI
and humoral responses [16]. Observed differences in the
maternal immune response to N. caninum may have a
profound effect on clinical outcome. A study by Bartley
et al., [17], showed that in a group of pregnant cows
given a similar challenge with N. caninum, some of the
animals aborted their foetuses whereas other did not.
These clinical differences could be related to the cell-
mediated immune response of the animals to the para-
site infection [17].
Neospora-specific cell mediated and innate immune
responses are likely to be involved in protection against
the parasite, in naturally [18] as well as experimentally
infected animals [10,13,19,20]. Data from several studies
has demonstrated that lymphocyte proliferation and
interferon-γ (IFN-γ) responses are involved during an
immune response to N. caninum [11,21-23], and that
these responding immune cells tend to be CD4+ T lym-
phocytes [20,24,25]. Less is known regarding the role of
innate immune responses during bovine neosporosis.
Work by Boysen et al. and Klevar et al. [26,27] reported
that natural killer (NK) cells produced IFN-γ during
early Neospora infection in calves. Work in mice infected
with N. caninum has demonstrated that IFN-γ produc-
tion is dependent on myeloid differentiation factor 88
signalling, in a mechanism triggered by interleukin-12
(IL-12) production in dendritic cells [28]. Increased toll
like receptor (TLR)-2 expression leads to the maturation
of antigen presenting cells such as macrophages and
NK-cells and pro-inflammatory cytokine production171[29]. These data show that the innate immune response
may be important in the initiation of immune responses
to N. caninum. Understanding of innate immunity to N.
caninum will help to improve the design of effective vac-
cines, which rely on the induction of appropriate im-
mune responses.
In this study the humoral, cell mediated and innate
immune responses were examined in pregnant cattle
and their foetuses experimentally challenged with live
N. caninum (NC1 isolate) tachyzoites on day 210 of gesta-
tion. This is of particular interest as a primary exposure of
cattle to N. caninum at late gestation can lead to high
levels of transplacental transmission and the birth of per-
sistently infected calves [30], which in turn are at risk of
transmitting the parasite to their own offspring. This work
will further the understanding of the role of both the ma-
ternal and foetal immune responses in cattle following an
infection with N. caninum at late gestation and help to
elucidate the mechanisms involved in disease pathogenesis
and parasite transmission in bovine neosporosis.
Materials and methods
Animals, inoculum and experimental design
Fifteen pregnant cattle all being seronegative for N.
caninum, Toxoplasma gondii, Bovine Viral Diarrhoea
Virus (BVDV), infectious bovine rhinotracheitis and
Leptospira spp., were divided into 2 groups (comprising
of control cattle (n = 4) and animals inoculated with N.
caninum (n = 11) with animals being sacrificed at 14, 28,
42 and 56 days post inoculation (dpi) (Table 1), a full de-
scription of the animals is given in Benavides et al. [30].
Parasites for the inoculum were prepared as previously
described [31]. Briefly, N. caninum (NC1 isolate)
tachyzoites were cultured within Vero cell monolayers.
After 4 days the parasites were harvested by scraping the
infected cell monolayers and releasing the tachyzoites
into the supernatant. The parasites were harvested,
counted and adjusted to the required concentration
2.5 × 108/mL in phosphate buffered saline (PBS). The
2 mL dose of parasites was inoculated sc into the ani-
mals over the left prefemoral lymph node (LPF) within
1 h of harvesting the tachyzoites from tissue culture.
Uninfected Vero cells (5 × 107 per 2 mL dose in PBS)
were used to inoculate each control animal over the LPF
(Table 1). This dose of Vero cells was used, as it was the
equivalent number of cells that was present in the para-
site inocula.
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the Moredun Research Institute ethics committee.
Samples collected at post mortem
At post mortem examination, samples of LPF, right
prefemoral lymph node (RPF), left uterine lymph node
(LUL), right uterine lymph node (RUL), retropharyngeal
lymph node (RLN) and spleen were collected from the
dams. Samples collected from the foetuses were hepatic
lymph node (HLN), mesenteric lymph node (MLN) and
spleen. Tissue samples for immunological assays, cell
proliferation and cytokine production were collected
into sterile wash buffer comprising Hanks Buffered sa-
line solution (HBSS) supplemented with 2% heat
inactivated (ΔH) foetal bovine serum (FBS) (Labtech
International, Ringmer, UK) and 100 IU/mL penicillin
and 50 μg/mL streptomycin (Northumbria Biologicals,
Cramlington, UK).
Blood was drawn from dams weekly and at post
mortem by jugular venipuncture and from foetuses via
the cordal vein, into non-heparinised vacutainer blood
collection tubes, and allowed to clot; serum was then
separated by centrifugation at 2000 × g for 10 min and
stored at −20 °C prior to enzyme linked immunosorbent
assay (ELISA) analysis of anti-Neospora IgG.
Sub-samples of the maternal and foetal lymph nodes
and spleen were collected for molecular analysis of innate
immune responses. Samples were snap frozen on dry ice
at post mortem examination, then stored at −80 °C prior
to RNA extraction, cDNA synthesis and analysis by SYBR
green quantitative polymerase chain reaction (qPCR).
Serology
Analysis of anti-Neospora IgG was performed using a
commercially available ELISA kit (IDEXX, Chalfont St
Peter, UK) following the manufacturer’s instructions.
Samples were considered positive with a sample/positive
(S/P) value of ≥ 0.50. The S/P value was calculated using
the optical density (OD) results and applying them to
the formulae listed below:
Sample OD Result–Negative Control OD ResultPositive
Control OD Result–Negative Control OD Result
Preparation of cells for immunological assays
Single cell suspensions of maternal and foetal lymph
node and spleen samples were prepared using the
method previously described by Bartley et al. [16].
Briefly; tissues were trimmed to remove excess fat and
then chopped into small pieces. These pieces were
resuspended in 10 mL of wash buffer and placed in a
stomacher bag (Seward Medical, Northampton, UK) and172homogenized for 10 s. The resultant cell suspension was
decanted through a double thickness of sterile lens tissue
into a sterile universal. The cells were washed twice by re-
peated centrifugation at 260 × g before being resuspended
at a final concentration of 2 × 106/mL in cell culture
medium (CCM) (Iscoves modified Dulbeco’s medium
(IMDM) (Gibco, Paisley, UK) supplemented with 10%
ΔH FBS and 100 IU/mL penicillin and 50 μg/mL
streptomycin).
Cell proliferation assays
Single cell suspensions of both lymph node and spleen
were treated as previously described by Bartley et al.
[16]. In brief, equal volumes of cells (2 × 106/mL) and
antigen were added in quadruplicate to 96-well round
bottom plates (Nunc, Roskilde, Denmark). Water-
soluble N. caninum tachyzoite antigen (NCA) [10] was
used at a final protein concentration of 1 μg/mL, the
T-cell mitogen concanavalin A (Con A) was used as a
positive control at a final protein concentration of
5 μg/mL. Vero cell lysate antigen at 1 μg/mL final protein
concentration was used as a control antigen and CCM
alone was used as a negative control to determine the
background level of cell proliferation. The cultures were
incubated at 37 °C in a humidified 5% CO2 atmosphere
for 5 days. The cultures were pulsed with 18.5 kBq 3H
Thymidine/well (Amersham Biosciences, Little Chalfont,
UK) for the final 18 h, before being harvested onto glass-
fibre filters (Wallac, Turku, Finland); the cell associated
radioactivity was determined using a microbeta Trilux
liquid scintillation counter (Perkin Elmer, Wellesley, MA,
USA).
Duplicate wells were prepared for each sample; after
4 days incubation at 37 °C in a humidified 5% CO2 at-
mosphere; cell free supernatants were harvested and
stored at −20 °C prior to analysis by ELISA to quantify
cytokine production.
Cytokine responses
The concentrations of bovine cytokines; IFN-γ, IL-4, IL-10
and IL-12 present in the cell free supernatant were deter-
mined using commercially available cytokine capture
ELISA; antibody pairs (Serotec, Oxford, UK) and serial di-
lutions of appropriate recombinant cytokines were used to
create standard regression curves (Table 2).
The ELISA method used for all of the cytokines was
based on that previously described by Kwong et al. [33].
In brief, 96-well ELISA plates (Greiner, Stonehouse, UK)
were coated with a primary capture antibody (50 μL per
well) (Table 2) and incubated at room temperature (RT)
overnight. The plates were washed five times using PBS
supplemented with 0.05% Tween 20 (PBS-T) between
each step, with the exception of the final 3, 3’, 5, 5’-
tetramethylbenzidine (TMB) – sulphuric acid (H2SO4)
Table 2 Antibody pairs and standard ranges for bovine cytokines IFN-γ, IL-4, IL-10 and IL-12 ELISA
Primary antibody Secondary antibody Standard range Reference
(Working concentration (μg/mL))
IFN-γ CC330 (5 μg/mL) CC302b (2 μg/mL) 5000 pg/mL –10 pg/mL
IL-4 CC314 (5 μg/mL) CC313b (2 μg/mL) 125.00 U/mL −0.488 U/mL [32]
IL-10 CC318 (5 μg/mL) CC320b (2 μg/mL) 11 U/mL −0.021 U/mL [33]
IL-12 CC301 (1.25 μg/mL) CC326b (1 μg/mL) 86.42 U/mL −0.013 U/mL [34]
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with PBS-T supplemented with 3 % bovine serum albumin
(BSA). Samples and standards (50 μL each) were added and
incubated at RT for 1 h. Plates were then coated with an ap-
propriate secondary biotinylated antibody (Table 2) (diluted
in PBS-T supplemented with 1% BSA) (50 μL per well)
and incubated at RT for 1 h. Streptavidin- horseradish
peroxidiase (HRP) (Dako Cytomation, Glostrup, Denmark)
diluted 1:500 in PBS-T 1% BSA (50 μL/well) was added and
incubated at RT for 45 min. Colour was developed by the
addition of TMB substrate (Insight Biotech. Ltd., Wembley,
UK) (100 μL/well) and incubated for 10–15 min in the
dark. Reactions were stopped by adding 1 M H2SO4 (50 μL
per well). The plates were read at 450/650 nm using a
MRX II plate reader (Dynex, East Grinstead, UK). Doubling
dilutions of known quantities of appropriate recombinant
Ovine (rOv) or Bovine (rBo) cytokines (rOv IFN-γ, rBo IL-4,
rBo IL-10 and rOv IL-12) (Moredun Research Institute,
Edinburgh, UK) were used to generate a standard regression
curve against which the test sample data was fitted. The rOv
cytokines were used as standards for the ELISA as good
cross reaction between rOv cytokines and bovine cells and
antibodies has been previously demonstrated [34,35].
Extraction of RNA from maternal and foetal tissues
Samples collected and snap frozen on dry ice at post
mortem were processed for RNA extraction as follows:
approximately 1 g of frozen tissue was cut into small
pieces and placed in a Precelys tissue homogeniser tube
(Cepheid, Stretton Derbyshire, UK) containing 1.5 mL
TRI reagent (Applied Biosystems, Carlsbad, CA, USA)
and homogenised for 50 s at 6500 rpm using a Precelys
24 tissue homogeniser, (Cepheid, Stretton Derbyshire,
UK). 700 μL of the resultant homogenate was split into
each of two fresh microfuge tubes containing a further
300 μL TRI reagent. The samples were then processed to
RNA as per manufacturer’s instructions. The final RNA
pellet was resuspended in 200 μL of RNase free water,
the concentration of RNA was determined by spectro-
photometry (Nanodrop ND1000); the samples were then
stored at −80 °C prior to cDNA synthesis and qPCR.
cDNA synthesis from maternal and foetal RNA samples
Following the manufactures instructions, a commercially
available high capacity cDNA reverse transcription kit173(Applied Biosystems, Carlsbad, CA, USA) was used to
create 2 μg of cDNA per sample. Each reaction (20 μL)
contained 2 μL 10× RT buffer, 0.8 μL dNTP (100 mM),
2 μL 10× random primers, 1 μL reverse transcriptase
(50 U/μL), 1 μL RNase inhibitor, 3.2 μL DNase/RNase
free water and 10 μL RNA (0.2 μg/μL); the reaction con-
ditions for the cDNA synthesis reaction were 10 min at
25 °C, 120 min at 37 °C, 5 min at 80 °C then held at 4 °C.
Following reverse transcription the cDNA was diluted to
400 μL in DNase / RNase free water and stored at 4 °C
prior to qPCR analysis.
SYBR green qPCR for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), toll like receptor-2 (TLR) and TLR-9
To determine whether TLR-2 and TLR-9 expression is be-
ing up or down regulated during N. caninum infections
we examined the expression of the TLRs in both maternal
and foetal tissues at different stages following challenge,
using the SYBR green qPCR primers and basic protocol
described by Menzies and Ingham [36]. All samples were
analysed in triplicate, each reaction (20 μL) consisted
of 10 μL (2× Fast SYBR green master mix) (Applied
Biosystems, Carlsbad, CA, USA), 1 μL each forward and
reverse primer (10 pmol), 4 μL DNase/RNase free water
and 4 μL cDNA. Analysis was performed under standard
conditions including a dissociation step (ABI prism 7000
using sequence detection software (SDS) (v1.2.3) (Applied
Biosystems, Carlsbad, CA, USA). The levels of TLR expres-
sion were normalised against a reference gene GAPDH,
which has been previously shown to be constitutively
expressed in bovine tissues [36].
Statistical analysis
To take into account the increased variability at higher
mean values, the maternal and foetal proliferation (cpm)
data and cytokine assay data (IFN-γ) were transformed
by logarithmic transformation (base 10) prior to the ana-
lysis. The TLR-2 and TLR-9 data were adjusted against
GAPDH. Separate linear models were fitted to the ma-
ternal and foetal proliferative responses, cytokine re-
sponses and TLR expression. Due to lack of replication
of the control group at each time point, data on the con-
trol group were pooled across all time points to estimate
the variability. The models included treatment group
(comprising five levels: infected group at each of four
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variable. The model assumes normal distribution for the
errors on the analysis scale and this was checked using
appropriate plots. The overall statistical significance of
the treatment group was evaluated using the F-statistic.
If the F-statistic was statistically significant (p ≤ 0.05),
two-sided p-values for multiple comparisons between
the means of the infected group at each time point and
the pooled mean of the control group were obtained;
these p-values were then adjusted using a False Discov-
ery Rate (FDR) approach [37] to take into account the
problems arising from multiple comparisons. The ad-
justed p-value, denoted in this paper as pf, summarises
the strength of evidence for there being a genuine differ-
ence in a way analogous to a standard p-value but
allowing multiple testing across different times. Differ-
ence in the median maternal serology IgG values be-
tween the infected and control group across each time
point was assessed using a two sample non-parametric
Mann–Whitney test. To take into account multiple
comparisons at all time points, the FDR approach as
discussed above was used to adjust the p-values. In gen-
eral, the statistical significance is considered at 5% level
(pf < 0.05), though for some instances where p < 0.05 but
not pf, both p and pf values are provided. All statistical
analyses were carried out using the R software version
2.15.2 (R Development Core Team, 2012).
Results
Proliferative responses from lymph nodes and spleen
Maternal
Infected dams showed increased mean levels of antigen-
specific proliferation (counts per minute (cpm) on log10
scale) (Additional file 1) from most tissues examined,
compared to the control animals at all the time points,
though for most samples no statistically significant dif-
ferences were seen. On 14 dpi statistically significantly
(p = 0.034) increased mean levels of antigen-specific pro-
liferative responses were observed in the spleen samples
from infected animals, compared to control animals. At
the same time point, significantly lower (p = 0.023) mean
levels of proliferation were observed in the RPF of
infected animals (mean, 2.56; 95% CI, 1.73 to 3.40) com-
pared to control animals (mean, 3.99; 95% CI, 3.16 to
4.82). However, after allowing for multiple testing, the
adjusted p-values for these mean comparisons were not
statistically significant for either spleen (pf = 0.137) or
RPF (pf = 0.09).
Foetal
The cell proliferation responses from the foetuses are il-
lustrated in Figure 1. Mean levels of antigen-specific
proliferation (cpm on log10 scale) in the spleen were sta-
tistically significantly higher in the infected foetuses on17414 dpi (pf = 0.032), 28 dpi (pf < 0.001), 42 dpi (pf < 0.001)
and on 56 dpi (pf < 0.001) compared to control foetuses.
Significantly increased mean levels of proliferation were
observed in HLN samples from infected foetuses on 42
dpi (pf = 0.038) and 56 dpi (pf = 0.038) compared to the
control foetuses. There was no evidence of a difference
in the mean levels of antigen-specific proliferation in
foetal MLN tissue from either group (Figure 1A-D).
Cytokine responses of lymph node and spleen
Maternal
IFN-γ
Increased mean levels of Neospora-specific IFN-γ (ng/mL
on log10 scale) (Additional file 2) were observed in most
maternal lymph nodes and spleen samples from infected
dams compared to control animals at all the time points.
Statistically significantly higher mean levels of IFN-γ were
observed on 14 dpi (pf = 0.021) in the spleen from infected
animals compared to the control animals, while on 56 dpi,
mean levels of antigen-specific IFN-γ in spleen samples
from infected animals were lower than those seen in
the control animals with marginal statistical significance
(pf = 0.060).
IL-4
Mean levels of antigen-specific IL-4 were higher in all
maternal samples from infected animals compared to
the control animals, at all of the time points tested
(Additional file 3). Statistically significantly increased
mean levels of antigen-specific IL-4 were demonstrated
on 14 dpi in the spleen (p = 0.028) and LPF (p = 0.012)
of the infected animals compared to the control animals
However, when allowing for multiple testing, the mean
differences between treatment groups were not statisti-
cally significant for either spleen or LPF (p = 0.130,
p = 0.121 respectively).
IL-10
Demonstrable antigen-specific IL-10 was only found in
the spleen sample from the control animal on 28 dpi, all
other lymph node and spleen samples from the control
animals were below the detection threshold of the
ELISA. In the infected animals, on 14 dpi demonstrable
levels of antigen-specific IL-10 were seen in spleen sam-
ples from 2 of 3 animals. On 28 dpi, IL-10 was produced
in 3 of 3 samples of spleen and LUL. On 42 dpi (2/3)
spleen, (1/3) RUL and RLN samples were shown to
be producing IL-10. On 56 dpi, IL-10 was only dem-
onstrable in the LUL from 1 of 2 of the infected
animals.
IL-12
All the maternal lymph node and spleen samples tested









































































































Figure 1 Foetal lymph node and spleen proliferation responses following stimulation with NCA for 5 days. Samples of foetal hepatic
lymph node (HLN), mesenteric LN (MLN) and and spleen were collected at post mortem examination. Samples were stimulated with NCA for
5 days (37° C in a humidified 5% CO2 atmosphere), with 18.5 kBq
3H Thymidine / well being added for the final 18 h, before being harvested
onto glass-fibre filters. The data were log-transformed (base 10) before analysis by a linear model. The predicted mean responses (counts per
minute (cpm) on log10 scale) (Infected -■-, Control -Δ-) and 95% confidence intervals (error bars) of foetal spleen and lymph node on (A) 14 dpi,
(B) 28 dpi, (C) 42 dpi and (D) 56 dpi are presented).
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onstrable levels of IL-12 were seen in maternal spleen
samples from infected animals on 14 and 28 dpi only.
Foetal
IFN-γ
The results from the IFN-γ ELISA are illustrated in
Figure 2A-D. Spleen samples from the foetuses in infected
dams showed increased mean levels of antigen-specific
IFN-γ production (ng/mL on log10 scale) compared to the
foetuses from control animals on 14, 28, 42 and 56 dpi.
These mean differences in IFN-γ levels of the spleen be-
tween control and infected foetuses were statistically signifi-
cant at all time points (pf = 0.018, pf = 0.028, pf = 0.028 and
pf = 0.018 for 14, 28, 42 and 56 dpi respectively) (Figure
2A-D). Samples of HLN and MLN from infected foetuses
were generally demonstrated increased mean levels of
antigen-specific IFN-γ production compared to the foetuses
from the control animals at all time points, though these
differences were not statistically significant (Figure 2A-D).
IL-4
The infected foetuses showed an increased mean level of
production of antigen-specific IL-4 in the spleen compared175to the control foetuses on 28, 42 and 56 dpi (pf = 0.012,
pf = 0.052 and pf = 0.012 respectively) (Additional file 4). On
14 dpi the mean MLN response from the infected foetuses
was significantly higher (p = 0.024) compared to the control
foetuses. However, this mean difference was not statistically
significant once allowance was made for multiple testing
(pf = 0.114). No statistically significant differences were ob-
served between the control and infected foetuses for mean
levels of antigen-specific IL-4 produced by foetal HLN
samples.
IL-10
All the samples tested for the control foetuses were
below the detection threshold of the ELISA. However,
demonstrable antigen-specific IL-10 was seen in spleen
samples from the infected foetuses at all time points, on
14 dpi one of three foetuses produced IL-10 and on 28
dpi two of three foetuses produced IL-10. On 42 dpi, all
infected foetal spleen samples (3 / 3) produced demon-
strable antigen-specific IL-10. On 56 dpi, spleen and
HLN samples from both infected foetuses produced
demonstrable levels of antigen-specific IL-10. The mean
levels of IL-10 produced by the foetal samples were

























































































































Figure 2 Foetal lymph node and spleen IFN-γ responses following stimulation with NCA for 4 day. Foetal hepatic lymph node (HLN),
mesenteric LN (MLN) and spleen samples were collected at post mortem examination. Following stimulation with NCA for 4 days (37° C in a humidified
5% CO2 atmosphere) cell free supernatants were harvested, ELISA were performed to determine the concentration of IFN-γ (ng/mL) produced. The data
were log-transformed (base 10) before analysis by a linear model. The predicted mean responses (ng/mL on log10 scale) (Infected -■-, Control -Δ-) and
95% confidence intervals (error bars) of foetal spleen and lymph node on (A) 14 dpi, (B) 28 dpi, (C) 42 dpi, (D) 56 dpi.
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All the samples tested for control foetuses were below
the ELISA detection threshold IL-12 at all time points
tested. Spleen samples from infected foetuses (1/3) pro-
duced demonstrable levels of IL-12 on 14 dpi. On 28
and 42 dpi, the levels of antigen-specific IL-12 were
below detectable levels. However, on 56 dpi, IL-12 was
demonstrated from the spleen samples of both infected
foetuses. The mean levels of IL-12 produced by the
foetal samples were comparable with maternal samples
(data not shown).
Expression of TLR-2 and TLR-9 in lymph node and spleen
Maternal
TLR-2
Levels of TLR-2 expression were examined at all time
points in both control and infected animals. The infected
dams demonstrated increased mean levels of TLR-2176expression (pg) in all tissues compared to the control
dams at almost all time points. On 56 dpi, the infected
dams demonstrated statistically significantly increased
mean levels of TLR-2 expression in the LPF and RPF com-
pared to the control dams (pf = 0.004 and pf < 0.001 re-
spectively) (Figure 3C), while the spleen, LUL and RUL
samples from the infected animals were all shown to be
producing statistically significantly higher mean levels of
TLR-2 (p = 0.035, p = 0.024 and p = 0.018 respectively)
than the control animals (Figure 3A-C).
TLR-9
Levels of TLR-9 expression were examined at all time
points in both control and infected animals. Infected ani-
mals demonstrated increased mean levels of TLR-9 ex-
pression (pg) from day 28 onwards in all tissues tested
compared to control animals. On 28 dpi statistically sig-
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Figure 3 Maternal lymph node and spleen TLR-2 expression. Samples of maternal left prefemoral lymph node (LPF), right prefemoral lymph
node (RPF), left uterine lymph node (LUL), right uterine lymph node (RUL), retropharyngeal lymph node (RLN) and spleen were collected at post
mortem examination and snap frozen on dry ice. RNA was extracted and used to synthesise cDNA. Levels of expression of TLR-2 were examined
with data being normalised against GAPDH expression(pg). The predicted mean responses (pg) (Infected -■-, Control -Δ-) and 95% confidence
intervals (error bars) of maternal spleen and lymph node on (A) 28 dpi, (B) 42 dpi, (C) 56 dpi.
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LPF (p = 0.051) and in spleen (p = 0.034) on 42 dpi. While
on 56 dpi, LPF (pf = 0.027) and RPF (pf = 0.028) from
infected animals demonstrated statistically significantly
higher mean levels of expression of TLR-9 compared with
the control animals (Figure 4A-C).
Foetal
TLR-2
The foetuses from infected animals generally demon-
strated increased mean levels of TLR-2 expression (pg)177(Additional file 5) in samples of spleen, HLN and MLN
compared to the control foetuses. However, these
mean differences were not statistically significant. The
mean levels of TLR-2 expression seen in the foetal
samples were comparable to those observed in the
adult samples.
TLR-9
When the mean levels of expression of TLR-9 (pg) were
examined, statistically significantly increased expression













































Figure 4 Maternal lymph node and spleen TLR-9 expression. Samples of maternal left prefemoral lymph node (LPF), right prefemoral lymph
node (RPF), left uterine lymph node (LUL), right uterine lymph node (RUL), retropharyngeal lymph node (RLN) and spleen were collected at post
mortem examination and snap frozen on dry ice. RNA was extracted and used to synthesise cDNA. Levels of expression of TLR-9 were examined
with data being normalised against GAPDH expression (pg). The predicted mean responses (pg) (Infected -■-, Control -Δ-) and 95% confidence
intervals (error bars) of maternal spleen and lymph node on (A) 28 dpi, (B) 42 dpi, (C) 56 dpi.
Bartley et al. Veterinary Research 2013, 44:91 Page 9 of 14
http://www.veterinaryresearch.org/content/44/1/91infected foetuses on 42 dpi compared to the control foe-
tuses. However, the mean difference was not statistically
significant when adjusted for multiple testing (pf =
0.101). Generally, the mean expression of TLR-9 of
infected foetuses was higher compared to control ani-
mals in the spleen, HLN and MLN tissues at all time
points. The mean expression of TLR-9 was consistently
higher for all samples on 14 dpi, with the spleen demon-
strating the highest levels of expression from any of the
samples tested (data not shown).178Serology
Maternal
Following inoculation with N. caninum tachyzoites all
infected dams seroconverted between 7 and 14 dpi
(Figure 5). The mean levels of IgG peaked on 21 dpi, the
levels of anti-Neospora IgG remained elevated throughout
the rest of the experimental period. The mean levels of
anti-Neospora IgG in all control animals remained below
the 0.50 cut off throughout. The infected animals demon-












Figure 5 Maternal serology (IgG ELISA) results. Blood was drawn from the dams by jugular venipuncture into non-heparinised vacutainer
blood collection tubes and allowed to clot. Serum was separated by centrifugation at 2000 × g for 10 min and stored at −20 °C prior to analysis
of anti-Neospora IgG using a commercially available ELISA kit (IDEXX). Samples were considered positive with a sample / positive (S / P) value
of≥ 0.50. The S / P value was calculated using the optical density (OD) results. The estimates of means (Infected -■-, Control -Δ-) and standard of
means (error bars) are presented.
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0.032, pf = 0.032 and pf = 0.032 respectively) than the con-
trol animals. The median levels of anti-Neospora IgG ex-
pression in the infected animals remained elevated above
the control animals for the remainder of the experiment,
though these were not found to be statistically significant.
Foetal
No anti-Neospora IgG was demonstrable in the samples
collected from infected foetuses on 14 and 28 dpi. How-
ever from 42 dpi onwards all foetuses from infected
dams tested positive for anti-Neospora IgG (Figure 6).












Figure 6 Foetal serology (IgG ELISA results). Blood was drawn from the
vacutainer blood collection tubes and allowed to clot. Serum was separate
to analysis of anti-Neospora IgG using a commercially available ELISA kit (ID
(S/P) value of≥ 0.50. The S/P value was calculated using the optical density
and standard of means (error bars) are presented.
179infected foetuses were comparable to those seen in the
adult infected animals. None of the samples tested from
control foetuses were considered positive for anti-
Neospora IgG as they remained below the 0.50 cut off
throughout. No statistical comparisons were made due
to the properties of the data.
Samples collected from control animal
Following post mortem examination, samples from the
control animal sacrificed on 14 dpi were shown to be
positive by N. caninum specific ITS1 PCR. Further
examination of these samples using primers designed
against regions of micro satellite DNA demonstrated42 56
pi
foetuses at the post mortem examination into non-heparinised
d by centrifugation at 2000 × g for 10 min and stored at −20 °C prior
EXX). Samples were considered positive with a sample / positive
(OD) results. The estimates of means (Infected -■-, Control -Δ-)
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the infection was due to a strain of N. caninum distinct
to NC1. As a result of these findings this animal and its
foetus were removed from all analysis. Full details of the
animal are given in Benavides et al. [30]. This animal
was serologically negative for anti-Neospora IgG (using
IDEXX ELISA) and had no demonstrable antigen spe-
cific responses in the cells from the spleen or any of the
lymph nodes tested. All the samples tested from the
foetus derived from this dam were also immunologically
and PCR negative.
Discussion
At late gestation (day 210), the foetuses are capable of
mounting Neospora specific cell mediated and humoral
immune responses, involving lymphocyte proliferation,
antigen-specific IFN-γ, IL-4 and IL-10 production as
well as anti-Neospora IgG antibodies. This study has also
examined the innate immune response during an experi-
mental infection of cattle, showing significantly increased
levels of expression of TLR-2 and TLR-9 in a number of
maternal and foetal lymphoid tissues including the spleen,
uterine and pre-femoral lymph nodes during the course of
the infection.
Maternal CMI responses
Following challenge there were significant increases in
cellular proliferation as well as IFN-γ and IL-4 produc-
tion on 14 dpi in the spleen and peripheral lymph nodes
of infected dams and their foetuses, The presence of a
CMI response by 14 dpi correlates well with the obser-
vation of a circulating parasitaemia observed in all
infected dams between 8 – 14 dpi [30], thus providing a
source of antigen for immunological priming to take
place. The presence of parasites and parasite antigens is
likely to lead to the rapid initiation of an immune re-
sponse. Our findings agree with work by Rosbottom
et al. [38] where pregnant cattle experimentally chal-
lenged with N. caninum on day 210 of gestation demon-
strated increased numbers of CD4+ T-cells and
increased expression of IFN-γ and IL-4 mRNA in
PBMC, 1–2 weeks following challenge.
Toll like receptors
Our study shows that TLR-2 and TLR-9 are up regulated
in the spleen and lymph nodes of infected animals and
their foetuses during N. caninum infection. Significant
increases in the levels of TLR-2 were not seen in mater-
nal tissues until 56 dpi and TLR-9 on 28 dpi. This is
later than we would have expected, as much of the
current data regarding TLR function shows they are in-
volved in the initiation and activation of immune re-
sponses. Work by Werling et al. [39] in cattle has shown
strong TLR-2 signalling to be associated with monocytes180and other antigen presenting cells (APC), while TLR-
9 signalling was associated with bovine dendritic
cells (DC) and B-cells. Similar finding were observed
in mice by where TLR-2 was associated with APC
maturation and pro-inflammatory cytokine produc-
tion [28,29]. Cantón et al. [40] observed large numbers
of phagocytic cells (in particular macrophages) in re-
solving lesions in the placenta of infected animals from
this experiment from 42 dpi onwards, While on 42 dpi
Benavides et al. [30] described lesions in foetal lung
and liver characterised by the infiltration of macro-
phages, lymphocytes and plasma cells. The presence of
these cells in the circulatory system may account for
the increased levels of TLR-2 expression seen in the
spleens of the infected compared to control animals.
The increase in TLR-9 expression may be a conse-
quence of increased B-cell activity following the sero-
conversion of the infected animals and the production
of anti-Neospora IgG.
Humoral immune responses
Infected dams and their foetuses developed strong anti-
N. caninum humoral responses following experimental
challenge with the parasite, which continues to suggest a
role for antibodies in a protective immune response
[41]. Antibody responses were seen in the infected dams
from 7 dpi onwards, this coincided with high levels of
circulating parasites, however in the foetuses anti-
Neospora antibodies were not observed until 42 dpi. The
delay in the generation of a foetal humoral response
could be a consequence of the low numbers of parasites
crossing the placenta and actively invading the foetuses,
until 28 dpi all foetal tissues were PCR negative [30]
Though antibodies against N. caninum have not been
shown to have a definitive role in protection; it is widely
believed that they are involved in extracellular tachyzoite
neutralisation. Work by Eperon et al. [42] demonstrated
increased susceptibility to infection with N. caninum of
B-cell deficient C57BL/6 μMT mice. While work on the
closely related parasite Toxoplasma has demonstrated
roles for antibodies in parasite killing by large granular
lymphocytes [43] and in opsonisation and intracellular
killing of parasites by mononuclear phagocytes [44].
Foetal immune response
Due to the nature of the ruminant cotyledonary placen-
tae (syndesmochorial placentation), any immune re-
sponses detected in the foetus are likely to be induced
by an active infection in utero [45]. Under normal cir-
cumstances a cotyledonary placentae does not allow the
transfer of maternal immune factors including anti-
bodies and cytokines. During our study foetal cell medi-
ated immune responses were detected at 14 dpi, which
suggests that even during the early stages of the infection
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effectively by the foetal immune response, before para-
site induced pathology can occur The mild placental
pathology being observed, may also be due to there be-
ing fewer parasites multiplying in the foetus, therefore
there are fewer parasites reinvading the placenta. A rea-
son for this may be that when the parasites reach the
placenta they initiate a local maternal immune response.
During our experiment increased levels of proliferation
and IFN-γ production were seen in the uterine lymph
nodes of infected animals compared to the controls at
14 dpi. This may in the first instance limit parasite es-
tablishment and multiplication reducing the severity of
necrosis and pathology in the tissues around the pla-
centa [45], allowing for more efficient parasite clearing.
Coupled with the developing foetal immunity could po-
tentially lead to the scarcity of lesions containing para-
site antigen found in the CNS of the infected foetuses.
A previous experimental study in cattle [46] showed
comparable results to this current study; where cattle
infected with N. caninum (NC Liverpool) at late gesta-
tion showed no foetal mortality, though mild placental
pathology was observed and parasite DNA was only found
sporadically in foetal brain, lung and skeletal muscle.
There is still limited information regarding the de-
velopment of foetal immune responses during bovine
Neospora infections. Following infection at early ges-
tation (Day 70 of gestation) [17] showed that no
Neospora-specific CMI responses were generated,
though the foetuses were capable of lymphocyte prolif-
eration and IFN-γ, IL-4, IL-10 and IL-12 production
following mitogenic stimulation with Con A from day
84 of gestation onwards, however by mid gestation the
foetal immune system is more capable of mounting
antigen specific humoral and cell-mediated immune re-
sponses [45]. Experimental infections in cattle with
Neospora at mid gestation (Day 140 of gestation) have
shown significant increases in IFN-γ, IL-10 and tumour ne-
crosis factor (TNF) expression [19] and Neospora-specific
CMI and humoral responses [16] in infected foetuses.
While, Andrianarivo et al. [21] showed Neospora-specific
immune responses in foetal PBMC at around day 220 of
gestation.
During our experiment antigen-specific immune re-
sponses were present in the foetuses on 14 dpi demon-
strating that parasites crossed the placenta, infected the
foetuses and induced an immune response. The num-
bers of parasites in foetal tissues is likely to be very low,
as no positive PCR results were seen at 14 dpi [30]. The
foetal spleen processes large volumes of blood, this may
result in it potentially trapping parasites as well as circu-
lating leukocytes, allowing more rapid presentation of
parasite antigens leading to proliferation and cytokine pro-
duction before the HLN and MLN have started to181respond. The presence of parasite DNA and strong cell
mediated immune responses being found in all foetuses
would suggest that though the parasite crossed the pla-
centa, the foetal immune response was sufficiently robust
to control the parasite resulting in the survival of all
infected foetuses to the end of the experimental period.Conclusions
The results from this study have demonstrated that fol-
lowing an experimental sc challenge of pregnant cattle
with live N. caninum tachyzoites on day 210 of gesta-
tion; both dams and foetuses mounting Neospora-spe-
cific cell mediated, humoral and innate responses. These
results show that the stage of gestation is important to
disease outcome, with the increasing immunological ma-
turity of the foetus limiting the clinical severity of the in-
fection compared to Neospora infections occurring
earlier in gestation. The results show that infections with
Neospora at late gestation may lead to congenitally
infected but otherwise clinically normal calves [30]. Ex-
perimental challenges of pregnant cattle with N.
caninum tachyzoites allows the detailed study of the
host – parasite relationship in bovine neosporosis in a
controlled environment, thus improving our understand-
ing of the pathogenesis of the disease.Additional files
Additional file 1: Mean Log10 proliferation data from maternal
lymph node and spleen samples following stimulation with NCA for
5 days. Mean Log10 proliferation data from maternal lymph node and
spleen samples following stimulation with NCA for 5 days. Samples of
maternal lymph node and spleen were collected at post mortem
examination. Samples were stimulated with NCA for 5 days (37 °C in a
humidified 5% CO2 atmosphere), with 18.5 kBq
3H Thymidine / well
being added for the final 18 h, before being harvested onto glass-fibre
filters. The data was Log10 transformed before analysis by a linear model.
(A) 14 dpi, (B) 28 dpi, (C) 42 dpi, (D) 56 dpi. Infected ■, Control Δ (Error
Bars = upper (U) & lower (L) 95% confidence intervals (CI)).
Additional file 2: Mean Log10 transformed IFN-γ data from
maternal lymph node and spleen samples following stimulation
with NCA for 4 days. Mean Log10 transformed IFN-γ data from maternal
lymph node and spleen samples following stimulation with NCA for 4 days.
Maternal lymph node and spleen samples were collected at post mortem
examination. Following stimulation with NCA for 4 days (37 °C in a humidified
5% CO2 atmosphere) cell free supernatants were harvested, ELISA were
performed to determine the concentration of IFN-γ produced. The data was
Log10 transformed before analysis by a linear model. (A) 14 dpi, (B) 28 dpi, (C)
42 dpi, (D) 56 dpi. Infected ■, Control Δ (Error Bars = U & L 95% CI).
Additional file 3: Concentration of IL-4 in maternal lymph node
and spleen samples following stimulation with NCA for 4 days.
Concentration of IL-4 in maternal lymph node and spleen samples
following stimulation with NCA for 4 days. Maternal lymph node and
spleen samples were collected at post mortem examination. Following
stimulation with NCA for 4 days (37 °C in a humidified 5% CO2
atmosphere) cell free supernatants were harvested, ELISA were
performed to determine the concentration of IL-4 produced. (A) 14 dpi,
(B) 28 dpi, (C) 42 dpi, (D) 56 dpi. Infected ■, Control Δ (Error Bars = U & L
95% CI).
Bartley et al. Veterinary Research 2013, 44:91 Page 13 of 14
http://www.veterinaryresearch.org/content/44/1/91Additional file 4: Concentration of IL-4 in foetal lymph node and
spleen samples following stimulation with NCA for 4 days.
Concentration of IL-4 in foetal lymph node and spleen samples following
stimulation with NCA for 4 days. Foetal lymph node and spleen samples
were collected at post mortem examination. Following stimulation with
NCA for 4 days (37 °C in a humidified 5% CO2 atmosphere) cell free
supernatants were harvested, ELISA were performed to determine the
concentration of IL-4 produced. (A) 14 dpi, (B) 28 dpi, (C) 42 dpi, (D) 56
dpi. Infected ■, Control Δ (Error Bars = U & L 95% CI).
Additional file 5: Levels of expression of TLR-2 in foetal spleen,
HLN and MLN samples. Levels of expression of TLR-2 in foetal spleen,
HLN and MLN samples. Samples of foetal lymph node and spleen were
collected at post mortem examination and snap frozen on dry ice. RNA
was extracted and used to synthesise cDNA. Levels of expression of TLR-2
were examined with data being normalised against GAPDH expression,
results are expressed in pg. (A) 28 dpi, (B) 42 dpi, (C) 56 dpi. Infected ■,
Control Δ (Error Bars = U & L 95% CI).
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Mean Log10 proliferation data from maternal lymph node and spleen samples following 
stimulation with NCA for 5 days 
Mean Log10 proliferation data from maternal lymph node and spleen samples following stimulation 
with NCA for 5 days. Samples of maternal lymph node and spleen were collected at post mortem 
examination. Samples were stimulated with NCA for 5 days (37°C in a humidified 5 % CO2 
atmosphere), with 18.5 kBq 3H Thymidine / well being added for the final 18 h, before being 
harvested onto glass-fibre filters. The data was Log10 transformed before analysis by a linear model.  
Infected ■, Control ∆ (Error Bars = upper (U) & lower (L) 95 % confidence intervals (CI)) 
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Mean Log10 transformed IFN-γ data from maternal lymph node and spleen samples following 
stimulation with NCA for 4 days.  
Maternal lymph node and spleen samples were collected at post mortem examination. Following 
stimulation with NCA for 4 days (37°C in a humidified 5 % CO2 atmosphere) cell free supernatants 
were harvested, ELISA were performed to determine the concentration of IFN-γ produced. The data 
was Log10 transformed before analysis by a linear model. 
Infected ■, Control ∆ (Error Bars = U & L 95 % CI). 
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Concentration of IL-4 in maternal lymph node and spleen samples following stimulation with NCA 
for 4 days 
Maternal lymph node and spleen samples were collected at post mortem examination. Following 
stimulation with NCA for 4 days (37°C in a humidified 5 % CO2 atmosphere) cell free supernatants 
were harvested, ELISA were performed to determine the concentration of IL-4 produced. 
Infected ■, Control ∆ (Error Bars = U & L 95 % CI).
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Concentration of IL-4 in foetal lymph node and spleen samples following stimulation with NCA for 
4 days.  
Foetal lymph node and spleen samples were collected at post mortem examination. Following 
stimulation with NCA for 4 days (37°C in a humidified 5 % CO2 atmosphere) cell free supernatants 
were harvested, ELISA were performed to determine the concentration of IL-4 produced.  
Infected ■, Control ∆ (Error Bars = U & L 95 % CI). 
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Levels of expression of TLR-2 in foetal spleen, HLN and MLN samples 
Samples of foetal lymph node and spleen were collected at post mortem examination and snap 
frozen on dry ice. RNA was extracted and used to synthesise cDNA. Levels of expression of TLR-2 
were examined with data being normalised against GAPDH expression, results are expressed in pg. 
Infected ■, Control ∆ (Error Bars = U & L 95 % CI). 
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8 General discussion 
8.1 Major findings 
Neospora caninum is considered to be one of the most commonly diagnosed causes of 
bovine abortion worldwide, costing the farming industry an estimated 1.3 billion US$ 
per annum in production losses (Reichel et al., 2012). There are currently no 
chemotherapeutics licensed for use in cattle that will completely resolve a Neospora 
infection, so once a cow becomes infected it remains persistently (chronically) infected 
for life and can pass the infection to its offspring over several successive pregnancies. 
These issues make the development of an effective vaccine against Neospora highly 
desirable. However to produce an efficacious vaccine we must first better understand the 
host–parasite interactions and immune responses involved in protection against infection 
with the Neospora parasites, in order to produce an appropriately targeted control 
strategy. 
The major findings of the studies included in this thesis have helped further our 
knowledge and understanding in a number of key areas of the host-parasite interaction 
with Neospora. Key findings include that prolonged in vitro cultivation of N. caninum 
tachyzoites leads to an attenuation of virulence in vivo, when tested in an experimental 
mouse model system (Bartley et al., 2006). Vaccination of mice with these tissue culture 
attenuated N. caninum tachyzoites protected susceptible animals against a known lethal 
challenge with virulent wild type Neospora parasites (Bartley et al., 2008) and that this 
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protection was associated with the induction of strong cell mediated immune (CMI) and 
interferon-γ (IFN-γ) responses (Bartley et al., 2009). These CMI responses not only 
protected against death but also lead to reduced cerebral parasite burdens in vaccinated 
mice compared to unvaccinated challenged controls (Bartley et al., 2009). However, 
vaccination of mice with the tissue culture attenuated Neospora tachyzoites did not 
totally limit the parasite associated pathology, as lesions and tissue cysts were still 
identified in the brains of mice receiving the attenuated parasites.  
Infection studies included in this thesis have further established the importance of the 
maternal immune response in determining the clinical outcome of a primary Neospora 
infection in pregnant cattle; showing that the type, location and timing of the maternal 
immune responses are critical in controlling the dissemination of the parasite throughout 
the host (Bartley et al., 2013a, Bartley et al., 2004, Bartley et al., 2012). The use of 
controlled serial kill experiments in pregnant cattle allowed the importance of the timing 
of a primary challenge and therefore the gestational age of the foetus on disease 
pathogenesis to also be demonstrated (Bartley et al., 2013a, Bartley et al., 2004, Bartley 
et al., 2012). These pregnant cattle experiments illustrate the proficiency of vertical 
transmission of Neospora following a primary challenge in naïve hosts. As gestation 
progresses, foetal immunity matures leading to a lower incidence of foetal death, but 
conversely an increased rate of parasite vertical transmission is observed (Bartley et al., 
2013a, Bartley et al., 2012). These data highlight the need for an effective vaccine to 
prevent the vertical transmission of the parasite and protect the developing foetus 
against in utero infection. 
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Results from the experimental infections in cattle included in this thesis not only show 
the importance of proliferative cell mediated immune responses and the production of 
the Th1 type cytokine IFN-γ in both dams and foetuses in controlling parasite 
multiplication (Bartley et al., 2013a, Bartley et al., 2012), but also demonstrated that the 
anti-Neospora immunity is predominantly involves CD4
+
 T-cells. The T-cells respond 
to immunodominant tachyzoite antigens, which are predominantly either parasite 
surface antigens or proteins that are involved in cellular adhesion and invasion. These 
include the peptides SAG1, SRS2, GRA2, GRA7, MIC3, and MIC11. Though MIC11 
had been previously been described, the work included in this thesis has shown MIC11 
to be immunostimulatory and potentially important in protection against Neospora 
(Rocchi et al., 2011). 
This project was also the first work to show the involvement of the toll like receptors 
(TLRs) in innate immune responses in pregnant cattle following an experimental 
challenge with Neospora. Both the dams and foetuses were shown to be up regulating 
TLR-2 and TLR-9 expression in PBMC and lymph nodes in response to infection 
(Bartley et al., 2013a). The findings from the serial analysis of experimentally infected 
pregnant cattle show that the innate, cell mediated and humoral immune responses are 
all induced following an infection with Neospora (Bartley et al., 2013a). The 
involvement of all aspects of the immune response in Neospora infections in cattle 




Comparing data generated by different research groups can often be problematic, as 
different parasite isolates, challenge doses and routes of inoculation are used. Also many 
different aspects of the immune response are measured (e.g. gene expression levels 
compared to serum immunoglobulins levels, cell supernatants compared to serum 
samples). Many different technologies (qPCR, ELISA, IFAT, cellular proliferation 
assays) and criteria are also used to analyse the data. The body of work presented in this 
thesis provided an ideal opportunity to serially examine large numbers of animals (mice 
and pregnant cattle) challenged and monitored under similar conditions, then examined 
using the same criteria, allowing clear comparisons to be able to be made not only 




Due to the high economic costs attributed to Neospora infections in the cattle industry 
(over 1.3 billion $US per annum) and the fact that there are currently no 
chemotherapeutics licensed to treat neosporosis in cattle, making vaccination an 
alternative control strategy. However due to the complex nature of Neospora, the 
different parasite life cycle stages (tachyzoite, bradyzoite and oocysts) and host species 
(definitive and intermediate) involved in the spread of the disease, leads to the questions 
of where and when to target a vaccination strategy for the greatest level of control of 
Neosporosis:  
Some of the questions I aim to discuss here include: 
 The vaccination of which species would likely have the greatest impact on 
helping to control the spread of Neosporosis? 
 What clinical outcome of a Neospora infection in cattle (abortion or vertical 
transmission) should be targeted for prevention by vaccination for the greatest 
benefit? 
 When would a vaccine need to be administered to be most effective? 
 What type of vaccine (live, killed or subunit) would be most efficacious in 
controlling bovine neosporosis? 
 What would the long and short term benefits of an effective vaccine against 
bovine neosporosis be to farming and the wider community? 
 What else needs to be done to help control the spread of Neospora? i.e. 
Biological control and education (an integrated control strategy). 
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The results and observations contained within this thesis help to address a number of 
these questions. We are unlikely to ever eradicate Neospora, as was achieved with 
smallpox in the 1980’s (Fenner, 1982), or Rinderpest “cattle plague” which was 
declared eradicated in 2011 (Cima, 2011), as chronic (persistent) Neospora infections 
are known to occur numerous wildlife species including rodents and deer (Dubey, 
2003). However a vaccine combined with other long term control strategies such as 
managing access of dogs (and other definitive hosts) to aborted materials and placenta, 
rodent control, testing and culling known infected cattle could significantly reduce the 
economic impact of neosporosis to the farming community. 
 
8.2 The vaccination of which species would likely have the greatest 
impact on helping to control the spread of Neosporosis? 
Though natural Neospora infections occur in many species including dogs, sheep and 
deer (Dubey, 2003), as well as wild carnivores (e.g. foxes and Badgers) (Bartley et al., 
2013b), cattle are considered the most economically important host of Neospora, with 
annual losses of over 1.3 billion $US being attributed to foetopathy / abortion caused by 
neosporosis across both the beef and dairy industries (Reichel et al., 2012). The losses 
seen in cattle are not all as a result of new (primary) infection, as transmission of 
Neospora from the dam to the foetus can occur as a result of two different infection 
scenarios. The first is through a primary infection during pregnancy, which leads to the 
exogenous transplacental transmission (ExTT) of the parasite. This occurs when the dam 
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becomes infected postnatally for the first time during pregnancy, through exposure to 
parasites (usually oocysts) in the environment often in contaminated feed and water 
(Trees and Williams, 2005, Williams et al., 2009). Our experiments demonstrate that 
this primary exposure of susceptible cattle to Neospora during pregnancy can lead to 
either foetal death (Bartley et al., 2012), or to very high rates of vertical transmission 
(Bartley et al., 2013a, Bartley et al., 2004), depending on the stage of gestation when the 
primary infection occurs. The second route of infection is by endogenous transplacental 
transmission (EnTT), which occurs as a result of the recrudescence (reactivation) of 
Neospora parasites in persistently (chronically) infected dams (Williams et al., 2009). It 
is this latter condition (EnTT) that is responsible for the majority of foetal infections 
(Dubey et al., 2007). Davidson and colleagues (1999) calculated that there is a 95% 
probability that a seropositive dam will produce seropositive offspring (Davison et al., 
1999a) (i.e. that vertical transmission will occur), combined with the fact that the 
parasite can vertically transmit over several successive generations (Bjorkman et al., 
1996) shows the scale of the problem facing those attempting to develop effective 
control strategies for bovine neosporosis.  
The work presented in this thesis clearly demonstrates the ease with which the parasite 
can be vertically transmitted from dam to foetus. Though our experiments show that 
exposure to Neospora during pregnancy can have fatal consequences for the foetus, they 
also show that cattle are capable of mounting protective immune responses that can stop 
the vertical transmission of the parasite (Bartley et al., 2012). The presence of a 
protective maternal response indicates that a vaccine is a viable option for controlling 
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neosporosis in cattle. The feasibility of a vaccine producing protection against a primary 
challenge with Neospora was confirmed through early experimental studies in cattle 
carried out at the Moredun Research Institute, where it was demonstrated that exposure 
of animals to Neospora prior to pregnancy lead to protection against vertical 
transmission, following a parasite challenge during pregnancy (Innes et al., 2001). 
The vaccination of dogs would help reduce the environmental contamination with 
oocysts, which are most likely the cause of abortion storms (Cavalcante et al., 2011). 
The vaccination of young farm dogs, in particular those that have access to raw bovine 
tissues (aborted foetuses and placentae) would help reduce the spread of Neospora by 
preventing primary infections in the definitive host and therefore preventing the 
shedding of oocysts into the environment. However, the results from this thesis along 
with the available data from field studies and other experimental infections would 
suggest that vaccinating cattle would have the greatest impact on controlling 




8.3 What clinical outcome of a Neospora infection in cattle (abortion 
or vertical transmission) should be targeted with vaccination for 
the greatest benefit? 
To answer this question we need to look at the dynamics of Neospora infections in 
cattle. Though the most visible outcome of a Neospora infection in cattle is the abortion 
of the foetus, the data from natural and experimental cases of bovine neosporosis would 
suggest that vertical transmission is actually more important, as it allows for the 
maintenance of Neospora within a herd perpetuating the economic losses. It is 
undeniable that abortion storms (point source outbreaks leading to mass ExTT events) 
have a profound and significant financial impact when they occur on a farm (Thurmond 
et al., 1997, Wouda et al., 1999a). However, following an abortion storm there is also an 
increased risk that the parasite will be endemically retained within a herd (Moen et al., 
1998), when EnTT will then likely become the main cause of foetal infections. So if you 
could stop vertical transmission (either EnTT or ExTT), you are by analogy also 
stopping the potential for Neospora induced abortions. A vaccine that only prevents the 
clinical symptoms of infection (i.e. abortion) may be easier to achieve, but is still going 
to leave lifelong persistently (chronically) infected animals that are capable of 
repeatedly transmitting the parasite to their offspring.  
The experimental data in three cattle experiments presented in this thesis (Bartley et al., 
2013a, Bartley et al., 2004, Bartley et al., 2012, Macaldowie et al., 2004, Maley et al., 
2003a) showed that post natal infections during early pregnancy (Day 70 of gestation) 
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resulted in foetal deaths in 56.2% (9/16) of infected animals (Bartley et al., 2012), while 
vertical transmission was seen in 14/14 infected dams at mid gestation (Bartley et al., 
2004, Maley et al., 2006) and in 12/12 dams challenged at late gestation (Bartley et al., 
2013a, Benavides et al., 2012). This means that across the three pregnant cattle 
experiments we saw a foetal death rate of 16.7% (7/42), but an overall 88.1% (37/42) 
rate of vertical transmission in infected animals. Our findings are comparable to those of 
other researchers, Williams and colleagues (2000) and Gibney and colleagues (2008) 
both demonstrated high rates of foetal death following a Neospora challenge during 
early gestation and high levels of vertical transmission at late gestation, but no foetal 
deaths (Gibney et al., 2008, Williams et al., 2000). The high levels of vertical 
transmission seen in our data indicates the ease with which Neospora could be 
maintained within a herd, with little obvious clinical symptomatology. It is in the 
parasites best interest to vertically transmit and not cause abortion, as this allows the 
parasite to survive and propagate itself with relative ease, where following an abortion 
the parasite would potentially have the opportunity to undergo sexual replication in a 
definitive host, but for this to occur the parasite needs to be consumed by a susceptible 
host to continue its life cycle. It appears that Neospora has naturally evolved to be less 
pathogenic in cattle than other closely related parasites like T. gondii, which is more 
likely to cause an abortion in sheep than to be vertically transmitted and cause a 
persistent infection (Buxton et al., 2007). The work by Reid and colleagues (2012) on 
the Neospora genome and transcriptome indicates that Neospora is missing a number of 
key genes that have been associated with virulence in T. gondii (including ROP18), but 
contains a greater repertoire of surface antigens than Toxoplasma (Reid et al., 2012). It 
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has been suggested that many of these extra surface antigens are associated with the 
bradyzoite stage of the parasite. As bradyzoites contain antigens that have not been 
produced during the tachyzoite life cycle stage they will not immediately be recognised 
by the host immune response allowing the parasite to evade detection and persistently 
infect a host, where it can remain immunologically quiescent for long periods of time. 
The data from the studies included in this thesis combined with that collected from other 
experimental infections would suggest that in an ideal world a future control strategy for 
bovine neosporosis would target vertical transmission. However the reality of the 
situation is that a vaccine that controls for abortion / foetal death in cattle is more likely 
to be achievable; especially given the very high rates of vertical transmission 
demonstrated in this thesis (Bartley et al., 2013a, Bartley et al., 2004, Bartley et al., 
2012) and the fact that the parasite can vertically transmit across successive generations 
(Bjorkman et al., 1996). Strong peripheral maternal immune responses produced during 
early pregnancy have been shown able to stop foetal death (Bartley et al., 2012). So a 
vaccine that could stimulate a strong CMI response, particularly during the early stages 





8.4 When would be the most effective / appropriate time to administer 
an anti-Neospora vaccine? 
A factor that must be considered when developing a vaccine to control bovine 
neosporosis is the regulation of the maternal immune response during pregnancy in 
persistently infected animals, parasite recrudescence and vertical transmission across the 
placenta occur during the down regulation of the maternal cell mediated Th1 type 
responses during mid pregnancy (Innes et al., 2001). This means that a vaccine would 
likely need to be administered to susceptible dams either prior to pregnancy to give an 
appropriate and proportionate protective immune response time to develop before the 
immunomodulation of pregnancy occurs. The protective response would also need to be 
maintained throughout the entire of pregnancy, because as the data in this thesis has 
shown, should a primary infection of susceptible animals occur at mid – late gestation 
there is a very high risk of parasite vertical transmission (Bartley et al., 2013a, Bartley et 
al., 2004). Any immune response induced by vaccine should to be rapid, as well as a 
long lived, as data from Bartley and colleagues (2004) demonstrated that vertical 
transmission of Neospora can occur within 14 days of infection (Bartley et al., 2004).  
The timing and location of any maternal immune responses are critical in controlling 
parasite dissemination, as is the type of immune response generated. Data presented in 
this thesis (Chapter 6) showed that following a Neospora challenge at early gestation, 
dams carrying live foetuses elicited a stronger Th1 type immune response in peripheral 
and uterine lymph nodes than the dams carrying dead foetuses (Bartley et al., 2012). 
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However examination of the same groups of animals by Maley and colleagues (2006) 







 T-cells, γδ T-cells and NK cells) 
and strong pro inflammatory cytokine (IFN-γ, IL-12 and TNF-α) responses occurring 
around the placenta were detrimental to foetal survival (Canton et al., 2013, Canton et 
al., 2014a, Canton et al., 2014b, Maley et al., 2006). The data produced by Maley et al 
(2006) and Canton et al (2013, 2014a and 2014b), where Th1 type immune responses 
are detrimental to foetal survival appears to be contradictory to the data presented in 
Chapters 5-7, which shows the importance of Th1 type responses. However, these 
results combine show that any control strategy needs to produce a strong peripheral 
immune response which can control the parasite before it reaches the placenta, where a 
strong cell mediated immune response can cause severe immunopathology and foetal 
death.  
The data in chapter 6 shows that a immune response biased more towards a Th2 type 
response (in particular interleukin 4 (IL-4) production) can also lead to an increase in 
disease severity. Such observations were made in cattle, where PBMC from dams 
carrying dead foetuses (challenged at day 70 gestation) produced higher Th2 type 
responses (IL-4 and IL-10) and lower Th1 type (IFN-γ), compared to the dams carrying 
live foetuses (Bartley et al., 2012).  
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All of these data combined indicate that successful control of Neospora will require a 
vaccine that promotes a finely balanced Th1 / Th2 response, which allows parasite 
control without the producing immune associated pathology. 
 
8.5 What type of vaccine formulation (live, killed or subunit) would 
be most efficacious in controlling bovine neosporosis? 
When examining the available data not only within the field of neosporosis but across 
the broader field of apicomplexan parasitology, it would appear that live parasites offer 
the best opportunity to produce an effective vaccine (Innes et al., 2011, Reichel et al., 
2015). Ideally for a parasite to be considered for use as a live vaccine against bovine 
neosporosis it would need to satisfy a number of criteria including: 
1. The vaccine needs to produce a long lasting protective immune response. 
2. Prevent parasite dissemination and the formation of tissue cysts by infecting 
strain. 
3. Demonstrate no reversion to virulence, even under immunosuppressive 
conditions (i.e. pregnancy) 
4. Not lead to a persistent (chronic) infection of the vaccine strain following 
inoculation. 
5. Most importantly in the case of Neospora, ensure there is no vertical 
transmission of the vaccine strain parasites from dam to foetus. 
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The precedent for using live vaccines to control apicomplexan parasites was set over 
five decades ago when Eimeria tenella was attenuated through serial passage in 
embryonated eggs (Long, 1965), which lead to the development of the vaccines Paracox 
/ Livacox which are licensed for use against Eimeria in chickens (Shirley and Bedrnik, 
1997). While Toxovax (the incomplete S48 strain of Toxoplasma) is licensed for use 
against Toxoplasmosis in sheep (Buxton, 1993). A recent study at the Moredun 
Research Institute, has demonstrated that pigs vaccinated with S48 strain Toxoplasma 
tachyzoites prior to a heterologous oocysts challenge showed a reduction in parasite 
burdens in muscle tissues used for human consumption (Burrells et al., 2015). As 
undercooked pork is considered a major source of Toxoplasma infections in humans, 
vaccination could reduce parasite burdens in meat and improve food safety (Dubey, 
2008). A live attenuated Babesia vaccine is also available to prevent “Tick fever” in 
Australia (Bock et al., 2004). Other live attenuated parasite species which are showing 
promise as experimental vaccines include Leishmania (Daneshvar et al., 2003), and 
Plasmodium (Vaughan and Kappe, 2013), both of which produced high levels of 
protection in recipient hosts.  
Live attenuated vaccines are likely to induce the most appropriate immune response 
against Neospora as they mimic natural infections. This protective immunity against 
Neospora involves humoral, innate, CMI response and Th1 type cytokines, which are 
predominantly produced by CD4+ T-cells, this has been demonstrated not only in mice 
but also in pregnant and non-pregnant cattle (Bartley et al., 2004, Bartley et al., 2009, 
Rocchi et al., 2011). There is currently little data from live Neospora vaccine studies in 
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cattle, to date only three strains of Neospora that have shown natural attenuation have 
been tested as possible vaccine candidates in cattle. These include the NC-6 Argentina 
strain which reduced vertical transmission by 75% (Hecker et al., 2013) and Nc Spain-
1H, which when administration prior to pregnancy has been shown to reduce foetal 
mortality by 50% following a heterologous challenge at early gestation. However, the 
Nc Spain-1H was unable to prevent vertical transmission following a challenge at mid 
gestation (Rojo-Montejo et al., 2013) and has also been shown to vertically transmit 
when administered to cattle during early gestation (Rojo-Montejo et al., 2009a). In field 
conditions administering the live NcIs491 Neospora isolate tachyzoites to Neospora 
sero-positive pregnant cattle during mid gestation resulted in a 39% reduction in 
abortion, but no information was available from this trial about the effect of NcIs491 
vaccination on levels of vertical transmission (Mazuz et al., 2015).  
If we consider the vaccine potential of the attenuated high passage NC1 parasites 
described in chapters 2-4 in this thesis, they are capable of protecting against a lethal 
challenge (Bartley et al., 2008, Bartley et al., 2006) and inducing a strong immune 
response (Bartley et al., 2009). However they are also still capable of causing a 
persistent (chronic) infection in a dose dependent manner (Bartley et al., 2008) and 
though it remains to be confirmed, it is highly likely that at their current level of 
attenuation the high passage NC1 parasites would also vertically transmit.  
Though attenuation of in vivo virulence by prolonged serial passage in tissue culture has 
clearly been demonstrated in chapters 2-4 in this thesis (Bartley et al., 2008, Bartley et 
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al., 2006, Bartley et al., 2009), the actual mechanisms of the attenuation remains 
unknown. There is currently no information available on the biological mechanisms 
involved in the in vitro attenuation of Neospora parasites, but we may be able draw 
analogy from Toxoplasma gondii and other protozoan parasites. Nischik and colleagues 
(2001) carried out comparative proteome analysis of attenuated and virulent Toxoplasma 
parasites, showing reductions in the expression of actin, catalase, microneme protein 5 
and several dense granule (excretory) proteins in the attenuated parasites, compared to 
the wild type virulent parasites (Nischik et al., 2001). In Theileria annulata the down 
regulation in the expression of matrix metalloproteinase 9 has been attributed to 
attenuation in parasites that had undergone an extended period of in vitro culture 
(Adamson et al., 2000).  
However we must also use caution when making these comparisons between parasite 
species, as the work by Reid and colleagues (2012) demonstrated Neospora and 
Toxoplasma show some profound differences in their transcriptomes. Just because a 
protein has been shown to have a function in one species does not mean it will have the 
same function in another, a prime example is ROP18, which has been shown by a 
number of research groups to be associated with virulence in Toxoplasma (Behnke et al., 
2015, Lei et al., 2014), but ROP18 is absent in Neospora (Reid et al., 2012). For 
researchers to more fully understand virulence in Neospora, direct genomic and 
proteomic comparisons need to be made of clonal populations of virulent and attenuated 
Neospora parasites to determine differences in protein coding genes and their 
subsequent expression. An ideal candidate for this would be the virulent and attenuated 
210
 
parasites described in this thesis (Bartley et al., 2008, Bartley et al., 2006, Bartley et al., 
2009), as they both originated from the same source and have been maintained under the 
similar conditions. The only clear differences in the virulent and attenuated parasites 
demonstrated to date are differences in the rates of in vitro multiplication and their in 
vivo pathogenicity (Bartley et al., 2008, Bartley et al., 2006, Bartley et al., 2009). 
Other factors that need to be considered when looking to produce live vaccines would 
include:  
1. The production costs of a live vaccine will likely be much higher than that of a 
killed or subunit vaccine.  
2. Live vaccines will also have a shorter shelf life than killed / subunit vaccines, 
which could possibly be dried / lyophilised and reconstituted when required.  
3. Live vaccines would likely need cold chain storage to keep the parasites viable, 
again this would not be required for killed parasites.  
4. Finally and probably most importantly live parasites can undergo reversion to 
virulence causing persistent infections (Bartley et al., 2008, Bartley et al., 2006, 
Bartley et al., 2009). 
 
Killed / subunit vaccines may at first glance appear to be a more appealing option for 
controlling bovine neosporosis. They would likely be cheaper to produce, easier to store, 
have longer shelf life and offer no opportunity for reversion to virulence. However, 
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sadly the experimental and field data from cattle would suggest that killed vaccines just 
do not work. The only commercially available killed Neospora vaccine Neoguard® has 
recently been withdrawn from the market. Evidence from field trials using the 
Neoguard® vaccine showed that it actually increased the risk of vertical transmission 
and could also have lead to an increase in embryonic deaths (Weston et al., 2012), 
though no reasons for this increase in susceptibility are stated, it is suggested by Weston 
and colleagues that the vaccine may be adversely effecting the balance of the host-
parasite relationship. Many killed / subunit vaccines have been tested in experimental 
mouse models with varying degrees of success (Baszler et al., 2000, Cannas et al., 
2003a, Debache et al., 2009, Jimenez-Ruiz et al., 2012, Liddell et al., 2003), however 
we must be careful when using mouse immunological data for drawing conclusions for 
cattle, as the biology, physiology and immunology of the two species are very different. 
Very few killed / subunit vaccines have ever made it to testing in cattle. and those that 
have, like the NC-6 Argentina strain native antigen extract (Hecker et al., 2013) and the 
polyvalent cocktail containing the recombinant proteins rNcSAG1, rNcHSP20 and 
rNcGRA7 which both failed to prevent foetal infection (Hecker et al., 2014). The 
polyvalent cocktail also appeared to promote a severe inflammatory cellular infiltration 
and cytokine response in the placentomes of vaccinated heifers (Hecker et al., 2015). 
The work in this thesis examining native tachyzoite antigens clearly demonstrated a 
number of immunodominant peptides including SAG1 and GRA7 (Rocchi et al., 2011). 
However it must be remembered that immunodominant does not necessarily mean 
immunoprotective. Other killed/subunit vaccines have merely been shown to cause no ill 
effect, like the tachyzoite lysate antigen using a soy-based aqueous adjuvant 
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(sNcAg/AVEC) (Mansilla et al., 2015) or promote an IFN-γ response in PBMC from 
non pregnant cattle, like the NcGRA7 entrapped in liposomes coated with mannotriose 
(M3-NcGRA7) (Nishimura et al., 2013). The fact that no killed / subunit vaccines have 
succeeded in protecting against vertical transmission in cattle would suggest that the 
killed vaccine are not stimulating a protective CMI response, this is likely due to the 
manner in which the killed vaccine antigens are processed by APC’s and presented to 
the immune system, compared to live vaccines which appear more likely to stimulate a 
protective CMI response similar to those seen during natural infections.   
So even though live vaccines have disadvantages, these I feel are outweighed by the 
overriding fact that they actually work. killed / subunit vaccines may have good efficacy 
data, but fail at the most important point, none have been shown to stop the vertical 
transmission of Neospora parasites in cattle and some can actually make the situation 
worse.  
 
8.6 What would the short and long term benefits of a vaccine against 
neosporosis be to farmers and the wider community? 
The most obvious short term gain seen directly by the farmers would be an increase in 
the productivity of their animals, by reducing abortions, foetal deaths and early neonatal 
mortality. This in turn would likely also result in a reduction in calving intervals, as 
Neospora negative animals are more likely to complete a pregnancy than Neospora 
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infected animals (Waldner et al., 2001b). In an experiment described in this thesis, four 
of the pregnant animals challenged iv on day 70 were empty at post mortem on days 42 
and 56 post challenge (Bartley et al., 2012). These animals were confirmed pregnant at 
day 36 of gestation by ultrasound (Macaldowie et al., 2004), so we know foetal loss 
occurred after this time. However on a farm, foetal loss (reabsorption) could occur due 
to neosporosis before the pregnancy is confirmed, where a farmer may assume the 
animal had either not taken at service (not been pregnant) or was infertile. Poor 
reproductive performance has been shown to be a major reason for culling on dairy 
farms in the UK (Esslemont and Kossaibati, 1997). Animals that were Neospora free 
would also have a greater saleable value, as Neospora infections in cattle have been 
shown to reduce the value of breeding stock (Trees et al., 1999). A Neospora vaccine 
may also improve the general health of the calves, if animals are not born persistently 
infected (potentially weakened) they will be healthier, which may allow them to more 
easily control other common infections. This improved general health may in turn lead 
to reduced farm costs, as healthier animals will gain weight more rapidly allowing either 
quicker finishing times and / or better body condition for beef herds at slaughter. 
Some of the long term implications of a Neospora vaccine would be an overall reduction 
in the numbers of aborted foetuses, which will lead to a reduction in the levels 
environmental contamination of parasite. This in turn will reduce the chances of 
susceptible dogs (and other definitive hosts) from acquiring the parasite through 
consuming infected foetal tissues (Cavalcante et al., 2011) and shedding oocysts which 
would lead to a reduction in abortion storms. 
214
 
In Britain there is probably less of a concern regarding the involvement of wild canids in 
the sylvatic cycle (non domestic animal cycle) of Neospora, as our only known 
definitive host is the dog, though badgers, foxes and other wild carnivores are known to 
be infected with Neospora (Bartley et al., 2013b) there is no evidence for their 
involvement in the spread of disease. The sylvatic cycle may be more important in 
countries where canids such as wolves, coyotes and dingoes are present as well as large 
populations of stray / feral dogs, as all of these species have been shown to act as 
definitive hosts for Neospora (Dubey et al., 2011, Gondim et al., 2004c, King et al., 
2010, McAllister et al., 1998). However when considering the sylvatic cycle we must 
also consider the involvement of wild / feral rodents, as house mice (Mus musculus), 
field mice (Apodemus sylvaticus) and brown rats (Rattus norvegicus) have all been 
shown to be naturally infected with Neospora (Ferroglio et al., 2007, Jenkins et al., 
2007). The natural hunting behaviour of dogs is to catch and eat rodents, so if you could 
reduce infections in farm rodents you would by proxy reduce the sylvatic infections.  
 
8.7 What factors may deter farmers from using a Neospora vaccine? 
The most obvious consideration would be the efficacy of the vaccine, does it work well? 
If a vaccine has poor performance, then a farmer may consider that the risk of abortion 
and vertical transmission outweighs the time and expense of administering the vaccine. 
A vaccine that was able to protect against vertical transmission of the parasite would 
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need to be used on young naïve animals, to stop the transmission of the parasite to the 
next generation of animals. So there would be a lack of immediate effect which may 
also deter users, data would be needed to demonstrate the long term benefits of using 
such a vaccine on improving reproductive rates. However, a vaccine to prevent abortion 
could also be effectively used on naïve and persistently infected dams and would show 
more immediate effects by reducing reproductive losses.  
For a vaccine to work it must be implemented as part of a wider integrated farm 
management strategy. We must educate both farmers and the general public (particularly 
dog walkers) to help them to understand not only what the parasite is and the disease it 
causes, but also how the parasite is transmitted and practical precautions that can be 
taken to try to limit the spread of the disease (i.e. cleaning up after their dogs even on 
pastures and not letting dogs eat rodents and aborted foetal material and placentas). 
Farmers can also try and limit disease spread by not using known Neospora infected 
cattle as breeding stock or even culling out known infected animals, if practicable. 
However there is also need for improved diagnostics for bovine neosporosis. Current 
commercially available serological tests rely on tissue culture derived tachyzoites or 
tachyzoite antigens. However antibodies against these tachyzoite antigens can drop to 
undetectable levels in naturally infected animals, leading to false negative results. This 
was the case for a control animal in the day 210 gestation experiment (Bartley et al., 
2013a, Benavides et al., 2012). Antibody levels against Neospora tachyzoites in cows 
can fluctuate depending on the physiological state of the animal (i.e. pregnant vs. non-
pregnant) (Guy et al., 2001) and the activity of the parasite itself (Innes et al., 2007), 
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while antibodies to the bradyzoite stage of the parasite have also been shown to be 
highly variable between individual animals (Aguado-Martinez et al., 2008). There is 
also an alternative explanation for why some animals appear seronegative, though 
actually infected with the parasite and that is that the animals are immunotolerant to the 
parasite. Immunotolerance may be due to a foetus becoming infected before its immune 
system is fully formed, so it is not immunocompetent and does not recognise the 
parasite as foreign and therefore it does not produce an immune response against it. 
Though this occurrence is not likely to be common, it could account for a proportion of 
seronegative cattle that produce pre-colostrally seropositive offspring and would make 
these animals very difficult to identify. 
 
9 Future work 
Work that I would like to carry out in the future to help further progress our 
understanding of the host – parasite interactions of Neospora include: 
The studies in mice described in this thesis, showed that after 70 passages in tissue 
culture, attenuation of virulence was present in Neospora tachyzoites. Further prolonged 
passage of the parasite in vitro may reveal increased or even complete attenuation of 
virulence (causes no pathology), or may even result in creation of an incomplete strain, 
which is unable to persist (form tissue cysts) within a host when tested in vivo. If 
different isolates were used for vaccination and challenge, then microsatellite DNA 
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could be used to differentiate between the isolates and determine whether any persistent 
infections identified are being caused by the vaccine or challenge strain. 
Wide gaps exist in our knowledge concerning the initiation of the innate immune 
responses in cattle following a challenge with Neospora and how those early responses 
drive the induction of a protective CMI response. It has been shown in this thesis that 
strong peripheral immune responses in cattle are able to inhibit the vertical transmission 
of the parasite following a challenge during early gestation (Bartley et al., 2012). 
However this experiment gave no data on the initiation of the immune response, as 
PBMC were only collected 7 days post challenge and lymph node and spleen samples 
were collected from day 14 post challenge. The priming of an immune response is likely 
to play a critical role in whether vertical transmission of the parasite occurs. Comparing 
the differences in immune initiation in pregnant cattle (at all three stages of gestation 
(early, mid and late) may allow us to determine why vertical transmission was inhibited 
at early gestation, but not at mid and late gestation. Phenotypic characterisation of the 
responding cells would also help direct vaccine development, by illustrating the 
interactions that occur between cell populations. Longitudinal studies of infected 
pregnant and non pregnant cattle could also be very informative in answering a key 
question. What changes immunologically during pregnancy in cattle that allows 
persistent Neospora infections to reactivate? 
In order to identify genes associated with virulence and attenuation, metagenomic and 
proteomic analyses of naturally virulent isolates (those known to be pathogenic in cattle) 
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and attenuated isolates (those known to show reduced pathogenicity in cattle) of 
Neospora from around the world could be conducted. This should include isolates that 
have shown attenuation and virulence in experimental models (i.e. in vitro attenuated 
and temperature sensitive mutants). Deep genomic and proteomic analysis could reveal 
which genes and proteins are up and down regulated. Immunological screening of these 
peptides using lymphocyte proliferation assays (Rocchi et al., 2011) and IFN-γ 
production assays (ELISA, qPCR) would indicate which are immunoreactive. The 
genome editing tool CRISPR-CAS9 could be used to silence genes of interest and 
demonstrate their involvement in an active infection, virulence and pathology. This 
information could be used to make a more informed choice for target antigens for use in 
subunit vaccines.  
Metagenomic and proteomic analysis could also be used to screen bradyzoites and 
tachyzoites, to identify more stage specific genes and proteins, as this information could 
be used to create a subunit vaccine containing unique recombinant antigens from each 
life cycle stage. Targeting multiple life cycle stages may improve the vaccine efficacy, 
as it would allow the host to mount immune responses against the parasite not only 
during the acute (tachyzoite) stage of infection, but may also allow the host to target the 
bradyzoites. If the host could reduce the numbers of parasites recrudescing, it may be 
able to inhibit vertical transmission; this however will only occur if the antigens are 
presented correctly to the host immune system. In addition, recombinant versions of 
bradyzoite specific proteins could potentially be developed into a sensitive and specific 
diagnostic test (i.e. ELISA). Using combinations of antigens i.e. BSR4 and SAG4 in 
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tandem with tachyzoite antigens may further increase the sensitivity of the assay, as 
antibodies to all antigens are not always present in the serum. An effective, sensitive 
ELISA could be used for large scale screening of beef and dairy herds, as well as in the 
sheep and goat populations. Though neosporosis is mainly considered an infection of 
cattle, natural infections are also found in smaller ruminants. This information would 
enable us to get a more accurate estimation of the true sero-prevalence of persistent 
Neospora infections in Britain’s domestic ruminant populations. 
 
10 Conclusions  
Prolonged in vitro cultivation (tissue culture) of Neospora caninum tachyzoites can lead 
to an attenuation of in vivo virulence, when tested in an experimental mouse model.  
Prior exposure (vaccination) with tissue culture attenuated Neospora tachyzoites not 
only protects against a known lethal challenge with the parasite in mice, but also reduces 
the morbidiy, mortality and parasite DNA loads in the tissues of vaccinated compared to 
infected control animals. 
Vaccination with tissue culture attenuated Neospora tachyzoites leads to the production 
of a protective immune response. This protection involves both humoral and cell 
mediated responses, with lymphoproliferative and IFN-γ responses being critical, while 
IL-10 production may help limit the immunopathology caused by the Th1 type response. 
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Suggesting, that a balance is needed in the responses that control a Neospora infection 
and those that help limit immunopathology. 
The route of inoculation has a profound impact on the clinical outcome of a Neospora 
infection in cattle. An iv compared to a sc challenge was shown to produce more severe 
disease in bovine foetuses during early gestation.  
By day 84 of gestation, bovine foetal lymphocytes are capable not only of mitogenic 
proliferation, but also produce IFN-γ, IL-4, IL-10 and IL-12 following mitogenic 
stimulation. On day 98 of gestation one foetus from an iv infected dam which was found 
dead in utero mounted a humoral (IgG) response against Neospora, (IFAT titre 1:128). 
However should the vertical transmission of the parasite occur during early gestation, 
the foetus is too immunologically immature to mount a protective immune response and 
foetal death will likely occur. 
The stage of gestation when a primary challenge with Neospora occurs is important to 
disease outcome. By mid and late gestation the bovine foetus is capable of mounting 
protective innate, humoral and cell mediated responses against Neospora, helping limit 
the clinical severity of disease, compared to infections earlier in pregnancy. However, 




A combined approach of cellular screening and proteomic characterisation of Neospora 
water soluble tachyzoite antigen has allowed the streamlining of the screening of 
biologically reactive antigen fractions, thus reducing the number of potentially 
interesting molecules, to a manageable size. Each protein that is characterised can be 
further investigated through lymphocyte proliferation assays and IFN-γ production for 




ADAMSON, R., LOGAN, M., KINNAIRD, J., LANGSLEY, G. & HALL, R. 2000. 
Loss of matrix metalloproteinase 9 activity in Theileria annulata-attenuated 
cells is at the transcriptional level and is associated with differentially 
expressed AP-1 species. Mol.Biochem.Parasitol, 106, 51-61. 
AGUADO-MARTINEZ, A., ALVAREZ-GARCIA, G., FERNANDEZ-GARCIA, 
A., RISCO-CASTILLO, V., ARNAIZ-SECO, I., REBORDOSA-
TRIGUEROS, X., NAVARRO-LOZANO, V. & ORTEGA-MORA, L. M. 
2008. Usefulness of rNcGRA7- and rNcSAG4-based ELISA tests for 
distinguishing primo-infection, recrudescence, and chronic bovine 
neosporosis. Vet Parasitol, 157, 182-95. 
AL-QASSAB, S., REICHEL, M. P., IVENS, A. & ELLIS, J. T. 2009. Genetic 
diversity amongst isolates of Neospora caninum, and the development of a 
multiplex assay for the detection of distinct strains. Mol Cell Probes, 23, 132-
9. 
ALMERIA, S., DE MAREZ, T., DAWSON, H., ARAUJO, R., DUBEY, J. P. & 
GASBARRE, L. C. 2003. Cytokine gene expression in dams and foetuses 
after experimental Neospora caninum infection of heifers at 110 days of 
gestation. Parasite Immunol, 25, 383-92. 
ANDERSON, M. L., ANDRIANARIVO, A. G. & CONRAD, P. A. 2000. 
Neosporosis in cattle. Anim Reprod.Sci, 60-61, 417-431. 
223
ANDRIANARIVO, A. G., BARR, B. C., ANDERSON, M. L., ROWE, J. D., 
PACKHAM, A. E., SVERLOW, K. W. & CONRAD, P. A. 2001. Immune 
responses in pregnant cattle and bovine fetuses following experimental 
infection with Neospora caninum. Parasitol Res, 87, 817-25. 
ANDRIANARIVO, A. G., CHOROMANSKI, L., MCDONOUGH, S. P., 
PACKHAM, A. E. & CONRAD, P. A. 1999. Immunogenicity of a killed 
whole Neospora caninum tachyzoite preparation formulated with different 
adjuvants. Int J Parasitol, 29, 1613-25. 
ARRANZ-SOLIS, D., AGUADO-MARTINEZ, A., MULLER, J., REGIDOR-
CERRILLO, J., ORTEGA-MORA, L. M. & HEMPHILL, A. 2015. Dose-
dependent effects of experimental infection with the virulent Neospora 
caninum Nc-Spain7 isolate in a pregnant mouse model. Vet Parasitol, 211, 
133-40. 
ATKINSON, R., HARPER, P. A., RYCE, C., MORRISON, D. A. & ELLIS, J. T. 
1999. Comparison of the biological characteristics of two isolates of 
Neospora caninum. Parasitology, 118 ( Pt 4), 363-70. 
BAILLARGEON, P., FECTEAU, G., PARE, J., LAMOTHE, P. & SAUVE, R. 
2001. Evaluation of the embryo transfer procedure proposed by the 
International Embryo Transfer Society as a method of controlling vertical 
transmission of Neospora caninum in cattle. J Am Vet Med Assoc, 218, 1803-
6. 
224
BARBER, J. S. & TREES, A. J. 1996. Clinical aspects of 27 cases of neosporosis in 
dogs. Vet Rec, 139, 439-43. 
BARR, B. C., ANDERSON, M. L., WOODS, L. W., DUBEY, J. P. & CONRAD, P. 
A. 1992. Neospora-like protozoal infections associated with abortion in 
goats. J Vet Diagn.Invest, 4, 365-367. 
BARTELS, C. J., VAN, S. G., VELDHUISEN, J. P., VAN DEN BORNE, B. H., 
WOUDA, W. & DIJKSTRA, T. 2006. Effect of Neospora caninum-
serostatus on culling, reproductive performance and milk production in Dutch 
dairy herds with and without a history of Neospora caninum-associated 
abortion epidemics. Prev.Vet Med, 77, 186-198. 
BARTLEY, P. M., KATZER, F., ROCCHI, M. S., MALEY, S. W., BENAVIDES, 
J., NATH, M., PANG, Y., CANTON, G., THOMSON, J., CHIANINI, F. & 
INNES, E. A. 2013a. Development of maternal and foetal immune responses 
in cattle following experimental challenge with Neospora caninum at day 
210 of gestation. Vet Res, 44, 91. 
BARTLEY, P. M., KIRVAR, E., WRIGHT, S., SWALES, C., ESTEBAN-
REDONDO, I., BUXTON, D., MALEY, S. W., SCHOCK, A., RAE, A. G., 
HAMILTON, C. & INNES, E. A. 2004. Maternal and fetal immune 
responses of cattle inoculated with Neospora caninum at mid-gestation. J 
Comp Pathol, 130, 81-91. 
225
BARTLEY, P. M., WRIGHT, S., CHIANINI, F., BUXTON, D. & INNES, E. A. 
2008. Inoculation of Balb/c mice with live attenuated tachyzoites protects 
against a lethal challenge of Neospora caninum. Parasitology, 135, 13-21. 
BARTLEY, P. M., WRIGHT, S., SALES, J., CHIANINI, F., BUXTON, D. & 
INNES, E. A. 2006. Long-term passage of tachyzoites in tissue culture can 
attenuate virulence of Neospora caninum in vivo. Parasitology, 133, 421-
432. 
BARTLEY, P. M., WRIGHT, S. E., MALEY, S. W., BUXTON, D., NATH, M. & 
INNES, E. A. 2009. The development of immune responses in Balb/c mice 
following inoculation with attenuated or virulent Neospora caninum 
tachyzoites. Parasite Immunol, 31, 392-401. 
BARTLEY, P. M., WRIGHT, S. E., MALEY, S. W., MACALDOWIE, C. N., 
NATH, M., HAMILTON, C. M., KATZER, F., BUXTON, D. & INNES, E. 
A. 2012. Maternal and foetal immune responses of cattle following an 
experimental challenge with Neospora caninum at day 70 of gestation. Vet 
Res, 43, 38. 
BARTLEY, P. M., WRIGHT, S. E., ZIMMER, I. A., ROY, S., KITCHENER, A. C., 
MEREDITH, A., INNES, E. A. & KATZER, F. 2013b. Detection of 
Neospora caninum in wild carnivorans in Great Britain. Vet Parasitol, 192, 
279-83. 
BASSO, W., SCHARES, S., MINKE, L., BARWALD, A., MAKSIMOV, A., 
PETERS, M., SCHULZE, C., MULLER, M., CONRATHS, F. J. & 
226
SCHARES, G. 2010. Microsatellite typing and avidity analysis suggest a 
common source of infection in herds with epidemic Neospora caninum-
associated bovine abortion. Vet Parasitol, 173, 24-31. 
BASZLER, T. V., LONG, M. T., MCELWAIN, T. F. & MATHISON, B. A. 1999. 
Interferon-gamma and interleukin-12 mediate protection to acute Neospora 
caninum infection in BALB/c mice. Int J Parasitol, 29, 1635-46. 
BASZLER, T. V., MCELWAIN, T. F. & MATHISON, B. A. 2000. Immunization of 
BALB/c mice with killed Neospora caninum tachyzoite antigen induces a 
type 2 immune response and exacerbates encephalitis and neurological 
disease. Clin Diagn Lab Immunol, 7, 893-8. 
BASZLER, T. V., SHKAP, V., MWANGI, W., DAVIES, C. J., MATHISON, B. A., 
MAZUZ, M., RESNIKOV, D., FISH, L., LEIBOVITCH, B., STASKA, L. 
M. & SAVITSKY, I. 2008. Bovine immune response to inoculation with 
Neospora caninum surface antigen SRS2 lipopeptides mimics immune 
response to infection with live parasites. Clin Vaccine Immunol, 15, 659-67. 
BEHNKE, M. S., KHAN, A., LAURON, E. J., JIMAH, J. R., WANG, Q., TOLIA, 
N. H. & SIBLEY, L. D. 2015. Rhoptry Proteins ROP5 and ROP18 Are Major 
Murine Virulence Factors in Genetically Divergent South American Strains 
of Toxoplasma gondii. PLoS Genet., 11, e1005434. 
BENAVIDES, J., COLLANTES-FERNANDEZ, E., FERRE, I., PEREZ, V., 
CAMPERO, C., MOTA, R., INNES, E. & ORTEGA-MORA, L. M. 2014. 
227
Experimental ruminant models for bovine neosporosis: what is known and 
what is needed. Parasitology, 141, 1471-88. 
BENAVIDES, J., KATZER, F., MALEY, S. W., BARTLEY, P. M., CANTON, G., 
PALAREA-ALBALADEJO, J., PURSLOW, C. A., PANG, Y., ROCCHI, M. 
S., CHIANINI, F., BUXTON, D. & INNES, E. A. 2012. High rate of 
transplacental infection and transmission of Neospora caninum following 
experimental challenge of cattle at day 210 of gestation. Vet Res, 43, 83. 
BENNETT, S. T., BARNES, C., COX, A., DAVIES, L. & BROWN, C. 2005. 
Toward the 1,000 dollars human genome. Pharmacogenomics, 6, 373-82. 
BJERKAS, I., MOHN, S. F. & PRESTHUS, J. 1984. Unidentified cyst-forming 
sporozoon causing encephalomyelitis and myositis in dogs. Z Parasitenkd, 
70, 271-4. 
BJORKMAN, C., JOHANSSON, O., STENLUND, S., HOLMDAHL, O. J. & 
UGGLA, A. 1996. Neospora species infection in a herd of dairy cattle. J Am 
Vet Med Assoc, 208, 1441-4. 
BJORKMAN, C., LUNDEN, A., HOLMDAHL, J., BARBER, J., TREES, A. J. & 
UGGLA, A. 1994. Neospora caninum in dogs: detection of antibodies by 
ELISA using an iscom antigen. Parasite Immunol, 16, 643-8. 
BJORKMAN, C., NASLUND, K., STENLUND, S., MALEY, S. W., BUXTON, D. 
& UGGLA, A. 1999. An IgG avidity ELISA to discriminate between recent 
and chronic Neospora caninum infection. J Vet Diagn Invest, 11, 41-4. 
228
BLAKE, D. P. 2015. Eimeria genomics: Where are we now and where are we 
going? Vet Parasitol, 212, 68-74. 
BOCK, R., JACKSON, L., DE VOS, A. & JORGENSEN, W. 2004. Babesiosis of 
cattle. Parasitology, 129 Suppl, S247-69. 
BOYSEN, P., KLEVAR, S., OLSEN, I. & STORSET, A. K. 2006. The protozoan 
Neospora caninum directly triggers bovine NK cells to produce gamma 
interferon and to kill infected fibroblasts. Infect Immun, 74, 953-60. 
BURRELLS, A., BENAVIDES, J., CANTON, G., GARCIA, J. L., BARTLEY, P. 
M., NATH, M., THOMSON, J., CHIANINI, F., INNES, E. A. & KATZER, 
F. 2015. Vaccination of pigs with the S48 strain of Toxoplasma gondii--safer 
meat for human consumption. Vet Res, 46, 47. 
BUXTON, D. 1993. Toxoplasmosis: the first commercial vaccine. Parasitol Today, 
9, 335-7. 
BUXTON, D., MALEY, S. W., WRIGHT, S. E., RODGER, S., BARTLEY, P. & 
INNES, E. A. 2007. Toxoplasma gondii and ovine toxoplasmosis: new 
aspects of an old story. Vet Parasitol, 149, 25-8. 
CAMPERO, L. M., VENTURINI, M. C., MOORE, D. P., MASSOLA, L., 
LAGOMARSINO, H., GARCIA, B., BACIGALUPE, D., RAMBEAUD, M., 
PARDINI, L., LEUNDA, M. R., SCHARES, G. & CAMPERO, C. M. 2015. 
Isolation and molecular characterization of a new Neospora caninum isolate 
from cattle in Argentina. Exp Parasitol, 155, 8-12. 
229
CANNAS, A., NAGULESWARAN, A., MULLER, N., EPERON, S., GOTTSTEIN, 
B. & HEMPHILL, A. 2003a. Vaccination of mice against experimental 
Neospora caninum infection using NcSAG1- and NcSRS2-based 
recombinant antigens and DNA vaccines. Parasitology, 126, 303-12. 
CANNAS, A., NAGULESWARAN, A., MULLER, N., GOTTSTEIN, B. & 
HEMPHILL, A. 2003b. Reduced cerebral infection of Neospora caninum-
infected mice after vaccination with recombinant microneme protein 
NcMIC3 and ribi adjuvant. J Parasitol, 89, 44-50. 
CANTON, G. J., KATZER, F., BENAVIDES-SILVAN, J., MALEY, S. W., 
PALAREA-ALBALADEJO, J., PANG, Y., SMITH, S., BARTLEY, P. M., 
ROCCHI, M., INNES, E. A. & CHIANINI, F. 2013. Phenotypic 
characterisation of the cellular immune infiltrate in placentas of cattle 
following experimental inoculation with Neospora caninum in late gestation. 
Vet Res, 44, 60. 
CANTON, G. J., KATZER, F., MALEY, S. W., BARTLEY, P. M., BENAVIDES-
SILVAN, J., PALAREA-ALBALADEJO, J., PANG, Y., SMITH, S. H., 
ROCCHI, M., BUXTON, D., INNES, E. A. & CHIANINI, F. 2014a. 
Cytokine expression in the placenta of pregnant cattle after inoculation with 
Neospora caninum. Vet Immunol Immunopathol, 161, 77-89. 
CANTON, G. J., KATZER, F., MALEY, S. W., BARTLEY, P. M., BENAVIDES-
SILVAN, J., PALAREA-ALBALADEJO, J., PANG, Y., SMITH, S. H., 
ROCCHI, M. S., BUXTON, D., INNES, E. A. & CHIANINI, F. 2014b. 
230
Inflammatory infiltration into placentas of Neospora caninum challenged 
cattle correlates with clinical outcome of pregnancy. Vet Res, 45, 11. 
CAVALCANTE, G. T., MONTEIRO, R. M., SOARES, R. M., NISHI, S. M., 
ALVES NETO, A. F., ESMERINI PDE, O., SERCUNDES, M. K., 
MARTINS, J. & GENNARI, S. M. 2011. Shedding of Neospora caninum 
oocysts by dogs fed different tissues from naturally infected cattle. Vet 
Parasitol, 179, 220-3. 
CHANG, J. S., RUSSELL, G. C., JANN, O., GLASS, E. J., WERLING, D. & 
HAIG, D. M. 2009. Molecular cloning and characterization of Toll-like 
receptors 1-10 in sheep. Vet Immunol Immunopathol, 127, 94-105. 
CHOUAIB, S., WELTE, K., MERTELSMANN, R. & DUPONT, B. 1985. 
Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: 
inhibition of interleukin 2 production and down-regulation of transferrin 
receptor expression. J Immunol, 135, 1172-9. 
CIMA, G. 2011. Rinderpest eradicated. International organizations declare "cattle 
plague" dead. J Am Vet Med Assoc, 239, 11-5. 
CLARK, D. A., SLAPSYS, R., CROY, B. A., KRCEK, J. & ROSSANT, J. 1984. 
Local active suppression by suppressor cells in the decidua: a review. Am J 
Reprod Immunol, 5, 78-83. 
COLLANTES-FERNANDEZ, E., ARRIGHI, R. B., ALVAREZ-GARCIA, G., 
WEIDNER, J. M., REGIDOR-CERRILLO, J., BOOTHROYD, J. C., 
ORTEGA-MORA, L. M. & BARRAGAN, A. 2012. Infected dendritic cells 
231
facilitate systemic dissemination and transplacental passage of the obligate 
intracellular parasite Neospora caninum in mice. PLoS One, 7, e32123. 
COLLANTES-FERNANDEZ, E., LOPEZ-PEREZ, I., ALVAREZ-GARCIA, G. & 
ORTEGA-MORA, L. M. 2006. Temporal distribution and parasite load 
kinetics in blood and tissues during Neospora caninum infection in mice. 
Infect Immun, 74, 2491-4. 
CONRAD, P. A., SVERLOW, K., ANDERSON, M., ROWE, J., BONDURANT, 
R., TUTER, G., BREITMEYER, R., PALMER, C., THURMOND, M. & 
ARDANS, A. 1993. Detection of serum antibody responses in cattle with 
natural or experimental Neospora infections. J Vet Diagn.Invest, 5, 572-578. 
DANESHVAR, H., COOMBS, G. H., HAGAN, P. & PHILLIPS, R. S. 2003. 
Leishmania mexicana and Leishmania major: attenuation of wild-type 
parasites and vaccination with the attenuated lines. J Infect.Dis, 187, 1662-
1668. 
DAVISON, H. C., OTTER, A. & TREES, A. J. 1999a. Estimation of vertical and 
horizontal transmission parameters of Neospora caninum infections in dairy 
cattle. Int J Parasitol, 29, 1683-9. 
DAVISON, H. C., OTTER, A. & TREES, A. J. 1999b. Significance of Neospora 
caninum in British dairy cattle determined by estimation of seroprevalence in 
normally calving cattle and aborting cattle. Int J Parasitol, 29, 1189-1194. 
232
DE MAREZ, T., LIDDELL, S., DUBEY, J. P., JENKINS, M. C. & GASBARRE, L. 
1999. Oral infection of calves with Neospora caninum oocysts from dogs: 
humoral and cellular immune responses. Int J Parasitol, 29, 1647-57. 
DE YANIZ, M. G., MOORE, D. P., ODEON, A. C., CANO, A., CANO, D. B., 
LEUNDA, M. R. & CAMPERO, C. M. 2007. Humoral immune response in 
pregnant heifers inoculated with Neospora caninum tachyzoites by 
conjunctival route. Vet Parasitol, 148, 213-218.  
DEBACHE, K., ALAEDDINE, F., GUIONAUD, C., MONNEY, T., MULLER, J., 
STROHBUSCH, M., LEIB, S. L., GRANDGIRARD, D. & HEMPHILL, A. 
2009. Vaccination with recombinant NcROP2 combined with recombinant 
NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in 
mice experimentally infected with Neospora caninum tachyzoites. Int J 
Parasitol, 39, 1373-84. 
DIJKSTRA, T., EYSKER, M., SCHARES, G., CONRATHS, F. J., WOUDA, W. & 
BARKEMA, H. W. 2001. Dogs shed Neospora caninum oocysts after 
ingestion of naturally infected bovine placenta but not after ingestion of 
colostrum spiked with Neospora caninum tachyzoites. Int J Parasitol, 31, 
747-52. 
DUBEY, J. P. 1999a. Neosporosis in cattle: biology and economic impact. J Am.Vet 
Med Assoc., 214, 1160-1163. 
DUBEY, J. P. 1999b. Recent advances in Neospora and neosporosis. Vet Parasitol, 
84, 349-67. 
233
DUBEY, J. P. 2003. Review of Neospora caninum and neosporosis in animals. 
Korean J Parasitol, 41, 1-16. 
DUBEY, J. P. 2008. The history of Toxoplasma gondii--the first 100 years. J 
Eukaryot Microbiol, 55, 467-75. 
DUBEY, J. P., BUXTON, D. & WOUDA, W. 2006. Pathogenesis of bovine 
neosporosis. J Comp Pathol, 134, 267-289. 
DUBEY, J. P., CARPENTER, J. L., SPEER, C. A., TOPPER, M. J. & UGGLA, A. 
1988a. Newly recognized fatal protozoan disease of dogs. J Am Vet Med 
Assoc, 192, 1269-85. 
DUBEY, J. P., HARTLEY, W. J. & LINDSAY, D. S. 1990. Congenital Neospora 
caninum infection in a calf with spinal cord anomaly. J Am.Vet Med Assoc., 
197, 1043-1044. 
DUBEY, J. P., HATTEL, A. L., LINDSAY, D. S. & TOPPER, M. J. 1988b. 
Neonatal Neospora caninum infection in dogs: isolation of the causative 
agent and experimental transmission. J Am.Vet Med Assoc., 193, 1259-1263. 
DUBEY, J. P., JENKINS, M. C., RAJENDRAN, C., MISKA, K., FERREIRA, L. 
R., MARTINS, J., KWOK, O. C. & CHOUDHARY, S. 2011. Gray wolf 
(Canis lupus) is a natural definitive host for Neospora caninum. Vet 
Parasitol, 181, 382-7. 
234
DUBEY, J. P., LEATHERS, C. W. & LINDSAY, D. S. 1989. Neospora caninum-
like protozoon associated with fatal myelitis in newborn calves. J Parasitol, 
75, 146-148. 
DUBEY, J. P. & LINDSAY, D. S. 1990. Neospora caninum induced abortion in 
sheep. J Vet Diagn.Invest, 2, 230-233. 
DUBEY, J. P. & LINDSAY, D. S. 1993. Neosporosis. Parasitol Today, 9, 452-458. 
DUBEY, J. P. & LINDSAY, D. S. 1996. A review of Neospora caninum and 
neosporosis. Vet Parasitol, 67, 1-59. 
DUBEY, J. P., LINDSAY, D. S. & LAPPIN, M. R. 2009. Toxoplasmosis and other 
intestinal coccidial infections in cats and dogs. Vet Clin North Am Small 
Anim Pract, 39, 1009-34, v. 
DUBEY, J. P., RIGOULET, J., LAGOURETTE, P., GEORGE, C., LONGEART, L. 
& LENET, J. L. 1996. Fatal transplacental neosporosis in a deer (Cervus eldi 
siamensis). J Parasitol, 82, 338-9. 
DUBEY, J. P. & ROMMEL, M. 1992. [Abortions caused by protozoa in agricultural 
animals]. Dtsch.Tierarztl Wochenschr, 99, 355-362. 
DUBEY, J. P., SCHARES, G. & ORTEGA-MORA, L. M. 2007. Epidemiology and 
control of neosporosis and Neospora caninum. Clin Microbiol Rev, 20, 323-
67. 
235
ELENI, C., CROTTI, S., MANUALI, E., COSTARELLI, S., FILIPPINI, G., 
MOSCATI, L. & MAGNINO, S. 2004. Detection of Neospora caninum in an 
aborted goat foetus. Vet Parasitol, 123, 271-274. 
ELLIS, J., SINCLAIR, D., MORRISON, D., AL-QASSAB, S., SPRINGETT, K. & 
IVENS, A. 2010. Microarray analyses of mouse responses to infection by 
Neospora caninum identifies disease associated cellular pathways in the host 
response. Mol Biochem Parasitol, 174, 117-27. 
EPERON, S., BRONNIMANN, K., HEMPHILL, A. & GOTTSTEIN, B. 1999. 
Susceptibility of B-cell deficient C57BL/6 (microMT) mice to Neospora 
caninum infection. Parasite Immunol, 21, 225-36. 
ESSLEMONT, R. J. & KOSSAIBATI, M. A. 1997. Culling in 50 dairy herds in 
England. Vet Rec., 140, 36-39. 
FENG, X., ZHANG, N. & TUO, W. 2010. Neospora caninum tachyzoite- and 
antigen-stimulated cytokine production by bone marrow-derived dendritic 
cells and spleen cells of naive BALB/c mice. J Parasitol, 96, 717-23. 
FENNER, F. 1982. A successful eradication campaign. Global eradication of 
smallpox. Rev Infect Dis, 4, 916-30. 
FERNANDEZ-GARCIA, A., RISCO-CASTILLO, V., ZABALLOS, A., 
ALVAREZ-GARCIA, G. & ORTEGA-MORA, L. M. 2006. Identification 
and molecular cloning of the Neospora caninum SAG4 gene specifically 
expressed at bradyzoite stage. Mol Biochem Parasitol, 146, 89-97. 
236
FERROGLIO, E., PASINO, M., ROMANO, A., GRANDE, D., PREGEL, P. & 
TRISCIUOGLIO, A. 2007. Evidence of Neospora caninum DNA in wild 
rodents. Vet Parasitol, 148, 346-9. 
FLYNN, R. J. & MARSHALL, E. S. 2011. Parasite limiting macrophages promote 
IL-17 secretion in naive bovine CD4(+) T-cells during Neospora caninum 
infection. Vet Immunol Immunopathol, 144, 423-9. 
GIBNEY, E. H., KIPAR, A., ROSBOTTOM, A., GUY, C. S., SMITH, R. F., 
HETZEL, U., TREES, A. J. & WILLIAMS, D. J. 2008. The extent of 
parasite-associated necrosis in the placenta and foetal tissues of cattle 
following Neospora caninum infection in early and late gestation correlates 
with foetal death. Int J Parasitol, 38, 579-88. 
GONDIM, L. F. 2006. Neospora caninum in wildlife. Trends Parasitol, 22, 247-52. 
GONDIM, L. F., LASKI, P., GAO, L. & MCALLISTER, M. M. 2004a. Variation of 
the internal transcribed spacer 1 sequence within individual strains and 
among different strains of Neospora caninum. J Parasitol, 90, 119-22. 
GONDIM, L. F., MCALLISTER, M. M., ANDERSON-SPRECHER, R. C., 
BJORKMAN, C., LOCK, T. F., FIRKINS, L. D., GAO, L. & FISCHER, W. 
R. 2004b. Transplacental transmission and abortion in cows administered 
Neospora caninum oocysts. J Parasitol, 90, 1394-400. 
GONDIM, L. F., MCALLISTER, M. M., PITT, W. C. & ZEMLICKA, D. E. 2004c. 
Coyotes (Canis latrans) are definitive hosts of Neospora caninum. Int J 
Parasitol, 34, 159-161. 
237
GONDIM, L. F. P., GAO, L. & MCALLISTER, M. M. 2002. Improved production 
of Neospora caninum oocysts, cyclical oral transmission between dogs and 
cattle, and in vitro isolation from oocysts. Journal of Parasitology, 88, 1159-
1163. 
GOODSWEN, S. J., KENNEDY, P. J. & ELLIS, J. T. 2013. A review of the 
infection, genetics, and evolution of Neospora caninum: from the past to the 
present. Infect Genet Evol, 13, 133-50. 
GUIDO, S., KATZER, F., NANJIANI, I., MILNE, E. & INNES, E. A. 2016. 
Serology-Based Diagnostics for the Control of Bovine Neosporosis. Trends 
Parasitol, 32, 131-43. 
GUY, C. S., WILLIAMS, D. J. L., KELLY, D. F., MCGARRY, J. W., GUY, F., 
BJORKMAN, C., SMITH, R. F. & TREES, A. J. 2001. Neospora caninum in 
persistently infected, pregnant cows: spontaneous transplacental infection is 
associated with an acute increase in maternal antibody. Vet Rec, 149, 443-9. 
HALDORSON, G. J., MATHISON, B. A., WENBERG, K., CONRAD, P. A., 
DUBEY, J. P., TREES, A. J., YAMANE, I. & BASZLER, T. V. 2005. 
Immunization with native surface protein NcSRS2 induces a Th2 immune 
response and reduces congenital Neospora caninum transmission in mice. Int 
J Parasitol, 35, 1407-15. 
HALDORSON, G. J., STANTON, J. B., MATHISON, B. A., SUAREZ, C. E. & 
BASZLER, T. V. 2006. Neospora caninum: antibodies directed against 
238
tachyzoite surface protein NcSRS2 inhibit parasite attachment and invasion 
of placental trophoblasts in vitro. Exp Parasitol, 112, 172-178. 
HECKER, Y. P., CANTON, G., REGIDOR-CERRILLO, J., CHIANINI, F., 
MORRELL, E., LISCHINSKY, L., ORTEGA-MORA, L. M., INNES, E. A., 
ODEON, A., CAMPERO, C. M. & MOORE, D. P. 2015. Cell mediated 
immune responses in the placenta following challenge of vaccinated pregnant 
heifers with Neospora caninum. Vet Parasitol, 214, 247-54. 
HECKER, Y. P., COCERES, V., WILKOWSKY, S. E., JARAMILLO ORTIZ, J. 
M., MORRELL, E. L., VERNA, A. E., GANUZA, A., CANO, D. B., 
LISCHINSKY, L., ANGEL, S. O., ZAMORANO, P., ODEON, A. C., 
LEUNDA, M. R., CAMPERO, C. M., MOREIN, B. & MOORE, D. P. 2014. 
A Neospora caninum vaccine using recombinant proteins fails to prevent 
foetal infection in pregnant cattle after experimental intravenous challenge. 
Vet Immunol Immunopathol, 162, 142-53. 
HECKER, Y. P., MOORE, D. P., QUATTROCCHI, V., REGIDOR-CERRILLO, J., 
VERNA, A., LEUNDA, M. R., MORRELL, E., ORTEGA-MORA, L. M., 
ZAMORANO, P., VENTURINI, M. C. & CAMPERO, C. M. 2013. Immune 
response and protection provided by live tachyzoites and native antigens 
from the NC-6 Argentina strain of Neospora caninum in pregnant heifers. Vet 
Parasitol, 197, 436-46. 
HEMPHILL, A., AGUADO-MARTINEZ, A. & MULLER, J. 2015. Approaches for 
the vaccination and treatment of Neospora caninum infections in mice and 
ruminant models. Parasitology, 1-15. 
239
HOBSON, J. C., DUFFIELD, T. F., KELTON, D., LISSEMORE, K., HIETALA, S. 
K., LESLIE, K. E., MCEWEN, B., CRAMER, G. & PEREGRINE, A. S. 
2002. Neospora caninum serostatus and milk production of Holstein cattle. J 
Am.Vet Med Assoc., 221, 1160-1164. 
HOPE, J. C., KWONG, L. S., ENTRICAN, G., WATTEGEDERA, S., 
VORDERMEIER, H. M., SOPP, P. & HOWARD, C. J. 2002. Development 
of detection methods for ruminant interleukin (IL)-12. J Immunol Methods, 
266, 117-26. 
HOPE, J. C., KWONG, L. S., THOM, M., SOPP, P., MWANGI, W., BROWN, W. 
C., PALMER, G. H., WATTEGEDERA, S., ENTRICAN, G. & HOWARD, 
C. J. 2005. Development of detection methods for ruminant interleukin (IL)-
4. J Immunol Methods, 301, 114-23. 
HUTCHISON, W. M., DUNACHIE, J. F., SIIM, J. C. & WORK, K. 1970. 
Coccidian-like nature of Toxoplasma gondii. Br Med J, 1, 142-4. 
INNES, E. A., BARTLEY, P. M., MALEY, S. W., WRIGHT, S. E. & BUXTON, D. 
2007. Comparative host-parasite relationships in ovine toxoplasmosis and 
bovine neosporosis and strategies for vaccination. Vaccine, 25, 5495-503. 
INNES, E. A., BARTLEY, P. M., ROCCHI, M., BENAVIDAS-SILVAN, J., 
BURRELLS, A., HOTCHKISS, E., CHIANINI, F., CANTON, G. & 
KATZER, F. 2011. Developing vaccines to control protozoan parasites in 
ruminants: dead or alive? Vet Parasitol, 180, 155-63. 
240
INNES, E. A., PANTON, W. R., MARKS, J., TREES, A. J., HOLMDAHL, J. & 
BUXTON, D. 1995. Interferon gamma inhibits the intracellular 
multiplication of Neospora caninum, as shown by incorporation of 3H uracil. 
J Comp Pathol, 113, 95-100. 
INNES, E. A., WRIGHT, S. E., MALEY, S., RAE, A., SCHOCK, A., KIRVAR, E., 
BARTLEY, P., HAMILTON, C., CAREY, I. M. & BUXTON, D. 2001. 
Protection against vertical transmission in bovine neosporosis. Int J 
Parasitol, 31, 1523-34. 
JARDINE, J. E. & LAST, R. D. 1993. Neospora caninum in aborted twin calves. J S 
Afr Vet Assoc, 64, 101-2. 
JENKINS, M., PARKER, C., TUO, W., VINYARD, B. & DUBEY, J. P. 2004a. 
Inclusion of CpG adjuvant with plasmid DNA coding for NcGRA7 improves 
protection against congenital neosporosis. Infect Immun, 72, 1817-9. 
JENKINS, M. C., PARKER, C., HILL, D., PINCKNEY, R. D., DYER, R. & 
DUBEY, J. P. 2007. Neospora caninum detected in feral rodents. Vet 
Parasitol, 143, 161-5. 
JENKINS, M. C., TUO, W. & DUBEY, J. P. 2004b. Evaluation of vaccination with 
Neospora caninum protein for prevention of fetal loss associated with 
experimentally induced neosporosis in sheep. Am J Vet Res, 65, 1404-8. 
JIMENEZ-RUIZ, E., ALVAREZ-GARCIA, G., AGUADO-MARTINEZ, A. & 
ORTEGA-MORA, L. M. 2013. Low rates of Neospora caninum infection 
241
reactivation during gestation are observed in both chronically and 
congenitally infected mice. Parasitology, 140, 220-8. 
JIMENEZ-RUIZ, E., ALVAREZ-GARCIA, G., AGUADO-MARTINEZ, A., 
SALMAN, H., IRACHE, J. M., MARUGAN-HERNANDEZ, V. & 
ORTEGA-MORA, L. M. 2012. Low efficacy of NcGRA7, NcSAG4, 
NcBSR4 and NcSRS9 formulated in poly-epsilon-caprolactone against 
Neospora caninum infection in mice. Vaccine, 30, 4983-92. 
KALINSKI, P., HILKENS, C. M., SNIJDERS, A., SNIJDEWINT, F. G. & 
KAPSENBERG, M. L. 1997. IL-12-deficient dendritic cells, generated in the 
presence of prostaglandin E2, promote type 2 cytokine production in 
maturing human naive T helper cells. J Immunol, 159, 28-35. 
KHAN, I. A., SCHWARTZMAN, J. D., FONSEKA, S. & KASPER, L. H. 1997. 
Neospora caninum: role for immune cytokines in host immunity. Exp 
Parasitol, 85, 24-34. 
KING, J. S., SLAPETA, J., JENKINS, D. J., AL-QASSAB, S. E., ELLIS, J. T. & 
WINDSOR, P. A. 2010. Australian dingoes are definitive hosts of Neospora 
caninum. Int J Parasitol, 40, 945-950. 
KLEVAR, S., KULBERG, S., BOYSEN, P., STORSET, A. K., MOLDAL, T., 
BJORKMAN, C. & OLSEN, I. 2007. Natural killer cells act as early 
responders in an experimental infection with Neospora caninum in calves. Int 
J Parasitol, 37, 329-39. 
242
KRAMER, L., DE, R. L., TRANQUILLO, V. M., MAGNINO, S. & GENCHI, C. 
2004. Analysis of risk factors associated with seropositivity to Neospora 
caninum in dogs. Vet Rec., 154, 692-693. 
KWONG, L. S., HOPE, J. C., THOM, M. L., SOPP, P., DUGGAN, S., 
BEMBRIDGE, G. P. & HOWARD, C. J. 2002. Development of an ELISA 
for bovine IL-10. Vet Immunol Immunopathol, 85, 213-23. 
KWONG, L. S., PARSONS, R., PATTERSON, R., COFFEY, T. J., THONUR, L., 
CHANG, J. S., RUSSELL, G., HAIG, D., WERLING, D. & HOPE, J. C. 
2011. Characterisation of antibodies to bovine Toll-like receptor (TLR)-2 and 
cross-reactivity with ovine TLR2. Vet Immunol Immunopathol, 139, 313-8. 
KWONG, L. S., THOM, M., SOPP, P., ROCCHI, M., WATTEGEDERA, S., 
ENTRICAN, G. & HOPE, J. C. 2010. Production and characterization of two 
monoclonal antibodies to bovine tumour necrosis factor alpha (TNF-alpha) 
and their cross-reactivity with ovine TNF-alpha. Vet Immunol Immunopathol, 
135, 320-4. 
LANDMANN, J. K., JILLELLA, D., O'DONOGHUE, P. J. & MCGOWAN, M. R. 
2002. Confirmation of the prevention of vertical transmission of Neospora 
caninum in cattle by the use of embryo transfer. Aust Vet J, 80, 502-3. 
LEI, T., WANG, H., LIU, J., NAN, H. & LIU, Q. 2014. ROP18 is a key factor 
responsible for virulence difference between Toxoplasma gondii and 
Neospora caninum. PLoS One, 9, e99744. 
243
LIDDELL, S., JENKINS, M. C., COLLICA, C. M. & DUBEY, J. P. 1999. 
Prevention of vertical transfer of Neospora caninum in BALB/c mice by 
vaccination. J Parasitol, 85, 1072-5. 
LIDDELL, S., PARKER, C., VINYARD, B., JENKINS, M. & DUBEY, J. P. 2003. 
Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 
confers partial protection against vertical transmission of Neospora caninum. 
J Parasitol, 89, 496-500. 
LINDSAY, D. S. & DUBEY, J. P. 1990. Infections in mice with tachyzoites and 
bradyzoites of Neospora caninum (Protozoa: Apicomplexa). J Parasitol, 76, 
410-413. 
LINDSAY, D. S., LENZ, S. D., BLAGBURN, B. L. & BRAKE, D. A. 1999a. 
Characterization of temperature-sensitive strains of Neospora caninum in 
mice. J Parasitol, 85, 64-7. 
LINDSAY, D. S., STEINBERG, H., DUBIELZIG, R. R., SEMRAD, S. D., 
KONKLE, D. M., MILLER, P. E. & BLAGBURN, B. L. 1996. Central 
nervous system neosporosis in a foal. J Vet Diagn Invest, 8, 507-10. 
LINDSAY, D. S., UPTON, S. J. & DUBEY, J. P. 1999b. A structural study of the 
Neospora caninum oocyst. Int J Parasitol, 29, 1521-1523. 
LONG, M. T. & BASZLER, T. V. 1996. Fetal loss in BALB/C mice infected with 
Neospora caninum. J Parasitol, 82, 608-11. 
244
LONG, M. T., BASZLER, T. V. & MATHISON, B. A. 1998. Comparison of 
intracerebral parasite load, lesion development, and systemic cytokines in 
mouse strains infected with Neospora caninum. J Parasitol, 84, 316-20. 
LONG, P. L. 1965. Development of Eimeria tenella in avian embryos. Nature, 208, 
509-10. 
LOPEZ-PEREZ, I. C., COLLANTES-FERNANDEZ, E., AGUADO-MARTINEZ, 
A., RODRIGUEZ-BERTOS, A. & ORTEGA-MORA, L. M. 2008. Influence 
of Neospora caninum infection in BALB/c mice during pregnancy in post-
natal development. Vet Parasitol, 155, 175-83. 
LOPEZ-PEREZ, I. C., COLLANTES-FERNANDEZ, E., ROJO-MONTEJO, S., 
NAVARRO-LOZANO, V., RISCO-CASTILLO, V., PEREZ-PEREZ, V., 
PEREIRA-BUENO, J. & ORTEGA-MORA, L. M. 2010. Effects of 
Neospora caninum infection at mid-gestation on placenta in a pregnant 
mouse model. J Parasitol, 96, 1017-20. 
MACALDOWIE, C., MALEY, S. W., WRIGHT, S., BARTLEY, P., ESTEBAN-
REDONDO, I., BUXTON, D. & INNES, E. A. 2004. Placental pathology 
associated with fetal death in cattle inoculated with Neospora caninum by 
two different routes in early pregnancy. J Comp Pathol, 131, 142-56. 
MACEDO, C. A., MACEDO, M. F., CARDIM, S. T., PAIVA, M. C., TARODA, 
A., BARROS, L. D., CUNHA, I. A., ZULPO, D. L. & GARCIA, J. L. 2013. 
Neospora caninum: evaluation of vertical transmission in slaughtered dairy 
cows (Bos taurus). Rev Bras Parasitol Vet, 22, 13-7. 
245
MACINTYRE, D. M., LIM, H. C., RYAN, K., KIMMINS, S., SMALL, J. A. & 
MACLAREN, L. A. 2002. Implantation-associated changes in bovine uterine 
expression of integrins and extracellular matrix. Biol Reprod, 66, 1430-6. 
MALEY, S. W., BUXTON, D., MACALDOWIE, C. N., ANDERSON, I. E., 
WRIGHT, S. E., BARTLEY, P. M., ESTEBAN-REDONDO, I., 
HAMILTON, C. M., STORSET, A. K. & INNES, E. A. 2006. 
Characterization of the immune response in the placenta of cattle 
experimentally infected with Neospora caninum in early gestation. J Comp 
Pathol, 135, 130-41. 
MALEY, S. W., BUXTON, D., RAE, A. G., WRIGHT, S. E., SCHOCK, A., 
BARTLEY, P. M., ESTEBAN-REDONDO, I., SWALES, C., HAMILTON, 
C. M., SALES, J. & INNES, E. A. 2003b. The pathogenesis of neosporosis in 
pregnant cattle: inoculation at mid-gestation. J.Comp.Pathol., 129, 186-195. 
MANSILLA, F. C., MOORE, D. P., QUINTANA, M. E., CARDOSO, N., 
HECKER, Y. P., GUAL, I., CZEPLUCH, W., ODEON, A. C. & CAPOZZO, 
A. V. 2015. Safety and immunogenicity of a soluble native Neospora 
caninum tachyzoite-extract vaccine formulated with a soy lecithin/beta-
glucan adjuvant in pregnant cattle. Vet Immunol Immunopathol, 165, 75-80. 
MARGULIES, M., EGHOLM, M., ALTMAN, W. E., ATTIYA, S., BADER, J. S., 
BEMBEN, L. A., BERKA, J., BRAVERMAN, M. S., CHEN, Y. J., CHEN, 
Z., DEWELL, S. B., DU, L., FIERRO, J. M., GOMES, X. V., GODWIN, B. 
C., HE, W., HELGESEN, S., HO, C. H., IRZYK, G. P., JANDO, S. C., 
ALENQUER, M. L., JARVIE, T. P., JIRAGE, K. B., KIM, J. B., KNIGHT, 
246
J. R., LANZA, J. R., LEAMON, J. H., LEFKOWITZ, S. M., LEI, M., LI, J., 
LOHMAN, K. L., LU, H., MAKHIJANI, V. B., MCDADE, K. E., 
MCKENNA, M. P., MYERS, E. W., NICKERSON, E., NOBILE, J. R., 
PLANT, R., PUC, B. P., RONAN, M. T., ROTH, G. T., SARKIS, G. J., 
SIMONS, J. F., SIMPSON, J. W., SRINIVASAN, M., TARTARO, K. R., 
TOMASZ, A., VOGT, K. A., VOLKMER, G. A., WANG, S. H., WANG, 
Y., WEINER, M. P., YU, P., BEGLEY, R. F. & ROTHBERG, J. M. 2005. 
Genome sequencing in microfabricated high-density picolitre reactors. 
Nature, 437, 376-80. 
MARKS, J., LUNDEN, A., HARKINS, D. & INNES, E. 1998. Identification of 
Neospora antigens recognized by CD4+ T cells and immune sera from 
experimentally infected cattle. Parasite Immunol, 20, 303-9. 
MARUGAN-HERNANDEZ, V., ORTEGA-MORA, L. M., AGUADO-
MARTINEZ, A. & ALVAREZ-GARCIA, G. 2011a. Genetic manipulation of 
Neospora caninum to express the bradyzoite-specific protein NcSAG4 in 
tachyzoites. Parasitology, 138, 472-80. 
MARUGAN-HERNANDEZ, V., ORTEGA-MORA, L. M., AGUADO-
MARTINEZ, A., JIMENEZ-RUIZ, E. & ALVAREZ-GARCIA, G. 2011b. 
Transgenic Neospora caninum strains constitutively expressing the 
bradyzoite NcSAG4 protein proved to be safe and conferred significant levels 
of protection against vertical transmission when used as live vaccines in 
mice. Vaccine, 29, 7867-74. 
247
MAZUZ, M. L., FISH, L., REZNIKOV, D., WOLKOMIRSKY, R., LEIBOVITZ, 
B., SAVITZKY, I., GOLENSER, J. & SHKAP, V. 2014. Neosporosis in 
naturally infected pregnant dairy cattle. Vet Parasitol, 205, 85-91. 
MAZUZ, M. L., FISH, L., WOLKOMIRSKY, R., LEIBOVICH, B., REZNIKOV, 
D., SAVITSKY, I., GOLENSER, J. & SHKAP, V. 2015. The effect of a live 
Neospora caninum tachyzoite vaccine in naturally infected pregnant dairy 
cows. Prev Vet Med, 120, 232-5. 
MCALLISTER, M., WILLS, R. A., MCGUIRE, A. M., JOLLEY, W. R., TRANAS, 
J. D., WILLIAMS, E. S., LINDSAY, D. S., BJORKMAN, C. & BELDEN, 
E. L. 1999. Ingestion of Neospora caninum tissue cysts by Mustela species. 
Int J Parasitol, 29, 1531-6. 
MCALLISTER, M. M., BJORKMAN, C., ANDERSON-SPRECHER, R. & 
ROGERS, D. G. 2000. Evidence of point-source exposure to Neospora 
caninum and protective immunity in a herd of beef cows. J Am Vet Med 
Assoc, 217, 881-7. 
MCALLISTER, M. M., DUBEY, J. P., LINDSAY, D. S., JOLLEY, W. R., WILLS, 
R. A. & MCGUIRE, A. M. 1998. Dogs are definitive hosts of Neospora 
caninum. Int J Parasitol, 28, 1473-1478. 
MCCANN, C. M., MCALLISTER, M. M., GONDIM, L. F., SMITH, R. F., 
CRIPPS, P. J., KIPAR, A., WILLIAMS, D. J. & TREES, A. J. 2007. 
Neospora caninum in cattle: experimental infection with oocysts can result in 
248
exogenous transplacental infection, but not endogenous transplacental 
infection in the subsequent pregnancy. Int J Parasitol, 37, 1631-9. 
MCKENZIE, F. E., SMITH, D. L., O'MEARA, W. P. & RILEY, E. M. 2008. Strain 
theory of malaria: the first 50 years. Adv Parasitol, 66, 1-46. 
MILLER, C., QUINN, H., RYCE, C., REICHEL, M. P. & ELLIS, J. T. 2005. 
Reduction in transplacental transmission of Neospora caninum in outbred 
mice by vaccination. Int J Parasitol, 35, 821-8. 
MILLER, C. M., QUINN, H. E., WINDSOR, P. A. & ELLIS, J. T. 2002. 
Characterisation of the first Australian isolate of Neospora caninum from 
cattle. Aust Vet J, 80, 620-5. 
MINEO, T. W., BENEVIDES, L., SILVA, N. M. & SILVA, J. S. 2009. Myeloid 
differentiation factor 88 is required for resistance to Neospora caninum 
infection. Vet Res, 40, 32. 
MINEO, T. W., OLIVEIRA, C. J., GUTIERREZ, F. R. & SILVA, J. S. 2010. 
Recognition by Toll-like receptor 2 induces antigen-presenting cell activation 
and Th1 programming during infection by Neospora caninum. Immunol Cell 
Biol, 88, 825-33. 
MODRY, D., VACLAVEK, P., KOUDELA, B. & SLAPETA, J. R. 2001. 
Placentophagia--an alternative way for horizontal transmission of Neospora 
caninum in cattle? Trends Parasitol, 17, 573-5. 
249
MOEN, A. R., WOUDA, W., MUL, M. F., GRAAT, E. A. & VAN, W. T. 1998. 
Increased risk of abortion following Neospora caninum abortion outbreaks: a 
retrospective and prospective cohort study in four dairy herds. 
Theriogenology, 49, 1301-1309. 
MONNEY, T., DEBACHE, K., GRANDGIRARD, D., LEIB, S. L. & HEMPHILL, 
A. 2012. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R 
induces a non-protective Th2-type immune response in the pregnant mouse 
model for N. caninum infection. Vaccine, 30, 6588-94. 
MONNEY, T., GRANDGIRARD, D., LEIB, S. L. & HEMPHILL, A. 2013. Use of a 
Th1 Stimulator Adjuvant for Vaccination against Neospora caninum 
Infection in the Pregnant Mouse Model. Pathogens, 2, 193-208. 
MORAVEJI, M., HOSSEINI, A., MOGHADDAR, N., NAMAVARI, M. M. & 
ESKANDARI, M. H. 2012. Development of latex agglutination test with 
recombinant NcSAG1 for the rapid detection of antibodies to Neospora 
caninum in cattle. Vet Parasitol, 189, 211-7. 
MORENO, B., COLLANTES-FERNANDEZ, E., VILLA, A., NAVARRO, A., 
REGIDOR-CERRILLO, J. & ORTEGA-MORA, L. M. 2012. Occurrence of 
Neospora caninum and Toxoplasma gondii infections in ovine and caprine 
abortions. Vet Parasitol, 187, 312-318. 
NISCHIK, N., SCHADE, B., DYTNERSKA, K., DLUGONSKA, H., 
REICHMANN, G. & FISCHER, H. G. 2001. Attenuation of mouse-virulent 
Toxoplasma gondii parasites is associated with a decrease in interleukin-12-
250
inducing tachyzoite activity and reduced expression of actin, catalase and 
excretory proteins. Microbes Infect., 3, 689-699. 
NISHIKAWA, Y., INOUE, N., MAKALA, L. & NAGASAWA, H. 2003. A role for 
balance of interferon-gamma and interleukin-4 production in protective 
immunity against Neospora caninum infection. Vet Parasitol, 116, 175-84. 
NISHIKAWA, Y., XUAN, X., NAGASAWA, H., IGARASHI, I., FUJISAKI, K., 
OTSUKA, H. & MIKAMI, T. 2001. Prevention of vertical transmission of 
Neospora caninum in BALB/c mice by recombinant vaccinia virus carrying 
NcSRS2 gene. Vaccine, 19, 1710-6. 
NISHIMURA, M., KOHARA, J., KURODA, Y., HIASA, J., TANAKA, S., 
MUROI, Y., KOJIMA, N., FURUOKA, H. & NISHIKAWA, Y. 2013. 
Oligomannose-coated liposome-entrapped dense granule protein 7 induces 
protective immune response to Neospora caninum in cattle. Vaccine, 31, 
3528-35. 
O'HANDLEY, R., LIDDELL, S., PARKER, C., JENKINS, M. C. & DUBEY, J. P. 
2002. Experimental infection of sheep with Neospora caninum oocysts. J 
Parasitol, 88, 1120-3. 
O'HANDLEY, R. M., MORGAN, S. A., PARKER, C., JENKINS, M. C. & 
DUBEY, J. P. 2003. Vaccination of ewes for prevention of vertical 
transmission of Neospora caninum. Am J Vet Res, 64, 449-52. 
OMATA, Y., NIDAIRA, M., KANO, R., KOBAYASHI, Y., KOYAMA, T., 
FURUOKA, H., MAEDA, R., MATSUI, T. & SAITO, A. 2004. Vertical 
251
transmission of Neospora caninum in BALB/c mice in both acute and 
chronic infection. Vet Parasitol, 121, 323-8. 
ORTEGA-MORA, L. M., FERRE, I., DEL-POZO, I., CAETANO-DA-SILVA, A., 
COLLANTES-FERNANDEZ, E., REGIDOR-CERRILLO, J., UGARTE-
GARAGALZA, C. & ADURIZ, G. 2003. Detection of Neospora caninum in 
semen of bulls. Vet Parasitol, 117, 301-8. 
PARE, J., FECTEAU, G., FORTIN, M. & MARSOLAIS, G. 1998. 
Seroepidemiologic study of Neospora caninum in dairy herds. J Am Vet Med 
Assoc, 213, 1595-8. 
PARE, J., HIETALA, S. K. & THURMOND, M. C. 1995. An enzyme-linked 
immunosorbent assay (ELISA) for serological diagnosis of Neospora sp. 
infection in cattle. J Vet Diagn.Invest, 7, 352-359. 
PARE, J., THURMOND, M. C. & HIETALA, S. K. 1996. Congenital Neospora 
caninum infection in dairy cattle and associated calfhood mortality. Can J Vet 
Res, 60, 133-9. 
PEREIRA GARCIA-MELO, D., REGIDOR-CERRILLO, J., COLLANTES-
FERNANDEZ, E., AGUADO-MARTINEZ, A., DEL POZO, I., 
MINGUIJON, E., GOMEZ-BAUTISTA, M., ADURIZ, G. & ORTEGA-
MORA, L. M. 2010. Pathogenic characterization in mice of Neospora 
caninum isolates obtained from asymptomatic calves. Parasitology, 137, 
1057-68. 
252
PETERS, M., LUTKEFELS, E., HECKEROTH, A. R. & SCHARES, G. 2001. 
Immunohistochemical and ultrastructural evidence for Neospora caninum 
tissue cysts in skeletal muscles of naturally infected dogs and cattle. Int J 
Parasitol, 31, 1144-1148. 
PINITKIATISAKUL, S., FRIEDMAN, M., WIKMAN, M., MATTSSON, J. G., 
LOVGREN-BENGTSSON, K., STAHL, S. & LUNDEN, A. 2007. 
Immunogenicity and protective effect against murine cerebral neosporosis of 
recombinant NcSRS2 in different iscom formulations. Vaccine, 25, 3658-68. 
POPE, G. S., GUPTA, S. K. & MUNRO, I. B. 1969. Progesterone levels in the 
systemic plasma of pregnant, cycling and ovariectomized cows. J Reprod 
Fertil, 20, 369-81. 
PRESTON, P. M., JACKSON, L. A., SUTHERLAND, I. A., BROWN, D. J., 
SCHOFIELD, J., BIRD, T., SANDERSON, A. & BROWN, C. G. 2001. 
Theileria annulata: attenuation of a schizont-infected cell line by prolonged 
in vitro culture is not caused by the preferential growth of particular host cell 
types. Exp Parasitol, 98, 188-205. 
QUINN, H. E., MILLER, C. M., RYCE, C., WINDSOR, P. A. & ELLIS, J. T. 2002. 
Characterization of an outbred pregnant mouse model of Neospora caninum 
infection. J Parasitol, 88, 691-6. 
RAGHUPATHY, R. 1997. Th1-type immunity is incompatible with successful 
pregnancy. Immunol Today, 18, 478-82. 
253
RAMAMOORTHY, S., DUNCAN, R., LINDSAY, D. S. & SRIRANGANATHAN, 
N. 2007a. Optimization of the use of C57BL/6 mice as a laboratory animal 
model for Neospora caninum vaccine studies. Vet Parasitol, 145, 253-9. 
RAMAMOORTHY, S., LINDSAY, D. S., SCHURIG, G. G., BOYLE, S. M., 
DUNCAN, R. B., VEMULAPALLI, R. & SRIRANGANATHAN, N. 2006. 
Vaccination with gamma-irradiated Neospora caninum tachyzoites protects 
mice against acute challenge with N. caninum. J Eukaryot Microbiol, 53, 
151-6. 
RAMAMOORTHY, S., SANAKKAYALA, N., VEMULAPALLI, R., JAIN, N., 
LINDSAY, D. S., SCHURIG, G. S., BOYLE, S. M. & 
SRIRANGANATHAN, N. 2007b. Prevention of vertical transmission of 
Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain 
RB51 expressing N. caninum protective antigens. Int J Parasitol, 37, 1531-8. 
REGIDOR-CERRILLO, J., DIEZ-FUERTES, F., GARCIA-CULEBRAS, A., 
MOORE, D. P., GONZALEZ-WARLETA, M., CUEVAS, C., SCHARES, 
G., KATZER, F., PEDRAZA-DIAZ, S., MEZO, M. & ORTEGA-MORA, L. 
M. 2013. Genetic diversity and geographic population structure of bovine 
Neospora caninum determined by microsatellite genotyping analysis. PLoS 
One, 8, e72678. 
REGIDOR-CERRILLO, J., GOMEZ-BAUTISTA, M., DEL POZO, I., JIMENEZ-
RUIZ, E., ADURIZ, G. & ORTEGA-MORA, L. M. 2010. Influence of 
Neospora caninum intra-specific variability in the outcome of infection in a 
pregnant BALB/c mouse model. Vet Res, 41, 52. 
254
REGIDOR-CERRILLO, J., GOMEZ-BAUTISTA, M., PEREIRA-BUENO, J., 
ADURIZ, G., NAVARRO-LOZANO, V., RISCO-CASTILLO, V., 
FERNANDEZ-GARCIA, A., PEDRAZA-DIAZ, S. & ORTEGA-MORA, L. 
M. 2008. Isolation and genetic characterization of Neospora caninum from 
asymptomatic calves in Spain. Parasitology, 135, 1651-9. 
REGIDOR-CERRILLO, J., GOMEZ-BAUTISTA, M., SODUPE, I., ADURIZ, G., 
ALVAREZ-GARCIA, G., DEL, P. I. & ORTEGA-MORA, L. M. 2011. In 
vitro invasion efficiency and intracellular proliferation rate comprise 
virulence-related phenotypic traits of Neospora caninum. Vet Res, 42, 41. 
REGIDOR-CERRILLO, J., PEDRAZA-DIAZ, S., GOMEZ-BAUTISTA, M. & 
ORTEGA-MORA, L. M. 2006. Multilocus microsatellite analysis reveals 
extensive genetic diversity in Neospora caninum. J Parasitol, 92, 517-24. 
REICHEL, M. P., ALEJANDRA AYANEGUI-ALCERRECA, M., GONDIM, L. F. 
& ELLIS, J. T. 2012. What is the global economic impact of Neospora 
caninum in cattle - The billion dollar question. Int J Parasitol. 
REICHEL, M. P., MOORE, D. P., HEMPHILL, A., ORTEGA-MORA, L. M., 
DUBEY, J. P. & ELLIS, J. T. 2015. A live vaccine against Neospora 
caninum abortions in cattle. Vaccine, 33, 1299-301. 
REID, A. J., VERMONT, S. J., COTTON, J. A., HARRIS, D., HILL-
CAWTHORNE, G. A., KONEN-WAISMAN, S., LATHAM, S. M., 
MOURIER, T., NORTON, R., QUAIL, M. A., SANDERS, M., 
SHANMUGAM, D., SOHAL, A., WASMUTH, J. D., BRUNK, B., GRIGG, 
255
M. E., HOWARD, J. C., PARKINSON, J., ROOS, D. S., TREES, A. J., 
BERRIMAN, M., PAIN, A. & WASTLING, J. M. 2012. Comparative 
genomics of the apicomplexan parasites Toxoplasma gondii and Neospora 
caninum: Coccidia differing in host range and transmission strategy. PLoS 
Pathog, 8, e1002567. 
RETTIGNER, C., DE MEERSCHMAN, F., FOCANT, C., VANDERPLASSCHEN, 
A. & LOSSON, B. 2004. The vertical transmission following the reactivation 
of a Neospora caninum chronic infection does not seem to be due to an 
alteration of the systemic immune response in pregnant CBA/Ca mice. 
Parasitology, 128, 149-60. 
RISCO-CASTILLO, V., FERNANDEZ-GARCIA, A., ZABALLOS, A., AGUADO-
MARTINEZ, A., HEMPHILL, A., RODRIGUEZ-BERTOS, A., ALVAREZ-
GARCIA, G. & ORTEGA-MORA, L. M. 2007. Molecular characterisation 
of BSR4, a novel bradyzoite-specific gene from Neospora caninum. Int J 
Parasitol, 37, 887-896. 
RITTER, D. M., KERLIN, R., SIBERT, G. & BRAKE, D. 2002. Immune factors 
influencing the course of infection with Neospora caninum in the murine 
host. J Parasitol, 88, 271-80. 
ROCCHI, M. S., BARTLEY, P. M., INGLIS, N. F., COLLANTES-FERNANDEZ, 
E., ENTRICAN, G., KATZER, F. & INNES, E. A. 2011. Selection of 
Neospora caninum antigens stimulating bovine CD4+ve T cell responses 
through immuno-potency screening and proteomic approaches. Vet Res, 42, 
91. 
256
ROJO-MONTEJO, S., COLLANTES-FERNANDEZ, E., BLANCO-MURCIA, J., 
RODRIGUEZ-BERTOS, A., RISCO-CASTILLO, V. & ORTEGA-MORA, 
L. M. 2009a. Experimental infection with a low virulence isolate of 
Neospora caninum at 70 days gestation in cattle did not result in foetopathy. 
Vet Res, 40, 49. 
ROJO-MONTEJO, S., COLLANTES-FERNANDEZ, E., LOPEZ-PEREZ, I., 
RISCO-CASTILLO, V., PRENAFETA, A. & ORTEGA-MORA, L. M. 
2012. Evaluation of the protection conferred by a naturally attenuated 
Neospora caninum isolate against congenital and cerebral neosporosis in 
mice. Vet Res, 43, 62. 
ROJO-MONTEJO, S., COLLANTES-FERNANDEZ, E., PEREZ-ZABALLOS, F., 
RODRIGUEZ-MARCOS, S., BLANCO-MURCIA, J., RODRIGUEZ-
BERTOS, A., PRENAFETA, A. & ORTEGA-MORA, L. M. 2013. Effect of 
vaccination of cattle with the low virulence Nc-Spain 1H isolate of Neospora 
caninum against a heterologous challenge in early and mid-gestation. Vet 
Res, 44, 106. 
ROJO-MONTEJO, S., COLLANTES-FERNANDEZ, E., REGIDOR-CERRILLO, 
J., ALVAREZ-GARCIA, G., MARUGAN-HERNANDEZ, V., PEDRAZA-
DIAZ, S., BLANCO-MURCIA, J., PRENAFETA, A. & ORTEGA-MORA, 
L. M. 2009b. Isolation and characterization of a bovine isolate of Neospora 
caninum with low virulence. Vet Parasitol, 159, 7-16. 
ROMAND, S., THULLIEZ, P. & DUBEY, J. P. 1998. Direct agglutination test for 
serologic diagnosis of Neospora caninum infection. Parasitol Res, 84, 50-3. 
257
ROMERO, J. J., PEREZ, E. & FRANKENA, K. 2004. Effect of a killed whole 
Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa 
Rican dairy cows under field conditions. Vet Parasitol, 123, 149-159. 
ROSBOTTOM, A., GIBNEY, E. H., GUY, C. S., KIPAR, A., SMITH, R. F., 
KAISER, P., TREES, A. J. & WILLIAMS, D. J. 2008. Upregulation of 
cytokines is detected in the placentas of cattle infected with Neospora 
caninum and is more marked early in gestation when fetal death is observed. 
Infect Immun, 76, 2352-61. 
ROSBOTTOM, A., GIBNEY, H., KAISER, P., HARTLEY, C., SMITH, R. F., 
ROBINSON, R., KIPAR, A. & WILLIAMS, D. J. 2011. Up regulation of the 
maternal immune response in the placenta of cattle naturally infected with 
Neospora caninum. PLoS One, 6, e15799. 
ROSBOTTOM, A., GUY, C. S., GIBNEY, E. H., SMITH, R. F., VALARCHER, J. 
F., TAYLOR, G. & WILLIAMS, D. J. 2007. Peripheral immune responses in 
pregnant cattle following Neospora caninum infection. Parasite Immunol, 29, 
219-28. 
SANGER, F., NICKLEN, S. & COULSON, A. R. 1977. DNA sequencing with 
chain-terminating inhibitors. Proc Natl Acad Sci U S A, 74, 5463-7. 
SCHARES, G., BARWALD, A., STAUBACH, C., SONDGEN, P., RAUSER, M., 
SCHRODER, R., PETERS, M., WURM, R., SELHORST, T. & 
CONRATHS, F. J. 2002a. p38-avidity-ELISA: examination of herds 
258
experiencing epidemic or endemic Neospora caninum-associated bovine 
abortion. Vet Parasitol, 106, 293-305. 
SCHARES, G., HEYDORN, A. O., CUPPERS, A., MEHLHORN, H., GEUE, L., 
PETERS, M. & CONRATHS, F. J. 2002b. In contrast to dogs, red foxes 
(Vulpes vulpes) did not shed Neospora caninum upon feeding of intermediate 
host tissues. Parasitol Res, 88, 44-52. 
SCHOCK, A., INNES, E. A., YAMANE, I., LATHAM, S. M. & WASTLING, J. M. 
2001. Genetic and biological diversity among isolates of Neospora caninum. 
Parasitology, 123, 13-23. 
SCHULTZ, R. D., DUNNE, H. W. & HEIST, C. E. 1973. Ontogeny of the bovine 
immune response. Infect Immun, 7, 981-91. 
SCHWAB, A. E., GEARY, T. G., BAILLARGEON, P., SCHWAB, A. J. & 
FECTEAU, G. 2009. Association of BoLA DRB3 and DQA1 alleles with 
susceptibility to Neospora caninum and reproductive outcome in Quebec 
Holstein cattle. Vet Parasitol, 165, 136-40. 
SENOGLES, D. R., PAUL, P. S., JOHNSON, D. W. & MUSCOPLAT, C. C. 1979. 
Ontogeny of T cells, B cells and monocytes in the bovine foetus. Clin Exp 
Immunol, 36, 299-303. 
SERRANO-MARTINEZ, E., FERRE, I., OSORO, K., ADURIZ, G., MOTA, R. A., 
MARTINEZ, A., DEL-POZO, I., HIDALGO, C. O. & ORTEGA-MORA, L. 
M. 2007. Intrauterine Neospora caninum inoculation of heifers and cows 
259
using contaminated semen with different numbers of tachyzoites. 
Theriogenology, 67, 729-737. 
SHIRLEY, M. W. & BEDRNIK, P. 1997. Live attenuated vaccines against avian 
coccidiosis: Success with precocious and egg-adapted lines of Eimeria. 
Parasitol Today, 13, 481-4. 
STASKA, L. M., DAVIES, C. J., BROWN, W. C., MCGUIRE, T. C., SUAREZ, C. 
E., PARK, J. Y., MATHISON, B. A., ABBOTT, J. R. & BASZLER, T. V. 
2005. Identification of vaccine candidate peptides in the NcSRS2 surface 
protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and 
gamma interferon-secreting T lymphocytes of infected holstein cattle. Infect 
Immun, 73, 1321-9. 
STASKA, L. M., MCGUIRE, T. C., DAVIES, C. J., LEWIN, H. A. & BASZLER, 
T. V. 2003. Neospora caninum-infected cattle develop parasite-specific 
CD4+ cytotoxic T lymphocytes. Infect Immun, 71, 3272-9. 
STENLUND, S., BJORKMAN, C., HOLMDAHL, O. J., KINDAHL, H. & UGGLA, 
A. 1997. Characterization of a Swedish bovine isolate of Neospora caninum. 
Parasitol Res, 83, 214-9. 
TEIXEIRA, L., MARQUES, A., MEIRELES, C. S., SEABRA, A. R., 
RODRIGUES, D., MADUREIRA, P., FAUSTINO, A. M., SILVA, C., 
RIBEIRO, A., FERREIRA, P., CORREIA DA COSTA, J. M., CANADA, N. 
& VILANOVA, M. 2005. Characterization of the B-cell immune response 
260
elicited in BALB/c mice challenged with Neospora caninum tachyzoites. 
Immunology, 116, 38-52. 
THILSTED, J. P. & DUBEY, J. P. 1989. Neosporosis-like abortions in a herd of 
dairy cattle. J Vet Diagn Invest, 1, 205-9. 
THURMOND, M. C. & HIETALA, S. K. 1996. Culling associated with Neospora 
caninum infection in dairy cows. Am.J Vet Res, 57, 1559-1562. 
THURMOND, M. C. & HIETALA, S. K. 1997. Effect of congenitally acquired 
Neospora caninum infection on risk of abortion and subsequent abortions in 
dairy cattle. Am.J Vet Res, 58, 1381-1385. 
THURMOND, M. C., HIETALA, S. K. & BLANCHARD, P. C. 1997. Herd-based 
diagnosis of Neospora caninum-induced endemic and epidemic abortion in 
cows and evidence for congenital and postnatal transmission. J Vet 
Diagn.Invest, 9, 44-49. 
TREES, A. J., DAVISON, H. C., INNES, E. A. & WASTLING, J. M. 1999. 
Towards evaluating the economic impact of bovine neosporosis. Int J 
Parasitol, 29, 1195-1200. 
TREES, A. J. & WILLIAMS, D. J. 2005. Endogenous and exogenous transplacental 
infection in Neospora caninum and Toxoplasma gondii. Trends Parasitol, 21, 
558-561. 
VALOUEV, A., ICHIKAWA, J., TONTHAT, T., STUART, J., RANADE, S., 
PECKHAM, H., ZENG, K., MALEK, J. A., COSTA, G., MCKERNAN, K., 
261
SIDOW, A., FIRE, A. & JOHNSON, S. M. 2008. A high-resolution, 
nucleosome position map of C. elegans reveals a lack of universal sequence-
dictated positioning. Genome Res, 18, 1051-63. 
VAUGHAN, A. M. & KAPPE, S. H. 2013. Vaccination using radiation- or 
genetically attenuated live sporozoites. Methods Mol.Biol, 923, 549-566. 
WALDNER, C. L. 2005. Serological status for N. caninum, bovine viral diarrhea 
virus, and infectious bovine rhinotracheitis virus at pregnancy testing and 
reproductive performance in beef herds. Anim Reprod.Sci, 90, 219-242. 
WALDNER, C. L., HENDERSON, J., WU, J. T., BREKER, K. & CHOW, E. Y. 
2001a. Reproductive performance of a cow-calf herd following a Neospora 
caninum-associated abortion epidemic. Can.Vet J, 42, 355-360. 
WALDNER, C. L., HENDERSON, J., WU, J. T., BREKER, K. & CHOW, E. Y. 
2001b. Reproductive performance of a cow-calf herd following a Neospora 
caninum-associated abortion epidemic. Can Vet J, 42, 355-60. 
WEBER, F. H., JACKSON, J. A., SOBECKI, B., CHOROMANSKI, L., OLSEN, 
M., MEINERT, T., FRANK, R., REICHEL, M. P. & ELLIS, J. T. 2013. On 
the efficacy and safety of vaccination with live tachyzoites of Neospora 
caninum for prevention of Neospora-associated fetal loss in cattle. Clin 
Vaccine Immunol, 20, 99-105. 
WESTON, J. F., HEUER, C. & WILLIAMSON, N. B. 2012. Efficacy of a Neospora 
caninum killed tachyzoite vaccine in preventing abortion and vertical 
transmission in dairy cattle. Prev.Vet Med, 103, 136-144. 
262
WHITAKER, D. A., KELLY, J. M. & SMITH, S. 2000. Disposal and disease rates 
in 340 British dairy herds. Vet Rec., 146, 363-367. 
WHITAKER, D. A., MACRAE, A. I. & BURROUGH, E. 2004. Disposal and 
disease rates in British dairy herds between April 1998 and March 2002. Vet 
Rec., 155, 43-47. 
WILLIAMS, D. J., GUY, C. S., MCGARRY, J. W., GUY, F., TASKER, L., 
SMITH, R. F., MACEACHERN, K., CRIPPS, P. J., KELLY, D. F. & 
TREES, A. J. 2000. Neospora caninum-associated abortion in cattle: the time 
of experimentally-induced parasitaemia during gestation determines foetal 
survival. Parasitology, 121 ( Pt 4), 347-358. 
WILLIAMS, D. J., HARTLEY, C. S., BJORKMAN, C. & TREES, A. J. 2009. 
Endogenous and exogenous transplacental transmission of Neospora 
caninum - how the route of transmission impacts on epidemiology and 
control of disease. Parasitology, 136, 1895-1900. 
WILLIAMS, R. B. 2002. Fifty years of anticoccidial vaccines for poultry (1952-
2002). Avian Dis, 46, 775-802. 
WOOD, P. R. & JONES, S. L. 2001. BOVIGAM: an in vitro cellular diagnostic test 
for bovine tuberculosis. Tuberculosis (Edinb), 81, 147-55. 
WOUDA, W. 2000. Diagnosis and epidemiology of bovine neosporosis: a review. 
Vet Q., 22, 71-74. 
263
WOUDA, W., BARTELS, C. J. & MOEN, A. R. 1999a. Characteristics of Neospora 
caninum-associated abortion storms in diary herds in The Netherlands (1995 
to 1997). Theriogenology, 52, 233-245. 
WOUDA, W., DIJKSTRA, T., KRAMER, A. M., VAN, M. C. & BRINKHOF, J. M. 
1999b. Seroepidemiological evidence for a relationship between Neospora 
caninum infections in dogs and cattle. Int J Parasitol, 29, 1677-1682. 
YUNKER, C. E., KUTTLER, K. L. & JOHNSON, L. W. 1987. Attenuation of 
Babesia bovis by in vitro cultivation. Vet Parasitol, 24, 7-13. 
ZIMIN, A. V., KELLEY, D. R., ROBERTS, M., MARCAIS, G., SALZBERG, S. L. 
& YORKE, J. A. 2012. Mis-assembled "segmental duplications" in two 
versions of the Bos taurus genome. PLoS One, 7, e42680. 
 
264
